<SEC-DOCUMENT>0001493152-23-019742.txt : 20230602 <SEC-HEADER>0001493152-23-019742.hdr.sgml : 20230602 <ACCEPTANCE-DATETIME>20230601081032 ACCESSION NUMBER: 0001493152-23-019742 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230601 DATE AS OF CHANGE: 20230601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REED'S, INC. CENTRAL INDEX KEY: 0001140215 STANDARD INDUSTRIAL CLASSIFICATION: BOTTLED & CANNED SOFT DRINKS CARBONATED WATERS [2086] IRS NUMBER: 352177773 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32501 FILM NUMBER: 23983043 BUSINESS ADDRESS: STREET 1: 201 MERRITT 7 CORPORATE PARK, CITY: NORWALK STATE: CT ZIP: 06851 BUSINESS PHONE: 800 997 3337 MAIL ADDRESS: STREET 1: 201 MERRITT 7 CORPORATE PARK, CITY: NORWALK STATE: CT ZIP: 06851 FORMER COMPANY: FORMER CONFORMED NAME: REED'S INC DATE OF NAME CHANGE: 20140512 FORMER COMPANY: FORMER CONFORMED NAME: REEDS INC DATE OF NAME CHANGE: 20020122 FORMER COMPANY: FORMER CONFORMED NAME: ORIGINAL BEVERAGE CORP / DATE OF NAME CHANGE: 20010508 </SEC-HEADER> <DOCUMENT> <TYPE>10-Q <SEQUENCE>1 <FILENAME>form10-q.htm <TEXT> <XBRL> <?xml version="1.0" encoding="utf-8"?> <html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:REED="http://drinkreeds.com/20230331"> <head> <title></title> <meta http-equiv="Content-Type" content="text/html" /> </head> <!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 --> <!-- Field: Set; Name: xdx; ID: xdx_033_REED_drinkreeds.com_20230331 --> <!-- Field: Set; Name: xdx; ID: xdx_04A_20230101_20230331 --> <!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0001140215 --> <!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false --> <!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 --> <!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== --> <!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD --> <!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure --> <!-- Field: Set; Name: xdx; ID: xdx_06B_Segment_0_Segment --> <body style="font: 10pt Times New Roman, Times, Serif"> <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityCentralIndexKey">0001140215</ix:nonNumeric> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:AmendmentFlag">false</ix:nonNumeric> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric> <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-03-31" id="xdx2ixbrl0147" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31" id="xdx2ixbrl0148" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0217" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0258" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0259" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0263" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0273" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0332" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0333" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0337" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0372" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:FairValueOfCommonSharesIssuedAsFinancingCosts" contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:AccrualOfInterestOnConvertibleNote" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0436" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0438" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31_us-gaap_ConvertibleNotesPayableMember" id="xdx2ixbrl0509" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0788" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0794" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0796" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0798" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0804" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0806" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0808" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0810" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0812" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0820" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" id="xdx2ixbrl0840" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0846" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0848" unitRef="USDPShares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0850" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0852" unitRef="USDPShares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0854" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0856" unitRef="USDPShares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="xdx2ixbrl0864" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="xdx2ixbrl0872" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonNumeric contextRef="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember_custom_EmployeesMember" id="xdx2ixbrl0880" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">P4Y</ix:nonNumeric> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" contextRef="AsOf2022-12-31_us-gaap_WarrantMember" id="xdx2ixbrl0916" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesGranted" contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0918" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0920" unitRef="USDPShares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesExercised" contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0922" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0924" unitRef="USDPShares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0926" unitRef="Shares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0928" unitRef="USDPShares" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" contextRef="AsOf2023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0936" unitRef="USD" xs:nil="true"></ix:nonFraction> <ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" contextRef="AsOf2023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0944" unitRef="USD" xs:nil="true"></ix:nonFraction> </ix:hidden> <ix:references> <link:schemaRef xlink:href="reed-20230331.xsd" xlink:type="simple" /> </ix:references> <ix:resources> <xbrli:context id="From2023-01-01to2023-03-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-05-15"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-05-15</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_RelatedPartyMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_RelatedPartyMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2024-01-222024-01-24_srt_ScenarioForecastMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-22</xbrli:startDate> <xbrli:endDate>2024-01-24</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-232023-01-25"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-23</xbrli:startDate> <xbrli:endDate>2023-01-25</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-01-25"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-01-25</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_ProductConcentrationRiskMember_us-gaap_SalesRevenueNetMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:VendorOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:VendorOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_StockOptionMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_StockOptionMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_ConvertibleNotesPayableMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_UnvestedRestrictedCommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_custom_UnvestedRestrictedCommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_RightOfUseAssetsUnderOperatingLeasesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:RightOfUseAssetsUnderOperatingLeasesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_custom_RightOfUseAssetsUnderOperatingLeasesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:RightOfUseAssetsUnderOperatingLeasesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_ComputerHardwareAndSoftwareMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_custom_ComputerHardwareAndSoftwareMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_MachineryAndEquipmentMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_custom_AlternaCapitalSolutionsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-03-27</xbrli:startDate> <xbrli:endDate>2022-03-28</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-28</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_AlternaCapitalSolutionsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_AlternaCapitalSolutionsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-05-09_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-05-09</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-05-082022-05-09_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-05-08</xbrli:startDate> <xbrli:endDate>2022-05-09</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:SeptemberTwoThousandTwentyTwoNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-09-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-09-012022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:SeptemberTwoThousandTwentyTwoNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-09-01</xbrli:startDate> <xbrli:endDate>2022-09-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-11-012022-11-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:SeptemberTwoThousandTwentyTwoNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-01</xbrli:startDate> <xbrli:endDate>2022-11-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-08-31_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-08-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-08-012022-08-31_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-01</xbrli:startDate> <xbrli:endDate>2022-08-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-02-10_custom_OptionNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:OptionNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-02-10</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-02-092023-02-10_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-09</xbrli:startDate> <xbrli:endDate>2023-02-10</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-02-092023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:FebruaryTwoThousandTwentyThreeNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-09</xbrli:startDate> <xbrli:endDate>2023-02-10</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:FebruaryTwoThousandTwentyThreeNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-02-10</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-02-13_custom_LimitedWaiverAndDeferralAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:LimitedWaiverAndDeferralAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-02-13</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-02-132023-02-13_custom_LimitedWaiverAndDeferralAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:LimitedWaiverAndDeferralAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-13</xbrli:startDate> <xbrli:endDate>2023-02-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_LimitedWaiverAndDeferralAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:LimitedWaiverAndDeferralAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_NotePurchaseAgreementMember_custom_FebruaryTwoThousandTwentyThreeNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:FebruaryTwoThousandTwentyThreeNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-02-132023-02-13"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-02-13</xbrli:startDate> <xbrli:endDate>2023-02-13</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_ConvertibleNotesPayableMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_ConvertibleNotesPayableMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_NotePurchaseAgreementMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_HoldersMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:HoldersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_srt_OfficerMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_RestrictedStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_RestrictedStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_RestrictedStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_RestrictedStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">REED:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember_custom_EmployeesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">REED:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:EmployeesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_BoardOfDirectorsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:BoardOfDirectorsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_EmployeeStockOptionMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-03-31_us-gaap_EmployeeStockOptionMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_EmployeeStockOptionMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_StockOptionMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_StockOptionMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_us-gaap_WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_us-gaap_WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_StockWarrantsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">REED:StockWarrantsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2018-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2022-01-012022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-01-01</xbrli:startDate> <xbrli:endDate>2022-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2018-12-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChrisReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChrisReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-03-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-01-012023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChrisReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-01-01</xbrli:startDate> <xbrli:endDate>2023-03-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-05-242023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:DDSourceofLifeHoldingLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-24</xbrli:startDate> <xbrli:endDate>2023-05-25</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:DDSourceofLifeHoldingLtdMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-05-25</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2023-05-292023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:OptionNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-29</xbrli:startDate> <xbrli:endDate>2023-05-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001140215</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:OptionNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-05-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> <xbrli:unit id="USDPShares"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit> <xbrli:unit id="Pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit> <xbrli:unit id="Segment"> <xbrli:measure>REED:Segment</xbrli:measure> </xbrli:unit> </ix:resources> </ix:header> </div> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1.5pt solid"> </div></div><!-- Field: /Rule-Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED STATES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES AND EXCHANGE COMMISSION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington, D.C. 20549</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM <span id="xdx_90F_edei--DocumentType_c20230101__20230331_zGeTvvmL21fd"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--DocumentQuarterlyReport_c20230101__20230331_zhGxrqh6pxr1"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">☒</ix:nonNumeric></span> QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the quarterly period ended <span id="xdx_90C_edei--DocumentPeriodEndDate_c20230101__20230331_zK361tufW0U4"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 31, <span id="xdx_904_edei--DocumentFiscalYearFocus_c20230101__20230331_zYGtTIe5Bx0b"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric></span></ix:nonNumeric></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--DocumentTransitionReport_c20230101__20230331_zYdwBAxiCF94"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">☐</ix:nonNumeric></span> TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the transition period from _______ to _______</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission file number: <span id="xdx_904_edei--EntityFileNumber_c20230101__20230331_z2kC4Z6bImp7"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityFileNumber">001-32501</ix:nonNumeric></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_905_edei--EntityRegistrantName_c20230101__20230331_z3X23oL0QvYf"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityRegistrantName">REED’S, INC.</ix:nonNumeric></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact name of registrant as specified in its charter)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20230101__20230331_z17PDBU3r538"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20230101__20230331_zKwjZTLtgxL7"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityTaxIdentificationNumber">35-2177773</ix:nonNumeric></span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State of</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation)</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20230101__20230331_zpl89Us3BcE6"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressAddressLine1">201 Merritt 7</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCityOrTown_c20230101__20230331_zFG8Nywi91R7"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressCityOrTown">Norwalk</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20230101__20230331_z1R3C8pmevgl"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressStateOrProvince">CT</ix:nonNumeric></span>. <span id="xdx_903_edei--EntityAddressPostalZipCode_c20230101__20230331_zgAyemBQhuM2"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityAddressPostalZipCode">06851</ix:nonNumeric></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices) (Zip Code)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--CityAreaCode_c20230101__20230331_zWOB0e4ZGWR2"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:CityAreaCode">(800)</ix:nonNumeric></span> <span id="xdx_909_edei--LocalPhoneNumber_c20230101__20230331_zm5ogdFBCwAc"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:LocalPhoneNumber">997-3337</ix:nonNumeric></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant’s telephone number, including area code)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities registered pursuant to Section 12(b) of the Act: None</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of Each Class</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Names of each exchange on which registered</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: There were a total of <span id="xdx_906_edei--EntityCommonStockSharesOutstanding_iI_c20230515_zz7rApSuFWA4"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-05-15" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,602,399</ix:nonFraction></span> shares of Common Stock outstanding as of May 15, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntityCurrentReportingStatus_c20230101__20230331_zhye0avZNed8"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> ☒ No ☐</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <span id="xdx_908_edei--EntityInteractiveDataCurrent_c20230101__20230331_zeWyPutBysH6"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> ☒ No ☐</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large Accelerated Filer ☐</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated Filer ☐</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityFilerCategory_c20230101__20230331_zQfMsFKQqj4i"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated Filer</ix:nonNumeric></span> ☒</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller Reporting Company <span id="xdx_90B_edei--EntitySmallBusiness_c20230101__20230331_zdvx6bTkBZO1"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">☒</ix:nonNumeric></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging Growth Company <span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20230101__20230331_z2yHGn5hjdN4"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">☐</ix:nonNumeric></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate by check mark whether the issuer is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ <span id="xdx_90C_edei--EntityShellCompany_c20230101__20230331_zwC1A7uhBuF6"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> ☒</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt; border-bottom: Black 4pt solid"> </div></div><!-- Field: /Rule-Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%"></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_001">PART I - FINANCIAL INFORMATION</a></span></td> <td style="width: 0.1in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_002">Item 1. Condensed Financial Statements</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_003">Condensed Balance Sheets - March 31, 2023 (Unaudited) and December 31, 2022</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_004">Condensed Statements of Operations for the three months ended March 31, 2023 and 2022 (Unaudited)</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_005">Condensed Statements of Changes in Stockholders’ Equity (Deficit) for the three months ended March 31, 2023 and 2022 (Unaudited)</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_006">Condensed Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (Unaudited)</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#bs_007">Notes to Condensed Financial Statements three months ended March 31, 2023 and 2022 (Unaudited)</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_1">Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_2">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_3">Item 4. Controls and Procedures</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_4">PART II – OTHER INFORMATION</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_5">Item 1. Legal Proceedings</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_6">Item 1A. Risk Factors</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_7">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_8">Item 3. Defaults Upon Senior Securities</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_9">Item 4. Mine Safety Disclosures</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_10">Item 5. Other Information</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_11">Item 6. Exhibits</a></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS AND INFORMATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>This Quarterly Report on Form 10-Q as well as our other public filings or public statements include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by terms and phrases such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “should,” and “will” and similar expressions and include references to assumptions and relate to our future prospects, developments, and business strategies.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><i>These forw<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ard-looking statements involve known and unknown risks, assumptions and uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by forward-looking statements. Management cautions that these forward-looking statements are qualified by their terms and/or important factors, many of which are outside of our control, and involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially from the statements made, including, but not limited to, the following risk factors:</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● We have a history of operating losses. Our estimates regarding the sufficiency of our cash resource and capital requirements and needs for additional financing raises substantial doubt about our ability to continue as a going concern.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● We may not be able to extend or repay our indebtedness owed to our secured lenders, which would have a material adverse effect on our financial condition and ability to continue as a going concern.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● <span>We require additional financing to support our working capital and execute our operating plans for fiscal 2023, which may not be available or may be costly and dilutive.</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Our ability to absorb, mitigate or pass on cost increases to our bottlers/distributors and/or customers;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The impact of rising costs, interest rates, and inflation on the discretionary income of our consumers, particularly the rising cost of energy;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Uncertainties associated with an economic slowdown or recession that could negatively impact the financial condition of our customers and could result in a reduced demand for our products;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The impact of the military conflict in Ukraine, including supply chain disruptions, volatility in commodity prices, increased economic uncertainty and escalating geopolitical tensions;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The impact of logistical issues and delays;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Our ability to effectively manage our inventories and/or our accounts receivables;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Our ability to continue to generate sufficient cash flows to support our expansion plans and general operating activities;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Changes in demand that are weather, or season related and/or for other reasons, including changes in product category and/or package consumption and changes in cost and availability of certain key ingredients including aluminum cans, as well as disruptions to the supply chain, as a result of climate change and poor or extreme weather conditions;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The impact on our business of competitive products and pricing pressures and our ability to gain or maintain our share of sales in the marketplace as a result of actions by competitors;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Our ability to implement and/or maintain price increases, including through reductions in promotional allowances;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The effectiveness of sales and/or marketing efforts by us and/or by distributors of our products, most of whom distribute products that may be regarded as competitive with our products;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The costs and/or effectiveness, now or in the future, of our advertising, marketing and promotional strategies;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The failure of our co-packers to manufacture our products on a timely basis or at all;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Our ability to make suitable arrangements and/or procure sufficient capacity for the co-packing of any of our products, the timely replacement of discontinued co-packing arrangements and/or limitations on co-packing availability;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Volatility of stock prices which may restrict stock sales, stock purchases or other opportunities as well as negatively impact the motivation of equity award grantees;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Any disruption in and/or lack of effectiveness of our information technology systems, including a breach of cyber security, which disrupts our business or negatively impacts customer relationships, as well as cybersecurity incidents involving data shared with third parties;</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● The imposition of additional regulation imposing excise taxes and/or sales taxes on sweetened beverages or alcoholic beverages; and</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; text-align: justify; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>● Recruitment and retention of senior management, other key employees and our employee base in general.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We undertake no obligation to update or revise the forward-looking statements included in this report, whether as a result of new information, future events or otherwise, after the date of this report. Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <!-- Field: Page; Sequence: 3; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_001"></span>Part I – FINANCIAL INFORMATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_002"></span>Item 1. Financial Statements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_003"></span>REED’S, INC,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED BALANCE SHEETS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts in thousands, except share amounts)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_303_111_pn3n3_zdWDzqWvPFYk" summary="xdx: Statement - Condensed Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230331_znECN2MDGGh6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20221231_zHtETCUcNWg7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">(Unaudited)</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB_zUooFl55MBIe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">ASSETS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AssetsCurrentAbstract_i01B_zalFa9BnlB95" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--Cash_i02I_maCzkMn_zuWE76vcNZa9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">533</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzkMn_zrnmmDNUrqe6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable, net of allowance of $<span id="xdx_900_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20230331_zYZQ8Iw3ljF1" title="Accounts receivable, net of allowance"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">213</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pn3n3_c20221231_zDj7jq6EZEe5" title="Accounts receivable, net of allowance"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">252</ix:nonFraction></span>, respectively</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,665</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,671</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryNet_i02I_maCzkMn_z5mkrnQm3xe9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Inventory, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,301</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,175</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherReceivablesNetCurrent_i02I_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_maCzkMn_zDraXPGrVX64" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Receivable from former related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">777</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">777</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCzkMn_zA1x7cUjbCyd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">601</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">939</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AssetsCurrent_i02TI_mtCzkMn_maCzI9j_za1A0ncASkwl" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left">Total current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,811</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,095</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzI9j_zJqW05sou571" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Property and equipment, net of accumulated depreciation of $<span id="xdx_90E_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20230331_z450rTaYzMB9" title="Property and equipment, accumulated depreciation"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">867</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iI_pn3n3_c20221231_zq2bYxP5uOr2" title="Property and equipment, accumulated depreciation"><ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">787</ix:nonFraction></span>, respectively</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">686</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">766</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzI9j_zWTkwnEuVS8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Intangible assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">626</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">626</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Assets_i01TI_mtCzI9j_zoMSzH0LzqU9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,123</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,487</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">LIABILITIES AND STOCKHOLDERS’ DEFICIT</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LiabilitiesCurrentAbstract_i01B_zhb1elOM6Boa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Current liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccountsPayableCurrent_i02I_maCzifm_zRZ3T2SvQrfe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,165</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,805</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCzifm_ziaJ2gs9ZeQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">233</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LinesOfCreditCurrent_i02I_maCzifm_zAScx0uh3By5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revolving line of credit, net of capitalized financing costs of $<span id="xdx_90D_eus-gaap--DeferredFinanceCostsCurrentNet_iI_pn3n3_c20230331_z1tKquuV6CF7" title="Capitalized financing costs"><ix:nonFraction name="us-gaap:DeferredFinanceCostsCurrentNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">322</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--DeferredFinanceCostsCurrentNet_iI_pn3n3_c20221231_zojR7oFOsEJ3" title="Capitalized financing costs"><ix:nonFraction name="us-gaap:DeferredFinanceCostsCurrentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">363</ix:nonFraction></span>, respectively</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,593</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,974</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherLiabilitiesCurrent_i02I_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_maCzifm_zb8PGw4SCDCa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Payable to former related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,859</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,025</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_i02I_maCzifm_zftKO7R4PbK8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current portion of convertible notes payable, net of debt discount of $<span id="xdx_90E_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_c20230331_zXkkAXcpJ623" title="Debt discount current"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">670</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscountCurrent_iI_pn3n3_c20221231_zGf5WjDeIz5f" title="Debt discount current"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">414</ix:nonFraction></span>, respectively</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,485</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,434</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_maCzifm_zYmzOCYdT9xe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion of lease liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">194</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">187</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LiabilitiesCurrent_i02TI_mtCzifm_maCza60_zo6Q4owFC34g" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left">Total current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26,763</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,658</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--ConvertibleLongTermNotesPayable_i01I_maCza60_zz6w9BD3AFr" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Convertible note payable, net of debt discount of $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscountNoncurrent_iI_pn3n3_c20230331_z6Nnh9ASn16d" title="Debt discount, noncurrent"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">484</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--DebtInstrumentUnamortizedDiscountNoncurrent_iI_pn3n3_c20221231_z19DC7C1EYCi" title="Debt discount, noncurrent"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">562</ix:nonFraction></span>, respectively, less current portion</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,526</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,092</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCza60_zPwskw33A41l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Lease liabilities, less current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">156</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">207</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--Liabilities_i01TI_mtCza60_maCzGu4_zAqAwFY3b8Dl" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,445</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,957</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Stockholders’ deficit:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--PreferredStockValue_i02I_maCz4tW_zw05mKMoX1md" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Series A Convertible Preferred stock, $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230331_zqE2LOMBCWP3" title="Series A convertible preferred stock, par value"><span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221231_zLeonlT3W3Ba" title="Series A convertible preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230331_z02ZbgxsOxEi" title="Series A convertible preferred stock, shares authorized"><span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221231_z1eM0DiNZXka" title="Series A convertible preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pid_c20230331_zdiOAdEFbIwj" title="Series A convertible preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20230331_zcXOdefo4HCe" title="Series A convertible preferred stock, shares outstanding"><span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_pid_c20221231_z0jHZD8uDd43" title="Series A convertible preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20221231_zUmVKgVOQJSc" title="Series A convertible preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,411</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> shares issued and outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--CommonStockValue_i02I_maCz4tW_z7FJZpROcPta" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common stock, $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230331_zchXMW3VDAuf" title="Common stock, par value"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_zW0ubm4fI6Ue" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value, <span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230331_zblRDzfJ3Wdl" title="Common stock, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zyBs5ttEqh0a" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">180,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_pid_c20230331_zn9y6gvaXjva" title="Common stock, shares issued"><span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20230331_zEoqk6BZAE09" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,602,399</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_z2Pie8g14lK" title="Common stock, shares issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zhBTFPsA3cO4" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,519,485</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding, respectively</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0147">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0148">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AdditionalPaidInCapital_i02I_maCz4tW_z78Fy6z1KOld" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additional paid in capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115,140</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">114,635</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCz4tW_zwecuPByqRFc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">127,556</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">123,199</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--StockholdersEquity_i02TI_pn3n3_mtCz4tW_maCzGu4_zWcZ8Nl58YSb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total stockholders’ deficit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,322</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,470</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pn3n3_mtCzGu4_zDpom00l7BS3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders’ deficit</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,123</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,487</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral part of these condensed financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_004"></span>REED’S, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED STATEMENTS OF OPERATIONS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Three Months Ended March 31, 2023 and 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts in thousands, except share and per share amounts)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_304_113_pn3n3_zj534K2sqPTf" summary="xdx: Statement - Condensed Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230101__20230331_zs53hDuAGJ12" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220331_zYgrFmXFK15g" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maCzgWx_z5aoLAzB6S2j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold; text-align: left">Net Sales</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,157</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,182</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--CostOfGoodsAndServicesSold_msCzgWx_zTxg3iHGqDPa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Cost of goods sold</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,459</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfGoodsAndServicesSold" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,250</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--GrossProfit_iT_mtCzgWx_maOILzLkx_zDjIajfRSFF3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,698</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,932</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--OperatingExpensesAbstract_iB_zOgjmrqrDOUf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Operating expenses:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--DeliveryAndHandlingExpense_i01_maOEzQTP_zDtAoBfEuC3h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Delivery and handling expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:DeliveryAndHandlingExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,120</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:DeliveryAndHandlingExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,812</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--SellingAndMarketingExpense_i01_maOEzQTP_zKB098ekN11" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Selling and marketing expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,447</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,178</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--GeneralAndAdministrativeExpense_i01_maOEzQTP_zfq9VkZMlQOa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">General and administrative expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,709</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,121</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingExpenses_i01T_mtOEzQTP_msOILzLkx_ze2mEhE186zi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,276</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,111</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--OperatingIncomeLoss_iT_mtOILzLkx_maNILzkvV_zJMBKp4zFLZ9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,578</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,179</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--InterestExpense_iN_di_msNILzkvV_z4FEB7YVaCyh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Interest expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,779</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">801</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_iT_mtNILzkvV_zojkQM7ZzhCf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,357</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,980</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--EarningsPerShareBasic_pid_zswD0ZiwI9Zf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss per share – basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.70</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.56</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_zVshOq0sqU0e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average number of shares outstanding – basic and diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,559,855</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,947,548</ix:nonFraction></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral part of these condensed financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 5; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_005"></span>REED’S, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Three Months Ended March 31, 2023 and 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts in thousands except share amounts)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_114_pn3n3_zxcKlTOXcIA" summary="xdx: Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4BA_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zuyKpa7EoE97" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zFCYl4mSUCUc" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B1_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zKmaU7XvMXKf" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_z7KsMfYensXh" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_4B7_z8AaAgkEoAf6" style="border-bottom: Black 1.5pt solid; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Preferred Stock</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Additional Paid In</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Total Stockholders’</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Capital</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Deficit</p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_438_c20230101__20230331_eus-gaap--StockholdersEquity_iS_z8VJdQzZ7wob" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%; font-weight: bold">Balance, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--SharesOutstanding_iS_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze7SxiYPHYod" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,519,485</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0217">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zLYonekSca2a" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,411</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">114,635</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">123,199</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">8,470</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_400_ecustom--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_zM5LDoTtVvlf" style="vertical-align: bottom; background-color: White"> <td>Fair value of vested options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">229</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">229</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_zoVMXz1m1zvj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of vested restricted shares granted to officers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDYsrhU4XTNf" title="Fair value of vested restricted shares granted to officers, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_zJ9O2Aej4SVd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Repurchase of common stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--StockRepurchasedDuringPeriodShares_iN_pid_di_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbYIwD0dlr3" title="Repurchase of common stock, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--StockIssuedDuringPeriodValueOther_zzKldk5NeeEj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common shares issued for financing costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9CVRtpVhIE1" title="Common shares issued for financing costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">82,438</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">273</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">273</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--NetIncomeLoss_zkBcWyPI3v33" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0258">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0259">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,357</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,357</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_43A_c20230101__20230331_eus-gaap--StockholdersEquity_iE_zX1GYGz2XD75" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpkaBsk4bCJl" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,602,399</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0263">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--SharesOutstanding_iE_pid_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zLOkN05oMR5f" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,411</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">115,140</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">127,556</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,322</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Preferred Stock</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Additional Paid In</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Total Stockholders’</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Capital</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Equity</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_438_c20220101__20220331_eus-gaap--StockholdersEquity_iS_zii1aQo6gDC5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 37%; font-weight: bold">Balance, December 31, 2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwWrE95DuUik" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,874,680</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0273">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGBbjHyevokf" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,411</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">107,246</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">103,137</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,203</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_434_c20220101__20220331_eus-gaap--StockholdersEquity_iS_zL3HcxbfARcl" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNDrFxCcG5u2" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,874,680</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zUkkuCIGsZW6" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,411</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">107,246</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">103,137</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,203</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_zXaA9t7KYcnj" style="vertical-align: bottom; background-color: White"> <td>Fair value of vested options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_znYz34g1yihb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Fair value of vested restricted shares granted to officers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFQs4o8epbtd" title="Fair value of vested restricted shares granted to officers, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,732</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_z2WIAJaWZRM4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Repurchase of common stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--StockRepurchasedDuringPeriodShares_iN_pid_di_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpK4uvw6GNSe" title="Repurchase of common stock, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">265</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--StockIssuedDuringPeriodValueOther_zBtnbnF4Sez4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Common shares issued for financing costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJcb6rjUkord" title="Common shares issued for financing costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueOther" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_ztm4kHdJ62U3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Common shares issued for cash, net of offering costs</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWvVGJffdSCf" title="Common shares issued for cash, net of offering costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">371,891</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,067</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,067</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--NetIncomeLoss_zS8bnK8MQH06" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Net loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0332">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0333">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,980</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_437_c20220101__20220331_eus-gaap--StockholdersEquity_iE_zlDR3BBZq8Ug" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, March 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3gvmQaElEZ3" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,251,038</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0337">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--SharesOutstanding_iE_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zhsiOlFrDAS4" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,411</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112,639</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">108,117</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,616</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_432_c20220101__20220331_eus-gaap--StockholdersEquity_iE_znGZlhn3pwm1" style="display: none; vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znR8Tvq88ZNe" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,251,038</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--SharesOutstanding_iE_pid_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zdlWNuKJCNNg" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,411</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">94</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">112,639</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">108,117</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,616</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral part of these condensed financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 6; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="bs_006"></span>REED’S, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED STATEMENTS OF CASH FLOWS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the Three Months Ended March 31, 2023 and 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Amounts in thousands)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30C_112_pn3n3_zNIAI9MxsFn4" summary="xdx: Statement - Condensed Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20230101__20230331_zrb1JcqRnFwk" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20220101__20220331_zKhppkQ5r7W7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">March 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zXNl5OdmIkCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Cash flows from operating activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLoss_i01_maNCPBUzMwa_zvVw24rTX4w6" style="vertical-align: bottom; background-color: White"> <td style="width: 64%; font-weight: bold; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,357</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,980</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_z1NBa3YlDMRe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DepreciationDepletionAndAmortization_i02_maNCPBUzMwa_zinXOQ3p2Et2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AmortizationOfDebtDiscountPremium_i02_maNCPBUzMwa_zHEByASeG93k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Amortization of debt discount</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">281</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">65</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AmortizationOfFinancingCosts_i02_maNCPBUzMwa_zJX13IHkKzB2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Amortization of prepaid financing costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0372">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfFinancingCosts" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">431</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--FairValueOfVestedOptions_i02N_di_msNCPBUzMwa_zb9W037i51a6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Fair value of vested options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:FairValueOfVestedOptions" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">229</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:FairValueOfVestedOptions" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">225</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--FairValueOfVestedRestrictedSharesGrantedToOfficers_i02N_di_msNCPBUzMwa_ziELKz6vWE3a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Fair value of vested restricted shares granted to officers</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:FairValueOfVestedRestrictedSharesGrantedToOfficers" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:FairValueOfVestedRestrictedSharesGrantedToOfficers" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">66</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--FairValueOfCommonSharesIssuedAsFinancingCosts_i02_maNCPBUzMwa_zB6KXJsduw9l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Fair value of common shares issued as financing costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0381">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:FairValueOfCommonSharesIssuedAsFinancingCosts" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ProvisionForDoubtfulAccounts_i02_maNCPBUzMwa_zW1H2Lqp29nc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Change in allowance for doubtful accounts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">39</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProvisionForDoubtfulAccounts" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InventoryWriteDown_i02_maNCPBUzMwa_zRpNRoMKRcUd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Inventory write-downs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">228</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InventoryWriteDown" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--AccrualOfInterestOnConvertibleNote_i02_maNCPBUzMwa_zExAUrIzwO28" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:AccrualOfInterestOnConvertibleNote" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,113</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_zZv0PVpbmKA1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Changes in operating assets and liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivable_i03N_di_msNCPBUzMwa_zm06r69E4kd8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,044</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInInventories_i03N_di_msNCPBUzMwa_ztNL4yAC5rq5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Inventory</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,102</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,810</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i03N_di_msNCPBUzMwa_zNbONQ1VobSh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Prepaid expenses and other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">338</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">617</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--IncreaseDecreaseInAmortizationOfRightOfUseAssets_i03_maNCPBUzMwa_zuxBeH66Dnxi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Decrease in right of use assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:IncreaseDecreaseInAmortizationOfRightOfUseAssets" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="REED:IncreaseDecreaseInAmortizationOfRightOfUseAssets" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsPayable_i03_maNCPBUzMwa_zRzvu1E3vjKe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,360</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,926</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_maNCPBUzMwa_zJ6xCM3yvKh2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">235</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">403</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i03_maNCPBUzMwa_z64t7oo0Mcye" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Lease liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">44</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">37</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzMwa_maCCERCzbsp_zmNQcUfIBkfk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) operating activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,117</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,207</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zZUuxu79tqvd" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left">Cash flows from investing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzMIu_maCCERCzbsp_zjEEWj4uDYc8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0424">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_z6cNEHgzbzfa" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left">Cash flows from financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--ProceedsFromLinesOfCredit_i01_maNCPBUzhgF_zDdo6GrVrrWd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Proceeds from line of credit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,699</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,508</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--RepaymentsOfLinesOfCredit_i01N_di_msNCPBUzhgF_zdCYZkJYxI1h" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Payments on line of credit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,120</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfLinesOfCredit" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,212</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzhgF_zTujbdyDla96" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Proceeds from convertible note payable, net of expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,405</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0436">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUzhgF_zdmbu64cAvk6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Proceeds from sale of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0438">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,067</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--PaymentsForRepurchaseOfCommonStock_i01N_di_msNCPBUzhgF_zCLt6QCL8qlg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Repurchase of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfCommonStock" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_i01_maNCPBUzhgF_zq7QxKV5Jml4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left; padding-left: 10pt">Amounts from former related party, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">166</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">81</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzhgF_maCCERCzbsp_zI43sG50RQsc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,183</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,280</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzbsp_zl4cr2UbcCE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net increase (decrease) in cash</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">66</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zueAuccn2iU1" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Cash at beginning of period</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">533</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zaG9ki2ZNtql" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Cash at end of period</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zlyp0xuF4oJ8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Supplemental disclosures of cash flow information:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InterestPaidNet_i01_zK2HMaeLg4Dh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash paid for interest</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">390</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">256</ix:nonFraction></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying notes are an integral part of these condensed financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <!-- Field: Page; Sequence: 7; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="bs_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REED’S, INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended March 31, 2023 and 2022 (Unaudited)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(In thousands, except share and per share amounts)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zC5sNFhQheBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_822_zEyCKqV7mUzi">Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zWaZuAbLpBJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zx6bm5chSKie">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on May 15, 2023. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2023, and the results of its operations and its cash flows for the three months ended March 31, 2023 and 2022. The balance sheet as of December 31, 2022 is derived from the Company’s audited financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="REED:GoingConcernPoliciesTextBlock"><p id="xdx_84C_ecustom--GoingConcernPoliciesTextBlock_zspy2yQKkutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_ziCBtRErE2Ll">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the three months ended March 31, 2023, the Company recorded a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20230101__20230331_zSZndycwUAX7" title="Net income loss"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,357</ix:nonFraction></span>, and at March 31, 2023, had a stockholders’ deficit of $<span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20230331_z4rTTYrnyWhi"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">12,322</ix:nonFraction></span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2022, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, we had a cash balance of $<span id="xdx_90A_eus-gaap--Cash_iI_pn3n3_c20230331_z1RfR6k1KJ07" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">467</ix:nonFraction></span>, with $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331_zkYNTPLx70ti" title="Line of credit facility, borrowing capacity"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></span> of current availability, and $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331_zbG85NCkH8nc" title="Line of credit facility, additional borrowing capacity"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,084</ix:nonFraction></span> of additional borrowing capacity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 8; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="REED:CovidNineteenConsiderationPolicyTextBlock"><p id="xdx_84F_ecustom--CovidNineteenConsiderationPolicyTextBlock_zr2RZDKAtlub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zoQsuS6IQL42">Recent Trends - Market Conditions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2022, the COVID-19 pandemic continued to impact our operating results and the Company anticipates a residual effect for the balance of the year. In addition, the pandemic could cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively affects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow during the first quarter of 2023, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations. We expect the inflationary trends and supply chain pressures to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended March 31, 2023, the Company experienced moderation from the elevated freight costs experienced in 2022. The average cost of shipping and handling for the period ended March 31, 2023, was $<span id="xdx_90A_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20230101__20230331_z9PPrSfmlsDd" title="Shipping and handling costs"><ix:nonFraction name="REED:CarryingCostPropertyAndExplorationRights" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.46</ix:nonFraction></span> per case, as compared to $<span id="xdx_90B_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20220101__20220331_zr3s93VrjdA3" title="Shipping and handling costs"><ix:nonFraction name="REED:CarryingCostPropertyAndExplorationRights" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">3.90</ix:nonFraction></span> per case for the period ended March 31, 2022. Although the Company has experienced decreases in freight costs over the last three quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. Although, the Company has been negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company has experienced moderation in inflation and anticipates this to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and protect our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through March 31, 2023, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part to be responsible to our employees and business partners in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="REED:ReverseStockSplitPolicyTextBlock"><p id="xdx_842_ecustom--ReverseStockSplitPolicyTextBlock_zcJIb3XlkaX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrnwZGZVIuLb">Reverse Stock Split</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At a special meeting of shareholders held on January 24, 2023, the Company’s shareholders granted the Company’s board of directors the discretion to effect a reverse stock split of the common stock through an amendment to the Company’s Certificate of Incorporation, as amended, at a ratio of any ratio not less than <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20240122__20240124__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGXsDvSvofih" title="Reverse stock split"><ix:nonNumeric contextRef="From2024-01-222024-01-24_srt_ScenarioForecastMember" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-6 and not more than 1-for-50</ix:nonNumeric></span>, at any time on or prior to January 24, 2024, with the exact ratio to be set at a whole number within this range by the board of directors in its sole discretion. On January 25, 2023, the Company announced that its board of directors approved a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230123__20230125_zX0vqkPDiiTa" title="Reverse stock split"><ix:nonNumeric contextRef="From2023-01-232023-01-25" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-50 reverse stock split</ix:nonNumeric></span> of the Company’s issued and outstanding shares of common stock, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230125_zk1kPlWomdYg" title="Common stock par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-01-25" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized number of shares of common stock were not affected by the reverse stock split. No fractional shares were issued in connection with the reverse stock split, as all fractional shares were rounded up to the next whole share. Accordingly, all share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the above-described reverse stock split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 9; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_848_eus-gaap--UseOfEstimates_zIV9whzmHNF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWsVc4Z17RCi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zRPXtDWYnH8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zKLte9A4xSoa">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztBZdn4dRhzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zFtoNpuLA6J6">Loss per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the periods ended March 31, 2023 and 2022, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:</span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zb1wya13MRa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zkdPk4CYZAyk" style="display: none">Schedule of Potentially Dilutive Securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPEXumPr24Ai" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220331_zFlbhz4U0Wpb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQfXVgvmSk67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">235,946</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">276,715</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_ztEgUXlVNqIk" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">174,460</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">202,904</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zwYMiz0YzYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">1,257,491</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zarSidTOZeKj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-03-31_custom_UnvestedRestrictedCommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">710</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31_custom_UnvestedRestrictedCommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">7,526</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_z5xumX8PAtmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock equivalent of Series A Convertible Preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-012023-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">753</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">753</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">1,669,360</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">487,898</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A5_zVOct0kq03V8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 10; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfLjV5frfB7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zcYAl67biuub">Stock Compensation Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation</i> whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zPqvbZHo5Mn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zMHSPY5jtJQb">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $<span id="xdx_90F_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zlyI0xGE7sIe" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20220331_zVRPF0CL1DTf" title="Advertising costs"><ix:nonFraction name="us-gaap:AdvertisingExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">312</ix:nonFraction></span> for the three months ended March 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zSJNEYtSF8th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zzuqbLkSRs0c">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the three months ended March 31, 2023, the Company’s two largest customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zhjWD7A0vtC3" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z8PY15ZIt8F7" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% of net sales, respectively. During the three months ended March 31, 2022, the Company’s two largest customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zQRhjXHwYAJe" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zu6OK4kd7j5e" title="Concentration risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% of net sales, respectively. No other customers exceeded 10% of net sales in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2023, the Company had accounts receivable from two customers which comprised <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkZGEPpt3xm" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">18</ix:nonFraction></span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFMIAIE4P3W7" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>% of its gross accounts receivable. As of December 31, 2022, the Company had accounts receivable from two customers which comprised <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPU0rP4JquH2" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19</ix:nonFraction></span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzI3sj3WGlrl" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-12-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and the year ended December 31, 2022, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company utilizes co-packers to produce <span id="xdx_90A_ecustom--PercentageOfCoPackersProducts_pid_dp_uPure_c20230101__20230331_zRozQ453RjIh" title="Percentage of co-packers products"><ix:nonFraction name="REED:PercentageOfCoPackersProducts" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of its products. The Company has long-standing relationships with two different co-packers, and in conjunction with the sale of its manufacturing plant we entered into a third co-packing agreement with California Custom Beverage LLC (“CCB”), the purchaser of the plant (see Note 11). CCB is <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zBn8F4bDgPEg" title="Concentration risk, percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_ProductConcentrationRiskMember_us-gaap_SalesRevenueNetMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% owned by Chris Reed, founder of the Company and formerly Chief Executive Officer, Chairman, director, and most recently, Chief Innovation Officer. Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zPrrhxezrSk2" title="Percentage of sale accounted to customer"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-01-012023-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11</ix:nonFraction></span>% of all purchases. During the three months ended March 31, 2022, the Company’s largest vendor accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zXFarhHr1lO4" title="Percentage of sale accounted to customer"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-01-012022-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% of all purchases. No other vendors exceeded 10% of all purchases in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zf0Pma4juc5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zdPV50cba8i5">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 11; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIVAdhofeuV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z0cRHst8Nmt8">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04 “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation— Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815- 40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). ASU 2021-04 provides guidance as to how an issuer should account for a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option (i.e., a warrant) that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument. An issuer should measure the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company adopted ASU 2021-04 effective January 1, 2022. The adoption of ASU 2021-04 did not have any impact on the Company’s financial statement presentation or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2016, the FASB issued ASU 2016-13, <i>Measurement of Credit Losses on Financial Instruments</i>. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company adopted this standard effective January 1, 2023 and there was no material impact of adopting this standard on the Company’s financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.</span></p> </ix:nonNumeric><p id="xdx_85C_zgmVICqzkfB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 12; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="text-align: center; width: 34%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_znmEgHHFV5ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_826_zWee98NzAJwb">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrOqFredCLSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z2ZtBxxqOpyd" style="display: none">Schedule of Inventory</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zafOs6QsMgCb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zJVVw8c0UK01" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz4dt_zAVtgXZcRXP7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Raw materials and packaging</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,178</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:InventoryRawMaterials" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,526</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz4dt_zKLsmCp6fM91" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Finished products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,123</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InventoryFinishedGoods" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,649</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz4dt_z0neJrSoJwdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,301</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:InventoryNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8AC_zrUMUCeUdGZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z2S1mUTouBI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_828_zbvglWbZ06zf">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_ztP0RtqFosQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zaqMbEpbSude" style="display: none">Schedule of Property and Equipment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331_zu3MX6JniaP1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zBfjOndsQvSc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsUnderOperatingLeasesMember_zuRJaL5Vb8qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Right-of-use assets under operating leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_RightOfUseAssetsUnderOperatingLeasesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">724</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_RightOfUseAssetsUnderOperatingLeasesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">724</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerHardwareAndSoftwareMember_zSRTFox0Qpcj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Computer hardware and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_custom_ComputerHardwareAndSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">400</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_custom_ComputerHardwareAndSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">400</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zC2U319Ct8tc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Machinery and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">429</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">429</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzorg_z2DlSRSuHwT" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,553</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,553</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzorg_zKqyPsJM7rF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">867</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">787</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzorg_zUbv2WIz6c36" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Net book value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">686</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">766</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8AD_ziALRRfNGQo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months ended March 31, 2023 and 2022 was $<span id="xdx_90C_eus-gaap--Depreciation_pn3n3_c20230101__20230331_zEJDRS9wj7sd" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--Depreciation_pn3n3_c20220101__20220331_z4e9May3G9z2" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span>, respectively, and amortization of right-of-use assets for the three months ended March 31, 2022 and 2021 was $<span id="xdx_90D_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20230101__20230331_zotzQKuBMKmf" title="Amortization of right-of-use assets"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20220101__20220331_zN7dzsquaIZi" title="Amortization of right-of-use assets"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27</ix:nonFraction></span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_z37xqau2dXG7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82D_z2MZ2ZzwSKmd">Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_z6t8G3PlNVMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zA3mQEGNTkea" style="display: none">Summary of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230331_zFYV6NsNhhj3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zlOzhmua1Czg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--IndefiniteLivedTradeNames_iI_pn3n3_maILIAEzdvn_zckpm6vOo64j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Brand names</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">576</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTradeNames" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">576</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IndefiniteLivedTrademarks_iI_pn3n3_maILIAEzdvn_zNNb6IH2Kp66" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Trademarks</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTrademarks" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedTrademarks" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzdvn_z7Kr9ehUn2ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">626</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">626</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8AA_zomCzP7KgdJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ShortTermDebtTextBlock"><p id="xdx_80A_eus-gaap--ShortTermDebtTextBlock_zNJOqn5RLmY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_828_zr1aGtU0Kzp1">Line of Credit</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zodfXAcYmQgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under the Company’s credit facilities are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_z6xvmyYxVxo4" style="display: none">Schedule of Amount Outstanding Under Credit Facilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Line of credit – Alterna Capital Solutions</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zmBayIASHv3k" title="Total" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,915</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zurvFg2UTC3f" title="Total" style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2022-12-31_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,337</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20230331_zyGgKRWEV9Q" title="Capitalized financing costs" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFinanceCostsCurrentNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">322</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20221231_zPKbkmNkCOxc" title="Capitalized financing costs" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFinanceCostsCurrentNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">363</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331_zJItTVBCb83l" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,593</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231_zdYYMKYCGB6" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LinesOfCreditCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,974</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A1_zfUiBbex1h8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Alterna Capital Solutions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 28, 2022, the Company entered into a financing agreement with Alterna Capital Solutions (“ACS”), for a line of credit to replace its existing credit facility. The ACS line of credit is for a term of <span id="xdx_906_eus-gaap--DebtInstrumentTerm_dtY_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ztGlDaQPT36" title="Debt instrument, term"><ix:nonNumeric contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm">3</ix:nonNumeric></span> years, provides for borrowings of up to $<span id="xdx_901_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z8e70GoXRY1e" title="Line of credit facility, maximum borrowing capacity"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,000</ix:nonFraction></span>, and is secured by eligible accounts receivable and inventory. An over advance rider provides for up to $<span id="xdx_904_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_pn3n3_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ze5QVlZC2MZe" title="Line of credit facility, maximum amount outstanding during period"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">400</ix:nonFraction></span> of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zoBV64UPchxc" title="Line of credit facility, maximum borrowing capacity"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,000</ix:nonFraction></span>. At March 31, 2023, $<span id="xdx_903_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zHsDEiNJHOZb" title="Line of credit facility, borrowing capacity"><ix:nonFraction name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">62</ix:nonFraction></span> of current availability and $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zJgOPAv2gQ5c" title="Line of credit facility, borrowing capacity"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,084</ix:nonFraction></span> of borrowing capacity was available under the financing agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 13; Options: NewSection; Value: 10 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zhbBKtNJwtsa" title="Line of credit facility, interest rate description"><ix:nonNumeric contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember" name="us-gaap:LineOfCreditFacilityInterestRateDescription">Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (12.75% at March 31, 2023 and 12.25% at December 31, 2022). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.40% at March 31, 2023 and 12.90% at December 31, 2022). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2023 and 18.00% at December 31, 2022). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility</ix:nonNumeric></span>. A loan balance of less than $<span id="xdx_90F_eus-gaap--LineOfCredit_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zG2b2rsFNHY2" title="Line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,500</ix:nonFraction></span> will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $<span id="xdx_909_ecustom--LineOfCreditMonitoringFee_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zZXoKlI3BwF8" title="Line of credit monitoring fee"><ix:nonFraction name="REED:LineOfCreditMonitoringFee" contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred $<span id="xdx_90C_eus-gaap--DirectOperatingCosts_pn3n3_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zrXQgnPUeqlh" title="Direct operating costs"><ix:nonFraction name="us-gaap:DirectOperatingCosts" contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">483</ix:nonFraction></span> of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the <span id="xdx_907_ecustom--AmortizationOfLineOfCreditPeriod_dtY_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_znsxkhOE7iE2" title="Amortization of line of credit period"><ix:nonNumeric contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember" format="ixt-sec:duryear" name="REED:AmortizationOfLineOfCreditPeriod">3</ix:nonNumeric></span>-year life of the ACS agreement. The unamortized debt discount balance was $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20220101__20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zf8QBh5MRms6" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2022-01-012022-12-31_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">363</ix:nonFraction></span> at December 31, 2022. For the three months ended March 31, 2023, amortization of debt discount was $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20230101__20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ztgKHckHYA8k" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-03-31_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></span>, and as of March 31, 2023, the remaining unamortized debt discount balance is $<span id="xdx_904_ecustom--DebtInstrumentRemainingUnamortizedDiscount_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zMx18RJxVbdg" title="Remaining unamortized debt discount amount"><ix:nonFraction name="REED:DebtInstrumentRemainingUnamortizedDiscount" contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">322</ix:nonFraction></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zxQVGmiUI6S5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_829_z7pSKLZYqBhj">Secured Convertible Notes Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zoZWIjZuktb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under secured convertible notes payable are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zNi9ZTxIlOl9" style="display: none">Schedule of Debt</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230331_zbgWjfKK4fK3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_ztfZ23A4fGK7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--SecuredDebt_iI_pn3n3_maCNPzwQW_zgEzJGrRTW47" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Secured Convertible Note Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:SecuredDebt" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,000</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:SecuredDebt" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,450</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_maCNPzwQW_zgRe811erj94" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,165</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,052</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredFinanceCostsNet_iNI_pn3n3_di_msCNPzwQW_zN8aolXsBwHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,154</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">976</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ConvertibleNotesPayable_iTI_pn3n3_mtCNPzwQW_zm8UYqldvhYb" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,011</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleNotesPayable" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,526</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iNI_pn3n3_di_zsXNfAVxRjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,485</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ConvertibleNotesPayableCurrent" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,434</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_z59erWFtAdA8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,526</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ConvertibleLongTermNotesPayable" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,092</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A6_zVJAbGfUC4y6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Secured Convertible Note Payable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, the Company entered into a note purchase agreement and agreed to issue $<span id="xdx_909_eus-gaap--SecuredDebt_iI_pn3n3_c20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zFU3sHUMxkW7" title="Secured convertible promissory notes"><ix:nonFraction name="us-gaap:SecuredDebt" contextRef="AsOf2022-05-09_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,250</ix:nonFraction></span> of secured convertible promissory notes (the “Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateTerms_pp0d_c20220508__20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_ze54X7u3cIfi" title="Debt instrument rate terms"><ix:nonNumeric contextRef="From2022-05-082022-05-09_custom_NotePurchaseAgreementMember" name="us-gaap:DebtInstrumentInterestRateTerms">The Notes bear interest at a rate of 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the Notes)</ix:nonNumeric></span>. The Notes are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with ACS, the Company’s existing secured lender (see Note 5). The Notes mature on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20220508__20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z4d4XtN6XGxf" title="Debt instrument maturity date"><ix:nonNumeric contextRef="From2022-05-082022-05-09_custom_NotePurchaseAgreementMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">May 9, 2025</ix:nonNumeric></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 9, 2022, the Company issued $<span id="xdx_905_eus-gaap--SecuredDebt_iI_pn3n3_c20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zzl8HUigHIPh" title="Secured convertible promissory notes"><ix:nonFraction name="us-gaap:SecuredDebt" contextRef="AsOf2022-05-09_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,250</ix:nonFraction></span> of Notes to Whitebox. In September 2022, the Company issued an additional $<span id="xdx_90F_eus-gaap--SecuredDebt_iI_pn3n3_c20220930__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_zxwjDChC0Rw3" title="Secured convertible promissory notes"><ix:nonFraction name="us-gaap:SecuredDebt" contextRef="AsOf2022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,500</ix:nonFraction></span> of Notes to Whitebox (the “September 2022 Notes”). The net proceeds from the issuance of the Notes and September 2022 Notes, after deducting placement agent fees and other debt issuance costs, was approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_c20220901__20220930__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_z8uvXtVIVNia" title="Proceeds from issuance of notes"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfSecuredDebt" contextRef="From2022-09-012022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,430</ix:nonFraction></span>. In November 2022, the Company paid off the $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_dd_c20221101__20221130__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_zMTJK7UpYgle" title="Common stock paid, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-11-012022-11-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,500</ix:nonFraction></span> of September 2022 Notes in cash. Beginning in August 2022, $<span id="xdx_908_eus-gaap--SecuredDebt_iI_pn3n3_c20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z3jtOEwG93q1" title="Secured convertible promissory notes"><ix:nonFraction name="us-gaap:SecuredDebt" contextRef="AsOf2022-08-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,250</ix:nonFraction></span> of the Notes have an amortization feature which requires the Company to make monthly payments of principal of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zlfuhkXjAYu1" title="Monthly payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2022-08-012022-08-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></span> plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company. Amortization payments that are paid in shares are priced at <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zwHlbqaoaRTa" title="Weighted average interest"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" contextRef="From2022-08-012022-08-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90</ix:nonFraction></span>% of the average of the daily volume weighted average prices of the Company’s common stock during the five trading days prior to the date of amortization payment. During the year ended December 31, 2022, the Company made monthly amortization principal payments aggregating $<span id="xdx_90A_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYQOLANw0jQ5" title="Principal payment"><ix:nonFraction name="us-gaap:RepaymentsOfSecuredDebt" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">800</ix:nonFraction></span>, made up of $<span id="xdx_905_eus-gaap--Cash_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zagOV5Q8WJha" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">600</ix:nonFraction></span> in cash, and the issuance of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_dd_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zbw9kcUfYoef" title="Common stock paid, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,362</ix:nonFraction></span> shares of common stock valued at $<span id="xdx_909_eus-gaap--CommonStockValue_iI_pn3n3_dd_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zRPHtNJAcVTh" title="Common stock value"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></span>. At December 31, 2022, the principal balance of the Notes was $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zeEn0iBL3Ryj" title="Principal balance"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,450</ix:nonFraction></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2023, the Company entered into a Partial Option Exercise and Second Amendment to the <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zDPv79bHi9A8" title="Debt instrument rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-02-10_custom_OptionNotesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% Convertible Notes with Whitebox. The Notes were amended so if the Company experiences a fundamental change as defined, the holders of the notes have the right to require the Company to repurchase the notes for cash at a repurchase price equal to <span id="xdx_90F_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20230209__20230210__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYrD31geg427" title="Percentage of repurchase price"><ix:nonFraction name="REED:PercentageOfRepurchasePrice" contextRef="From2023-02-092023-02-10_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">110</ix:nonFraction></span>% (amended from <span id="xdx_909_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_znNwRJvdDj44" title="Percentage of repurchase price"><ix:nonFraction name="REED:PercentageOfRepurchasePrice" contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%) of the principal amount, plus accrued interest. In addition, Whitebox exercised a partial option to purchase $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_c20230209__20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_zUa3qDJZrB9l" title="Options to purchase"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-02-092023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,550</ix:nonFraction></span> of additional notes (the “February 2023 Notes”) from the Company. The February 2023 Notes bear interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_z3wCC1BCdqu8" title="Debt instrument rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% per annum. payable in cash and mature on June 20, 2023. No amortization payments (as defined in the Notes) are payable on the February 2023 Notes, and the February 2023 Notes may be prepaid without premium or penalty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 14; Value: 10 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 13, 2023, the Company entered into a Limited Waiver and Deferral Agreement with Whitebox. Whitebox waived the Company’s covenant violation of its Excess ABL Amount at November 30, 2022, December 31, 2022, and January 31, 2023, and deferred payment of the <span id="xdx_906_ecustom--PercentageForDeferredPayment_iI_pid_dp_uPure_c20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zHo30icII6ma" title="Percentage for deferred payment"><ix:nonFraction name="REED:PercentageForDeferredPayment" contextRef="AsOf2023-02-13_custom_LimitedWaiverAndDeferralAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% fee for the Excess ABL Amount until June 2023. In addition, Whitebox also temporarily waived any requirement that the Company repurchase the Notes in the event of fundamental change (as defined in the Notes), through April 1, 2023, subject to the terms and conditions contained therein. As an inducement, the Company issued an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230213__20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zxe2LFj0Nol7" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-02-132023-02-13_custom_LimitedWaiverAndDeferralAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">82,438</ix:nonFraction></span> shares of common stock to the holders with a fair value of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230213__20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zmpJX8b6wm3g" title="Number of common stock issued, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-02-132023-02-13_custom_LimitedWaiverAndDeferralAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">273</ix:nonFraction></span>. These costs have been capitalized and are being amortized over the term of the waiver. For the three months ended March 31, 2023, amortization of interest was $<span id="xdx_907_eus-gaap--InterestExpenseDebtExcludingAmortization_pn3n3_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zAhBHyduL0O6" title="Amortization of interest"><ix:nonFraction name="us-gaap:InterestExpenseDebtExcludingAmortization" contextRef="From2023-01-012023-03-31_custom_LimitedWaiverAndDeferralAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">96</ix:nonFraction></span>. The shares issued and the shares of common stock issuable upon conversion of the Option Notes are registrable and subject to that certain Registration Rights Agreement dated May 9, 2023. At March 31, 2023, the principal balance of the Notes and February 2023 Notes was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_z3uULc1L2IWg" title="Principal balance"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2023-03-31_custom_NotePurchaseAgreementMember_custom_FebruaryTwoThousandTwentyThreeNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,000</ix:nonFraction></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon conversion, holders of the Note are entitled to receive an interest make-whole payment, as defined. The make-whole amount is equal to the sum of the remaining scheduled payments of interest on the Notes to be converted that would be due if such notes matured <span id="xdx_905_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20230213__20230213_z5diV9UAXNj4" title="Maturity date"><ix:nonNumeric contextRef="From2023-02-132023-02-13" format="ixt:datemonthdayyearen" name="us-gaap:LineOfCreditFacilityExpirationDate1">May 9, 2025</ix:nonNumeric></span>, payable, at the Company’s option in cash or in shares of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the balance of accrued interest was $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zvowSmVx3IN7" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2022-12-31_us-gaap_ConvertibleNotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,052</ix:nonFraction></span>. During the three months ended March 31, 2023, the Company recorded interest of $<span id="xdx_90B_eus-gaap--InterestExpense_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z9TsBWmE827e" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpense" contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,113</ix:nonFraction></span>, made up of $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zgtqbHI9rKg8" title="Interest on the notes"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">366</ix:nonFraction></span> of interest on the Notes, and $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSyDe3jWCuVk" title="Whole interest"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">747</ix:nonFraction></span> related to the excess line of credit debt fee. At March 31, 2023, the balance of accrued interest was $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_znZSVlAE8VR4" title="Accrued interest"><ix:nonFraction name="us-gaap:InterestPayableCurrentAndNoncurrent" contextRef="AsOf2023-03-31_us-gaap_ConvertibleNotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,165</ix:nonFraction></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentType_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zvpgoObs8zmc" title="Debt instrument conversion, description"><ix:nonNumeric contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember" name="us-gaap:DebtConversionConvertedInstrumentType">The initial conversion rate of the Notes is 0.08306 shares of the Company’s common stock per one dollar of principal converted, or approximately $12.04 per share, subject to customary anti-dilution adjustments. In addition, if certain corporate events occur that constitute a make-whole fundamental change as defined, then the note holders are, under certain circumstances, are entitled to an increase in the conversion rate, limited to 0.12155 shares of Common Stock per one dollar of principal, or approximately $8.23 per share</ix:nonNumeric></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to settle conversions and make amortization payments and interest make-whole payments using shares of the Company’s common stock is subject to certain limitations set forth in the Notes. If the Company experiences a fundamental change as defined, the holders of the notes have the right to require the Company to repurchase the notes for cash at a repurchase price equal to <span id="xdx_904_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zMWnY49bF8Ah" title="Percentage of repurchase price"><ix:nonFraction name="REED:PercentageOfRepurchasePrice" contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the principal amount, plus accrued interest thereon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023, the Notes, including accrued interest, are convertible into <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z69rYm3BuGq5" title="Debt conversion into shares"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,257,491</ix:nonFraction></span> shares of the Company’s common stock pursuant to a share conversion cap limit as defined in the Notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unamortized debt discount was $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zAY7MMM0t0Jk" title="Unamortized debt discount amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">976</ix:nonFraction></span> at December 31, 2022. During the three months ended March 31, 2023, the Company incurred $<span id="xdx_907_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zWZlZxGE0KX9" title="Direct costs"><ix:nonFraction name="us-gaap:DeferredFinanceCostsNet" contextRef="AsOf2023-03-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">145</ix:nonFraction></span> of direct costs of the transactions, consisting primarily of placement agent fees and other offering expenses and the issuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--HoldersMember_zOZvKpsijZt7" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-03-31_custom_HoldersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">82,438</ix:nonFraction></span> valued at $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--HoldersMember_zc5oVFlabMYk" title="New issuance of common stock"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-03-31_custom_HoldersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">273</ix:nonFraction></span> as inducement for the aforementioned waiver. These costs have been capitalized and are being amortized over the term of the Notes and waiver period. For the three months ended March 31, 2023, amortization of debt discount was $<span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zEAmjzHnVOUi" title="Amortization of debt discount"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">240</ix:nonFraction></span>, and as of March 31, 2023, the remaining unamortized debt discount balance is $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zkEp0BRbktOh" title="Unamortized debt discount amount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2023-03-31_custom_NotePurchaseAgreementMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,154</ix:nonFraction></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_804_eus-gaap--LesseeOperatingLeasesTextBlock_zPYP6birGRs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_829_zJFAa3M0l19j">Leases Liabilities</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, lease costs totaled $<span id="xdx_90F_eus-gaap--LeaseCost_pn3n3_c20230101__20230331_zjYQox5l5S0k" title="Lease cost"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--LeaseCost_pn3n3_c20220101__20220331_ztt1tK7AkWGh" title="Lease cost"><ix:nonFraction name="us-gaap:LeaseCost" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">27</ix:nonFraction></span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, operating lease liabilities totaled $<span id="xdx_909_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20221231_z8M19u1X83Nb" title="Operating leases liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">394</ix:nonFraction></span>. During the three months ended March 31, 2023, the Company made payments of $<span id="xdx_909_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20230331_zd8R4pDfSWp6" title="Payments of operating lease liability"><ix:nonFraction name="us-gaap:OperatingLeasePayments" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span> towards its operating lease liability. As of March 31, 2023, operating lease liabilities totaled $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20230331_z8Ai7jRRC1Hc" title="Operating leases liability"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">350</ix:nonFraction></span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the weighted average remaining lease terms for an operating lease are <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331_zEJZHrfoJUBc" title="Weighted average remaining lease term for operating lease"><ix:nonNumeric contextRef="AsOf2023-03-31" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1">1.76</ix:nonNumeric></span> years. As of March 31, 2023, the weighted average discount rate on the operating lease is <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zmwmr4X2epW8" title="Weighted average discount rate for operating lease"><ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.60</ix:nonFraction></span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ze8eFSXJhFwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_827_z8jqMLZVZi49">Stockholder’s Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company repurchased <span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20230331__srt--TitleOfIndividualAxis__srt--OfficerMember_zfXCwokrrJw6" title="Stock repurchased, shares"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-01-012023-03-31_srt_OfficerMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">274</ix:nonFraction></span> shares of common stock from an officer for $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__srt--OfficerMember_zLWlAQbS37Ac" title="Stock repurchased, value"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31_srt_OfficerMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span> based on the market value of share on the date repurchased. The Company retired the shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 15; Value: 10 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_80F_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z6zshYg2zRA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_82B_zM6GBH2EBPp9">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Restricted common stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock"><p id="xdx_89A_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zsFwyY3jB2c4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes restricted stock activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zP5XnOXUCWj1" style="display: none">Summary of Non-vested Restricted Stock Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested<br /> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Issuable<br /> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value<br /> at Date of<br /> Issuance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br /> Average <br /> Grant Date<br /> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Balance, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhYwL9dgtte" title="Unvested Shares, beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,460</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKAygSFawnc3" title="Issuable Shares, beginning balance" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iS_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjmeN6GaKck1" title="Fair Value at Date of Issuance, beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26.00</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhxsnUtxjUd" title="Weighted Average Grant Date Fair Value, Unvested, beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.75</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPOTajjURMtg" title="Unvested Shares, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0794">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zTAfL3JeBBUd" title="Issuable Shares, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziUSxI8gRGz5" title="Fair Value at Date of Issuance, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0798">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjS4kUDx2o99" title="Unvested Shares, Vested" style="text-align: right">(<ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zysKmil7Odh7" title="Issuable Shares, Vested" style="text-align: right"><ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoMYZGIy99m2" title="Fair Value at Date of Issuance, Vested" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSiZbyHdPTgb" title="Unvested Shares, Forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zq5W7F6eoxX4" title="Issuable Shares, Forfeited" style="font-size: 11pt; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></span></td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9dcnj3qlqu" title="Fair Value at Date of Issuance, Forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z0InI5dTzM5a" title="Unvested Shares, Issued" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zIHWuo5JdpD1" title="Issuable Shares, Issued" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">750</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBd6N9SH05ma" title="Fair Value at Date of Issuance, Issued" style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6.00</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zyKUsCOXHnk6" title="Unvested Shares, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">710</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoWWvVlsSbr8" title="Issuable Shares, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iE_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSDcwkdf21Ki" title="Fair Value at Date of Issuance, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20.00</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhGBB8xjbMO6" title="Weighted Average Grant Date Fair Value, Unvested, ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.75</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A8_zWnPAZCnuHDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total fair value of restricted common stock vesting during the three months ended March 31, 2023 and 2022, was $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zsRgMCXHOCF9" title="Number of restricted shares, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span> and $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKepQwqMJnC1" title="Number of restricted shares, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" contextRef="From2022-01-012022-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66</ix:nonFraction></span>, respectively, and is included in general and administrative expenses in the accompanying statements of operations. As of March 31, 2023, the amount of unvested compensation related to issuances of restricted common stock was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z4DoB3z18R11" title="Aggregate value of unvested compensation"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span>, which will be recognized as an expense in future periods as the shares vest. When calculating basic loss per share, these shares are included in weighted average common shares outstanding from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares outstanding as of their grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock options</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zBpYMW1oi4fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes stock option activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zVc2uhVTtMa1" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br /> Average <br /> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br /> Average<br /> Remaining<br /> Contractual<br /> Terms <br /> (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate <br /> Intrinsic <br /> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2SNl00YKn1c" title="Shares Outstanding, Beginning balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">164,423</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuUJaWCYKwP" title="Weighted-Average Exercise Price, Outstanding, Beginning" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">48.90</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSd9kSxrgQsc" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">7.58</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9EmoXyXsnDe" title="Aggregate Intrinsic Value, Shares Outstanding, Beginning" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0840">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVoZWFJp3EHb" title="Shares, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,037</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvW0t2ZWOY98" title="Weighted-Average Exercise Price, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.50</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAF94qZxbk5" title="Shares, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvMl2ST4FSa" title="Weighted-Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkX6XQbtmmOc" title="Shares, Unvested forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9YTMEtHPXIc" title="Weighted-Average Exercise Price, Unvested forfeited" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vested forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxhyAq7UYtMj" title="Shares, Vested forfeited" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvEDp1qr8MMa" title="Weighted-Average Exercise Price, Vested forfeited" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zokyJJjusar5" title="Shares Outstanding, Ending Balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">174,460</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIjfxCeyd1Ak" title="Weighted-Average Exercise Price, Outstanding, Ending" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">46.34</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z273mWlE5KT" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" format="ixt-sec:duryear" name="REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1">7.47</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFRVpb2VdES" title="Aggregate Intrinsic Value, Shares Outstanding, Ending" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIwpHC2j7xjj" title="Shares, Exercisable" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">102,520</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsHxWcMvpyqa" title="Weighted-Average Exercise Price, Exercisable Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">54.41</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z63qbKqbFRPf" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">6.86</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znmhvM4p4fUk" title="Aggregate Intrinsic Value, Ending balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A9_zxEMRl2eldLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company approved options exercisable into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember_zV0MmXgXXbv6" title="Options exercisable"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,037</ix:nonFraction></span> shares to be issued pursuant to Reed’s 2020 Equity Incentive Plan. <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_za5WHnlcwQp5" title="Stock issued during period shares employee benefit plan"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" contextRef="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember_custom_EmployeesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,037</ix:nonFraction></span> options were issued to employees, <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20230331_zVuH69qFVCRf" title="Number of stock option shares vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,016</ix:nonFraction></span> options vesting annually over a <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zT4pCJzx1Tv7" title="Vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0880">four</span></span>-year vesting period, and <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z373V8tAnIs" title="Number of stock option shares vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2023-01-012023-03-31_custom_BoardOfDirectorsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,021</ix:nonFraction></span> options vesting based on performance criteria to be established by the board of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The stock options are exercisable at a price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20230331_zsCtKT0ar9Lb" title="Stock options exercisable price"><ix:nonFraction name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.50</ix:nonFraction></span> per share and expire in <span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dc_c20230101__20230331_zHo5iTH38Ob5" title="Expiration years"><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">ten years</ix:nonNumeric></span>. The total fair value of these options at grant date was approximately $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20220101__20221231_z5zmpSbHz3Qi" title="Options grant date"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span>, which was determined using a Black-Scholes-Merton option pricing model with the following average assumption: stock price of $<span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20230331_zi0S3GVSDUDd" title="Stock price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.50</ix:nonFraction></span> share, expected term of six years, volatility of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230331_zDSpvmuhEGUd" title="Volatility"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">82</ix:nonFraction></span>%, dividend rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230331_zge1amAGgO13" title="Dividend rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0</ix:nonFraction></span>%, and weighted average risk-free interest rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230331_zQoY9q1yNYUl" title="Weighted average risk-free interest rate"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.59</ix:nonFraction></span>%. The expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future; and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:exclude><!-- Field: Page; Sequence: 16; Value: 10 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, the Company recognized $<span id="xdx_908_ecustom--FairValueOfVestedStockOption_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zC2nFxDUjdZg" title="Fair value of vested stock option"><ix:nonFraction name="REED:FairValueOfVestedStockOption" contextRef="From2023-01-012023-03-31_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">229</ix:nonFraction></span> and $<span id="xdx_90D_ecustom--FairValueOfVestedStockOption_pn3n3_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zOvXuRUIkVbg" title="Fair value of vested stock option"><ix:nonFraction name="REED:FairValueOfVestedStockOption" contextRef="From2022-01-012022-03-31_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></span> of compensation expense relating to vested stock options. As of March 31, 2023, the aggregate amount of unvested compensation related to stock options was approximately $<span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z6Yt9Fc6m78d" title="Aggregate value of unvested compensation"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2023-03-31_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,039</ix:nonFraction></span> which will be recognized as an expense as the options vest in future periods through March 28, 2027.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2023, which was $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdVPz8v6Nh1c" title="Stock price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-31_us-gaap_EmployeeStockOptionMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.45</ix:nonFraction></span>, and the exercise price of the outstanding stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="REED:StockWarrantsTextBlock"><p id="xdx_805_ecustom--StockWarrantsTextBlock_zVk03cY1LBbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_82A_zRMkiE0Cjlha">Stock Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zkE55migrDKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s warrant activity during the three months ended March 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zedw11Hunbfi" style="display: none">Schedule of Warrant Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Remaining Contractual Terms (Years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBkeF3h1MYT4" title="Shares Outstanding, Beginning Balance" style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2022-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,946</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znnHiATgbCa" title="Weighted-Average Exercise Price, Outstanding Beginning Balance" style="width: 12%; text-align: right"><ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" contextRef="AsOf2022-12-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.99</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z40a4hORR28" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms">4.20</ix:nonNumeric></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zEifyPmGoDOk" title="Aggregate Intrinsic Value, Outstanding Beginning" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGranted_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSzD7jaCcudj" title="Shares, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zN0IwnPs5pNb" title="Weighted-Average Exercise Price, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercised_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zA8vUHqIWXZe" title="Shares, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z7dQrzo0QdOh" title="Weighted-Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw8mzZ4x5VX6" title="Shares, Forfeited" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zvA6Dbjp5ff3" title="Weighted-Average Exercise Price, Forfeited" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUJtEiWUMC4f" title="Shares Outstanding, Ending Balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2023-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,946</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zikpFePQ6DK7" title="Weighted-Average Exercise Price, Outstanding Ending Balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.99</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znJ4KgsFTRZi" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1">4.20</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zuFQBiv9kFna" title="Aggregate Intrinsic Value, Outstanding Ending" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisable_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_ziurI0G7Vyo2" title="Shares Exercisable, Ending Balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritieExercisable" contextRef="AsOf2023-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">235,946</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUnbOsyAA1q5" title="Weighted-Average Exercise Price, Exercisable Ending Balance" style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="REED:ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" contextRef="AsOf2023-03-31_us-gaap_WarrantMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.99</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90C_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zdFeJPoEKYE9" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance"><ix:nonNumeric contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="REED:ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms">4.20</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zc2ArIYcTpDf" title="Aggregate Intrinsic Value, Exercisable" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8AF_zLT6poeJt3dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2023, which was $<span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--StockWarrantsMember_zffRYNkZXNGf" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-03-31_custom_StockWarrantsMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.45</ix:nonFraction></span>, and the exercise price of the Company’s warrants to purchase common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zm66y4MsHNVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_82A_zpGKqtA0piea">Transactions with California Custom Beverage, LLC, former related party</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a <span id="xdx_906_ecustom--RoyaltyPercentage_iI_dp_uPure_c20181231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zmUY9VeOlmb" title="Royalty percentage"><ix:nonFraction name="REED:RoyaltyPercentage" contextRef="AsOf2018-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5</ix:nonFraction></span>% royalty through 2021 on certain private label sales made by CCB.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, the Company incurred co-packing fees due to CCB of $<span id="xdx_90F_eus-gaap--OtherLiabilities_iI_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z0tzYQyOBWF1" title="Copacking fees"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">428</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--OtherLiabilities_iI_pn3n3_c20220331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z6TPwRSHF008" title="Copacking fees"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">636</ix:nonFraction></span>, respectively. As of March 31, 2023 and 2022, the aggregate of co-packing fees payable to CCB were $<span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zlRtYXBO9zlg" title="Notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,859</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--NotesPayable_iI_pn3n3_c20220331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zdPQTTiu7kW8" title="Notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,025</ix:nonFraction></span>, respectively. At March 31, 2023 and December 31, 2022, the Company had also recorded receivables from CCB of $<span id="xdx_907_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zTNBmUEcepnb" title="Receivables"><ix:nonFraction name="us-gaap:ReceivablesNetCurrent" contextRef="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,315</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zfLN8yIbAP6e" title="Receivables"><ix:nonFraction name="us-gaap:ReceivablesNetCurrent" contextRef="AsOf2022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,315</ix:nonFraction></span>, respectively, including royalty receivable of $<span id="xdx_906_ecustom--RoyaltyReceivable_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_ztskNONfrZb4" title="Royalty receivable"><ix:nonFraction name="REED:RoyaltyReceivable" contextRef="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">297</ix:nonFraction></span> and $<span id="xdx_904_ecustom--RoyaltyReceivable_pn3n3_c20220101__20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zvNJyuUxZ9vj" title="Royalty receivable"><ix:nonFraction name="REED:RoyaltyReceivable" contextRef="From2022-01-012022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">297</ix:nonFraction></span>, and charge backs of certain costs management determined were permittable under the co-packing agreement of $<span id="xdx_906_ecustom--CopackingFees_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_z4CaJcCnff4g" title="Copacking fees"><ix:nonFraction name="REED:CopackingFees" contextRef="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,018</ix:nonFraction></span> and $<span id="xdx_907_ecustom--CopackingFees_c20220101__20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zZxQnappjeaa" title="Copacking fees"><ix:nonFraction name="REED:CopackingFees" contextRef="From2022-01-012022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,018</ix:nonFraction></span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zI3er1dz0J0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and December 31, 2022, accounts receivable due from and accounts payable due to CCB were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zaAiCH0xULVi" style="display: none">Schedule of Related Parties</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230331_zPRgkv1i2kF8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zmFe2ByAZxVg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zjiuF2a3bxie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable, net of provision of $<span id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zYDQzmCb14z" title="Net of provision" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="REED:ProvisionForReceivableWithFormerRelatedParty" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">538</ix:nonFraction></span> and $<span id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_z28BqdJay44f" title="Net of provision" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="REED:ProvisionForReceivableWithFormerRelatedParty" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">538</ix:nonFraction></span> at March 31, 2023 and December 31, 2022, respectively</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">777</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:OtherReceivablesNetCurrent" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">777</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zirQLj82PSE1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,859</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,025</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--OtherReceivables_iNTI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zidqRkyQ4hR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Net (payable) receivable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,082</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,248</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> </ix:nonNumeric><p id="xdx_8A8_zuD1eWdZmN6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, CCB disputes that it owes $<span id="xdx_903_eus-gaap--OtherReceivables_iI_pn3n3_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zBFPQjliW6jh" title="Net receivable"><ix:nonFraction name="us-gaap:OtherReceivables" contextRef="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,043</ix:nonFraction></span> of the $<span id="xdx_905_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember_zcS1McDftvbe" title="Receivables"><ix:nonFraction name="us-gaap:ReceivablesNetCurrent" contextRef="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,315</ix:nonFraction></span> recorded as receivable by the Company. The Company believes that it will prevail in this dispute, however, as of March 31, 2023 and December 31, 2022, due to the uncertainty about the ultimate amount that will be settled, the Company has provided a reserve for $<span id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zVhnGQpx7Ua6" title="Provision for disputed receivable with former related party" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><span id="xdx_903_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_zN8A9YOtUhF2" title="Provision for disputed receivable with former related party" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="REED:ProvisionForReceivableWithFormerRelatedParty" contextRef="From2023-01-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD"><ix:nonFraction name="REED:ProvisionForReceivableWithFormerRelatedParty" contextRef="From2022-01-012022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">538</ix:nonFraction></ix:nonFraction></span></span> based on management’s estimate. In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $<span id="xdx_904_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_c20230331__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zsimglxOnxTh" title="Accounts payable"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,859</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_c20221231__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zbVBV0lAURm7" title="Accounts payable"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,025</ix:nonFraction></span> outstanding at March 31, 2023 and December 31, 2022, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z4RN0Cr9Ct8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_821_zVxSF3Q4vw3d">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $<span id="xdx_90C_eus-gaap--SecurityDeposit_iI_pn3n3_c20181231__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zaG3wFUZUpel" title="Deposit of security with lessor"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2018-12-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,200</ix:nonFraction></span> of security with the lessor. As of March 31, 2023, $<span id="xdx_900_eus-gaap--SecurityDeposit_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zehoWZTXv85i" title="Deposit of security with lessor"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">800</ix:nonFraction></span> has been deposited with the lessor and Chris J. Reed has placed approximately <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zzN9rQusiVt7" title="Number of common stock value placed"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-012023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,260</ix:nonFraction></span> shares of the Company’s common stock valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zjarPTJku753" title="Value of stock placed"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-012023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span> that remain in escrow with the lessor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that there are no material litigation matters at the current time. Although the results of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2023-01-01to2023-03-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z4OLh4ufw67c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13. <span id="xdx_829_zwLFW44aNbn5">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2023, the Company entered into a Securities Purchase Agreement with D&D Source of Life Holding Ltd., as the lead investor, and certain of Reed’s affiliates pursuant to which the investors agreed to purchase an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230524__20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3JgqRecybr7" title="Common shares issued for cash"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-05-242023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,566,732</ix:nonFraction></span> shares of Reed’s common stock and warrants to purchase <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6YwIWhJHuo9" title="Warrants to purchase stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,346</ix:nonFraction></span> shares of Common Stock. The purchase price per share of Common Stock and associated warrant was $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zeSZDbXbFnge" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.585</ix:nonFraction></span>. The gross proceeds to the Company, before deducting offering expenses, are approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230524__20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrOGiRggY4dl" title="Proceeds from issuance of private placement"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2023-05-242023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,100</ix:nonFraction></span>. <span style="background-color: white"> </span>The warrants are exercisable for a term of <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUnuwl9lVJ98" title="Warrant term"><ix:nonNumeric contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" format="ixt-sec:durwordsen" name="us-gaap:WarrantsAndRightsOutstandingTerm">three years</ix:nonNumeric></span> at a per share exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0eUaZB4p7l8" title="Exercise price of warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.50</ix:nonFraction></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2023, in order to induce the lead investor to subscribe, the Company granted the lead investor certain preemptive rights and agreed to support the lead investor’s nomination of two board designees, one of which shall be an independent director.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 30, 2023, the Company entered into a Partial Option Exercise and Third Amendment to 10% Convertible Notes (the Notes, see Note 6) with Whitebox a Limited Waiver and Deferral Agreement. Whitebox exercised a partial option to purchase an aggregate of approximately $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20230529__20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zbslHR74Vc96" title="Common shares issued on exercise of options"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2023-05-292023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500</ix:nonFraction></span> of additional notes (the “Option Notes”) from the Company. The Option Notes bear interest at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zXpt7Rrt22Xg" title="Debt instrument rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% per annum. payable in cash and mature on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20230529__20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zbpmT8nzpQK1" title="Debt instrument, maturity date"><ix:nonNumeric contextRef="From2023-05-292023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember" format="ixt:datemonthdayyearen" name="us-gaap:DebtInstrumentMaturityDate">September 29, 2023</ix:nonNumeric></span>. No amortization payments (as defined in the Notes) are payable on the Option Notes, and the Option Notes may be prepaid without premium or penalty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares issued and the shares of common stock issuable upon conversion of the Option Notes are registrable and subject to that certain Registration Rights Agreement dated May 25, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> </ix:nonNumeric><p id="xdx_81C_z2EwDsuQ6kf5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br /> <br /></b></span></p> <!-- Field: Page; Sequence: 17; Value: 10 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="a_1"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cautionary Statement Regarding Forward-Looking Statements and Information</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes appearing elsewhere in this report.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>In addition to our GAAP results, the following discussion includes Modified EBITDA as a supplemental measure of our performance. We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts, and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, and one-time restructuring-related costs including employee severance and asset impairment.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The following discussion also includes the use of gross billing, a key performance indicator and metric. Gross billing represents invoiced amounts to distributors and retailers, excluding sales adjustments. Gross billing may include deductions from MSRP or “list price”, where applicable, and excludes promotional costs of generating such sales. Management utilizes gross billing to monitor operating performance of products and salespersons, which performance can be masked by the effect of promotional or other allowances. Management believes that the presentation of gross billing provides a useful measure of Reed’s operating performance.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company continued to strengthen its supply chain, implement gross margin enhancement initiatives, drive efficiencies in transportation and warehouse costs and reduce operating expenses. In addition, it continues to build its innovation pipeline with sustained growth in Reed’s Real Ginger Ale, Reed’s Classic and Stormy Mule, and Reed’s Hard Ginger Ale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company remains focused on driving sales growth, improving gross margin, and reducing freight costs. The sales growth focus is on channel expansion, increase in store placements, new product introduction and improved sales execution. The margin enhancement initiative is driven by packaging savings, co-packer upgrades, and better leveraged purchasing and improved efficiency. Underpinning these initiatives is a focus on strategically reducing operating costs particularly delivery and handling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>COVID-19 Considerations</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2022, the COVID-19 pandemic continued to impact our operating results and the Company anticipates a residual effect for the balance of the year. In addition, the pandemic could cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively affects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow during the first quarter of 2023, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations. We expect the inflationary trends and supply chain pressures to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 18; Options: NewSection; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended March 31, 2023, the Company experienced moderation from the elevated freight costs experienced in 2022. The average cost of shipping and handling for the period ended March 31, 2023, was $3.46 per case, as compared to $3.90 per case for the period ended March 31, 2022. Although the Company has experienced decreases in freight costs over the last three quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. Although, the Company has been negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company has experienced moderation in inflation and anticipates this to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and protect our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through March 31, 2023, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part to be responsible to our employees and business partners in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through March 31, 2023, we continued to generate cash flows to meet our short-term liquidity needs, and we expected to maintain access to the capital markets. We did not observe any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results of Operations – Three Months Ended March 31, 2023, as compared to March 31, 2022</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth key statistics for the three months ended March 31, 2023 and 2022, respectively, in thousands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Three Months Ended <br /> March 31,</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Pct.</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Change</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Gross billing (A)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">12,453</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">13,636</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">-9</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: Promotional and other allowances (B)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,296</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,454</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-11</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Net sales</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,157</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">12,182</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Cost of goods sold</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,459</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-9</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; font-style: italic">% of Gross billing</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">68</td><td style="font-style: italic; text-align: left">%</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">68</td><td style="font-style: italic; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; font-style: italic; padding-bottom: 1.5pt">% of Net sales</td><td style="font-style: italic; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">76</td><td style="padding-bottom: 1.5pt; font-style: italic; text-align: left">%</td><td style="font-style: italic; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">76</td><td style="padding-bottom: 1.5pt; font-style: italic; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,698</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,932</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-8</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; font-style: italic">% of Net sales</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">24</td><td style="font-style: italic; text-align: left">%</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">24</td><td style="font-style: italic; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Delivery and handling</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,120</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2,812</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-25</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; font-style: italic">% of Net sales</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">19</td><td style="font-style: italic; text-align: left">%</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">23</td><td style="font-style: italic; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; font-style: italic">Dollar per case ($)</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left">$</td><td style="font-style: italic; text-align: right">3.46</td><td style="font-style: italic; text-align: left"> </td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left">$</td><td style="font-style: italic; text-align: right">3.90</td><td style="font-style: italic; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Selling and marketing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,447</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,178</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-34</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; font-style: italic">% of Net sales</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">13</td><td style="font-style: italic; text-align: left">%</td><td style="font-style: italic"> </td> <td style="font-style: italic; text-align: left"> </td><td style="font-style: italic; text-align: right">18</td><td style="font-style: italic; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">General and administrative</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,709</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,121</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-19</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; font-style: italic; padding-bottom: 1.5pt">% of Net sales</td><td style="font-style: italic; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">15</td><td style="padding-bottom: 1.5pt; font-style: italic; text-align: left">%</td><td style="font-style: italic; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-style: italic; text-align: right">17</td><td style="padding-bottom: 1.5pt; font-style: italic; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,276</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,111</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-26</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from operations</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(2,578</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(4,179</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-38</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Interest expense and other expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,779</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(801</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">122</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,357</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,980</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right">-13</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Loss per share – basic and diluted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1.70</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2.56</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right">-33</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Weighted average shares outstanding - basic & diluted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,559,855</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,947,548</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">31</td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 19; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(A) We define gross billing as the total sales for the Company unadjusted for costs related to generating those sales. Management utilizes gross billing as an indicator of and to monitor operating performance of products and salespersons before the effect of any promotional or other allowances, which are determined in accordance with GAAP, and can mask certain performance issues. We believe that the presentation of gross billing provides a useful measure of our operating performance. Additionally, gross billing may not be comparable to similarly titled measures used by other companies, as gross billing has been defined by our internal reporting practices</i>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(B) We define promotional and other allowances as costs deducted from gross billing which are associated with generating those sales. Management utilizes promotional and other allowances as an indicator of and to monitor operating performance of products, salespersons, and customer agreements. We believe that the presentation of promotional and other allowances provides a useful measure of our operating performance. The presentation of promotional and other allowances facilitates an evaluation of their impact on the determination of net sales and the spending levels incurred or correlated with such sales. The expenditures described in this line item are determined in accordance with GAAP and meet GAAP requirements, the disclosure thereof does not conform to GAAP presentation requirements. Additionally, our definition of promotional and other allowances may not be comparable to similar items presented by other companies. Promotional and other allowances primarily include consideration given to the Company’s distributors or retail customers including, but not limited to the following: (i) reimbursements given to the Company’s distributors for agreed portions of their promotional spend with retailers, including slotting, shelf space allowances and other fees for both new and existing products; (ii) the Company’s agreed share of fees given to distributors and/or directly to retailers for in-store marketing and promotional activities; (iii) the Company’s agreed share of slotting, shelf space allowances and other fees given directly to retailers; (iv) incentives given to the Company’s distributors and/or retailers for achieving or exceeding certain predetermined sales goals; and (v) discounted or free products. Promotional and other allowances constitute a material portion of our marketing activities. The Company’s promotional allowance programs with its numerous distributors and/or retailers are executed through separate agreements in the ordinary course of business. These agreements generally provide for one or more of the arrangements described above and are of varying durations, ranging from one week to one year.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales, Cost of Sales, and Gross Margins</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following chart sets forth key statistics for the transition of the Company’s top line activity from the first quarter of 2022 through the first quarter of 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">vs PY</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Q1 Per Case</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Q1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Q1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Q1</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">vs PY</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Cases:</td><td> </td> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 16%"> </td><td style="width: 2%"> </td> <td style="width: 10%">Reed’s</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">370</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">415</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right">-11</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 8%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">Virgil’s</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">241</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">302</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-20</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left">Total Core</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">611</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">717</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">-15</td><td style="font-weight: bold; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left">Non Core</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">Candy</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-50</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold">Total</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">613</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">721</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">-15</td><td style="font-weight: bold; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Gross Billing:</td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td>Core</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">12,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,287</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-7</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">20.18</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">18.53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left">Non Core</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-30</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">Candy</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">274</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-76</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">42.51</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">68.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-38</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold">Total</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">12,453</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">13,636</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">-9</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">20.33</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">18.91</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">8</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Discounts:</td><td style="font-weight: bold"> </td> <td style="font-weight: bold">Total</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(1,296</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(1,454</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">-11</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(2.12</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(2.02</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">5</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">COGS:</td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td>Core</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(8,422</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(9,150</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-8</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(13.75</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(12.76</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left">Non Core</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(13</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-100</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt">Candy</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(87</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-57</td><td style="padding-bottom: 1.5pt; text-align: left">%</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(23.63</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21.75</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9</td><td style="padding-bottom: 1.5pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold">Total</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(8,459</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(9,250</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">-9</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(13.81</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(12.83</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">8</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Gross Margin:</td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,698</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,932</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">-8</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">4.40</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">4.07</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">8</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">as % Net Sales</td><td> </td> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 20; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales, Cost of Sales, and Gross Margins</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Company’s ongoing initiative to simplify and streamline operations the Company has identified core products on which to place its strategic focus. These core products consist of Reed’s and Virgil’s branded beverages. Non-core products consist primarily of Wellness Shots, candy and slower selling discontinued Reed’s and Virgil’s SKUs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core beverage volume for the three months ended March 31, 2023, represents 99% of all beverage volume.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Core brand gross billing decreased by 7% to $12,333 compared to $13,287 during the same period last year, driven by a Reed’s volume decline of 11% and Virgil’s volume decline of 20%. The result is a decrease in total gross billing of 9%, to $12,453 during the three months ended March 31, 2023, from $13,636 in the same period last year. Price on our core brands increased 9% to $20.18 per case. The decrease was a result of volume declines that have impacted the CSD segment as a result of price increases coupled with the Company’s inability to produce sufficient levels of inventory to meet current demand as a result of tighter credit terms from suppliers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discounts as a percentage of gross sales decreased to 10% from 11% in the same period last year. As a result, net sales revenue decreased 8% in the three months ended March 31, 2023, to $11,157, compared to $12,182 in the same period last year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cost of Goods Sold</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of goods sold decreased $791 during the three months ended March 31, 2023, as compared to the same period last year. As a percentage of net sales, cost of goods sold for the three months ended March 31, 2023, was 76% as compared to 76% for the same period last year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total cost of goods per case increased to $13.81 per case in the three months ended March 31, 2023, from $12.83 per case for the same period last year. The cost of goods sold per case on core brands was $13.75 during the three months ended March 31, 2023, compared to $12.77 for the same period last year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross Margin</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross margin was 24% for the three months ended March 31, 2023, compared to 24% for the same period last year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Operating Expenses</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Delivery and Handling Expenses</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delivery and handling expenses consist of delivery costs to customers and warehousing costs incurred for handling our finished goods after production. Delivery and handling expenses decreased by $692 in the three months ended March 31, 2023, to $2,120 from $2,812 in the same period last year, driven by our efforts to mitigate inflationary costs. Delivery costs in the three months ended March 31, 2023, were 19% of net sales and $3.46 per case, compared to 23% of net sales and $3.90 per case during the same period last year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 21; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Selling and Marketing Expenses</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketing expenses consist of direct marketing, marketing labor, and marketing support costs. Selling expenses consist of all other selling-related expenses including personnel and contractor support. Total selling and marketing expenses were $1,447 during the three months ended March 31, 2023, compared to $2,178 during the same period last year. As a percentage of net sales, selling and marketing costs was 13% during the three months ended March 31, 2023, as compared to 18% during the same period last year. The decrease was primarily driven by lower employee related costs, marketing expenditures, and travel and entertainment expense, partially offset by higher broker fees, product samples, and trade show spend.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General and Administrative Expenses</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses consist primarily of the cost of executive, administrative, and finance personnel, as well as professional fees. General and administrative expenses decreased in the three months ended March 31, 2023, to $1,709 from $2,121, a decrease of $412 over the same period last year. As a percentage of net sales, general and administrative expense was 15% during the three months ended March 31, 2023, as compared to 17% during the same period last year. The decrease was driven by lower employee related costs, professional fees and stock compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Loss from Operations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loss from operations was $2,578 for the three months ended March 31, 2023, as compared to a loss of $4,179 in the same period last year driven by decreased gross profit offset by decreases in operating expenses discussed above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Interest and Other Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest and other expense for the three months ended March 31, 2023, consisted of $1,779 of interest expense. During the same period last year, interest and other expense consisted of $801 of interest expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Modified EBITDA</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to our GAAP results, we present Modified EBITDA as a supplemental measure of our performance. However, Modified EBITDA is not a recognized measurement under GAAP and should not be considered as an alternative to net income, income from operations or any other performance measure derived in accordance with GAAP, or as an alternative to cash flow from operating activities as a measure of liquidity. We define Modified EBITDA as net income (loss), plus interest expense, depreciation and amortization, stock-based compensation, changes in fair value of warrant expense, legal settlements, and one-time restructuring-related costs including employee severance and asset impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations during that period. Non-GAAP adjustments to our results prepared in accordance with GAAP are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Modified EBITDA, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. Our presentation of Modified EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 22; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set forth below is a reconciliation of net loss to Modified EBITDA for the three months ended March 31, 2023 and 2022 (unaudited; in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Three Months Ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Net loss</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(4,357</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(4,980</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Modified EBITDA adjustments:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">80</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,779</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">801</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Stock option and other noncash compensation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">233</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">291</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Total EBITDA adjustments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,092</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,144</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Modified EBITDA</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,265</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,836</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We present Modified EBITDA because we believe it assists investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Modified EBITDA in developing our internal budgets, forecasts and strategic plan; in analyzing the effectiveness of our business strategies in evaluating potential acquisitions; making compensation decisions; and in communications with our board of directors concerning our financial performance. Modified EBITDA has limitations as an analytical tool, which includes, among others, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modified EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modified EBITDA does not reflect changes in, or cash requirements for, our working capital needs;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modified EBITDA does not reflect future interest expense, or the cash requirements necessary to service interest or principal payments, on our debts; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">● </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Modified EBITDA does not reflect any cash requirements for such replacements.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Liquidity and Capital Resources</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared under the assumption that the Company will continue as a going concern. Such assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three months ended March 31, 2023, we recorded a net loss of $4,357. As of March 31, 2023, we had a cash balance of $467, with $62 of current availability, and $5,084 of additional borrowing capacity, a stockholder’s deficit of $12,322 and negative working capital of $4,952, compared to a <span style="background-color: white">cash </span>balance of $533, with $110 of current availability, and $1,633 of additional borrowing capacity, a stockholder’s deficit of $8,470 and negative working capital of $1,563 <span style="background-color: white">at December 31, 2022</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing will be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 23; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical Accounting Policies and Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of those judgments can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in estimates for reserves of uncollectible accounts, inventory obsolescence, depreciable lives of property and equipment, analysis of impairments of recorded long-term tangible and intangible assets, realization of deferred tax assets, accruals for potential liabilities and assumptions made in valuing stock instruments issued for services. There were no changes to our critical accounting policies described in the condensed financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, that impacted our condensed financial statements and related notes included herein.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent Accounting Pronouncements</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Note 2 of the Notes to Condensed Financial Statements for a discussion of recent accounting pronouncements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_2"></span>Item 3. Quantitative and Qualitative Disclosures About Market Risk.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A smaller reporting company is not required to provide the information required by this Item.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_3"></span><b>Item 4. Controls and Procedures.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Evaluation of Disclosure Controls and Procedures</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective as of March 31, 2023, to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Changes in Internal Control Over Financial Reporting</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There have been no changes in the Company’s internal control over financial reporting during the three months ended March 31, 2023 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_4"></span><b>PART II – OTHER INFORMATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_5"></span><b>Item 1. Legal Proceedings</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are subject to various legal proceedings from time to time in the ordinary course of business, none of which are required to be disclosed under this Item 1.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 24; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="a_6"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 1A. Risk Factors</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in Part I, Item 1A of our Annual Report on Form 10-K (our Form 10-K) for the year ended December 31, 2022 and any subsequent filings with the Securities and Exchange Commission (SEC) made prior to the date hereof, which could materially affect our business, financial condition, results of operations or future results. These risks and uncertainties discussed in our Form 10-K and in any subsequent filings with the SEC made prior to the date hereof are not the only ones facing our business. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially adversely affect our business, cash flows, financial condition and/or results of operations. Please also read the Cautionary Notice Regarding Forward-Looking Statements and Information of this Quarterly Report on Form 10-Q.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_7"></span>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None that have not been previously disclosed in a Current Report on Form 8-K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="a_8"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 3. Defaults Upon Senior Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_9"></span>Item 4. Mine Safety Disclosures</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="a_10"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5. Other Information</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_11"></span>Item 6. Exhibits</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Filed</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporated by Reference</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit Title</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Herewith</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File No.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.65in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date Filed</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223017571/ex3i.htm" style="-sec-extract: exhibit">Certificate of Incorporation of Reed’s, Inc., as amended</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/15/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315220006033/ex3-8.htm" style="-sec-extract: exhibit">Amended and Restated Bylaws of Reed’s, Inc.</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-KA</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/08/2020</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">4.1</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ex4-1.htm">Form of Option Note issued February 10, 2023</a></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">X</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant issued March 25, 2023</span></a></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex4-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Option Note issued May 30, 2023</span></a></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">10.1</p></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223017571/ex10-19.htm" style="-sec-extract: exhibit">Partial Option Exercise and Second Amendment to 10% Convertible Notes by Reed’s, Inc. and Wilmington Savings Fund Society, FSB dated February 10, 2023</a></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">10-K</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">10.19</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">001-32501</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">5/15/2023</p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">10.2</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223017571/ex10-20.htm" style="-sec-extract: exhibit">Limited Waiver and Deferral Agreement by Reed’s, Inc. and Wilmington Savings Fund Society, FSB dated February 10, 2023</a></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">10-K</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">10.20</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">001-32501</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">5/15/2023</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement dated May 25, 2023 between Reed’s, Inc. and investors</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex10-2.htm" style="-sec-extract: exhibit">Shareholders Agreement dated May 25, 2023 by and between Reed’s, Inc. and investors</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement dated May 25, 2023 between Reed’s, Inc., and investors</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></p></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex10-4.htm" style="-sec-extract: exhibit">Amended Registration Rights Agreement by Reed’s, Inc. and the holders of 10% secured convertible notes dated May 30, 2023</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7+</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex10-5.htm" style="-sec-extract: exhibit">Partial Option Exercise and Third Amendment Agreement to 10% Secured Convertible Notes by Reed’s, Inc. and Wilmington Savings Fund Society, FSB dated May 30, 2023</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center">10.8<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1140215/000149315223019681/ex10-6.htm" style="-sec-extract: exhibit">Limited Waiver and Deferral Agreement by Reed’s, Inc. and Wilmington Savings Fund Society, FSB dated May 30, 2023</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-32501</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5/31/2023</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-2.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-2.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">+Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulations S-K. The Company will furnish supplementally an unredacted copy of such exhibit to the Securities and Exchange Commission or its staff upon request.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished herewith, XBRL (Extensive Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <!-- Field: Page; Sequence: 25; Value: 1 --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div> <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span id="a_12"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reed’s, Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 1, 2023</span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Norman E. Snyder, Jr.</i></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman E. Snyder, Jr.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 1, 2023</span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Joann Tinnelly</i></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joann Tinnelly</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chief Financial Officer</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></p> <!-- Field: Page; Sequence: 26; Options: Last --> <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> </body> </html> <!-- Field: Set; Name: xdx; ID: xdx_08B_extensions --> <!-- 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 --> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>2 <FILENAME>ex4-1.htm <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 4.1</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I> </I></B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER THE SECURITIES REPRESENTED HEREBY NOR THE SECURITIES INTO WHICH THE SECURITIES REPRESENTED HEREBY ARE CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT (AS DEFINED HEREIN) OR UNDER ANY STATE SECURITIES LAWS. BY ITS ACQUISITION HEREOF, THE HOLDER AGREES FOR THE BENEFIT OF THE BORROWER (AS DEFINED HEREIN) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THESE SECURITIES OR ANY BENEFICIAL INTEREST HEREIN, EXCEPT: (A) TO THE BORROWER OR ANY SUBSIDIARY THEREOF; (B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; (C) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT; OR (D) PURSUANT TO ANY OTHER EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH <FONT STYLE="letter-spacing: -0.1pt">CLAUSE </FONT>(C) OR (D) ABOVE, THE BORROWER RESERVES THE RIGHT TO REQUIRE THE DELIVERY OF SUCH CERTIFICATIONS, OPINIONS OF COUNSEL OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES <FONT STYLE="letter-spacing: -0.1pt">LAWS.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE PAYMENT OF THIS PROMISSORY NOTE AND THE RIGHTS AND REMEDIES OF <FONT STYLE="letter-spacing: -0.1pt">HOLDERS OF THIS PROMISSORY NOTE SHALL BE SUBJECT TO THE INTERCREDITOR </FONT>AGREEMENT (AS DEFINED HEREIN).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS NOTE IS ISSUED WITH “ORIGINAL ISSUE DISCOUNT” (WITHIN THE MEANING OF SECTION 1272 OF THE INTERNAL REVENUE CODE) FOR U.S. FEDERAL INCOME TAX PURPOSES. UPON WRITTEN REQUEST, THE COMPANY WILL PROMPTLY MAKE AVAILABLE TO ANY PURCHASER OF THIS NOTE: (1) THE ISSUE PRICE AND DATE OF THE NOTE, (2) THE AMOUNT OF ORIGINAL ISSUE DISCOUNT ON THE NOTE <FONT STYLE="letter-spacing: -0.25pt">AND</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) THE YIELD TO MATURITY OF THE <FONT STYLE="letter-spacing: -0.1pt">NOTE.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REED’S, <FONT STYLE="letter-spacing: -0.2pt">INC.</FONT></B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURED CONVERTIBLE PROMISSORY <FONT STYLE="letter-spacing: -0.2pt">NOTE</FONT></B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><B> </B></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$____________</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 10, 2023</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note No. ___</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR VALUE RECEIVED, the undersigned, REED’S, INC., a Delaware corporation (the “<U>Borrower</U>”), promises to pay to _____________, or its registered assigns (the “<U>Holder</U>”), in lawful money of the United States of America and in immediately available funds, the principal sum of _________________________ (US$__________) (as such amount may, from time to time, be increased or <FONT STYLE="letter-spacing: -0.1pt">decreased </FONT>pursuant to the terms hereof, the “<U>Principal Amount</U>”) on the Maturity Date (as defined herein), together with interest as provided herein.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Note is one of a series of secured convertible promissory notes issued by the Borrower at several closings pursuant to that certain Note Purchase Agreement, dated as of May 9, 2022 (the “<U>Purchase Agreement</U>”), by and among the Borrower, Wilmington Savings Fund Society, FSB, in its capacity as representative for the holders of Notes (the “<U>Holder Representative</U>”), the Holder and the other purchasers from time to time party thereto (this Note, together with the other secured convertible promissory notes of the same series issued pursuant to the Purchase Agreement, are collectively referred to as the “<U>Notes</U>”).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Definitions</U>. All terms defined in the Code (as defined herein) and not defined in this Note have the meanings specified therein. As used in this Note, in addition to the terms defined elsewhere in this Note, the following terms shall have the following meanings:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>ABL Debt</U>” means the “Obligations” as defined in the ABL Debt <FONT STYLE="letter-spacing: -0.1pt">Documents.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>ABL Debt Documents</U>” means that certain Ledgered ABL Agreement dated as of March 28, 2022 between Borrower and ABL Lender, that certain Overadvance Rider to Ledgered ABL Agreement dated as of March 28, 2022 between Borrower and ABL Lender, and that certain Inventory Finance Rider to Purchasing and Security Agreement dated as of dated as of March 28, 2022 between Borrower and ABL Lender.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>ABL Lender</U>” means Alterna Capital Solutions, LLC, a Florida limited liability company.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Additional Interest</U>” has the meaning set forth in the Registration Rights Agreement.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Affiliate</U>” means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, controls or is controlled by or is under common control with the Person specified. For the purposes of this definition, “control,” when used with respect to any specified Person means the power to direct or cause the direction of the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>AHYDO Payment</U>” means any payment required to be made pursuant to the terms of any Subordinated Debt instrument after the fifth anniversary of the issuance thereof that is intended to avoid such Subordinated Debt instrument being classified as an “applicable high yield discount obligation” within the meaning of Section 163(i) of the Internal Revenue Code.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Amortization/Interest Conversion Price</U>” means, with respect to any Amortization Payment Date or Conversion Date, ninety percent (90%) of the arithmetic average of the Daily VWAP for the five (5) VWAP Trading Days ending on the VWAP Trading Day immediately preceding such Amortization Payment Date or Conversion Date, as applicable.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Anti-Corruption Laws</U>” means the United States Foreign Corrupt Practices Act of 1977, the U.K. Bribery Act of 2010, as amended, and all other applicable laws and regulations <FONT STYLE="letter-spacing: -0.25pt">or </FONT>ordinances concerning or relating to bribery, money laundering or corruption in any jurisdiction in which any Note Party or any of its Subsidiaries or Affiliates is located or is doing business.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 2; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Anti-Money Laundering Laws</U>” means the applicable laws, statutes, regulations or rules in any jurisdiction in which any Note Party or any of its Subsidiaries or Affiliates is located or is doing business that relates to money laundering, any predicate crime to money laundering, or any financial record keeping and reporting requirements related thereto, including, but not limited to, the Bank Secrecy Act (31 U.S.C. § 5311 et seq.) and the USA Patriot Act.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">“<U>Attribution Parties</U>” means, with respect to the Holder, collectively, the following Persons: </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) any investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the issuance of this Note, directly or indirectly managed or advised by the Holder’s investment manager or any of its affiliates or principals; (ii) any direct or indirect Affiliates of the Holder or any of the foregoing; (iii) any person acting or who would be deemed to be acting as a “group” (as such term is used Section 13(d) of the Exchange Act and as defined in Rule 13d-5 thereunder) together with the Holder or any of the foregoing; and (iv) any other persons whose beneficial ownership shares of Common Stock would be aggregated with the Holder and the other Attribution Parties for purposes of Section 13(d) of the Exchange Act.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Authorized Share Amendment</U>” means an amendment to the Borrower’s certificate of incorporation, as amended, increasing the number of authorized shares of Common Stock to an amount that is sufficient, in the Borrower’s sole judgment after taking into account all shares of Common Stock outstanding on the Business Day immediately preceding the date that the definitive proxy statement relating to the Authorized Share Amendment is filed with the Commission, as well as all shares of Common Stock reserved or necessary to satisfy the Borrower’s obligations as of such date to issue shares of Common Stock pursuant to the terms of any then outstanding convertible or exchangeable securities or contractual obligations (other than the Notes) or the Borrower’s anticipated future capital raising activities, to settle the conversion of all then- outstanding Notes at the Conversion Rate then applicable, after giving effect to the maximum number of shares of Common Stock that may be deliverable upon conversion in connection with a Make-Whole Fundamental Change, plus such additional number of shares of Common Stock that the Borrower reasonably anticipates issuing in connection with Amortization Payments and Interest Make-Whole Payments on the Notes, in each case without giving effect to any Beneficial Ownership Limitation.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Authorized Share Amendment Date</U>” means the date the Borrower has adopted and duly filed with the Secretary of State of the State of Delaware the Authorized Share Amendment (which shall be following receipt by the Borrower of the requisite stockholder approvals for such Authorized Share Amendment and the Nasdaq Stockholder Approval).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Bank Services</U>” mean any products, credit services or financial accommodations previously, now or hereafter provided to any Note Party or any of its Subsidiaries by any third party bank, including any cash management services (including merchant services, direct deposit of payroll, business credit cards, and check cashing services), interest rate swap arrangements and foreign exchange services as any such products or services may be identified in such third party bank’s various agreements related thereto.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 3; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Board of Directors</U>” means the board of directors of the <FONT STYLE="letter-spacing: -0.1pt">Borrower.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Business Day</U>” means any day other than a Saturday, a Sunday or other day on which commercial banks in New York, New York or Wilmington, Delaware are authorized or required by law or executive order to close or be closed.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Capital Lease Obligations</U>” of any Person means the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP (consistently applied), and the amount of such obligations shall be the capitalized amount thereof determined in accordance with GAAP (consistently applied); <I>provided </I>that any lease that would properly be recognized as an “operating lease” by any Note Party as of the date hereof shall continue to be treated as an operating lease and shall not constitute a Capital Lease Obligation for purposes <FONT STYLE="letter-spacing: -0.1pt">hereof.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Capital Stock</U>” means, any and all shares, interests, rights to purchase, warrants and options (whether denominated as common stock or preferred stock), equity interests, beneficial, partnership or membership interests, joint venture interests, participations or other ownership or profit interests in or equivalents (regardless of how designated) of or in a Person (other than an individual), whether voting or non-voting.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Cash Equivalents</U>” means, as to any Person: (a) securities issued or directly and fully and unconditionally guaranteed or insured by the United States or any agency or instrumentality thereof (but only so long as the full faith and credit of the United States is pledged in support thereof) having maturities of not more than twelve months from the date of <FONT STYLE="letter-spacing: -0.1pt">acquisition; </FONT>(b) securities issued by any state of the United States or any political subdivision of any such state or any public instrumentality thereof having maturities of not more than 180 days from the date of acquisition and having one of the two highest ratings from either Standard & Poor’s, a division of The McGraw-Hill Companies, Inc., or Moody’s Investors Service, Inc.; (c) certificates of deposit, denominated solely in U.S. Dollars, maturing within twelve months after the date of acquisition, issued by any commercial bank organized under the laws of the United States or any state thereof or the District of Columbia or that is a U.S. subsidiary of a foreign commercial bank; in each of the foregoing cases, solely to the extent that (i) such commercial bank’s short-term commercial paper is rated at least A-1 or the equivalent by Standard & Poor’s, a division of The McGraw-Hill Companies, Inc., or at least P-1 or the equivalent thereof by Moody’s Investors Service, Inc. (any such commercial bank, an “<U>Approved Bank</U>”) or (ii) the par amount of all certificates of deposit acquired from such commercial bank are fully insured by the Federal Deposit Insurance Corporation; or (d) commercial paper issued by any Approved Bank (or by the parent company thereof), in each case maturing not more than twelve months after the date of the acquisition <FONT STYLE="letter-spacing: -0.1pt">thereof.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>CFC</U>” means a “controlled foreign corporation” within the meaning of Section 957 of the Internal Revenue Code in which any Note Party would be treated as a United States shareholder (as defined in Section 951(b)) for purposes of including income under Sections 951(a)(1) or 951A(a) of the Internal Revenue Code.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 4; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>CFC Holdco</U>” means any Subsidiary substantially all of the assets of which (directly or indirectly) consist of Capital Stock (including, for this purpose, any debt or other instrument treated as equity for U.S. federal income tax purposes) in, or debt issued by, one or more (a) CFCs or (a) other CFC Holdcos.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Close of Business</U>” means 5:00 p.m., New York City <FONT STYLE="letter-spacing: -0.1pt">time.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Code</U>” means the Uniform Commercial Code as adopted and in effect in the State of New York, as amended from time to time; <I>provided</I>, that, to the extent that the Code is used to define any term herein or in any other Note Document and such term is defined differently in different Articles or Divisions of the Code, the definition of such term contained in Article or Division 9 shall govern; <I>provided further</I>, that in the event that, by reason of mandatory provisions of law, any or all of the attachment, perfection or priority of, or remedies with respect to, the Collateral Agent’s Lien on any Collateral is governed by the Uniform Commercial Code in effect in a jurisdiction other than the State of New York, the term “Code” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions thereof relating to such attachment, perfection, priority or remedies and for purposes of definitions relating to such provisions.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Collateral</U>” means the Article 9 Collateral and the Pledged Collateral, in each case, other than any Excluded Assets.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Collateral Agent</U>” means Wilmington Savings Fund Society, FSB, in its capacity as collateral agent for the holders of Notes (together with its successors and permitted assigns in such <FONT STYLE="letter-spacing: -0.1pt">capacity).</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Collateral Pledge Agreements</U>” mean, collectively, any pledge agreement relating to the Capital Stock or evidence of Indebtedness of any Subsidiary owned directly or indirectly by the Borrower or any other Note Party to the extent necessary or useful to perfect the Collateral Agent’s security interest therein under applicable Laws.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Commission</U>” means the U.S. Securities and Exchange <FONT STYLE="letter-spacing: -0.1pt">Commission.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Common Stock</U>” means the Borrower’s Common Stock, par value $0.0001 per share (as such stock may be renamed or reclassified from time to time).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Common Equity</U>” of any Person means Capital Stock of such Person that is generally entitled (a) to vote in the election of directors of such Person or (b) if such Person is not a corporation, to vote or otherwise participate in the selection of the governing body, partners, managers, trustees or others that will control the management or policies of such Person.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Contingent Obligation</U>” means, as applied to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to (a) any indebtedness, lease, dividend, letter of credit or other obligation of another, (b) any obligations with respect to undrawn letters of credit, corporate credit cards, or merchant services issued or provided for the account of that Person <FONT STYLE="letter-spacing: -0.25pt">and </FONT>(c) all obligations arising under any agreement or arrangement designed to protect such Person against fluctuation in interest rates, currency exchange rates or commodity prices; <I>provided</I>, <I>however</I>, that the term “Contingent Obligation” shall not include endorsements for collection <FONT STYLE="letter-spacing: -0.25pt">or </FONT>deposit in the ordinary course of business. The amount of any Contingent Obligation shall be deemed to be an amount equal to the stated or determined amount of the primary obligation in respect of which such Contingent Obligation is made or, if not stated or determinable, the maximum liability in respect thereof as determined by the Majority Holders in good faith; <I>provided</I>, <I>however</I>, that such amount shall not in any event exceed the maximum amount of the obligations under the guarantee or other support arrangement.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 5; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Control Agreement</U>” means an agreement, the terms of which are satisfactory to the Majority Holders and the Collateral Agent, as to its rights, duties and obligations (it being agreed that any agreement that shall require the Collateral Agent to indemnify any institution in its individual capacity shall not be satisfactory to the Collateral Agent), which is executed by the Collateral Agent, the applicable Note Party and the applicable financial institution or <FONT STYLE="letter-spacing: -0.1pt">securities/investment intermediary, and which perfects the Collateral Agent’s (for its benefit and for </FONT>the benefit of the Holder Representative and the holders of Notes) first priority security interest in such Note Party’s deposit, securities or commodities accounts maintained as such financial institution or securities/investment intermediary.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Conversion Price</U>” means, as of any time, an amount equal to (A) one dollar ($1) divided by (B) the Conversion Rate in effect at such time.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Conversion Rate</U>” initially means 4.1530 shares of Common Stock per one dollar ($1) Principal Amount; <I>provided</I>, <I>however</I>, that the Conversion Rate is subject to adjustment pursuant to <U>Section 4</U>; <I>provided</I>, <I>further</I>, that whenever this Note refers to the Conversion Rate as of a particular date without setting forth a particular time on such date, such reference will be deemed to be to the Conversion Rate immediately after the Close of Business on such date.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Conversion/PIK Schedule</U>” means the Conversion/PIK Schedule in the form of <U>Schedule 1</U> maintained by the Borrower and the Holder; <I>provided </I>that in the event of any dispute or discrepancy regarding the Conversion/PIK Schedule, the records of the Holder shall be controlling and determinative in the absence of manifest error.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Conversion Shares</U>” means the shares of Common Stock issued or issuable upon conversion of this Note (including any such shares issued as part of any Interest Make-Whole <FONT STYLE="letter-spacing: -0.1pt">Payment).</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Copyright License</U>” means any written agreement, now or hereafter in effect, granting any right to any third party under any Copyright now or hereafter owned by any Note Party or that such Note Party otherwise has the right to license, or granting any right to any Note Party under any copyright now or hereafter owned by any third party, and all rights of such Note Party under any such agreement.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Copyrights</U>” means any and all copyright rights, copyright applications, copyright <FONT STYLE="letter-spacing: -0.1pt">registrations and like protections in each work or authorship and derivative work thereof, whether or </FONT>not filed with the USCO or foreign equivalent.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">“<U>Daily VWAP</U>” means, with respect to the Common Stock for any Trading Day, the per share </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">volume-weighted average price of the Common Stock for such Trading Day as reported by Bloomberg through its “Volume at Price” function in respect of the period from 9:30 a.m. to <FONT STYLE="letter-spacing: -0.2pt">4:00 p.m., New York City time, or if such volume-weighted average price is unavailable, the market value of one share of Common Stock on such Trading Day using a volume-weighted method as determined </FONT>by a nationally recognized independent investment banking firm retained for this purpose by the <FONT STYLE="letter-spacing: -0.1pt">Borrower.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 6; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Debtor Relief Laws</U>” means Title 11 of the United States Code entitled “Bankruptcy” and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization or similar debtor relief Laws of the United States or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Default</U>” means any event which with the passing of time or the giving of notice or both would become an Event of Default.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Depositary</U>” means The Depository Trust Company or its <FONT STYLE="letter-spacing: -0.1pt">successor.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Disclosure Letter</U>” means the disclosure letter dated as of the date hereof containing certain information and schedules delivered by the Note Parties to the Holder Representative and the Collateral Agent (as such disclosure letter may be supplemented from time to time in accordance with the terms hereof).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Disqualified Stock</U>” means any Capital Stock that, by its terms (or by the terms of any security into which it is convertible or for which it is exchangeable), or upon the happening of any event, (a) matures (excluding any maturity as the result of an optional redemption by the issuer thereof) or is mandatorily redeemable, pursuant to a sinking fund obligation or otherwise, or is redeemable at the option of the holder thereof, in whole or in part, or requires the payment of any cash dividend or any other scheduled payment constituting a return of capital, in each case at any time on or prior to the date that is one year and one day following the Maturity Date; or (b) is convertible into or exchangeable (unless at the sole option of the issuer thereof) for (i) debt securities or (ii) any Capital Stock referred to in clause (a) above, in each case at any time on or prior to the date that is one year and one day following the Maturity Date.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>DWAC Eligible</U>” means that (a) the Common Stock is eligible at the Depositary for full services pursuant to DTC’s Operational Arrangements, including transfer through the Depositary’s DWAC system, (b) the Borrower has been approved (without revocation) by the Depositary’s underwriting department, (c) the Transfer Agent is approved as an agent in the Depositary’s Fast Automated Securities Transfer Program, (d) the applicable shares of Common Stock are otherwise eligible for delivery via DWAC, and (e) the Transfer Agent does not have a policy prohibiting or limiting delivery of the applicable shares of Common Stock via DWAC.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Equity Payment Conditions</U>” means, at the time of the relevant payment, (i) Nasdaq Stockholder Approval shall have been obtained or the Majority Holders shall have waived the covenant contained in Section 7(ii), (ii) the shares of Common Stock to be issued must be duly authorized under the Borrower’s Organizational Documents, (iii) the Beneficial Ownership Limitations would not limit such payment, (iv) any shares of Common Stock issued in connection with such payment are either eligible for resale under Rule 144 without regard to the current public information requirements contained therein or are registered for resale by the Holder on <FONT STYLE="letter-spacing: -0.25pt">an </FONT>effective registration statement with a current prospectus relating thereto, (v) no Event of Default has occurred and is ongoing, (vi) the shares of Common Stock to be issued are listed on any of The New York Stock Exchange, The NASDAQ Capital Market, The NASDAQ Global Market or The NASDAQ Global Select Market (or any of their respective successors), and (vii) the shares of Common Stock to be issued must be DWAC Eligible and not subject to a “DTC chill”.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 7; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>ERISA</U>” means the Employee Retirement Income Security Act of 1974, as amended from time to time.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>ERISA Affiliate</U>” means any entity, trade or business (whether or not incorporated) under common control with the Borrower or any of its Affiliates within the meaning of Section 414(b) or (c) of the Internal Revenue Code (and Sections 414(m) and (o) for purposes of provisions relating to Section 412 of the Internal Revenue Code).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>ERISA Event</U>” means: (a) a Reportable Event with respect to a Pension Plan; (b) a withdrawal by any Note Party or any ERISA Affiliate from a Pension Plan subject to Section 4063 of ERISA during a plan year in which it was a substantial employer (as defined in Section 4001(a)(2) of ERISA) or a cessation of operations that is treated as such a withdrawal under Section 4062(e) of ERISA; (c) a complete or partial withdrawal by any Note Party or any ERISA Affiliate from a Multiemployer Plan or notification that a Multiemployer Plan is in <FONT STYLE="letter-spacing: -0.1pt">reorganization; </FONT>(d) the filing of a notice of intent to terminate a Pension Plan, the treatment of a Plan amendment as a termination under Section 4041 or 4041A of ERISA, or the commencement of proceedings by the PBGC to terminate a Pension Plan or Multiemployer Plan; (e) an event or condition which constitutes grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan or Multiemployer Plan; or (f) the imposition of any liability under Title IV of ERISA, other than for PBGC premiums due but not delinquent under Section 4007 of ERISA, upon any Note Party or any ERISA Affiliate.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Exchange Act</U>” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Ex-Dividend Date</U>” means, with respect to an issuance, dividend or distribution on the Common Stock, the first date on which shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such issuance, dividend or distribution (including pursuant to due bills or similar arrangements required by the relevant stock exchange). To avoid doubt, any alternative trading convention on the applicable exchange or market in respect of the Common Stock under a separate ticker symbol or CUSIP number will not be considered “regular way” for this purpose.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Foreign Subsidiary</U>” means any Subsidiary of a Note Party that is organized under the Laws of a jurisdiction other than the United States, any state thereof or the District of Columbia.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Fundamental Change</U>” means any of the following <FONT STYLE="letter-spacing: -0.1pt">events:</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) a “person” or “group” (within the meaning of Section 13(d) of the Exchange Act), other than the Borrower or its Wholly Owned Subsidiaries, or their respective employee benefit plans files a Schedule TO (or any successor schedule, form or report) or any schedule, form or report under the Exchange Act disclosing that such person or <FONT STYLE="letter-spacing: -0.1pt">group </FONT>has become the direct or indirect “beneficial owner” (as defined below) of Common Stock (or such other Common Equity into which the Common Stock has been reclassified) representing more than 50% of the voting power of the Common Stock (or such other Common Equity into which the Common Stock has been reclassified);</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 8; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) the consummation of (i) any sale, lease or other transfer, in one transaction or a series of transactions, of all or substantially all of the assets of the Borrower and its Subsidiaries, taken as a whole, to any Person other than any of the Borrower’s Wholly Owned Subsidiaries; or (ii) any transaction or series of related transactions in connection with which (whether by means of merger, consolidation, share exchange, combination, reclassification, recapitalization, acquisition, liquidation or otherwise) all of the Common Stock is exchanged for, converted into, acquired for, or constitutes solely the right to receive, other securities, cash or other property; <I>provided</I>, <I>however</I>, that any merger, consolidation, share exchange or combination of the Borrower pursuant to which the Persons that directly or indirectly “beneficially owned” (as defined below) Common Stock (or such other Common Equity into which the Common Stock has been reclassified) immediately before such transaction directly or indirectly “beneficially own,” immediately after such transaction, more than fifty percent (50%) of the Common Stock (or such other Common Equity into which the Common Stock has been reclassified) of the surviving, continuing or acquiring company or other transferee, as applicable, or the parent thereof, in substantially the same proportions vis-à-vis each other as immediately before such transaction will be deemed not to be a Fundamental Change pursuant to this clause (B);</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C) the Borrower’s stockholders approve any plan or proposal for the liquidation or dissolution of the Borrower; or</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D) the Common Stock ceases to be listed on any of The New York Stock Exchange, The NASDAQ Capital Market, The NASDAQ Global Market or The NASDAQ Global Select Market (or any of their respective successors);</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>provided</I>, <I>however</I>, that a transaction or event described in clause (A) or (B) above will not constitute a Fundamental Change if at least ninety percent (90%) of the consideration received or to be received by the holders of Common Stock (excluding cash payments for fractional shares or pursuant to dissenters rights), in connection with such transaction or event, consists of shares of common stock listed on any of The New York Stock Exchange, The NASDAQ Capital Market, The NASDAQ Global Market or The NASDAQ Global Select Market (or any of their respective successors), or that will be so listed when issued or exchanged in connection with such transaction or event, and such transaction or event constitutes a Common Stock Change Event whose Reference Property consists of such consideration.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the purposes of this definition, (x) any transaction or event described in both clause (A) and in clause (B)(i) or (ii) above (without regard to the proviso in clause (B)) will be deemed to occur solely pursuant to clause (B) above (subject to such proviso); and (y) whether a Person is a “beneficial owner” and whether shares are “beneficially owned” will be determined in accordance with Rule 13d-3 under the Exchange Act.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 9; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>GAAP</U>” means, as of any date of determination, generally accepted accounting principles as then in effect in the United States of America set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>guarantee</U>” of or by any Person (the “<U>guarantor</U>”) means any obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the “<U>primary obligor</U>”) in any manner, whether directly or indirectly, and including any obligation of the guarantor, direct or <FONT STYLE="letter-spacing: -0.1pt">indirect, </FONT>(a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of) any security for the payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment <FONT STYLE="letter-spacing: -0.1pt">thereof, </FONT>(c) to maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of any letter of credit or letter of guaranty issued to support such Indebtedness or obligation; <I>provided </I>that the term “guarantee” shall not include endorsements for collection or deposit in the ordinary course of business.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Guarantor</U>” means each Subsidiary of the Borrower and their respective successors <FONT STYLE="letter-spacing: -0.25pt">and </FONT><FONT STYLE="letter-spacing: -0.1pt">assign.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Guaranty</U>” means, collectively, the guaranty of the Note Obligations by the <FONT STYLE="letter-spacing: -0.1pt">Guarantors </FONT>pursuant to this <FONT STYLE="letter-spacing: -0.1pt">Note.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Governmental Authority</U>” shall mean the government of the United States of America or any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Hedging Agreement</U>” means any interest rate protection agreement, foreign currency exchange agreement, commodity price protection agreement or other interest or currency exchange rate or commodity price hedging arrangement.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Holder Representative</U>” has the meaning set forth in the first paragraph of this Note (together with its successors and permitted assigns in such capacity).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Indebtedness</U>” of any Person means without duplication (a) all indebtedness created, assumed or incurred in any manner by the Borrower representing money borrowed (including by the issuance of debt securities, notes, bonds, debentures or similar instruments) and all obligations with respect to deposits or advances of any kind, (b) all obligations of such Person or with respect to letters of credit, bankers’ acceptances and other similar extensions of credit whether or not representing obligations for borrowed money, (c) all obligations of such Person upon which interest charges are customarily paid, (d) all obligations of such Person under conditional sale or other title retention agreements relating to property or assets purchased by such Person, <FONT STYLE="letter-spacing: -0.1pt">including </FONT>any earn-out obligations, (e) all obligations of such Person issued or assumed as the deferred purchase price of property or services (excluding trade accounts payable and accrued obligations incurred in the ordinary course of business and not more than 90 days past due), (f) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on property owned or acquired by such Person, whether or not the obligations secured thereby have been assumed, (g) all Contingent Obligations of such Person including indebtedness of others, (h) all Capital Lease Obligations and Synthetic Lease Obligations of such Person, (i) obligations in respect of Disqualified Stock and (j) all obligations of such Person in respect of any exchange traded or over the counter derivative transaction, including any Hedging Agreement, in each case, whether entered into for hedging or speculative purposes or otherwise. The amount of any Indebtedness of any Person in respect of a Hedging Agreement shall be the amount determined in respect thereof as of the end of the then most recently ended fiscal quarter of such Person, based on the assumption that such Hedging Agreement had terminated at the end of such fiscal quarter. In making such determination, if any agreement relating to such Hedging Agreement provides for the netting of amounts payable by and to such Person thereunder or if any such agreement provides for the simultaneous payment of amounts by and to such Person, then in each such case, the amount of such obligation shall be the net amount so determined, in each case to the extent that such agreement is legally enforceable in any insolvency proceedings against the applicable counterparty thereof. The Indebtedness of any Person shall include the Indebtedness of any partnership or joint venture in which such Person is a general partner or joint venturer. For the avoidance of doubt, ordinary course operating leases and guarantees thereof shall not constitute Indebtedness.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 10; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Initial Closing Date</U>” shall have the meaning given to such term in the Purchase <FONT STYLE="letter-spacing: -0.1pt">Agreement.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Initial Holders</U>” means, together, Whitebox Multi-Strategy Partners, LP, Whitebox Relative Value Partners, LP, Pandora Select Partners, LP and Whitebox GT Fund, LP.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Insurance/Condemnation Event</U>” means any casualty or other insured damage to, or any taking under the power of eminent domain or by condemnation or similar proceeding of, or any disposition under a threat of such taking of, all or any part of any assets of any Note Party or any Subsidiary thereof.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">“<U>Intellectual Property</U>” means all of a Person’s right, title and interest in and to the following: </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">domain names; Copyrights, Trademarks and Patents (including registrations and applications therefor prior to granting, and whether or not filed, recorded or issued); all trade secrets and related rights, including rights to unpatented inventions, know-how and manuals; all design rights; claims <FONT STYLE="letter-spacing: -0.1pt">for damages by way of past, present and future infringement of any of the rights included above; and </FONT>all amendments, renewals and extensions of any Copyrights, Trademarks or Patents.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Intellectual Property Security Agreement</U>” means any short-form Patent Security Agreement, short-form Trademark Security Agreement or short-form Copyright Security Agreement, each in form and substance satisfactory to the Majority Holders for filing with the USPTO or USCO, as applicable.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"> </FONT></P> <!-- Field: Page; Sequence: 11; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">“<U>Intercreditor Agreement</U>” means that certain Collateral Sharing Agreement, dated as of May </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9, 2022, among the ABL Lender, the Borrower, the Holder Representative and the Collateral <FONT STYLE="letter-spacing: -0.1pt">Agent.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Interest Payment Date</U>” means the Maturity Date and each May 9 and November 9 of each year, beginning on November 9, 2022.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Internal Revenue Code</U>” means the Internal Revenue Code of 1986, as amended from time to time, and the regulations promulgated and rulings issued thereunder.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Inventory</U>” means “inventory” as defined in the Code, including work in process and finished products intended for sale or lease or to be furnished under a contract of service, of every kind and description now or at any time hereafter owned by or in the custody or possession, actual or constructive, of any Note Party, including such inventory as is temporarily out of its custody or possession or in transit and including any returns upon any accounts or other proceeds, including insurance proceeds, resulting from the sale or disposition of any of the foregoing and any documents of title representing any of the above, and the applicable Note Party’s books and records relating to any of the foregoing.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Investment</U>” means, as to any Person, all investments by such Person in other Persons (including Affiliates) in the form of loans (including guarantees), advances or capital contributions (other than advances made in the ordinary course of business that would be recorded as accounts receivable on the balance sheet of the specified Person prepared in conformity with GAAP), purchases or other acquisitions for consideration of Indebtedness, Capital Stock or other securities issued by any other Person and the purchase or other acquisition (in one transaction or a series of transactions) of all or substantially all of the property or assets or business of another Person or assets constituting a business unit, line of business or division of such other Person</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Joinder Agreement</U>” means an agreement substantially in the form of <U>Exhibit A</U>.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Landlord Subordination and Access Agreement</U>” means an agreement between <FONT STYLE="letter-spacing: -0.25pt">the </FONT>applicable Note Party’s landlord(s) and the Collateral Agent that provides the Collateral Agent access to the premises that such Note Party leases from such <FONT STYLE="letter-spacing: -0.45pt">landlord</FONT> in a form reasonably <FONT STYLE="letter-spacing: -0.1pt">satisfactory to the Majority Holders and the Collateral Agent, as to its rights, duties and obligations.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Last Reported Sale Price</U>” of the Common Stock for any Trading Day means the closing sale price per share (or, if no closing sale price is reported, the average of the last bid price and the last ask price per share or, if more than one in either case, the average of the average last bid prices and the average last ask prices per share) of Common Stock on such Trading Day as reported in composite transactions for the principal U.S. national or regional securities exchange on which the Common Stock is then listed. If the Common Stock is not listed on a U.S. national or regional securities exchange on such Trading Day, then the Last Reported Sale Price will be the last quoted bid price per share of Common Stock on such Trading Day in the over-the-counter market as reported by OTC Markets Group Inc. or a similar organization. If the Common Stock is not so quoted on such Trading Day, then the Last Reported Sale Price will be the average of the mid- point of the last bid price and the last ask price per share of Common Stock on such Trading <FONT STYLE="letter-spacing: -0.25pt">Day </FONT><FONT STYLE="letter-spacing: -0.1pt">from each of at least three (3) nationally recognized independent investment banking firms selected </FONT>by the Borrower.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 12; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Laws</U>” means, collectively, all international, foreign, Federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the legally binding interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, legally binding requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>License</U>” means any Patent License, Trademark License, Copyright License or other Intellectual Property license or sublicense agreement to which any Note Party is a party, together with any and all (a) renewals, extensions, amendments, restatements, supplements and <FONT STYLE="letter-spacing: -0.1pt">continuations thereof, (b) income, fees, royalties, damages, claims and payments now and hereafter </FONT>due or payable thereunder or with respect thereto including damages and payments for past, present or future breach or violations thereof and (c) rights to sue for past, present and future breach or violations thereof.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Lien</U>” means any pledge, bailment, lease, mortgage, hypothecation, conditional sales and title retention agreement, charge, claim, encumbrance or other lien in favor of any Person.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Majority Holders</U>” means, with respect to any date, the holders of Notes representing more than 50% of the aggregate principal amount of the Notes outstanding on such date; <I>provided</I>, at any time that any of the Initial Holders continue to hold any of the Notes, (i) for purposes of Section 12, “Majority Holders” must include such Initial Holder(s) and (ii) for all other purposes, “Majority Holders” means the Initial Holders.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Market Disruption Event</U>” means, with respect to any date, (1) a failure by the <FONT STYLE="letter-spacing: -0.1pt">principal </FONT>U.S. national securities exchange or market on which the Common Stock is listed or admitted for trading to open for trading during its regular trading session or (2) the occurrence or existence prior to 1:00 p.m., New York City time, on any scheduled Trading Day for the Common Stock for more than one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits permitted by the relevant stock exchange or otherwise) in the Common Stock or in any options contracts or futures contracts relating to the Common Stock.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Make-Whole Fundamental Change</U>” means a Fundamental Change (determined after giving effect to the proviso immediately after clause (D) of the definition thereof, but without regard to the proviso to clause (B)(ii) of such definition).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Make-Whole Fundamental Change Conversion Period</U>” means the period from, and including, the Make-Whole Fundamental Change Effective Date of such Make-Whole Fundamental Change to, and including, the thirty fifth (35th) Trading Day after such Make-Whole Fundamental Change Effective Date (or, if such Make-Whole Fundamental Change also constitutes a Fundamental Change, to, but excluding, the related Fundamental Change Repurchase <FONT STYLE="letter-spacing: -0.1pt">Date).</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 13; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Make-Whole Fundamental Change Effective Date</U>” means the date on which such Make- Whole Fundamental Change occurs or becomes effective.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Material Adverse Effect</U>” means a material adverse effect on or material adverse developments with respect to (i) the business, operations, properties, assets, financial condition of the Borrower and its Subsidiaries taken as a whole; (ii) the ability of the Borrower to fully and timely perform its obligations under this Note or (iii) the legality, validity, binding effect or enforceability against the Borrower of this Note.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Maturity Date</U>” means the earlier of (i) June 30, 2023 and (ii) ninety-one (91) days before the scheduled maturity of any unsecured Indebtedness incurred by the Borrower that is junior in right of payment to the Note Obligations.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Mortgage</U>” means a mortgage, deed of trust or deed to secure debt, in form and substance reasonably satisfactory to Majority Holders and the Collateral Agent, as to its rights, duties and obligations, made by a Note Party in favor of the Collateral Agent for the benefit of the Collateral Agent and the holders of Notes, securing the Note Obligations.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Multiemployer Plan</U>” means any “multiemployer plan” (as defined in Section 4001(a)(3) of ERISA) to which the Borrower, any of its Subsidiaries or any ERISA Affiliate makes or is obligated to make contributions, or during the preceding six years has made or been obligated to make contributions.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Nasdaq Stockholder Approval</U>” means the receipt by the Borrower of requisite approval from its stockholders to issue more than 19.9% of its outstanding shares of Common Stock at an issue price below the “minimum price” in payment of interest, amortization and settlement of conversions of the Notes in accordance with Nasdaq Stock Market Rule 5635.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Negotiable Collateral</U>” means all letters of credit of which any Note Party is a beneficiary, notes, drafts, instruments, securities, documents of title, and chattel paper, and any Note Party’s books and records relating to any of the foregoing.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Net Proceeds</U>” means, with respect to any event, the cash (which term, for purposes of this definition, shall include Cash Equivalents) proceeds (including, in the case of any Insurance/Condemnation Event, insurance, condemnation and similar proceeds) received in respect of such event, including any cash and Cash Equivalents received in respect of any non- cash proceeds, but only as and when received, net of (a) all fees and out-of-pocket costs and expenses incurred in connection with such event by any Note Party or any Subsidiary thereof to Persons that are not Affiliates of the Note Parties or their Subsidiaries (including attorneys’, accountants’ and consultants’ fees, investment banking and advisory fees and underwriting discounts and commissions), (b) the amount of all payments (including in respect of principal, accrued interest and premiums) required to be made by any Note Party or any Subsidiary thereof as a result of such event to repay Indebtedness (other than the Notes) secured by the assets subject thereto, (c) the amount of all payments reasonably estimated to be required to be made by any Note Party or any Subsidiary thereof in respect of purchase price adjustment, indemnification and similar contingent liabilities that are directly attributable to such event or in respect of any retained liabilities associated with such event (including pension and other post-employment benefit liabilities and environmental liabilities) and (d) the amount of all Taxes (including transfer taxes, deed or recording taxes and repatriation taxes or any withholding or deduction) paid (or reasonably estimated to be payable) by any Note Party or any Subsidiary thereof in connection with such <FONT STYLE="letter-spacing: -0.1pt">event.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 14; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Note Collateral Documents</U>” means, collectively, all Intellectual Property Security Agreements, Mortgages, Control Agreements, Notice and Access Agreements, Landlord Subordination and Access Agreements, each other agreement, instrument or document that creates or purports to create a Lien in favor of the Collateral Agent for the benefit of the Collateral Agent and the holders of Notes and all financing statements (or comparable documents now or hereafter filed in accordance with the Code or comparable Law) against any Note Party as debtor in favor of the Collateral Agent for the benefit of the Collateral Agent and the holders of Notes, as secured party, as any of the foregoing may be amended, restated, supplemented or modified from time to <FONT STYLE="letter-spacing: -0.1pt">time.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Note Documents</U>” means, collectively, the Notes, the Purchase Agreement, the Registration Rights Agreement, the Note Collateral Documents, the Intercreditor Agreement, each Subordination Agreement and any other agreement, document or instrument entered into in connection with the foregoing.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Note Obligations</U>” means the Obligations of the Borrower and the other obligors (including the Guarantors) under this Note to pay principal, premium, if any, and interest (including all interest accruing after the commencement of any bankruptcy, insolvency, reorganization or similar proceeding, whether or not a claim for such post-petition interest is allowed or allowable in such proceeding) when due and payable, and all other amounts due or to become due under or in connection with the performance of all other Obligations of the Borrower and the Guarantors under the Note Documents, according to the respective terms thereof.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Note Party</U>” means the Borrower and each <FONT STYLE="letter-spacing: -0.1pt">Guarantor.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Notice and Access Agreement</U>” means an agreement between a third party warehouse, fulfillment center, bailee or similar entity, on the one hand, and the Collateral Agent on the other, that provides the Collateral Agent access to the premises containing a Note Party’s Inventory or other Collateral and otherwise in form and substance reasonably satisfactory to Majority Holders and the Collateral Agent, as to its rights, duties and obligations.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Obligations</U>” means all advances to, and debts, liabilities, obligations, covenants and duties of, any Note Party and its Subsidiaries arising under this Note and any other Note Document or otherwise, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after acceleration of the Obligations or after the commencement by or against any Note Party or any Subsidiary of a Note Party of any proceeding under any Debtor Relief Laws naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding. Without limiting the generality of the foregoing, the Obligations include the obligation (including guarantee obligations) to pay all principal, interest, penalties, fees, charges, expenses, attorneys’ costs, indemnifications, reimbursements, <FONT STYLE="letter-spacing: -0.1pt">debts, </FONT>liabilities and other amounts, and all obligations, covenants, damages and duties of any Note Party and its Subsidiaries arising under any Note Document or otherwise.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 15; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>OFAC</U>” means the Office of Foreign Assets Control of the U.S. Treasury Department.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Open of </U>Business” means 9:00 a.m., New York City time.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Organizational Documents</U>” means (a) with respect to any corporation or company, its certificate or articles of incorporation, organization or association, as amended, and its bylaws, as amended, (b) with respect to any limited partnership, its certificate or declaration of limited partnership, as amended, and its partnership agreement, as amended, (c) with respect to any general partnership, its partnership agreement, as amended, and (d) with respect to any limited liability company, its certificate of formation or articles of organization, as amended, and its operating agreement, as amended.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Original Issue Date</U>” means February 10, <FONT STYLE="letter-spacing: -0.1pt">2023.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Patent License</U>” means any written agreement, now or hereafter in effect, granting to any third party any right to make, use or sell any invention or designs on which a Patent, now or hereafter owned by any Note Party or that any Note Party otherwise has the right to license, or granting to any Note Party any right to make, use or sell any invention or designs on which a patent, now or hereafter owned by any third party, is in existence, and all rights of any Note Party under any such agreement.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>“</I><U>Patents</U><I>” </I>means all patents, patent applications and like protections including <FONT STYLE="letter-spacing: -0.1pt">improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of </FONT>the same, whether or not filed with the USPTO or any foreign equivalent.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">“<U>PBGC</U>” means the Pension Benefit Guaranty Corporation.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Pension Plan</U>” means any “employee benefit plan” (as such term is defined in Section 3(2) of ERISA), other than a Multiemployer Plan, which is subject to Title IV of ERISA or Sections 412 of the Internal Revenue Code or Section 302 of ERISA, and which is or was, within the preceding six years, maintained by the Borrower, any of its Subsidiaries or any ERISA Affiliate.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">“<U>Permitted Indebtedness</U>” means the following:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Indebtedness of any Note Party in favor of the Collateral Agent or a holder of Notes arising under the Notes or any other Note Document;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Indebtedness existing on the Initial Closing Date and disclosed in Section 2 of the Disclosure Letter;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Indebtedness consisting of: (i) Permitted Investments allowed pursuant to clause (f) of the definition of “Permitted Investments”; and (ii) purchase money obligations for fixed or capital assets within the limitations set forth in clause (c) of the defined term “Permitted Liens”; <I>provided </I>that such Indebtedness does not exceed the lesser of the cost or fair market value of the equipment and software financed with such Indebtedness;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 16; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument inadvertently (except in the case of daylight overdrafts) drawn against insufficient funds in the ordinary course of business, <I>provided </I>that such Indebtedness is promptly extinguished;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Indebtedness arising in connection with endorsement of instruments for deposit in the ordinary course of business;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Indebtedness of any Note Party or any Subsidiary that may be deemed to exist in connection with agreements providing for warranty obligations entered into in the ordinary course of business;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Indebtedness of any Note Party or any Subsidiary arising from (i) customary credit card charges incurred in the ordinary course of business and (ii) Bank Services provided by any third party bank (in each case, other than Indebtedness for borrowed <FONT STYLE="letter-spacing: -0.1pt">money);</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Indebtedness consisting of the financing of insurance premiums contemplated by clause (o) of the definition of “Permitted Liens”;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) unsecured Indebtedness to trade creditors in the ordinary course of business not to exceed at any time outstanding $500,000 individually or $1,000,000 in the aggregate;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Indebtedness of any Note Party or any Subsidiary with respect to performance bonds, surety bonds, appeal bonds or customs bonds required in the ordinary course of business not to exceed in the aggregate more than $100,000 at any time <FONT STYLE="letter-spacing: -0.1pt">outstanding;</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) intercompany Indebtedness by and among the Borrower and its Subsidiaries (subject to clause (d) of the definition of “Permitted Investments”);</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) Subordinated Debt, so long as such Subordinated Debt (x) is on then current market terms (as reasonable determined by the Borrower and the Majority Holders), (y) has no scheduled amortization payments prior to 180 days after the Maturity Date and (z) does not mature prior to the date that is 180 days after the Maturity Date (except in case of clause (y) and (z) above, customary asset sale or change-of-control provisions that provide for the prior repayment in full of the Notes);</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) advances or deposits received in the ordinary course of business from customers or vendors;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) Indebtedness in favor of the ABL Lenders arising under the ABL Debt Documents not to exceed in the aggregate at any time outstanding or committed the sum of (i) on or prior to September 30, 2022, $11,534,395, or, on or after October 1, <FONT STYLE="letter-spacing: -0.1pt">2022, </FONT>$6,000,000 plus (ii) the aggregate principal amount of Notes voluntarily converted into Conversion Consideration pursuant to <U>Section 4</U> of each applicable Note, in each case subject to the terms of the Intercreditor Agreement; <I>provided </I>that the amount in the foregoing clause (ii) shall not exceed $10,000,000 at any time; and</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 17; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) extensions, refinancings, modifications, amendments and restatements of any items of Permitted Indebtedness (b) through (n) above; <I>provided </I>that (i) the principal amount thereof is not increased or the terms thereof are not modified to impose more burdensome or restrictive terms upon any Note Party or any Subsidiary, as the case may be, (ii) the maturity and weighted average life to maturity with respect to any Indebtedness incurred pursuant to clauses (b), (l) and (n) above in this definition is not shortened in connection with any such extensions, refinancings, modifications, amendments and restatements, (iii) no Event of Default shall have occurred and be continuing, (iv) if such Indebtedness being extended, refinanced, modified, amended or restated is subordinated in right of payment to the Obligations, such extension, refinancing, modification, amendment or restatement shall be subordinated in right of payment to the Obligations on terms at least as favorable to the holders of Notes as those contained in the documentation governing the Indebtedness being extended, refinanced, modified, amended or restated, (v) if such Indebtedness being extended, refinanced, modified, amended or restated is unsecured, such extension, refinancing, modification, amendment or restatement shall be unsecured, (vi) to the extent such Indebtedness being extended, refinanced, modified, amended or restated is secured or subject to intercreditor arrangements for the benefit of the holders of Notes, such extension, refinancing, modification, amendment or restatement is either (1) unsecured or (2) secured and, if secured, subject to an intercreditor arrangement in form and substance reasonably acceptable to the Collateral Agent, as to its rights, duties and obligations, and the Majority Holders on terms at least as favorable (including with respect to priority) to the holders of Notes as those contained in the documentation governing the Indebtedness being extended, refinanced, modified, amended or restated, and such extension, refinancing, modification, amendment or restatement is incurred by one or more Persons who is an obligor of the Indebtedness being extended, refinanced, modified, amended or restated and (vii) any such extension, refinancing, modification, amendment or restatement has the same primary obligor and the same (or fewer) guarantors as the Indebtedness being extended, refinanced, modified, amended or restated.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">“<U>Permitted Investments</U>” means the following:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Investments existing on the Initial Closing Date disclosed in Section 1 of the Disclosure Letter;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Investments constituting cash and Cash Equivalents; <I>provided </I>such cash and Cash Equivalents are in accounts which are subject to a Control Agreement in favor of the Collateral Agent to the extent required under Section 7(ee);</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Investments accepted in connection with Permitted <FONT STYLE="letter-spacing: -0.1pt">Transfers;</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Investments among Note <FONT STYLE="letter-spacing: -0.1pt">Parties;</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Investments (including debt obligations) received in connection with the bankruptcy or reorganization of customers or suppliers and in settlement of delinquent <FONT STYLE="letter-spacing: -0.1pt">obligations of, and other disputes with, customers or suppliers arising in the ordinary course </FONT>of the Note Parties’ business;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 18; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Investments consisting of the purchase of capital assets in an amount not to exceed $750,000 per fiscal year; provided that the aggregate amount of Investments made pursuant to this clause (f) after the Initial Closing Date shall not exceed $1,250,000 at any time outstanding;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Investments consisting of (i) travel advances and employee relocation loans and other employee loans and advances in the ordinary course of business in an aggregate amount not to exceed $50,000 per fiscal year and (ii) loans to employees, officers or directors relating to the purchase of Capital Stock of the Borrower or its Subsidiaries pursuant to employee stock purchase plans or agreements approved by the Board of Directors in an aggregate amount not to exceed $100,000 per fiscal year;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Investments consisting of the endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Investments in accounts at financial institutions; <I>provided</I>, that such accounts are permitted pursuant to Section 7(ee) and the Collateral Agent has a perfected Lien on the amounts held in such accounts as required pursuant to Section 7(ee);</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) Investments consisting of notes receivable of, or prepaid royalties and other credit extensions, to customers and suppliers who are not Affiliates of any Note Party or any Subsidiary, in the ordinary course of business, and Investments received in satisfaction or partial satisfaction thereof from financially troubled Account Debtors to the extent reasonably necessary in order to prevent or limit loss; <I>provided</I> that this shall not apply to Investments of any Note Party in any Subsidiary;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) deposits made to secure the performance of leases, licenses or contracts in the ordinary course of business, and other deposits made in connection with the incurrence of Permitted Liens; and</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) Investments for fair market value not otherwise permitted hereunder in an amount not to exceed $200,000 per fiscal year.</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Permitted Liens</U>” means the <FONT STYLE="letter-spacing: -0.1pt">following:</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Liens existing on the Initial Closing Date and disclosed in Section 3 of the Disclosure Letter;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Liens for taxes, fees, assessments or other governmental charges or levies that are not delinquent, not to exceed $100,000 in the aggregate at any time, and for which the applicable Note Party maintains adequate reserves in accordance with GAAP;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) Liens (i) upon or in any equipment acquired or held by a Note Party or any of its Subsidiaries to secure the purchase price of such equipment incurred solely for the purpose of financing the equipment not to exceed $1,250,000 outstanding at any time, <FONT STYLE="letter-spacing: -0.25pt">or </FONT>(ii) existing on such assets at the time of their acquisition; <I>provided </I>that with respect to clauses (i) and (ii), the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds of such assets; <I>provided further</I> that the same <FONT STYLE="letter-spacing: -0.2pt">have </FONT>no priority over the Collateral Agent’s Lien in the Collateral (other than with respect to such equipment and related proceeds) and do not encumber the Collateral (other than with respect to such equipment and related proceeds);</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 19; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) Liens incurred in connection with the extension, renewal or refinancing of the indebtedness secured by Liens of the type described in clauses (a) through (c) above; <I>provided</I> that any extension, renewal or replacement Lien (i) shall be limited to the property encumbered by the existing Lien, (ii) shall not exceed the principal amount and interest rate of the indebtedness being extended, renewed or refinanced and (iii) the term for payment, the maturity and weighted average life to maturity with respect to items listed in clause (a) above in this definition shall not decrease in connection with any such extension, renewal or refinancing;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) Non-exclusive licenses of Intellectual Property granted to third parties in the ordinary course of the Note Parties’ business;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) Liens arising from judgments in circumstances not constituting an Event of Default under Section 12(a)(iv);</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) Liens in favor of other financial institutions arising in connection with a Note Party’s Deposit Accounts or Securities Accounts held at such institutions to secure standard fees for services charged by, but not financing made available by, such institutions; <I>provided </I>that the Collateral Agent, for its benefit and the benefit of the Holder Representative and the holders of Notes has a perfected security interest in the amounts held in such accounts to the extent required under Section 7(ee);</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) Liens in favor of customs and revenue authorities arising as a matter of Law to secure payments of customs duties in connection with the importation of goods;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Liens on deposits securing obligations with suppliers entered into in the ordinary course of business and deposits to secure the performance of bids, trade contracts and leases (other than Indebtedness), statutory obligations, surety and appeal bonds, performance bonds and other obligations of a like nature incurred in the ordinary course of <FONT STYLE="letter-spacing: -0.1pt">business;</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) customary statutory Liens of landlords and Liens of carriers, warehousemen, mechanics and suppliers and other Liens imposed by Law or pursuant to customary reservations or retentions of title arising in the ordinary course of business; <I>provided</I> that such Liens attach only to Inventory and secure only amounts not yet due and payable or, if due and payable, are unfiled and no other action has been taken to enforce the same;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) Liens in favor of the ABL Lenders arising under the ABL Debt Documents to secure Permitted Indebtedness under clause (n) of the definition thereof, in each case subject to the terms of the Intercreditor Agreement;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 20; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) <FONT STYLE="letter-spacing: -0.1pt">Liens in favor of any third party bank providing Bank Services not to exceed </FONT>$200,000 in the aggregate for Indebtedness described in clause (g) of the definition of “Permitted Indebtedness”;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) Liens arising from the filing of any financing statement on operating leases, to the extent such operating leases are permitted hereunder;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) Liens to secure workers’ compensation, employment insurance, old-age pensions, social security and other like obligations incurred in the ordinary course of business; and</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) Liens on insurance proceeds in favor of insurance companies granted solely as security for financed premiums.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Person</U>” means an individual, a corporation, a limited liability company, an association, a partnership, a joint venture, a joint stock company, a trust, an unincorporated organization or a government or an agency or a political subdivision thereof.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Pledged Securities</U>” means the Pledged Equity and Pledged <FONT STYLE="letter-spacing: -0.1pt">Debt.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Prohibited Transaction</U>” means a “prohibited transaction” as defined in Section 406 of ERISA and Section 4975(c) of the Internal Revenue Code.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Real Property Deliverables</U>” means each of the following agreements, instruments and other documents in respect of each Facility, each in form and substance reasonably satisfactory to the Majority Holders:</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) a Mortgage duly executed by the applicable Note <FONT STYLE="letter-spacing: -0.1pt">Party;</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) a title insurance policy with respect to each <FONT STYLE="letter-spacing: -0.1pt">Mortgage;</FONT></FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) a current ALTA survey and a surveyor’s certificate, certified to the Collateral Agent and to the issuer of the title insurance policy with respect thereto by a professional surveyor licensed in the state in which such real property is located and reasonably satisfactory to the Majority Holders;</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) a customary opinion of counsel in the state where such Facility is located with respect to the enforceability of the Mortgage to be recorded; and</FONT></P> <P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) to the extent reasonably requested by the Majority Holders an ASTM 1527- 13 Phase I Environmental Site Assessment by an independent firm reasonably satisfactory to Majority Holders with respect to such Facility.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Registration Rights Agreement</U>” means the Registration Rights Agreement, dated May 9, 2022, among the Borrower and the several holders signatory thereto.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Reportable Event</U>” means a reportable event as defined in Section 4043 of ERISA and the regulations issued under such section, with respect to a Pension Plan, excluding, however, <FONT STYLE="letter-spacing: -0.2pt">such </FONT>events as to which the PBGC by regulation waived the requirement of Section 4043(a) of ERISA that it be notified within 30 days of the occurrence of such event, <I>provided</I>, <I>however</I>, that a failure to meet the minimum funding standard of Section 412 of the Internal Revenue Code and of Section 302 of ERISA shall be a Reportable Event regardless of the issuance of any such waiver of the notice requirement in accordance with either Section 4043(a) of ERISA or Section 412(d) of the Internal Revenue Code.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 21; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Responsible Officer</U>” means the President, Chief Executive Officer, Chief Financial Officer, Head of Finance or Controller of the Borrower.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Rule 144</U>” means Rule 144 under the Securities Act (including any successor rule thereto), as the same may be amended from time to time.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Sanctions</U>” means economic or financial sanctions, requirements or trade embargoes imposed, administered or enforced from time to time by U.S. Governmental Authorities (including, but not limited to, OFAC, the U.S. Department of State and the U.S. Department of Commerce), the United Nations Security Council, the European Union, Her Majesty’s Treasury or any other relevant Governmental Authority.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Sanctions Target</U>” means any Person: (a) that is the subject or target of any Sanctions; (b) named in any Sanctions-related list maintained by OFAC, the U.S. Department of State, the U.S. Department of Commerce or the U.S. Department of the Treasury, including the OFAC list of “Specially Designated Nationals and Blocked Persons,” or any similar list maintained by the United Nations Security Council, the European Union, Her Majesty’s Treasury or any other relevant Governmental Authority; (c) located, organized or resident in a country, territory or geographical region which is itself the subject or target of any Sanctions (including the Crimea region of Ukraine, Cuba, Iran, North Korea, Syria and, prior to January 1, 2017, Sudan); or (d) owned or controlled by any such Person or Persons described in the foregoing clauses (a) through (c), inclusive.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Securities Act</U>” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Share Conversion Cap</U>” means (i) as of any time prior to the receipt of Nasdaq Stockholder Approval, 22,457,782 shares of Common Stock, and (ii) following the receipt of Nasdaq Stockholder Approval and prior to the Authorized Share Amendment Date, 35,564,397 shares of Common Stock, which amount shall be subject to increase on a share-by-share basis for any shares of Common Stock repurchased by the Borrower, or any reserves of shares of Common Stock released by the Borrower, on or after the Initial Closing Date that remain available for re-issuance by the Borrower. All share amounts in clauses (i) and (ii) above shall be subject to the same adjustments as the Conversion Rate, including those contained in <U>Section 4(c)</U>. To avoid doubt, after the later to occur of the receipt of Nasdaq Stockholder Approval and the Authorized Share Amendment Date, the Share Conversion Cap shall no longer be applicable.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Subordinated Debt</U>” means any unsecured Indebtedness incurred by the Borrower that is subordinated to the Note Obligations pursuant to a Subordination Agreement on terms acceptable to the Majority Holders and the Collateral Agent, as to its rights, duties and obligations.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 22; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Subordination Agreement</U>” means any subordination and intercreditor agreement substantially in the form attached hereto as <U>Exhibit B</U> or otherwise in form and substance <FONT STYLE="letter-spacing: -0.1pt">satisfactory to the Majority Holders and the Collateral Agent, as to its rights, duties and obligations, </FONT>entered into between the Collateral Agent and the other creditor.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Subsidiary</U>” means, with respect to any Person, any corporation, association, partnership or other business entity of which more than 50% of the total voting power of the Common Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, general partners or trustees thereof is at the time owned or controlled, directly or indirectly, by (a) such Person; (b) such Person and one or more Subsidiaries of such Person; or (c) one or more Subsidiaries of such <FONT STYLE="letter-spacing: -0.1pt">Person.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Synthetic Lease Obligations</U>” means, as to any Person, an amount equal to the capitalized amount of the remaining lease payments under any synthetic lease that would appear on a balance sheet of such Person in accordance with GAAP (consistently applied) if such obligations were accounted for as Capital Lease Obligations.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Taxes</U>” means taxes, duties, levies, imposts, deductions, assessments, fees, withholdings or similar charges imposed under U.S. federal, state, local or any foreign Law (including additions to tax, penalties and interest).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Trademark License</U>” means any written agreement, now or hereafter in effect, granting to any third party any right to use any Trademark now or hereafter owned by any Note Party or that any Note Party otherwise has the right to license, or granting to any Note Party any right to use any trademark now or hereafter owned by any third party, and all rights of any Note Party under any such agreement.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Trademarks</U>” means any trademark and servicemark rights, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business of a Person connected with and symbolized by such trademarks, whether or not filed with the USPTO or any foreign equivalent.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Trading Day</U>” means any day on which (a) trading in the Common Stock generally occurs on the principal U.S. national securities exchange or market on which the Common Stock is then listed or, if the Common Stock is not then listed on a U.S. national securities exchange or market, on the principal other market on which the Common Stock is then traded; and (b) there is no Market Disruption Event. If the Common Stock is not so listed or traded, then “Trading Day” means a Business Day.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Transfer Agent</U>” means Transfer Online, Inc. the current transfer agent of the Borrower, with a mailing address of 512 SE Salmon St. Portland, OR 97214 and a facsimile number of (503) 227-6874, and any successor transfer agent of the Borrower.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>USCO</U>” means the United States Copyright Office of the Library of Congress.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>USPTO</U>” means the United States Patent and Trademark Office.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 23; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“<U>Wholly Owned Subsidiary</U>” means, with respect to any Person, any Subsidiary of such Person, except that, solely for purposes of this definition, the reference to “more than 50%” in the definition of “Subsidiary” shall be deemed replaced by a reference to “100%”.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Interest; Amortization and <FONT STYLE="letter-spacing: -0.1pt">Maturity</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Payment of Principal Amount</U>. The Principal Amount of this Note shall be due and payable to the Holder on the earlier of (A) the Maturity Date and (B) the date on which the Principal Amount is otherwise accelerated as provided for under this Note. Except as set forth in <U>Section 2(b)</U> or <U>Section 2(c)</U>, the Borrower may not prepay or redeem all or any portion of the Principal Amount of this Note without the prior written consent of the Holder. Upon the occurrence and during the continuation of any Event of Default, the outstanding Principal Amount and, to the extent permitted by applicable law, any interest payments thereon not paid when due and any fees and other amounts then due and payable hereunder, shall thereafter, automatically in the case of an Event of Default under <U>Section 12(a)(v)</U> or <U>Section 12(a)(vi)</U>, and at the written election of the Holder otherwise, bear interest (including post-petition interest in any proceeding under any applicable bankruptcy laws) payable upon written demand at the rate otherwise applicable thereto, plus 2.00% per annum. Payment or acceptance of the increased rate of interest provided for in this paragraph is not a permitted alternative to timely payment and shall not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of the Holder Representative, the Collateral Agent, the Holder or the holders of the other Notes.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Amortization of Principal</U>.<SUP>1</SUP> At the written election of the Majority Holders, the Borrower shall repay $200,000 of the aggregate Principal Amount of all of the outstanding Notes on the first of each month commencing on August 9, 2022 and continuing through the Maturity Date (each, an “<U>Amortization Payment Date</U>”), together with (i) accrued and unpaid Interest from, and including, the last Interest Payment Date to, but excluding, the applicable Amortization Payment Date and (ii) one-half of the Interest Make-Whole Payment that would be due if such $200,000 of the aggregate Principal Amount of all of the outstanding Notes repaid were converted with a Conversion Date on such Amortization Payment Date (clauses (i) and (ii), <FONT STYLE="letter-spacing: -0.1pt">together with the Principal Amount to be repaid, an “<U>Amortization Payment</U>”). Any written election </FONT>pursuant to this <U>Section 2(b)</U> shall be delivered to the Borrower (with a copy to the Holder Representative) at least three (3) Business Days before the applicable Amortization Payment Date, which shall include the calculation of the Amortization Payment in reasonable detail. Each Amortization Payment shall, at the option of the Borrower, be payable in cash or, subject to satisfaction of the Equity Payment Conditions and to the limitations set forth in <U>Section 5</U>, in shares of Common Stock (together with cash in lieu of any fractional share) at a value per share of Common Stock equal to the Amortization/Interest Conversion Price. The Borrower initially <FONT STYLE="letter-spacing: -0.1pt">elects </FONT>to settle any Amortization Payment in shares of Common Stock (together with cash in lieu of any fractional share based on the Amortization/Interest Conversion Price); <I>provided</I> that the Borrower shall be deemed to have elected to settle any Amortization Payment in cash to the extent specified in <U>Section 5</U>. In order to change its election to pay any Amortization Payment in cash or in Common Shares (together with cash in lieu of any fractional share based on the Amortization/Interest Conversion Price), the Borrower must send a notice of such election to the Holder (with a copy to the Holder Representative), and such change in election shall become effective for Amortization Payment Dates more than ten (10) Trading Days following the receipt of such notice by the Holder. With respect to each Amortization Payment, the Holder shall receive a pro rata amount of the cash, Common Shares or combination of cash and Common Shares paid or delivered by the Borrower according to the Holders’ respective proportionate interest in the amount of Notes Obligations owed one Business Day immediately prior to such Amortization Payment. Each Amortization Payment made shall be reflected on the Conversion/PIK Schedule, containing at a minimum the information shown on <U>Schedule 1</U> hereto. Except as set forth in this <U>Section 2(b)</U> or <U>Section 2(c)</U>, the Borrower may not prepay or redeem all or any portion of the Principal Amount of this Note without the prior written consent of the Holder.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P> <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"> </DIV></DIV><!-- Field: /Rule-Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt"><SUP>1</SUP></FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to that certain Partial Option Exercise and Second Amendment to the 10% Senior Convertible Notes, dated February 9, 2023 (the “<U>Second Amendment</U>”), between the Company, the holders party thereto and the Agent, notwithstanding anything in Section 2(b) of the Purchased Third Option Notes to the contrary, no Amortization Payments shall be made on or in respect of the Purchased Third Option Notes. The Holders hereby irrevocably elect not to receive Amortization Payments with respect to the Purchased Third Option Notes at any time prior to the Maturity Date for the Purchased Third Option Notes. Nothing herein shall be construed to waive, terminate or otherwise impact in any manner the election of the Holders to receive Amortization Payments in the full amount of $200,000 each month on Notes other than the Purchased Third Option Notes.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 24; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Mandatory <FONT STYLE="letter-spacing: -0.1pt">Prepayment</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Subject to clause (ii) below, if (A) any Note Party or any Subsidiary thereof Transfers any assets or property (other than any Transfer permitted by clauses (i) through (iv) of Section 7(t)) or (B) any Insurance/Condemnation Event in respect of any assets or property of any Note Party or any Subsidiary thereof occurs, in each case which results in the realization or receipt by a Note Party or any Subsidiary thereof of Net Proceeds, the Borrower shall cause to be prepaid on or prior to the date which is five (5) Business Days after the date of such realization or receipt by such Note Party of such Net Proceeds, an aggregate principal amount of the Notes in an amount equal to 100% of all such Net Proceeds realized or received. Any such prepayment shall be reflected on the Conversion/PIK Schedule, containing at a minimum the information shown on <U>Schedule 1</U> hereto.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) So long as no Default or Event of Default has occurred and is continuing, with respect to any Net Proceeds realized or received with respect to any Insurance/Condemnation Event, at the option of the Borrower, the applicable Note Party or Subsidiary may reinvest an amount equal to all or any portion of such Net Proceeds to replace the assets or property subject to such Insurance/Condemnation Event (which assets or property may, for the avoidance of doubt, be replaced with assets or property that are substantially similar to such assets or property subject to such Insurance/Condemnation Even) within (A) six (6) months following receipt of such Net Proceeds or (B) if the applicable Note Party or Subsidiary enters into a legally binding commitment to reinvest such Net Proceeds to replace such assets or property within six (6) months following receipt thereof, ninety (90) days after the six (6) month period that follow receipt of such Net Proceeds; <I>provided </I>that if any Net Proceeds are not so reinvested by the deadline specified in clause (A) or (B) above, as applicable, or if any such Net Proceeds are no longer intended to be or cannot be so reinvested, any such <FONT STYLE="letter-spacing: -0.25pt">Net </FONT>Proceeds shall be applied to the prepayment of the Notes as set forth in <U>Section <FONT STYLE="letter-spacing: -0.1pt">2(c)(i)</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 25; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Interest</U>. This Note shall bear interest on the aggregate unconverted and unamortized Principal Amount then outstanding of this Note semiannually in arrears at a rate of 10% per annum, with 10% per annum payable in cash (“<U>Cash Interest</U>”) and 0% per annum payable “in kind” by adding such accrued and unpaid interest to the unpaid Principal Amount of this Note (“<U>PIK Interest</U>”) from the Original Issue Date to, but excluding, the Maturity Date. Interest on this <FONT STYLE="letter-spacing: -0.1pt">Note is payable in arrears on the Maturity Date. Additional Interest will be payable by the Borrower </FONT>to the Holder as set forth in <U>Section 2(d)</U> of the Registration Rights Agreement.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Optional Prepayment</U>. The Borrower shall have the right at any time and from time to time to prepay the Purchased Third Option Notes, in whole or in part, at a price equal to 100% of the Principal Amount of the Purchased Third Option Notes being prepaid plus all accrued and unpaid interest thereon to the date of prepayment. The Borrower shall provide the Holders of the Purchased Third Option Notes and the Agent with at least five (5) Business Days prior written notice of any election to exercise its right to prepay any portion of the Purchased Third Option Notes pursuant to this Section 2(e). Any such prepayment shall be reflected on the Conversion/PIK Schedule, containing at a minimum the information shown on <U>Schedule 1</U> <FONT STYLE="letter-spacing: -0.1pt">hereto.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Interest and Fee Calculations and Payment Provisions</U>. Interest and fees shall be calculated on the basis of a 360-day year consisting of twelve 30 day months. Interest hereunder will be paid to the initial Holder or, if the Borrower has received notice of any transfer thereof signed by the initial Holder or any successive Holders, to the Person in whose name this Note is registered on the Note Register. All payments made hereunder (other than regular interest payments on each Interest Payment Date) will be applied <U>first</U> to the repayment of fees and expenses payable under this Note, <U>then</U> to accrued and unpaid interest until all then outstanding accrued and unpaid interest has been paid in full, and <U>then</U> to the repayment of the Principal Amount and other Note Obligations until the Principal Amount and such other Note Obligations have been paid in full. If after all applications of such payments have been made as provided in this paragraph any amounts remain, then the remaining amount of such payments shall be returned to the Borrower. Except as otherwise provided herein, all payments under this Note (including cash interest payments) shall be made in lawful money of the United States of America and in immediately available funds. Each such payment must be received by the Holder not later than <FONT STYLE="letter-spacing: -0.1pt">12:00 p.m., New York City time, on the date such payment becomes due and payable. Any payment </FONT>received by the Holder after such time will be deemed to have been made on the next following Business Day and such extension of time shall be reflected in computing interest or fees, as the case may be. If a payment under this Note otherwise would become due and payable on a Saturday, Sunday or legal holiday, the due date thereof shall be extended to the next day which is not a Saturday, Sunday or legal holiday, and interest shall be payable thereon during such extension. Except as otherwise provided in this Note, all amounts due under this Note shall be payable without defense or counterclaim. All payments under this Note shall be subject to any deduction or withholding as required by applicable law. Each Holder of a Note, if reasonably requested by the Borrower, shall deliver documentation prescribed by applicable law or reasonably requested by the Borrower as will enable the Borrower to determine whether or not and to what extent the Holder is subject to withholding, backup withholding, or information reporting requirements.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 26; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <FONT STYLE="letter-spacing: -0.1pt"><U>Ranking</U>.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) The Notes shall be <I>pari passu </I>in right of payment with respect to each other. All payments (other than any payments in respect of a conversion of Notes, any Initially Issued Notes Pro Rata Payments or any Purchased Third Option Notes Pro Rata Payments (collectively, the “<U>Non-Pro Rata Payments</U>”)) to the holders of the Notes (including the Holder) shall be made pro rata among the holders based upon the aggregate unpaid principal amount and accrued interest of the Notes outstanding as of one Business Day immediately prior to any such payment. The Borrower shall not make, and no holder of Notes shall accept, any payment (other than any Non-Pro Rata Payments) except as shall be shared ratably between the holders of the Notes so as to maintain as near as possible the amount of the indebtedness owing under the Notes pro rata according to the holders’ respective proportionate interest in the amount of Notes Obligations owed as of the date immediately prior to such payment or payments. If one holder of the Notes obtains any payment (whether voluntary, involuntary or by offset or otherwise, but not including any Non-Pro Rata Payments) of principal, interest or other amount with respect to the Notes in excess of such holder’s pro rata share of such payments obtained by all holders of the Notes, then the holder receiving such payment in excess of its pro rata share shall return to the Agent, for distribution to each of the other holders, an amount sufficient to cause all holders of the Notes to receive their respective pro rata shares of any payment of principal, interest or other amounts with respect to the Notes.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Any (A) Amortization Payments made with respect to any Notes dated May 9, 2022 (the “<U>Initially Issued Notes</U>”), (B) payments of Cash Interest with respect to any Initially Issued Notes, (C) compounding of PIK Interest with respect to any Initially Issued Notes, and (D) payments of Principal Amounts in connection with the maturity of any Initially Issued Notes (collectively, the “<U>Initially Issued Notes Pro Rata Payments</U>”) to the holders of the Initially Issued Notes (including, if applicable, the Holder) shall be made pro rata among the holders of the Initially Issued Notes based upon the aggregate unpaid principal amount and accrued interest of the Initially Issued Notes outstanding as of one Business Day immediately prior to any such payment. The Borrower shall not make, and no holder of Initially Issued Notes shall accept, any Initially Issued Notes Pro Rata Payment except as shall be shared ratably between the holders of the Initially Issued Notes so as to maintain as near as possible the amount of the indebtedness owing under the Initially Issued Notes pro rata according to the holders’ respective proportionate interest in the amount of Notes Obligations owed as of the date immediately prior to such payment or payments. If one holder of the Initially Issued Notes obtains any Initially Issued Notes Pro Rata Payment (whether voluntary, involuntary or by offset or otherwise) of principal, interest or other amount with respect to the Initially Issued Notes in excess of such holder’s pro rata share of such payments obtained by all holders of the Initially Issued Notes, then the holder receiving such payment in excess of its pro rata share shall return to the Agent, for distribution to each of the other holders, an amount sufficient to cause all holders of the Initially Issued Notes to receive their respective pro rata shares of such payment.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 27; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Any (A) payments of Cash Interest with respect to any Notes issued pursuant to the Third Option (as defined in the Purchase Agreement) (the “<U>Purchased Third Option Notes</U>”), (B) payments of Principal Amounts in connection with the maturity of any Purchased Third Option Notes and (C) payments in connection with an exercise of the optional prepayments rights set forth in Section 2(e) of the Purchased Third Party Notes (collectively, the “<U>Purchased Third Option Notes Pro Rata Payments</U>”) to the holders of the Purchased Third Option Notes (including, if applicable, the Holder) shall be made pro rata among the holders of the Purchased Third Option Notes based upon the aggregate unpaid principal amount and accrued interest of the Purchased Third Option Notes outstanding as of one Business Day immediately prior to any such payment. The Borrower shall not make, and no holder of Purchased Third Option Notes shall accept, any Purchased Third Option Notes Pro Rata Payment except as shall be shared ratably between the holders of the Purchased Third Option Notes so as to maintain as near as possible the amount of the indebtedness owing under the Purchased Third Option Notes pro rata according to the holders’ respective proportionate interest in the amount of Notes Obligations owed as of the date immediately prior to such payment or payments. If one holder of the Purchased Third Option Notes obtains any Purchased Third Option Notes Pro Rata Payment (whether voluntary, involuntary or by offset or otherwise) of principal, interest or other amount with respect to the Purchased Third Option Notes in excess of such holder’s pro rata share of such payments obtained by all holders of the Purchased Third Option Notes, then the holder receiving such payment in excess of its pro rata share shall return to the Agent, for distribution to each of the other holders, an amount sufficient to cause all holders of the Purchased Third Option Notes to receive their respective pro rata shares of such payment.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Registration of Transfers and <FONT STYLE="letter-spacing: -0.1pt">Exchanges</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Different Denominations</U>. This Note is exchangeable for an equal aggregate principal amount of Notes of different authorized denominations, as requested by the Holder surrendering the same. No service charge will be payable for such registration of transfer or <FONT STYLE="letter-spacing: -0.1pt">exchange.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Reliance on Note Register</U>. The Initial Holders are listed herein. The Borrower shall maintain a copy of each transfer and a register for the recordation of the names and addresses of the applicable holders of the Notes, and the principal amounts (and stated interest) of the Notes held by each holder pursuant to the terms hereof from time to time (the “<U>Note Register</U>”). The Company, the Holder Representative and the holders shall treat each Person whose name is recorded in the Note Register pursuant to the terms hereof as a holder for all purposes of the Notes. The Note Register shall be available for inspection by the Holder Representative and any holder, at any reasonable time and from time to time upon reasonable prior notice. Prior to due presentment for transfer to the Borrower of this Note, the Borrower and any agent of the Borrower may, upon receipt of appropriate signed notice from the Person previously listed on the Note Register as owner hereof, treat the Person in whose name this Note is duly registered on the Note Register as the owner hereof for the purpose of receiving payment as herein provided and for all other purposes, whether or not this Note is overdue, and neither the Borrower nor any such agent shall be affected by notice to the contrary.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 28; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <FONT STYLE="letter-spacing: -0.1pt"><U>Conversion</U>.</FONT></FONT></P> <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Right to <FONT STYLE="letter-spacing: -0.1pt">Convert</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></FONT></P> <P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Generally</I>. At any time after the earlier of (x) the date that the Nasdaq Stockholder Approval has been obtained and (y) the date that a Majority Holders waive the covenant contained in <U>Section 7(ii)</U>, and until this Note is no longer outstanding, this Note shall be convertible, in whole or in part, into the Conversion Consideration at the option of the Holder, at any time and from time to time (subject to the limitations set forth in <U>Section 5</U>); <I>provided </I>that if a Fundamental Change Repurchase Notice is validly delivered pursuant to <U>Section 6</U> with respect to any portion of this Note, then such portion of this Note may not be converted, except to the extent (A) such notice is withdrawn in accordance with <U>Section 6</U>; or (B) the Borrower fails to pay the Fundamental Change Repurchase Price in accordance with this Note. Provisions of this <U>Section 4</U> applying to the conversion of this Note in whole will equally apply to conversions in part.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <I>Conversion Consideration</I>. Subject to <U>Section 4(b)(vii)</U>, the type and amount of consideration due in respect of each $1 principal amount of the Principal Amount to be converted will be (together with any Interest Make-Whole Payments that may be due pursuant to <U>Section 4(a)(iii)</U>, the “<U>Conversion Consideration</U>”) (x) a number of shares of Common Stock equal to the Conversion Rate in effect on the Conversion Date for such conversion and (y) an amount in cash equal to the accrued and unpaid Cash Interest and PIK Interest to, but excluding, the Conversion Date.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <I>Interest Make-Whole</I>.<SUP>2</SUP> In connection with any conversion pursuant to this <U>Section 4</U>, the Borrower shall make an interest make-whole payment (an “<U>Interest Make-Whole Payment</U>”) to the Holder equal to the remaining scheduled payments of interest that would have been made on the portion of this Note to be converted had such portion of this Note remained outstanding from the Conversion Date through the Maturity Date as of the Conversion Date. The Borrower will satisfy its obligation to pay any Interest Make-Whole Payment, at its election, in cash or, subject to satisfaction of the Equity Payment Conditions and the limitations set forth in <U>Section 5</U>, in shares of Common Stock (together with cash in lieu of any fractional share as set forth in <U>Section 4(b)(vii)</U>). The Borrower initially elects to settle any Interest Make-Whole Payment in shares of Common Stock (together with cash in lieu of any fractional share as set forth in <U>Section 4(b)(vii)</U>); <I>provided </I>that the Borrower shall be deemed to have elected to settle any Interest Make- Whole Payment in cash to the extent specified in <U>Section 5</U>. In order to change its election to pay any Interest Make-Whole Payment in cash or in Common Shares (together with cash in lieu of any fractional share as set forth in <U>Section 4(b)(vii)</U>), the Borrower must send a notice of such election to the Holder, and such change in election shall become effective for conversions with a Conversion Date more than ten (10) Trading Days following the receipt of such notice by the Holder. If the Borrower makes an Interest Make-<FONT STYLE="letter-spacing: -0.1pt">Whole </FONT>Payment in shares of Common Stock, then the number of shares of Common Stock (together with cash in lieu of any fractional share as set forth in <U>Section 4(b)(vii)</U>) that the Holder will receive will be equal to (x) the dollar amount of the Interest Make-Whole <FONT STYLE="letter-spacing: -0.1pt">Payment owed to the Holder <I>divided by</I> (y) the Amortization/Interest Conversion Price with </FONT>respect to such Conversion Date.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P> <!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"> </DIV></DIV><!-- Field: /Rule-Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt"><SUP>2</SUP></FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Second Amendment, notwithstanding anything in Section 4(a)(ii) or Section 4(a)(iii) of the Purchased Third Option Notes to the contrary, no Holder will be entitled to receive any Interest Make-Whole Payments in connection with a conversion of all or any portion of the Purchased Third Option Notes pursuant to Section 4 of the Purchased Third Option Notes.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 29; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Conversion Procedures; Mechanics of <FONT STYLE="letter-spacing: -0.1pt">Conversion</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Generally</I>. To convert all or a portion of the Note, the Holder will deliver to the Borrower a Notice of Conversion, substantially in the form attached as <U>Annex A</U> (each, a “<U>Notice of Conversion</U>”), specifying the portion of the Principal Amount of this Note to be converted and the date on which such conversion shall be effected (such date, the “<U>Conversion Date</U>”). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. To effect conversions hereunder, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire Principal Amount of this Note has been so converted. Conversions hereunder shall have the effect of lowering the outstanding Principal Amount of this Note in an amount equal to the applicable conversion. The Holder and the Borrower shall maintain a Conversion/PIK Schedule, containing at a minimum the information shown on <U>Schedule 1 </U>hereto, and showing historically, among other things, the principal amounts converted and the date of such conversions. On the date of receipt of a Notice of Conversion, the Borrower shall transmit by facsimile or electronic mail an acknowledgment of confirmation and representation as to whether to Borrower’s knowledge such shares of Common Stock may then be resold pursuant to Rule 144 or an effective and available registration statement, in the form attached as <U>Annex B</U>, of receipt of such Notice of Conversion to the Holder and the Transfer Agent, which confirmation shall constitute an instruction to the Transfer Agent to process such Notice of Conversion in accordance with the terms of this Note.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <I>Delivery of Certificates Upon Conversion</I>. Not later than two (2) Trading Days after a Conversion Date (the “<U>Share Delivery Date</U>”), the Borrower will deliver, or cause to be delivered, to the Holder the Conversion Consideration payable pursuant to any conversion pursuant to this <U>Section 4</U> which, on or promptly after the date on which such Conversion Shares are eligible to be sold by persons who are not affiliates (as defined in Rule 144) (and have not been affiliates at any time during the prior three months) under Rule 144 of the Securities Act without the need for current public information and the Borrower has received an opinion of counsel to such effect (which opinion the Borrower shall be responsible for obtaining at its sole cost and expense; <I>provided</I> that the Holder may be required to execute and deliver a customary representation letter to the Borrower and the Transfer Agent), shall be free of restrictive legends and trading restrictions, representing the number of Conversion Shares being acquired upon the conversion of this Note by the Holder. All Conversion Shares required to be delivered by the Borrower under this <U>Section 4</U> shall be delivered in book-entry form through the facilities of the Depositary; <I>provided </I>that, if the Conversion Date is prior to the date on which such Conversion Shares are eligible to be sold under Rule 144 by persons who <FONT STYLE="letter-spacing: -0.25pt">are </FONT>not affiliates (as defined in Rule 144) (and have not been affiliates at any time during the prior three months) without the need for current public information, the Conversion Shares shall be delivered in book-entry form with the Transfer Agent and shall bear a restrictive legend in the following form, as appropriate:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 30; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “<U>SECURITIES ACT</U>”) OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER AGREES FOR THE BENEFIT OF REED’S, INC. (THE “<U>COMPANY</U>”) THAT IT WILL NOT OFFER, SELL, PLEDGE OR OTHERWISE TRANSFER THESE SECURITIES OR ANY BENEFICIAL INTEREST HEREIN, EXCEPT: (A) TO THE COMPANY OR ANY SUBSIDIARY THEREOF; (B) PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BECOME EFFECTIVE UNDER THE SECURITIES ACT; (C) PURSUANT TO AN EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 UNDER THE SECURITIES ACT; OR (D) PURSUANT TO ANY OTHER EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRIOR TO THE REGISTRATION OF ANY TRANSFER IN ACCORDANCE WITH CLAUSE (C) OR (D) ABOVE, THE COMPANY RESERVES THE RIGHT TO REQUIRE THE DELIVERY OF SUCH CERTIFICATIONS, OPINIONS OF COUNSEL OR OTHER EVIDENCE AS MAY REASONABLY BE REQUIRED IN ORDER TO DETERMINE THAT THE PROPOSED TRANSFER IS BEING MADE IN COMPLIANCE WITH THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS. NO REPRESENTATION IS MADE AS TO THE AVAILABILITY OF ANY EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS.”</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding the foregoing, commencing on such date that the Conversion Shares are eligible for sale by persons who are not affiliates (as defined in Rule 144) (and have not been affiliates at any time during the prior three months) under Rule 144, subject to current public information requirements, but without any requirements as to volume, manner of sale or notice under the Securities Act, the Borrower, upon request and at the sole cost and expense of the Borrower, shall obtain a legal opinion to allow for such sales under Rule 144, but only if the holder is not an affiliate (and has not been an affiliate at any time during the prior three months) of the Borrower and current public information as contemplated by Rule 144 is available (or not required for sales under Rule 144); <I>provided </I>that the Holder may be required to execute and deliver a customary representation letter to the Borrower and the Transfer Agent.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 31; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <I>Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Conversion</I>. In addition to any other rights available to the Holder, if the Borrower fails for any reason to deliver to the Holder the Conversion Shares by the Share Delivery Date pursuant to <U>Section 4(b)(ii)</U>, and if after such Share Delivery Date the Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Conversion Shares which the Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a “<U>Buy-In</U>”), then the Borrower shall (A) pay in cash to the Holder (in addition to any other remedies available to or elected by the Holder) the amount, if any, by which (x) the Holder’s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y) the product of (1) the aggregate number of shares of Common Stock that the Holder was entitled to receive from the conversion at issue multiplied by (2) the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B) at the option of the Holder, either reissue (if surrendered) this Note in a principal amount equal to the principal amount of the attempted conversion (in which case such conversion shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued if the Borrower had timely complied with its delivery requirements under <U>Section 4(b)(ii)</U>. For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of this Note with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A) of the immediately preceding sentence, the Borrower shall be required to pay the Holder $1,000. The Holder shall provide the Borrower written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Borrower, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including a decree of specific performance and/or injunctive relief with respect to the Borrower’s failure to timely deliver certificates representing shares of Common Stock upon conversion of this Note as required pursuant to the terms <FONT STYLE="letter-spacing: -0.1pt">hereof.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <I>Effect of Conversion; Holder of Record of Conversion Shares</I>. Subject to <U>Section 4(b)(v)</U>, and assuming there is no Default in the delivery of any portion of the Conversion Consideration due pursuant to this <U>Section 4</U>, upon conversion of any portion of this Note, as of the Close of Business on the Conversion Date for such conversion, (A) the converted portion of this Note will be deemed to cease to be outstanding and (B) the Person in whose name any Conversion Share is issuable in connection with such conversion will be deemed to be the holder of record of such Conversion Share.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) <I>Failure to Deliver Conversion Shares</I>. If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Holder by the Share Delivery Date as contemplated by <U>Section 4(b)(ii)</U>, the Holder shall be entitled to elect by written notice to the Borrower at any time on or before its receipt of such Conversion Shares, to rescind such conversion, in which event the Borrower shall promptly return to the Holder any original Note delivered to the Borrower and the Holder shall promptly return to the Borrower any portion of the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 32; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) <I>Obligation Absolute; Partial Liquidated Damages</I>. The Borrower’s obligations to issue and deliver the Conversion Shares upon conversion of this Note in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Borrower or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Borrower to the Holder in connection with the issuance of such Conversion Shares; <I>provided</I>, <I>however</I>, that such delivery shall not operate as a waiver by the Borrower of any such action the Borrower may have against the Holder. In the event the Holder shall convert all or a portion of the Principal Amount, the Borrower may not refuse conversion based on any claim that the Holder or anyone associated or affiliated with the Holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice to the Holder, restraining and or enjoining conversion of all or part of this Note shall have been sought. If the injunction is not granted, the Borrower shall promptly comply with all conversion obligations herein. If the injunction is obtained, the Borrower must post a surety bond for the benefit of the applicable Holder(s) in the amount of one hundred fifty percent (150%) of the outstanding Principal Amount of this Note, which is subject to the injunction, which bond shall remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall be payable to the Holder to the extent it obtains judgment. In the absence of seeking such injunction, the Borrower shall issue Conversion Shares upon a properly noticed conversion. Nothing herein shall limit the Holder’s right to pursue actual damages or declare an Event of Default pursuant to <U>Section 12(a)</U> for Borrower’s failure to deliver Conversion Shares within the period specified herein and the Holder shall have the right to pursue all remedies available to them hereunder, at law or in equity including a decree of specific performance or injunctive relief. The exercise of any such rights shall not prohibit the Holder from seeking to enforce damages pursuant to any provision of this Note or under applicable law.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) <I>Fractional Shares</I>. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note. As to any fraction of a share which the Holder would otherwise be entitled to receive upon such conversion, the Borrower shall at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the applicable Conversion Price or round up to the next whole share.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) <I>Transfer Taxes and Expenses</I>. The issuance of certificates for shares of the Common Stock on conversion of this Note shall be made without charge to the Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such certificates, <I>provided </I>that, the Borrower shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such certificate upon conversion in a name other than that of the Holder so converted and the Borrower shall not be required to issue or deliver such certificates unless or until the Person or Persons requesting the issuance thereof shall have paid to <FONT STYLE="letter-spacing: -0.25pt">the </FONT>Borrower the amount of such tax or shall have established to the satisfaction of the Borrower that such tax has been paid.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 33; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Adjustments to the Conversion <FONT STYLE="letter-spacing: -0.2pt">Rate</FONT></U><FONT STYLE="letter-spacing: -0.2pt">.</FONT></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <I>Events Requiring an Adjustment to the Conversion Rate</I>. <FONT STYLE="letter-spacing: -0.2pt">The </FONT>Conversion Rate will be adjusted from time to time as follows:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(A) </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Stock Dividends, Splits and Combinations</I>. If the Borrower issues solely shares of Common Stock as a dividend or distribution on all or substantially all shares of the Common Stock, or if the Borrower effects a stock split or a stock combination of the Common Stock (in each case excluding an issuance solely pursuant to a Common Stock Change Event, as to which <U>Section 4(g)</U> will apply), then the Conversion Rate will be adjusted based on the following formula:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I> </I></FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD ROWSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.2in; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR</I><SUB>1 </SUB><I>= CR</I><SUB>0</SUB></FONT></TD> <TD ROWSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.1in; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD> <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.2in; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS</I><SUB>1</SUB></FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS</I><SUB>0</SUB></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I> </I></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">where:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>0 </SUB></I>=</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately before the Open of Business on the Ex-Dividend Date for such dividend or distribution, or immediately before the Open of Business on the effective date of such stock split or stock combination, as applicable;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>1 </SUB></I>=</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date or effective date, as applicable;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS<SUB>0 </SUB></I>=</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of Common Stock outstanding immediately before the Open of Business on such Ex-Dividend Date or effective date, as applicable, without giving effect to such dividend, distribution, stock split or stock combination; and</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS<SUB>1 </SUB></I>=</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of Common Stock outstanding immediately after <FONT STYLE="letter-spacing: -0.1pt">giving effect to such dividend, distribution, stock split or stock combination.</FONT></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If any dividend, distribution, stock split or stock combination of the type described in this <U>Section 4(c)(i)(A)</U> is declared or announced, but not so paid or made, then the Conversion Rate will be readjusted, effective as of the date the Board of Directors determines not to pay such dividend or distribution or to effect such stock split or stock combination, to the Conversion Rate that would then be in effect had such dividend, distribution, stock split or stock combination not been declared or announced.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(B) </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Rights, Options and Warrants</I>. If the Borrower distributes, to all or substantially all holders of Common Stock, rights, options or warrants (other than rights issued or otherwise distributed pursuant to a stockholder rights plan, as to which <U>Sections 4(c)(i)(C)</U> and <U>4(c)(vi)</U> will apply) entitling such holders, for a period of not more than sixty (60) calendar days after the record date of such distribution, to subscribe for or purchase shares of Common Stock at a price per share that is less than the average of the Last Reported Sale Prices per share of Common Stock for the ten (10) consecutive Trading Days ending on, and including, the Trading Day immediately before the date such distribution is announced, then the Conversion Rate will be increased based on the following formula:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD ROWSPAN="2" STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; width: 0.2in; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR</I><SUB>1 </SUB><I>= CR</I><SUB>0</SUB></FONT></TD> <TD ROWSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 0.1in; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD> <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.2in; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS+X</I></FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS+Y</I></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 34; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">where:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 96pt"><FONT STYLE="letter-spacing: -0.25pt"><I> </I></FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt; width: 0.5in"> </TD> <TD STYLE="text-indent: 0pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR0 </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately before the Open of Business on the Ex-Dividend Date for such distribution;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR1 </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of Common Stock outstanding immediately before the Open of Business on such Ex-Dividend Date;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt"><I>X </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the total number of shares of Common Stock issuable pursuant to such rights, options or warrants; and</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Y </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a number of shares of Common Stock obtained by dividing (x) the aggregate price payable to exercise such rights, options or warrants by (y) the average of the Last Reported Sale Prices per share of Common Stock for the ten (10) consecutive Trading Days ending on, and including, the Trading Day immediately before the date such distribution is announced.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">To the extent such rights, options or warrants are not so distributed, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the increase to the Conversion Rate for such distribution been made on the basis of only the rights, options or warrants, if any, actually distributed. In addition, to the extent that shares of Common Stock are not delivered after the expiration of such rights, options or warrants (including as a result of such rights, options or warrants not being exercised), the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the increase to the Conversion Rate for such distribution been made on the basis of delivery of only the number of shares of Common Stock actually delivered upon exercise of such rights, option or warrants.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">For purposes of this <U>Section 4(c)(i)(B)</U> and <U>Section 4(f)</U>, in determining whether any rights, options or warrants entitle holders of Common Stock to subscribe for or purchase shares of Common Stock at a price per share that is less than the average of the Last Reported Sale Prices per share of Common Stock for the ten (10) consecutive Trading Days ending on, and including, the Trading Day immediately before the date the distribution of such rights, options or warrants is announced, and in determining the aggregate price payable to exercise such rights, options or warrants, there will be taken into account any consideration the Borrower receives for such rights, options or warrants and any amount payable <FONT STYLE="letter-spacing: -0.25pt">on</FONT> exercise thereof, with the value of such consideration, if not cash, to be determined by the Board of Directors.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 35; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(C) </FONT><I>Distributions Other than Spin-Offs</I>. If the Borrower distributes shares of its Capital Stock, evidences of its indebtedness or other assets or property of the Borrower, or rights, options or warrants to acquire Capital Stock of the Borrower or other securities, to all or substantially all holders of the Common Stock, <FONT STYLE="letter-spacing: -0.1pt">excluding:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 1in">(1) dividends, distributions, rights, options or warrants for which an adjustment to the Conversion Rate is required pursuant to <U>Section 4(c)(i)(A)</U> or <U>Section 4(c)(i)(B)</U>;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 1in">(2) dividends or distributions paid exclusively in cash for which an adjustment to the Conversion Rate is required pursuant to <U>Section 4(c)(i)(E)</U>;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 1in">(3) rights issued or otherwise distributed pursuant to a stockholder rights plan, except to the extent provided in <U>Section 4(c)(vi)</U>;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 1in">(4) Spin-Offs for which an adjustment to the Conversion Rate is required pursuant to <U>Section 4(c)(i)(D)</U>;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 1in">(5) a distribution solely pursuant to a tender offer or exchange offer for shares of Common Stock, as to which <U>Section 4(c)(i)(F)</U> will apply; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify; text-indent: 1in">(6) a distribution solely pursuant to a Common Stock Change Event, as to which <U>Section 4(g)</U> will apply;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">then the Conversion Rate will be increased based on the following <FONT STYLE="letter-spacing: -0.1pt">formula:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD ROWSPAN="2" STYLE="text-align: right; width: 48%; vertical-align: middle; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>1</SUB>= CR</I><FONT STYLE="letter-spacing: -0.5pt"><SUB>0</SUB></FONT></FONT></TD> <TD ROWSPAN="2" STYLE="text-align: left; width: 6%; vertical-align: middle; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</FONT></TD> <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 46%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><I>SP</I></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>SP</I>-<FONT STYLE="letter-spacing: -0.25pt"><I>FMV</I></FONT></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="letter-spacing: -0.1pt">where:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I> </I></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt; width: 0.5in"> </TD> <TD STYLE="text-indent: 0pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>0</SUB> </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately before the Open of Business on the Ex-Dividend Date for such distribution;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>1</SUB> </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>SP </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the average of the Last Reported Sale Prices per share of Common Stock for the ten (10) consecutive Trading Days ending on, and including, the Trading Day immediately before such Ex-Dividend Date; and</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt; width: 0.5in"> </TD> <TD STYLE="text-indent: 0pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FMV </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the fair market value (as determined by the Board of Directors), as of such Ex-Dividend Date, of the shares of Capital Stock, evidences of indebtedness, assets, property, rights, options or warrants distributed per share of Common Stock pursuant to such distribution;</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 36; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><I>provided</I>, <I>however</I>, that if <I>FMV</I> is equal to or greater than <I>SP</I>, then, in lieu of the foregoing adjustment to the Conversion Rate, the Holder will receive, for each $1 Principal Amount held by the Holder on the record date for such distribution, at the same time and on the same terms as holders of Common Stock, the amount and kind of shares of Capital Stock, evidences of indebtedness, assets, property, rights, options or warrants that the Holder would have received if the Holder had owned, on such record date, a number of shares of Common Stock equal to the Conversion Rate in effect on such record date.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">To the extent such distribution is not so paid or made, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the distribution, if any, actually made or paid.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(D) </FONT><I>Spin-Offs</I>. If the Borrower distributes or dividends shares of Capital Stock of any class or series, or similar equity interests, of or relating to an Affiliate, a Subsidiary or other business unit of the Borrower to all or substantially all holders of the Common Stock (other than solely pursuant to (x) a Common Stock Change Event, as to which <U>Section 4(g)</U> will apply; or (y) a tender offer or exchange offer for shares of Common Stock, as to which <U>Section 4(c)(i)(F)</U> will apply), and such Capital Stock or equity interests are listed or quoted (or will be listed or quoted upon the consummation of the transaction) on a U.S. national securities exchange (a “<U>Spin-Off</U>”), then the Conversion Rate will be increased based on the following formula:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <TR STYLE="vertical-align: top"> <TD ROWSPAN="2" STYLE="text-align: right; width: 48%; vertical-align: middle; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR </I><SUB>1</SUB><I>=CR<SUB>0</SUB></I></FONT></TD> <TD ROWSPAN="2" STYLE="text-align: center; width: 6%; vertical-align: middle"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</FONT></TD> <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 46%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FMV </I>+<FONT STYLE="letter-spacing: -0.25pt"><I>SP</I></FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><I>SP</I></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 1.9pt 0 0"><FONT STYLE="letter-spacing: -0.1pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="letter-spacing: -0.1pt">where:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I> </I></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt; width: 0.5in"> </TD> <TD STYLE="text-indent: 0pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>0</SUB> </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately before the Close of Business on the last Trading Day of the Spin-Off Valuation Period for such Spin-Off;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>1</SUB> </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately after the Close of Business on the last Trading Day of the Spin-Off Valuation Period;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>FMV </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the product of (x) the average of the Last Reported Sale Prices per share or unit of the Capital Stock or equity interests distributed in such Spin-Off over the ten (10) consecutive Trading Day period (the “<U>Spin-Off Valuation Period</U>”) beginning on, and including, the Ex-Dividend Date for such Spin- Off (such average to be determined as if references to Common Stock in the definitions of Last Reported Sale Price, Trading Day and Market Disruption Event were instead references to such Capital Stock or equity interests); <FONT STYLE="letter-spacing: -0.25pt">and</FONT> (y) the number of shares or units of such Capital Stock or equity interests distributed per share of Common Stock in such Spin-Off; and</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt; width: 0.5in"> </TD> <TD STYLE="text-indent: 0pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.3pt"><I>SP </I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt">=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the average of the Last Reported Sale Prices per share of Common Stock for each Trading Day in the Spin-Off Valuation Period.</FONT></TD></TR> </TABLE> <P STYLE="margin-top: 0; margin-bottom: 0"> </P> <!-- Field: Page; Sequence: 37; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Notwithstanding anything to the contrary in this <U>Section 4(c)(i)(D)</U>, if a Conversion Date occurs during the Spin-Off Valuation Period for such Spin-Off, then, solely for purposes of determining the Conversion Consideration for such conversion, such Spin-Off Valuation Period will be deemed to consist of the Trading Days occurring in the period from, and including, the Ex-Dividend Date for such Spin-Off to, and including, such Conversion <FONT STYLE="letter-spacing: -0.1pt">Date.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">To the extent any dividend or distribution of the type set forth in this <U>Section 4(c)(i)(D)</U> is declared but not made or paid, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the dividend or distribution, if any, actually made or paid.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(E) </FONT><I>Cash Dividends or Distributions</I>. If any cash dividend or distribution is made to all or substantially all holders of Common Stock, then the Conversion Rate will be increased based on the following formula:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 30%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif"> <TR STYLE="vertical-align: top"> <TD ROWSPAN="2" STYLE="text-align: right; width: 48%; vertical-align: top; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR </I><SUB>1</SUB><I>=CR<SUB>0</SUB></I></FONT></TD> <TD ROWSPAN="2" STYLE="text-align: center; width: 6%; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">x</FONT></TD> <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 46%; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><I>SP</I></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: center; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"><I>SP</I>- </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt"><I>D</I></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I> </I></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="letter-spacing: -0.1pt">where:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I> </I></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt; width: 0.5in"> </TD> <TD STYLE="text-indent: 0pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><I>CR<SUB>0 </SUB></I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt">=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately before the Open of Business on the Ex-Dividend Date for such dividend or distribution;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><I>CR<SUB>1 </SUB></I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt">=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately after the Open of Business on such Ex-Dividend Date;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.3pt"><I>SP </I></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt">=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Last Reported Sale Price per share of Common Stock on the Trading Day immediately before such Ex-Dividend Date; and</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.5pt"><I>D </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the cash amount distributed per share of Common Stock in such dividend or distribution;</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><I>provided</I>, <I>however</I>, that if <I>D </I>is equal to or greater than <I>SP</I>, then, in lieu of the foregoing adjustment to the Conversion Rate, the Holder will receive, for each $1 Principal Amount held by the Holder on the record date for such dividend or distribution, at the same time and on the same terms as holders of Common Stock, the amount of cash that the Holder would have received if the Holder had owned, on such record date, a number of shares of Common Stock equal to the Conversion Rate in effect on such record date.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">To the extent such dividend or distribution is declared but not made or paid, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the dividend or distribution, if any, actually made or paid.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.65pt 0 95.95pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt"> </FONT></P> <!-- Field: Page; Sequence: 38; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in"><FONT STYLE="letter-spacing: -0.05pt">(F) </FONT><I>Tender Offers or Exchange Offers</I>. If the Borrower or any of its Subsidiaries makes a payment in respect of a tender offer or exchange offer for shares of Common Stock (other than solely pursuant to an odd-lot tender offer pursuant to Rule 13e-4(h)(5) under the Exchange Act), and the value (determined as of the Expiration Time by the Board of Directors) of the cash and other consideration paid per share of Common Stock in such tender or exchange offer exceeds the Last Reported Sale Price per share of Common Stock on the Trading Day immediately after the last date (the “<U>Expiration Date</U>”) on which tenders or exchanges may be made pursuant to such tender or exchange offer (as it may be amended), then the Conversion Rate will be increased based on the following <FONT STYLE="letter-spacing: -0.1pt">formula:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 28%"> <TR STYLE="vertical-align: top; text-align: left"> <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CR<SUB>1 </SUB>= CR<SUB>0</SUB> x </FONT></TD> <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AC + (SP x OS<SUB>1</SUB>)</FONT></TD></TR> <TR STYLE="vertical-align: top; text-align: left"> <TD> </TD> <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SP x OS<SUB>0</SUB></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="letter-spacing: -0.1pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="letter-spacing: -0.1pt">where:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt; width: 0.5in"> </TD> <TD STYLE="text-indent: 0pt; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>0</SUB> </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately before the Close of Business on the last Trading Day of the Tender/Exchange Offer Valuation Period for such tender or exchange offer;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>CR<SUB>1</SUB> </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Conversion Rate in effect immediately after the Close of Business on the last Trading Day of the Tender/Exchange Offer Valuation Period;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>AC </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the aggregate value (determined as of the time (the “<U>Expiration Time</U>”) such tender or exchange offer expires by the Board of Directors) of all cash and other consideration paid for shares of Common Stock purchased or exchanged in such tender or exchange offer;</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS0 </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of Common Stock outstanding immediately before the Expiration Time (including all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer);</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>OS1 </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of shares of Common Stock outstanding immediately after the Expiration Time (excluding all shares of Common Stock accepted for purchase or exchange in such tender or exchange offer); and</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: justify; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>SP </I>=</FONT></TD> <TD STYLE="text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the average of the Last Reported Sale Prices per share of Common Stock over the ten (10) consecutive Trading Day period (the “<U>Tender/Exchange Offer Valuation Period</U>”) beginning on, and including, the Trading Day immediately after the Expiration Date;</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><I>provided</I>, <I>however</I>, that the Conversion Rate will in no event be adjusted down pursuant to this <U>Section 4(c)(i)(F)</U>, except to the extent provided in the immediately following paragraph. Notwithstanding anything to the contrary in this <U>Section 4(c)(i)(F)</U>, if the Conversion Date for a Note occurs during the Tender/Exchange Offer Valuation Period for such tender or exchange offer, then, solely for purposes of determining the Conversion Consideration for such conversion, such Tender/Exchange Offer Valuation Period will be deemed to consist of the Trading Days occurring in the period from, and including, <FONT STYLE="letter-spacing: -0.25pt">the</FONT> Trading Day immediately after the Expiration Date to, and including, such Conversion <FONT STYLE="letter-spacing: -0.1pt">Date.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">To the extent such tender or exchange offer is announced but not consummated (including as a result of the Borrower being precluded from consummating such tender or exchange offer under applicable law), or any purchases or exchanges of shares of Common Stock in such tender or exchange offer are rescinded, the Conversion Rate will be readjusted to the Conversion Rate that would then be in effect had the adjustment been made on the basis of only the purchases or exchanges of shares of Common Stock, if any, actually made, and not rescinded, in such tender or exchange offer.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 39; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) <I>No Adjustments in Certain Cases</I>. Notwithstanding anything to the contrary in <U>Section 4(c)(i)</U>, the Borrower will not be obligated to adjust the Conversion Rate on account of a transaction or other event otherwise requiring an adjustment pursuant to <U>Section 4(c)(i)</U> (other than a stock split or combination of the type set forth in <U>Section 4(c)(i)(A)</U> or a tender or exchange offer of the type set forth in <U>Section 4(c)(i)(F)</U>) if the Holder participates, at the same time and on the same terms as holders of Common Stock, and solely by virtue of holding this Note, in such transaction or event without having to convert this Note and as if the Holder held a number of shares of Common Stock equal to the product of (A) the Conversion Rate in effect on the related record date and (B) the aggregate Principal Amount on such date.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iii) <I>Certain Events</I>. The Borrower will not be required to adjust the Conversion Rate except as provided in <U>Section 4(c)</U> or <U>Section 4(e)</U>. Without limiting the foregoing, the Borrower will not be obligated to adjust the Conversion Rate on account of:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(A) </FONT>except as otherwise provided in <U>Section 4(c)</U>, the sale of shares of Common Stock for a purchase price that is less than the market price per share of Common Stock or less than the Conversion Price;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(B) </FONT>the issuance of any shares of Common Stock pursuant to any present or future plan providing for the reinvestment of dividends or interest payable on the Borrower’s securities and the investment of additional optional amounts in shares of Common Stock under any such plan;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(C) </FONT>the issuance of any shares of Common Stock or options or rights to purchase shares of Common Stock pursuant to any present or future employee, director or consultant benefit plan or program of, or assumed by, the Borrower or any of its Subsidiaries;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(D) </FONT>the issuance of any shares of Common Stock pursuant to any option, warrant, right or convertible or exchangeable security of the Borrower outstanding as of the Initial Closing Date;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(E) </FONT>solely a change in the par value of the Common Stock; <FONT STYLE="letter-spacing: -0.25pt">or</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(F) </FONT>accrued and unpaid interest, if any, on the <FONT STYLE="letter-spacing: -0.1pt">Notes.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.95pt 0 96pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 40; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iv) <I>Adjustments Not Yet Effective</I>. Notwithstanding anything to the contrary contained herein, if:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.95pt 0 96pt; text-align: justify; text-indent: 1in"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(A) </FONT>the record date, effective date or Expiration Time for any event that requires an adjustment to the Conversion Rate pursuant to <U>Section 4(c)(i)</U> has occurred on or before the Conversion Date for such conversion, but an adjustment to the Conversion Rate for such event has not yet become effective as of such Conversion Date, as applicable;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(B) </FONT>the Conversion Consideration due upon such conversion includes any whole shares of Common Stock; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(C) </FONT>such shares are not entitled to participate in such event (because they were not held on the related record date or otherwise),</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">then, solely for purposes of such conversion, the Borrower will, without duplication, give effect to such adjustment on such Conversion Date. In such case, if the date on which the Borrower is otherwise required to deliver the consideration due upon such conversion is before the first date on which the amount of such adjustment can be determined, then the Borrower will delay the settlement of such conversion until the second (2nd) Business Day after such first date.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(v) <I>Conversion Rate Adjustments where the Holder Participates in the Relevant Transaction or Event</I>. Notwithstanding anything to the contrary contained herein, <FONT STYLE="letter-spacing: -0.2pt">if:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(A) </FONT>a Conversion Rate adjustment for any dividend or distribution becomes effective on any Ex-Dividend Date pursuant to <U>Section 4(c)(i)</U>;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(B) </FONT>the Conversion Date for such conversion occurs on or after such Ex-Dividend Date and on or before the related record date;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(C) </FONT>the Conversion Consideration due upon such conversion includes any whole shares of Common Stock, in each case based on a Conversion Rate that is adjusted for such dividend or distribution; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(D) </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">such shares would be entitled to participate in such <FONT STYLE="letter-spacing: -0.1pt">dividend </FONT></FONT>or <FONT STYLE="letter-spacing: -0.1pt">distribution;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">then such Conversion Rate adjustment will not be given effect for such conversion and the shares of Common Stock issuable upon such conversion based on such unadjusted Conversion Rate will not be entitled to participate in such dividend or distribution, but there will be added, to the Conversion Consideration otherwise due upon such conversion, the same kind and amount of consideration that would have been delivered in such dividend or distribution with respect to such shares of Common Stock had such shares been entitled to participate in such dividend or distribution.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 96pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 41; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(vi) <I>Stockholder Rights Plans</I>. If any shares of Common Stock are to be issued upon conversion of this Note and, at the time of such conversion, the Borrower has in effect any stockholder rights plan, then the Holder will be entitled to receive, in addition to, and concurrently with the delivery of, the Conversion Consideration otherwise payable upon such conversion, the rights set forth in such stockholder rights plan, unless such rights have separated from the Common Stock at such time, in which case, and only in such case, the Conversion Rate will be adjusted pursuant to <U>Section 4(c)(i)(C)</U> on account of such separation as if, at the time of such separation, the Borrower had made a distribution of the type referred to in <U>Section 4(c)(i)(C)</U> to all holders of the Common Stock, subject to potential readjustment in accordance with the last paragraph of <U>Section 4(c)(i)(C)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(vii) <I>Limitation on Effecting Transactions Resulting in Certain Adjustments</I>. The Borrower will not engage in or be a party to any transaction or event that would require the Conversion Rate to be adjusted pursuant to <U>Section 4(c)(i)</U> or <U>Section 4(e)</U> to an amount that would result in the Conversion Price per share of Common Stock being less than the par value per share of Common Stock.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(viii) <I>Equitable Adjustments to Prices</I>. Whenever any provision of this Note requires the Borrower to calculate the average of the Last Reported Sale Prices, Daily VWAPs, or any function thereof, over a period of multiple days (including to calculate an adjustment to the Conversion Rate), the Borrower will make proportionate adjustments, if any, to such calculations to account for any adjustment to the Conversion Rate pursuant to <U>Section 4(c)(i)(A)</U> that becomes effective, or any event requiring such an adjustment to the Conversion Rate where the Ex-Dividend Date or effective date, as applicable, of such event occurs, at any time during such period.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ix) <I>Calculation of Number of Outstanding Shares of Common Stock</I>. For purposes of <U>Section 4(c)(i)</U><I>,</I> the number of shares of Common Stock outstanding at any time will (i) include shares issuable in respect of scrip certificates issued in lieu of fractions of shares of Common Stock and (ii) exclude shares of Common Stock held in the Borrower’s treasury (unless the Borrower pays any dividend or makes any distribution on shares of Common Stock held in its treasury).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(x) <I>Calculations</I>. All calculations with respect to the Conversion Rate and adjustments thereto will be made by the Borrower to the nearest 1/10,000th of a share of Common Stock (with 5/100,000ths rounded upward). The Borrower shall be responsible for making all calculations called for under or in connection with the Notes. These calculations include, but are not limited to, determinations of the Stock Price, the Last Reported Sale Prices of the Common Stock, accrued interest payable on the Notes and the Conversion Rate of the Notes. The Borrower shall make all these calculations in good faith and, absent manifest error, such calculations shall be final and binding on the Holders of Notes. Upon written request, the Borrower shall provide a schedule of its calculations to the Holder Representative, and the Holder Representative is entitled to rely conclusively upon the accuracy of the Borrower’s calculations without independent verification. The Holder Representative will forward the Borrower’s calculations to any Holder upon the request of that Holder at the sole cost and expense of the Borrower.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.85pt 0 96pt; text-align: justify; text-indent: 0.5in"> </P> <!-- Field: Page; Sequence: 42; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">The Holder Representative shall not have any responsibility for making any <FONT STYLE="letter-spacing: -0.1pt">calculations, for determining amounts to be paid or for monitoring stock price or be charged </FONT>with any knowledge of or have any duties to monitor any measurement period.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(xi) <I>Notice of Conversion Rate Adjustments</I>. Upon the effectiveness of any adjustment to the Conversion Rate pursuant to <U>Section 4(c)(i)</U>, the Borrower will promptly send written notice to the Holder containing (A) a brief description of the transaction or other event on account of which such adjustment was made; (B) the Conversion Rate in effect immediately after such adjustment; and (C) the effective time of such adjustment.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Voluntary Adjustments</U>. To the extent permitted by law and applicable stock exchange rules, the Borrower, from time to time, may (but is not required to) increase the Conversion Rate by any amount if (A) the Board of Directors determines that such increase is either (x) in the best interest of the Borrower; or (y) advisable to avoid or diminish any income tax imposed on holders of Common Stock or rights to purchase Common Stock as a result of any dividend or distribution of shares (or rights to acquire shares) of Common Stock or any similar event; (B) such increase is in effect for a period of at least twenty (20) Business Days; and (C) such increase is irrevocable during such period. If the Board of Directors determines to increase the Conversion Rate pursuant to this <U>Section 4(d)</U>, then, no later than the first Business Day of the related twenty (20) Business Day period referred to in this <U>Section 4(d)</U>, the Borrower will send notice to each Holder and the Holder Representative of such increase, the amount thereof and the period during which such increase will be in effect.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <U>Adjustments to the Conversion Rate in Connection with a Make-Whole Fundamental Change</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in">(i) <I>Generally</I>. If a Make-Whole Fundamental Change occurs and the Conversion Date for the conversion of part or all of this Note occurs during the related Make-Whole Fundamental Change Conversion Period, then, subject to this <U>Section 4(e)</U>, the Conversion Rate applicable to such conversion will be increased by a number of shares (the “<U>Additional Shares</U>”) set forth in the table below corresponding (after interpolation as provided in, and subject to, the provisions below) to the Make-Whole Fundamental Change Effective Date and the Stock Price of such Make-Whole Fundamental Change:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 393.85pt 0 65.3pt"><B> </B></P> <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%"> <TR STYLE="vertical-align: bottom"> <TD STYLE="font-weight: bold; text-indent: 0pt">Make-Whole Fundamental Change</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="34" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">Stock Price</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: bottom"> <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-indent: 0pt">Effective Date</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$0.10000</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$0.21890</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$0.24079</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$0.30000</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$0.40000</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$0.50000</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$1.00000</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$1.50000</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD> <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold; text-indent: 0pt">$2.0000</TD> <TD STYLE="font-weight: bold; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)"> <TD STYLE="width: 28%; font-weight: bold; text-indent: 0pt">May 9, 2022</TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">1.7019</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.6756</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.6058</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.4713</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.3418</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.2676</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.1282</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.0849</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-indent: 0pt"> </TD> <TD STYLE="width: 1%; text-align: center; text-indent: 0pt"> </TD> <TD STYLE="width: 5%; text-align: right; text-indent: 0pt">0.0637</TD> <TD STYLE="width: 1%; text-align: left; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: bottom; background-color: White"> <TD STYLE="font-weight: bold; text-indent: 0pt">May 9, 2023</TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">1.8060</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.6204</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.5479</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.4139</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.2912</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.2242</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.1051</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.0697</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.0524</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)"> <TD STYLE="font-weight: bold; text-indent: 0pt">May 9, 2024</TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">1.9246</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.4381</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.3738</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.2659</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.1792</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.1363</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.0650</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.0440</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">0.0336</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD></TR> <TR STYLE="vertical-align: bottom; background-color: White"> <TD STYLE="font-weight: bold; text-indent: 0pt">May 9, 2025</TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">1.7019</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD> <TD STYLE="text-indent: 0pt"> </TD> <TD STYLE="text-align: center; text-indent: 0pt"> </TD> <TD STYLE="text-align: right; text-indent: 0pt">—</TD> <TD STYLE="text-align: left; text-indent: 0pt"> </TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B> </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">If such Make-Whole Fundamental Change Effective Date or Stock Price is not set forth in the table above, then:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(A) </FONT>if such Stock Price is between two Stock Prices in the table above or the Make-Whole Fundamental Change Effective Date is between two dates in the table above, then the number of Additional Shares will be determined by straight-line interpolation between the numbers of Additional Shares set forth for the higher and lower Stock Prices in the table above or the earlier and later dates in the table above, based on a 365- or 366-day year, as applicable; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 43; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(B) </FONT>if the Stock Price is greater than $2.00 (subject to adjustment in the same manner as the Stock Prices set forth in the column headings of the table above are adjusted pursuant to <U>Section 4(e)(ii)</U>, or less than $0.010 (subject to adjustment in the same manner), per share, then no Additional Shares will be added to the Conversion Rate.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Notwithstanding anything to the contrary in this Note, in no event will the Conversion Rate be increased to an amount that exceeds 6.0776 shares of Common Stock per $1 Principal Amount, which amount is subject to adjustment in the same manner as, and at the same time and for the same events for which, the Conversion Rate is required to be adjusted pursuant to <U>Section 4(c)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Notwithstanding anything to the contrary in this Note, if an Interest Make-Whole Payment is due in respect of a conversion of part or all of this Note entitled to Additional Shares pursuant to this <U>Section 4(e)</U>, the Holder of such Note shall be entitled to receive the greater of the Interest Make-Whole Payment or such Additional Shares, but not both; <I>provided</I> that the arithmetic average of the Daily VWAP for the five (5) VWAP Trading Days ending on the VWAP Trading Day immediately preceding the Conversion Date shall be used to determine the value of such Additional Shares for this purpose.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in">(ii) <I>Adjustment of Stock Prices and Number of Additional Shares</I>. The Stock Prices in the first row (<I>i.e.</I>, the column headers) of the table set forth in <U>Section 4(e)(i)</U> will be adjusted in the same manner as, and at the same time and for the same events for which, the Conversion Price is adjusted as a result of the operation of <U>Section 4(c)</U>. The numbers of Additional Shares in the table set forth in <U>Section 4(e)(i)</U> will be adjusted in the same manner as, and at the same time and for the same events for which, the Conversion Rate is adjusted pursuant to <U>Section 4(c)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1.5in">(iii) <I>Notice of the Occurrence of a Make-Whole Fundamental Change</I>. The Borrower will notify the Holder and the Holder Representative in writing of each Make-Whole Fundamental Change in accordance with <U>Section 4(f)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) <U>Notice of the Occurrence of Certain Corporate Events</U>. If the Borrower elects to (I) distribute, to all or substantially all holders of Common Stock, any rights, options or warrants (other than rights issued pursuant to a stockholder rights plan, so long as such rights have not separated from the Common Stock and are not exercisable until the occurrence of a triggering event, except that such rights will be deemed to be distributed under this clause (I) upon their separation from the Common Stock or upon the occurrence of such triggering event) entitling them, for a period of not more than sixty (60) calendar days after the record date of such distribution, to subscribe for or purchase shares of Common Stock at a price per share that is less than the average of the Last Reported Sale Prices per share of Common Stock for the ten (10) consecutive Trading Days ending on, and including, the Trading Day immediately before the date such distribution is announced (determined in the manner set forth in the third paragraph <FONT STYLE="letter-spacing: -0.25pt">of </FONT><U>Section 4(c)(i)(B)</U>); or (II) distribute, to all or substantially all holders of Common Stock, assets or securities of the Borrower or rights to purchase the Borrower’s securities, which distribution per share of Common Stock has a value, as reasonably determined by the Board of Directors, exceeding ten percent (10%) of the Last Reported Sale Price per share of Common Stock on the Trading Day immediately before the date such distribution is announced, then, in either case, (x) the Borrower will send notice of such distribution to the Holders and the Holder Representative at least twenty five (25) Scheduled Trading Days before the Ex-Dividend Date for such distribution (or, if later in the case of any such separation of rights issued pursuant to a stockholder rights plan or the occurrence of any such triggering event under a stockholder rights plan, as soon as reasonably practicable after the Borrower becomes aware that such separation or triggering event has occurred or will occur). If a Fundamental Change, Make-Whole Fundamental Change (other than a Make-Whole Fundamental Change pursuant to clause (B) of the definition thereof) or Common Stock Change Event occurs (other than a merger or other business combination transaction that is effected solely to change the Borrower’s jurisdiction of incorporation and that does not constitute a Fundamental Change or a Make-Whole Fundamental Change), then, in each case, then, no later than the effective date thereof, the Borrower will send notice to the Holder of such transaction or event and such effective date.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 44; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) <U>Effect of Common Stock Change <FONT STYLE="letter-spacing: -0.1pt">Event</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">(i) <I>Generally</I>. If there occurs <FONT STYLE="letter-spacing: -0.2pt">any:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(A) </FONT>recapitalization, reclassification or change of the Common Stock (other than (x) changes solely resulting from a subdivision or combination of the Common Stock, (y) a change only in par value or from par value to no par value or no par value to par value and (z) stock splits and stock combinations that do not involve the issuance of any other series or class of securities);</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(B) </FONT>consolidation, merger, combination or binding or statutory share exchange involving the Borrower;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(C) </FONT>sale, lease or other transfer of all or substantially all of the assets of the Borrower and its Subsidiaries, taken as a whole, to any Person; or</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in"><FONT STYLE="letter-spacing: -0.05pt">(D) </FONT>other similar <FONT STYLE="letter-spacing: -0.1pt">event,</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0pt">and, as a result of which, the Common Stock is converted into, or is exchanged for, or represents solely the right to receive, other securities, cash or other property, or any combination of the foregoing (such an event, a “<U>Common Stock Change Event</U>,” and such other securities, cash or property, the “<U>Reference Property</U>,” and the amount and kind of Reference Property that a holder of one (1) share of Common Stock would be entitled to receive on account of such Common Stock Change Event (without giving effect to any arrangement not to issue or deliver a fractional portion of any security or other property), a “<U>Reference Property Unit</U>”), then, notwithstanding anything to the contrary in this Note,</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">(1) from and after the effective time of such Common Stock Change Event, (I) the Conversion Consideration due upon conversion will be determined in the same manner as if each reference to any number of shares <FONT STYLE="letter-spacing: -0.25pt">of </FONT>Common Stock in this <U>Section 4</U> (or in any related definitions) were instead a reference to the same number of Reference Property Units and (II) for purposes of the definitions of “Fundamental Change” and “Make-Whole Fundamental Change,” references to “Common Stock” and the Borrower’s “Common Equity” will be deemed to refer to the Common Equity, if any, forming part of such Reference Property;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 45; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">(2) if such Reference Property Unit consists entirely of cash, then (I) each conversion of any Note with a Conversion Date that occurs on or after the effective date of such Common Stock Change Event will be settled entirely in cash in an amount, per $1 principal amount of this Note being converted, equal to the product of (x) the Conversion Rate in effect on such Conversion Date (as may be increased by any Additional Shares pursuant to <U>Section 4(e)</U>) and (y) the amount of cash constituting such Reference Property Unit, together with an Interest Make- Whole Payment, if applicable, which shall be payable solely in cash (regardless of whether the Borrower elected to settle Interest Make-Whole Payments in shares of Common Stock in accordance with <U>Section 4(c)(i)(B)</U> and (II) the Borrower will settle each such conversion no later than the second (2nd) Business Day after the relevant Conversion Date; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 1in">(3) for these purposes, (I) the Daily VWAP of any Reference Property Unit or portion thereof that consists of a class of Common Equity securities will be determined by reference to the definition of “Daily VWAP,” substituting, if applicable, the Bloomberg page for such class of securities in such definition; and (II) the Daily VWAP of any Reference Property Unit or portion thereof that does not consist of a class of Common Equity securities, and the Last Reported Sale Price of any Reference Property Unit or portion thereof that does not consist of a class of securities, will be the fair value of such Reference Property Unit or portion thereof, as applicable, determined in good faith by the Borrower (or, in the case of cash denominated in U.S. dollars, the face amount thereof).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0pt">If the Reference Property consists of more than a single type of consideration to be determined based in part upon any form of stockholder election, then the composition of the Reference Property Unit will be deemed to be the weighted average of the types and amounts of consideration actually received, per share of Common Stock, by the holders of Common Stock. The Borrower will notify the Holder of such weighted average as soon as practicable after such determination is made.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0pt">At or before the effective time of such Common Stock Change Event, the Borrower and the resulting, surviving or transferee Person (if not the Borrower) of such Common Stock Change Event (the “<U>Successor Person</U>”) will execute and deliver to the Holder one or more documents (x) providing for subsequent conversions of this Note in the manner set forth in this <U>Section 4(g)</U>; (y) providing for subsequent adjustments to the Conversion Rate pursuant to <U>Section 4(c)(i)</U> in a manner consistent with this <U>Section 4(g)</U>; and (z) containing such other provisions that are appropriate to preserve the economic interests of the Holder and to give effect to the provisions of this <U>Section 4(g)</U>. If the Reference Property includes shares of stock or other securities or assets (other than cash) of a Person other than <FONT STYLE="letter-spacing: -0.25pt">the</FONT> Successor Person, then such other Person will also execute such documentation, which will contain such additional provisions, if any, that the Borrower reasonably determines are appropriate to preserve the economic interests of the Holder.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 46; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) <I>Notice of Common Stock Change Events</I>. The Borrower will provide notice of each Common Stock Change Event in the manner provided in <U>Section 4(f)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) <I>Compliance Covenant</I>. The Borrower will not become a party to any Common Stock Change Event unless its terms are consistent with this <U>Section 4(g)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0pt">5. <U>Limitations on Conversions and Other Share <FONT STYLE="letter-spacing: -0.1pt">Issuances</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Share Conversion Cap</U>. Notwithstanding anything to the contrary in this Note, prior to the Authorized Share Amendment Date, the aggregate number of shares of Common Stock issuable upon under the Notes will be subject to, and shall not exceed, the Share Conversion Cap, including shares of Common Stock issuable upon (x) conversion of all of the Notes in the aggregate, (y) satisfaction of all Interest Make-Whole Payments or any analogous interest make- whole payments on any of the Notes in shares of Common Stock and (z) satisfaction of any portion of any Amortization Payments in shares of Common Stock or any analogous amortization payments on any of the Notes, to the extent permissible, in shares of Common Stock. To the extent that the Borrower is unable to issue any shares of Common Stock otherwise issuable pursuant to the terms of this Note as a result of the application of this <U>Section 5(a)</U>:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i) in the case such shares of Common Stock that are unable to be issued would be used to satisfy a conversion of this Note in whole or in part, the Borrower shall be required to, at the election of the Holder, either (A) pay an amount in cash for any shares not so delivered in an amount based on the Conversion Price in the case of a conversion of part or all of this Note or (B) allow the Holder to revoke, in whole or in part, its related Notice of Conversion, in which event the portion of this Note to be converted shall not be extinguished and any entries to the contrary in the Conversion/PIK Schedule shall be reversed; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) in the case such shares of Common Stock that are unable to be issued would be used to satisfy any portion of an Interest Make-Whole Payment or Amortization Payment, the Borrower shall be deemed for all purposes under this Note to have elected to make the applicable Interest Make-Whole Payment or Amortization Payment solely in <FONT STYLE="letter-spacing: -0.1pt">cash.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">Prior to the Authorized Share Amendment Date, whenever the Share Conversion Cap is adjusted as herein provided, the Borrower shall prepare a notice of such adjustment of the Share Conversion Cap setting forth the adjusted Share Conversion Cap and the date on which each adjustment becomes effective and shall send such notice of such adjustment to the Holder. Failure to deliver such notice shall not affect the legality or validity of any such adjustment.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 47; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-indent: 0pt">(b) <U>Beneficial Ownership <FONT STYLE="letter-spacing: -0.1pt">Limitations</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i) Notwithstanding anything to the contrary in this Note, the Holder will not be entitled to receive shares of Common Stock upon conversion of Notes (including as part of any Interest Make-Whole Payment) or as any portion of any Amortization Payment, and no conversion of Notes or payment of any portion of any Amortization Payment in shares of Common Stock shall take place, to the extent (but only to the extent) that such receipt (or conversion or payment) would cause the Holder and its Attribution Parties to beneficially own shares of Common Stock in excess of the Beneficial Ownership Limitations. For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of this Note (including as part of any Interest Make-Whole Payment) or as any portion of any Amortization Payment in shares of Common Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable <FONT STYLE="letter-spacing: -0.2pt">upon</FONT> (1) conversion of the remaining, unconverted portion of this Note beneficially owned by the Holder or any of its Attribution Parties and (ii) exercise, conversion or exchange of the unexercised, unconverted or unexchanged portion of any other securities of the Borrower subject to a limitation on exercise, conversion or exchange analogous to the limitation contained herein beneficially owned by the Holder or any of its Attribution Parties. Except as set forth in the preceding sentence, for purposes of this provision, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act, and a determination as to any “group” status shall be determined in accordance with Section 13(d) of the Exchange Act. Any purported delivery of shares of Common Stock upon conversion of this Note (including as part of any Interest Make-Whole Payment) or as payment of any portion of any Amortization Payment in shares of Common Stock shall be void and have no effect to the extent (but only to the extent) that such delivery would result in the Holder exceeding the Beneficial Ownership Limitation in violation of this <U>Section 5(b)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) To the extent that the limitation contained in this <U>Section 5(b)</U> applies, the determination of whether and the extent that this Note is convertible (in relation to other securities beneficially owned by the Holder) or that any portion of an Amortization Payment can be made in shares of Common Stock shall be in the sole discretion of the Holder, and, unless otherwise indicated in writing, the submission of a Notice of Conversion or written confirmation regarding the applicability of this <U>Section 5(b)</U> upon request by the Borrower shall be deemed to be the Holder’s determination of whether and the extent that this Note may be converted (in relation to other securities beneficially owned by the Holder) or any portion of an Amortization Payment can be made in shares of Common Stock, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, unless otherwise indicated in writing connection with a Notice of Conversion, the Holder shall be deemed to represent to the Borrower each time it delivers a Notice of Conversion that such Notice of Conversion has not violated the restrictions set forth in this <U>Section 5(b)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iii) For purposes of this <U>Section 5(b)</U>, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding shares of Common Stock as stated in the most recent of the following: (1) the Borrower’s most recent periodic or annual report filed with the SEC, as the case may be, (2) a more recent public announcement by the Borrower, or (3) a more recent written notice by the <FONT STYLE="letter-spacing: -0.1pt">Borrower or the Transfer Agent to the Holder setting forth the number of shares of Common </FONT>Stock outstanding. Upon request, the Borrower shall within two Trading Days confirm in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the exercise, conversion or exchange of securities of the Borrower, including this Note, by the Holder since the date as of which such number of outstanding shares of Common Stock was reported.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 48; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(iv) The “<U>Beneficial Ownership Limitation</U>” shall be 9.9% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of this Note. The Holder, upon written notice to the Borrower, may elect a beneficial ownership limit that is less than or equal to 9.9%. Any such election will be effective as of the date specified in such notice, which shall not be earlier than (i) the date such notice is delivered to the Borrower in the event such notice decreases the Beneficial Ownership Limitation, and (ii) 61 days after the date such notice is delivered to the Borrower in all other cases.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(v) To the extent that the limitation contained in this <U>Section <FONT STYLE="letter-spacing: -0.2pt">5(b) </FONT></U><FONT STYLE="letter-spacing: -0.1pt">applies:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(A) </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in the case such shares of Common Stock that are unable to be <FONT STYLE="letter-spacing: -0.1pt">issued </FONT></FONT>would be used to satisfy a conversion of this Note in whole or in part, the Holder may either (1) revoke, in whole or in part, its related Notice of Conversion, in which event the portion of this Note to be converted shall not be extinguished and any entries to the contrary in the Conversion/PIK Schedule shall be reversed or (2) when possible, certify to the Borrower that the Person (or Persons) receiving shares of Common Stock upon conversion is not, and would not, as a result of such conversion, become the beneficial owner of shares of Common Stock outstanding at such time in excess of the applicable Beneficial Ownership Limitation, after which the Borrower shall cause to be delivered any such shares of Common Stock withheld on account of such applicable Beneficial Ownership Limitation no later than two Trading Days after receipt of such certification; <I>provided</I>, <I>however</I>, until such time as the affected Holder gives such certification, no Person shall be deemed to be the shareholder of record with respect to the shares of Common Stock otherwise deliverable upon conversion in excess of any applicable Beneficial Ownership Limitation; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(B) </FONT>in the case such shares of Common Stock that are unable to be issued would be used to satisfy any portion of an Interest Make-Whole Payment or Amortization Payment, the Borrower shall be deemed for all purposes under this Note <FONT STYLE="letter-spacing: -0.1pt">to have elected to make the applicable Interest Make-Whole Payment or Amortization </FONT>Payment solely in cash.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0pt">6. <U>Repurchase at the Option of the Holder Upon a Fundamental <FONT STYLE="letter-spacing: -0.1pt">Change</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) If a Fundamental Change occurs at any time, the Holder shall have the right, at its option, to require the Borrower to repurchase for cash all or any portion of the Notes, on the date (the “<U>Fundamental Change Repurchase Date</U>”) specified by the Borrower that is not less than twenty (20) Business Day or more than thirty-five (35) Business Day following the date of the Fundamental Change Borrower Notice at a repurchase price equal to 110% of the Principal Amount, plus any accrued and unpaid interest to, but excluding, the Fundamental Change Repurchase Date (the “<U>Fundamental Change Repurchase Price</U>”).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 49; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) Repurchases under this <U>Section 6</U> shall be made, at the option of the <FONT STYLE="letter-spacing: -0.1pt">Holder, upon:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i) delivery to the Borrower of a duly completed notice (the “<U>Fundamental Change Repurchase Notice</U>”) in the form set forth in <U>Annex C</U> hereto on or before the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) if the entire remaining Principal Amount of this Note is being repurchased, delivery of this Note to the Borrower at any time after delivery of the Fundamental Change Repurchase Notice (together with all necessary endorsements for transfer), such delivery being a condition to receipt by the Holder of the Fundamental Change Repurchase Price therefor.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notwithstanding anything herein to the contrary, the Holder shall have the right to withdraw, in whole or in part, such Fundamental Change Repurchase Notice at any time prior to the Close of Business on the Business Day immediately preceding the Fundamental Change Repurchase Date by delivery of a written notice of withdrawal to the Borrower in accordance with <U>Section 6(c)</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) On or before the twentieth (20<SUP>th</SUP>) Business Day after the occurrence of the effective date of a Fundamental Change, the Borrower shall provide to the Holder a notice (the “<U>Fundamental Change Borrower Notice</U>”) of the occurrence of the effective date of the Fundamental Change and of the repurchase right at the option of the Holder arising as a result thereof specifying the following: (i) the events causing the Fundamental Change; (ii) the date of the Fundamental Change; (iii) the last date on which the Holder may exercise the repurchase right pursuant to this <U>Section 6</U>; (iv) the Fundamental Change Repurchase Price; (v) the Fundamental Change Repurchase Date; and (vi) if applicable, the Conversion Rate and any adjustments to the Conversion Rate. No failure of the Borrower to give the foregoing notice and no defect therein shall limit the Holder’s repurchase rights or affect the validity of the proceedings for the repurchase of this Note pursuant to this Section 6.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) Notwithstanding the foregoing, no Notes may be repurchased by the Borrower on any date at the option of the Holders upon a Fundamental Change if the principal amount of the Notes has been accelerated, and such acceleration has not been rescinded, on or prior to such date (except in the case of an acceleration resulting from a Default by the Borrower in the payment of the Fundamental Change Repurchase Price with respect to such Notes).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) To the extent that, as a result of a change in law occurring after the first date on which this Note is issued, the provisions of any applicable securities laws or regulations conflict with the provisions of this Note relating to the Borrower’s obligations to purchase the Notes upon a Fundamental Change, the Borrower shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under such provisions of this Note by virtue of such conflict.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.8pt 0 60pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 50; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) A Fundamental Change Repurchase Notice may be withdrawn (in whole or in part) by means of a written notice of withdrawal delivered to the Borrower at any time prior to the Close of Business on the Business Day immediately preceding the Fundamental Change Repurchase Date, specifying the Principal Amount with respect to which such notice of withdrawal is being submitted, and the Principal Amount, if any, that remains subject to the original Fundamental Change Repurchase Notice.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) The Borrower will set aside, segregate and hold in trust on or prior to 11:00 a.m., New York City time, on the Fundamental Change Repurchase Date an amount of money, in immediately available funds, sufficient to repurchase all of the Notes to be repurchased at the appropriate Fundamental Change Repurchase Price. Subject to receipt of Notes, payment for Notes surrendered for repurchase (and not withdrawn prior to the close of business on the Business Day immediately preceding the Fundamental Change Repurchase Date) will be made on the Fundamental Change Repurchase Date by mailing checks for the amount payable to the Holders of such Notes entitled thereto as they shall appear in the Note Register.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h) In connection with any repurchase offer, the Borrower will, if <FONT STYLE="letter-spacing: -0.1pt">required: </FONT>(i) comply with the provisions of Rule 13e-4, Rule 14e-1 and any other tender offer rules under the Exchange Act that may then be applicable; (ii) file a Schedule TO or any other required schedule under the Exchange Act; and (iii) otherwise comply with all federal and state securities laws in connection with any offer by the Borrower to repurchase the Notes; in each case, so as to permit the rights and obligations under this Section 6 to be exercised in the time and in the manner specified in this Section 6.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0pt">7. <FONT STYLE="letter-spacing: -0.1pt"><U>Covenants</U>.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Registration Rights; Additional Interest</U>. The Borrower agrees that the Holder is entitled to the benefits of the Registration Rights Agreement. By its acceptance hereof, the Holder will have agreed to be bound by the terms of the Registration Rights Agreement relating to the Registrable Securities (as defined in the Registration Rights Agreement). If a Registration Default occurs under the Registration Rights Agreement, the Borrower shall pay Additional Interest on this Note in accordance with the Registration Rights Agreement. Any Additional Interest that accrues on this Note will be payable on the same dates and in the same manner as the Cash Interest on this Note; <I>provided</I>, <I>however</I>, that in no event will Additional Interest that may accrue pursuant to this Section 7(a) accrue on any day on this Note at a rate per annum that exceeds one half of one percent (0.50%). Any Additional Interest that accrues on this Note will be in addition to the Cash Interest and the PIK Interest that accrues on this Note.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Good Standing</U>. Each Note Party shall, and shall cause each of its Subsidiaries to, maintain its organizational existence and good standing in its jurisdiction of organization and maintain qualification in each other material jurisdiction. Each Note Party shall, and shall cause each of its Subsidiaries to, maintain in force all material licenses, approvals and <FONT STYLE="letter-spacing: -0.1pt">agreements.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Government Compliance</U>. Each Note Party shall, and shall cause each of its Subsidiaries to, comply in all material respects with all applicable federal and state statutes, laws, ordinances and government rules and regulations to which it or its operations is subject.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 51; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Financial Statements, Reports, Certificates</U>. Subject to <U>Section 7(jj)</U>, the Borrower shall deliver the following to the Holder, and the Holder shall be entitled to rely on the information contained therein: (i) as soon as available, but in any event within thirty (30) days after the end of each calendar month after the Original Issue Date, consolidated financial statements of the Borrower and its Subsidiaries, including a cash flow statement, income statement and balance sheet for the period reported, and certified by a Responsible Officer; (ii) as soon as available, but in any event within ninety (90) days after the end of each fiscal year of the Borrower, audited consolidated financial statements of the Borrower and its Subsidiaries in accordance with GAAP, consistently applied, together with an unqualified opinion on the financial statements from an independent certified public accounting firm reasonably acceptable to the Majority Holders; (iii) as soon as available, but in any event within forty-five (45) days after the end of each fiscal year of the Borrower, an annual operating budget and financial projections (including income statements, balance sheets and cash flow statements) for the subsequent fiscal year, presented in a quarterly format, as approved by the Board of Directors and the Majority Holders (with the Majority Holders’ approval not to be unreasonably withheld); (iv) upon the Holder’s request, within thirty (30) days after the end of any month that ends on the last day of a fiscal quarter, together with the delivery of the financial statements required pursuant to clause (i) above for such month, a management’s discussion and analysis of the important operational and financial developments during such fiscal quarter with a comparison to such period during the prior year; (v) copies of all statements, reports and notices sent or made available generally by the Borrower to its security holders and debt holders, when made available to such holders; (vi) promptly upon receipt of notice thereof, a report of any legal actions pending or threatened against the Borrower or any Subsidiary that could result in damages to the Borrower or any Subsidiary <FONT STYLE="letter-spacing: -0.1pt">exceeding </FONT>$100,000, fines, penalties or other sanctions by any Governmental Authority, or claims for injunctive or equitable relief; (vii) promptly upon receipt thereof (but in any event no more than three (3) Business Days thereafter), (A) copies of any amendments, waivers, consents or other modifications to the ABL Debt Documents and (B) notices of default required to be delivered pursuant to the ABL Debt Documents and (viii) other financial information as the Holder may reasonably request from time to time promptly after such request.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <U>Certificates of Compliance</U>. Each time financial statements are required to be furnished pursuant to <U>Section 7(d)</U> above, there shall be delivered to the Holder a certificate signed by a Responsible Officer (each a “<U>Compliance Certificate</U>”) certifying that as of the end of the reporting period for such financial statements, the Note Parties were in full compliance with all of the terms and conditions of the Note Documents, and setting forth such other information as the Holder shall reasonably request.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) <U>Notice of Defaults</U>. As soon as possible, and in any event within three (3) Business Days after the discovery of a Default or an Event of Default, the Borrower shall notify the Holder Representative, Collateral Agent and the Holder in writing of the facts relating to or giving rise to such Default or Event of Default and the action which the Note Parties propose to take with respect thereto.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) <U>Taxes</U>. Each Note Party shall, and shall cause each of its Subsidiaries to, make due and timely payment or deposit of all federal and material state and local Taxes, assessments or contributions required of it by Law or imposed on its income or upon any properties belonging to it, and will, upon request, furnish the Holder with proof satisfactory to the Majority Holders indicating that each Note Party and each Subsidiary thereof has made such payments or deposits; <I>provided </I>that the Note Parties and their Subsidiaries need not make any payment if the amount or validity of such payment is contested in good faith by appropriate proceedings and is fully reserved against by the Note Parties and their Subsidiaries.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 52; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h) <U>Maintenance</U>. Each Note Party, at its expense, shall maintain the Collateral in good condition, normal wear and tear and casualty and condemnation excepted, and will comply in all material respects with all Laws to which the use and operation of the Collateral may be or become subject. Such obligation shall extend to repair and replacement of any partial loss or damage to the Collateral, regardless of the cause, except where the failure to do so would not reasonably be expected to result in a Material Adverse Effect.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i) <FONT STYLE="letter-spacing: -0.1pt"><U>Insurance</U>.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) Each Note Party shall, and shall cause each of its Subsidiaries to, maintain, at its sole cost and expense, with financially sound and reputable insurance companies not affiliates of the Note Parties or their Subsidiaries, insurance with respect to the Collateral and its and its Subsidiaries’ properties and businesses against loss or damage of the kinds customarily insured against by Persons engaged in the same or similar business, of such types and in such amounts as are customarily carried under similar circumstances by such other Persons. All such policies of insurance shall be in such form, with such companies, and in such amounts as are reasonably satisfactory to the Majority Holders.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) From and after the date that is thirty (30) days after the Initial Closing Date, all such policies of property insurance shall contain a lender’s loss payable endorsement, in a form satisfactory to the Majority Holders, showing the Collateral Agent for its benefit and the benefit of the Holder Representative and the holders of Notes as a loss payee thereof, and all liability insurance policies shall show the Collateral Agent for its benefit and the benefit of the Holder Representative and the holders of Notes as an additional insured and shall specify that the insurer must give at least thirty (30) days’ notice to the Collateral Agent before canceling its policy for any reason (except for nonpayment, which shall be ten (10) days’ prior notice); provided that the Collateral Agent shall have no obligation or duty to obtain or monitor insurance in respect of the Collateral. Each Note Party shall promptly deliver to the Holder its current copy of such policies of insurance, evidence of the payments of all premiums therefor and insurance certificates and related endorsements thereto, it being understood that any time there is a change or renewal of insurance, it is the Note Parties’ obligation to promptly deliver such materials to the Holder.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) The Note Parties shall bear the risk of the Collateral being lost, stolen, destroyed, damaged beyond repair, rendered permanently unfit for use, or seized by a Governmental Authority for any reason whatsoever at any time.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 168pt; text-indent: -0.5in"> </P> <!-- Field: Page; Sequence: 53; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(j) <U>Intellectual Property <FONT STYLE="letter-spacing: -0.1pt">Rights</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) With respect to registration or pending application of each item of its Intellectual Property for which such Note Party has standing to do so, each Note Party agrees to take, at its expense, all reasonable steps, including in the USPTO, the USCO and any other Governmental Authority located in the United States, to pursue the registration and maintenance of each material Patent, Trademark, or Copyright registration or application now or hereafter included in the Intellectual Property of such Note Party that is not an Excluded Asset.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) No Note Party shall do or permit any act or knowingly omit to do any act whereby any of its Intellectual Property or Licenses, excluding Excluded Assets, may lapse, be terminated or become invalid or unenforceable or placed in the public domain (or in the case of a trade secret, become publicly known).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) Each Grantor shall take all reasonable steps to preserve and protect each item of its Intellectual Property and Licenses, including maintaining the quality of any and all products or services used or provided in connection with any of its Trademarks, consistent with the quality of the products and services as of the date hereof, and taking reasonable steps necessary to ensure that all licensed users of any of its Trademarks abide by the applicable License’s terms with respect to standards of quality.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv) (iv) Concurrently with the delivery of each Compliance Certificate for the months ending March 31, June 30, September 30 and December 31 of each year pursuant to Section 7(e), the Note Parties shall give the Holder written notice of: (A) any registration or filing of any Trademark, Copyright or Patent by any Note Party or any Subsidiary thereof, including the date of such registration or filing, the registration or filing numbers, the location of such registration or filing, and a general description of such registration or filing; (B) any intent-to-use Trademark application of any Note Party that no longer qualifies as an Excluded Asset; (C) any material change to any Note Party’s or any Subsidiary’s Intellectual Property, but excluding changes to source code, operating manuals and the like made in the ordinary course of business and (E) any Note Party’s knowledge of an event that could reasonably be expected to materially and adversely affect the value of its or any Subsidiary’s Intellectual Property. Within five (5) Business Days (or such longer period as the Majority Holders may agree in their reasonable discretion) following the delivery of such Compliance Certificate, the applicable Note Parties shall execute and deliver to the Collateral Agent Intellectual Property Security Agreements containing a description of such Intellectual Property (other than any Excluded Asset) in appropriate form for filing and recording in the USPTO or USCO, as applicable, and shall promptly file and record with the USPTO or USCO, as applicable, and provide evidence thereof to the Collateral Agent. For the avoidance of doubt, the provisions hereof shall automatically apply to such Intellectual Property (other than any Excluded Asset) and such Intellectual Property (other than any Excluded Asset) shall automatically constitute Article 9 Collateral hereunder.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 131.95pt; text-align: justify; text-indent: 0.5in"> </P> <!-- Field: Page; Sequence: 54; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(v) The Collateral Agent (as directed by the Majority Holders) or the <FONT STYLE="letter-spacing: -0.1pt">Holder may audit the Note Parties’ Intellectual Property to confirm compliance with </FONT>this Section, <I>provided </I>such audit may not occur more often than twice per year, unless an Event of Default has occurred and is continuing. The Collateral Agent and the Holder shall have the right, but not the obligation, to take, at the Note Parties’ sole expense, any actions that any Note Party is required under this Section to take but which such Note Party fails to take, after fifteen (15) days’ notice to the Borrower. The Note Parties shall reimburse and indemnify the Collateral Agent and the Holder for all costs, charges and expenses (including reasonable and <FONT STYLE="letter-spacing: -0.1pt">documented attorneys’ fees and expenses) incurred in the exercise of its rights under </FONT>the previous sentence.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(k) <U>Formation or Acquisition of Subsidiaries</U>. Notwithstanding and without limiting the negative covenants contained in Section 7(x) or Section 8, within thirty (30) days of the date that any Note Party forms any direct or indirect Subsidiary or acquires (including by division) any direct or indirect Subsidiary, such Note Party shall (i) cause such new Subsidiary to provide to the Collateral Agent a Joinder Agreement, together with such other Note Documents, all in form and substance satisfactory to the Majority Holders and the Collateral Agent, as to its rights, duties and obligations, as applicable, (including being sufficient to grant the Collateral Agent, for its benefit and for the benefit of the Holder Representative and the holders of Notes, a first priority Lien (subject to Permitted Liens) in and to the assets of such newly formed or acquired Subsidiary), (ii) provide to the Collateral Agent appropriate certificates and powers and financing statements, pledging all of the direct or beneficial ownership interest in such new Subsidiary (to the extent the same constitutes Collateral), in form and substance satisfactory to the Majority Holders and (iii) provide to the Collateral Agent all other documentation in form and substance satisfactory to the Majority Holders that in their opinion is appropriate with respect to the execution and delivery of the applicable documentation referred to above, including all documentation and other information which the Collateral Agent may reasonably request with respect to any new Subsidiary that signs and delivers a Joinder Agreement in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the USA PATRIOT ACT, the USA FREEDOM Act, an IRS Form W-9 or other applicable tax forms.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(l) <U>Defense of Article 9 Collateral</U>. Each Note Party shall, at its own expense, upon the reasonable request of the Majority Holders, take any and all commercially reasonable actions necessary to defend title to all material amounts of the Article 9 Collateral against all Persons and to defend the Security Interest of the Collateral Agent in the Article 9 Collateral and the priority thereof against any Lien other than Permitted Liens.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(m) <U>Further Assurances</U>. At any time and from time to time, the Note Parties shall, at their own expense, execute, acknowledge, deliver and cause to be duly filed all such further instruments and documents and take all such actions as the Collateral Agent or the Majority Holders may from time to time reasonably request to better assure, preserve, protect and perfect the Security Interest and the rights and remedies created hereby, including the payment of any fees and Taxes required in connection with the execution and delivery of this Note and the other Note Documents, the granting of the Security Interest and the filing of any financing statements or other documents in connection herewith or therewith.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.65pt 0 59.95pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 55; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(n) <U>Inventory, Returns</U>. The Note Parties shall keep all Inventory in good and marketable condition, free from all material defects except for Inventory for which adequate reserves have been made. Returns and allowances, if any, as between any Note Party and its Account Debtors shall be on the same basis and in accordance with GAAP, consistently applied, or with the usual customary practices of such Note arty, as they exist at the time of the execution and delivery of this Note. Each Note Party shall promptly notify the Holder of all returns and recoveries and of all disputes and claims, where the return, recovery, dispute or claim involves more than $100,000.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(o) <U>Delivery of Third-Party <FONT STYLE="letter-spacing: -0.1pt">Agreements</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) In the event that any Note Party shall at any time be a party to a lease with respect to any location where $250,000 or more of assets will be located, then such Note Party shall, upon the Holder’s request, within sixty (60) days after the date hereof (or, with respect to any lease entered into after the date hereof, within sixty (60) days after the execution of such lease), use commercially reasonable efforts to obtain and deliver to the Collateral Agent a Landlord Subordination and Access Agreement with respect to such lease, in form and substance reasonably satisfactory to the Majority Holders and the Collateral Agent, as to its rights, duties and obligations.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) Within sixty (60) days following the Holder’s written request, the applicable Note Party shall obtain and deliver to the Collateral Agent a Notice and Access Agreement for any location that contains or any Person that holds greater than $250,000.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) In the event that any Note Party shall at any time own or acquire any fee interest in any real property (wherever located) (each such interest being a “<U>Facility</U>”) with a Current Value (as defined below) in excess of $300,000, the Borrower shall promptly so notify the Collateral Agent, setting forth with reasonable specificity a description of the interest acquired, the location of the real property, any structures or improvements thereon and either an appraisal or such Note Party’s good-faith estimate of the current value of such real property at the time of such acquisition (for purposes of this Section, the “<U>Current Value</U>”). The Collateral Agent (at the direction of the Majority Holders) shall notify the Borrower or the applicable Note Party whether it intends to require a Mortgage (and any other Real Property Deliverables) with respect to any such Facility with a Current Value in excess of $300,000. Upon receipt of such notice requesting a Mortgage (and any other Real Property Deliverables), the applicable Note Party shall promptly furnish <FONT STYLE="letter-spacing: -0.1pt">the same to the Collateral Agent within ninety (90) days of such Note Party’s receipt </FONT>of such notice. The Note Parties shall pay all reasonable fees and out-of-pocket expenses, including reasonable and documented attorneys’ fees and expenses, and all customary and reasonable title insurance charges and premiums, in connection with its obligations under this Section 7(o)(iii).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 56; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(p) <U>Inspections and Rights to Consult with Management</U>. The Collateral Agent or a representative of the Majority Holders (through any of their officers, employees or agents) shall have the right, upon reasonable prior notice, from time to time during the Note Parties’ usual business hours but no more once per 365 consecutive day period at the expense of the Note Parties (unless an Event of Default has occurred and is continuing), to inspect the Note Parties’ books and records and to make copies thereof and to check, test and appraise the Collateral in order to verify the Note Parties’ financial condition or the amount, condition of, or any other matter relating to, the Collateral. In addition, each Note Party shall permit any representative that the Holder or the Collateral Agent authorizes, including attorneys and accountants, to meet, at reasonable times and upon reasonable notice, with management and officers of the Note Parties no more than twice per calendar quarter (unless an Event of Default is continuing, in which case no such restriction on the frequency of meetings shall apply).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(q) <U>Privacy and Data Security</U>. Each Note Party shall, and shall cause each of its Subsidiaries to, at all times, remain in compliance in all material respects with all applicable United States and international privacy and data security laws and regulations, including the European Union General Data Protection Regulation, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 of the European Parliament and the Council of the European Union and all regulations promulgated thereunder.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(r) <U>Deposit Accounts/Securities Accounts</U>. Except with respect to Deposit Accounts permitted without a Control Agreement pursuant to Section 7(ee), prior to opening or acquiring any Deposit Account or Securities Account after the Initial Closing Date, each Note Party shall first notify the Collateral Agent and shall not deposit any funds or securities into such account until such account is subject to a Control Agreement in favor of the Collateral Agent, whereupon, such Note Party shall update the Disclosure Letter to include such new account.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(s) <U>Chief Executive Office; Location of Collateral</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, change its jurisdiction of organization, chief executive office or principal place of business or remove or cause to be removed, except in the ordinary course of its business, the Collateral (or any portion thereof) or the records concerning the Collateral (or any portion thereof) from the premises listed in Section 4 of the Disclosure Letter without twenty (20) days’ prior written notice to the Collateral Agent; <I>provided </I>that any such removal of any portion of the Collateral may not be to a location outside of the United States without the Majority Holder’s prior written consent.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(t) <U>Disposal of Assets</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, convey, sell, lease, license, transfer or otherwise dispose of (collectively, <FONT STYLE="letter-spacing: -0.1pt">a “<U>Transfer</U>”), or permit any of its Subsidiaries to Transfer, all or any part of its business or property, </FONT>other than: (i) Inventory in the ordinary course of business (including with respect to consignment arrangements with respect to such Inventory); (ii) Transfers of surplus, worn-out or obsolete Equipment; (iii) uses of cash and Cash Equivalents not prohibited under this Note or the other Note Documents, (iv) Transfers consisting of or made in connection with Permitted Liens and Permitted Investments or (v) other assets of the Borrower or its Subsidiaries that do not in the aggregate exceed $250,000 in any fiscal year for fair market value (collectively, the “<U>Permitted <FONT STYLE="letter-spacing: -0.1pt">Transfers</FONT></U><FONT STYLE="letter-spacing: -0.1pt">”).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 57; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(u) <U>Restructure</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to: (i) without providing not less than twenty (20) days’ advance written notice to the Collateral Agent, change its name, identity, type of organization, corporate structure or organizational identification number, (ii) suspend operation of its business (other than in connection with a dissolution permitted pursuant to Section 7(u)(vi)), (iii) engage in any business other than the businesses engaged in by the Note Parties and their Subsidiaries as of the date hereof, and any business substantially similar or reasonably related thereto; (iv) cause, experience or allow a departure of a Responsible Officer, without providing the Collateral Agent a written notice within ten (10) days after the occurrence of such departure; (v) without the Holder’s prior written consent, change the date on which its fiscal year ends or change its accounting policies in any manner that would be material and adverse to the Holder; (vi) permit any Subsidiary to liquidate or dissolve (other than the liquidation or dissolution of Subsidiaries whose assets are transferred to the Borrower or another Note Party at the time of such liquidation or dissolution); or (vii) consummate any transaction or series of related transactions in which the stockholders of such Note Party or such Subsidiary, as applicable, who were not stockholders immediately prior to the first such transaction own more than fifty percent (50%) of the voting Capital Stock of such Note Party or such Subsidiary, as applicable, immediately after giving effect to such transaction or related series of such transactions.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(v) <U>Liens/Negative Pledge</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, create, incur, assume or suffer to exist any Lien with respect to any of its property, including Intellectual Property and Inventory held at warehouse or fulfilment centers, or assign or otherwise convey any right to receive income, except for Permitted Liens, or enter into any agreement with any Person other than the holders of Notes or the Collateral Agent that prohibits such Note Party or Subsidiary from granting a security interest in, or otherwise encumbering, any of its property, or from paying dividends or making distributions or payments on account of or in redemption, retirement or purchase of any of its Capital Stock, except for (i) restrictions by reason of customary provisions restricting assignments, subletting, sublicensing, pledging or other transfers contained in leases, subleases or licenses in the ordinary course of business (<I>provided</I> that such restrictions are limited to the agreement itself or the property or assets secured by such Liens or the property or assets subject to such leases, subleases or licenses, as the case may be) and (ii) restrictions set forth in the ABL Debt Documents.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(w) <U>Indebtedness</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, create, incur, assume or suffer to exist any Indebtedness other than Permitted <FONT STYLE="letter-spacing: -0.1pt">Indebtedness.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(x) <U>Investments</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, make any Investment in any Person other than Permitted Investments.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(y) <U>Distributions</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, pay any dividends or make any other distribution or payment on account of or in redemption, retirement or purchase of any of its Capital Stock, except that (i) Subsidiaries may pay dividends or make any other distributions or payments to the Borrower (either directly or indirectly) or any Guarantor that is a Subsidiary of the Borrower, (ii) the Borrower may convert any of the Notes into other Capital Stock upon the terms of such Notes, (iii) each Note Party may make de minimis payments of cash in lieu of the issuance of fractional Capital Stock (including upon the conversion of any Notes) and (iv) each Note Party may pay dividends solely in its Capital <FONT STYLE="letter-spacing: -0.1pt">Stock.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.85pt 0 59.95pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 58; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(z) <U>Payments of Other Indebtedness</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to prepay, redeem, purchase, defease or otherwise satisfy prior to the scheduled maturity thereof in any manner any Subordinated Debt (it being understood that payments of regularly scheduled interest, AHYDO Payments and mandatory prepayments under any such Subordinated Debt shall not be prohibited by this clause, so long as such payments do not violate the subordination provisions of the Subordination Agreement applicable thereto).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(aa) <U>Transactions with Affiliates</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, directly or indirectly enter into or permit to exist any material transaction with any Affiliate of any Note Party after the Initial Closing Date except for (i) ordinary course compensatory agreements (including employment agreements and benefit plans) with officers and directors, (ii) transactions that are in the ordinary course of the Note Parties’ business, on terms no less favorable to the Note Party than would be obtained in an arm’s length transaction with a Person that is not an Affiliate of a Note Party, (iii) transactions between or among Note Parties, (iv) equity financings with the Borrower’s investors (or their Affiliates), as permitted hereunder, and (v) other transactions approved by the Collateral Agent in writing (at the direction of the Majority Holders).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(bb) <U>Amendments or Waivers of Organizational Documents and Certain Agreements</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, agree to any amendment, restatement, supplement or other modification to, or waiver of any of its rights under, (i) any Subordinated Indebtedness to the extent such amendment, restatement, supplement, modification or waiver could reasonably be expected to be adverse in any material respect to the Holder or (ii) its Organizational Documents to the extent such amendment, restatement, supplement, modification or waiver could reasonably be expected to be adverse in any material respect to the Holder.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(cc) <U>Stock Certificates</U>. For any Subsidiary for which any Note Party’s ownership interest is not evidenced by a certificate, no Note Party shall allow such Subsidiary to certificate such ownership interest without the Majority Holders’ prior written consent, which consent may be conditioned upon requiring such Subsidiary to execute and deliver a Collateral Pledge Agreement satisfactory to the Majority Holders.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(dd) <U>Compliance</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, (i) become an “investment company” under the Investment Company Act of 1940 or undertake as one of its important activities extending credit to purchase or carry margin stock, or use the proceeds of the Notes for that purpose; (ii) except as could not be reasonably expected to have a Material Adverse Effect, fail to meet the minimum funding requirements of ERISA with respect to any Pension Plan or permit a Reportable Event (within the meaning of Section 4043(c) of ERISA) or a Prohibited Transaction (as such term is defined in Section 4975 of the Internal Revenue Code) to occur; or (iii) fail to comply in any material respect with the Federal Fair Labor Standards Act or violate any other Law or regulation in any material respect.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ee) <U>Deposit Accounts and Securities Accounts</U>. From and after the date that is thirty (30) days after the Initial Closing Date, no Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, maintain any Deposit Accounts or Securities Accounts except accounts respecting which the Collateral Agent has obtained a Control Agreement, <I>provided however</I>, <FONT STYLE="letter-spacing: -0.2pt">that </FONT>the Borrower may maintain Deposit Accounts established solely as payroll and other zero balance accounts without them being subject to a Control Agreement.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 59; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ff) <U>Inventory</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, store Inventory or other tangible Collateral with a bailee, warehouseman or other third party where the aggregate amount of Inventory or other tangible Collateral with such bailee, warehouseman or other third party shall be in excess of 15% of the Borrower’s Inventory for a period of ninety (90) days or longer (other than those entities for which the applicable Note Party has delivered a Notice and Access Agreement pursuant to Section 7(o)(ii)).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(gg) <U>Restrictions on Use of Proceeds</U>. No Note Party shall, nor shall any Note Party permit any of its Subsidiaries to, (i) use the proceeds of any Note or any portion thereof to make any payments to a Sanctions Target, to fund any investments, loans or contributions in, or otherwise make such proceeds available to, a Sanctions Target, to fund any operations, activities or business of a Sanctions Target or in any other manner that would result in a violation of Sanctions applicable to any party hereto or to any other Note Document or (ii) use the proceeds of any Note or any portion thereof in furtherance of an offer, payment, promise to pay or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws or Anti-Money Laundering Laws.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(hh) <U>Reservation of Shares; Listing</U>. The Borrower covenants that, subject to the Share Conversion Cap, it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock a sufficient number of shares of Common Stock for the sole purpose of issuance upon conversion of this Note (including payment of any Interest Make-Whole Payment) and issuance upon payment of any Amortization Payment, each as herein provided, free from preemptive rights or any similar rights, taxes, liens, charges, encumbrances or other actual <FONT STYLE="letter-spacing: -0.1pt">contingent purchase rights of Persons other than the Holder. The Borrower covenants that all shares </FONT>of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable, with the holder being entitled to all rights accorded to a holder of Common Stock. If the Common Stock is then listed on any securities exchange, or quoted on any inter-dealer quotation system, then the Borrower will cause each share of Common Stock issued pursuant to the terms of this Note to be admitted for listing on such exchange or quotation on such <FONT STYLE="letter-spacing: -0.1pt">system.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(ii) <U>Covenant to Seek Approvals</U>. As promptly as practicable after the Initial Closing Date, and in any case no later than August 30, 2022, the Borrower shall cause to be held a meeting of the Borrower’s stockholders and shall cause to be presented to the Borrower’s stockholders for their approval at such meeting, and recommend the approval of, the Authorized Share Amendment and the Nasdaq Stockholder Approval. The Borrower will use its reasonable best efforts to obtain approval of the Authorized Share Amendment and the Nasdaq Stockholder Approval, including by seeking such approval, if not previously obtained, at each future regular annual meeting of its stockholders and endorsing its approval in the related proxy materials. If approval by the Borrower’s stockholders of the Authorized Share Amendment and the Nasdaq Stockholder Approval are obtained at such meeting, the Borrower shall cause the Authorized Share Amendment to be duly adopted and filed with the Secretary of State of the State of Delaware no later than one Business Day following the receipt of such approval.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.65pt 0 59.95pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 60; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(jj) <U>Opt-In Notices</U>. Notwithstanding anything herein or in any other Note Document to the contrary, prior to receipt of an Opt-In Notice and at any time when all Opt-In Notices from the Holder have been revoked, the Borrower shall not deliver to the Holder any information pursuant to any Note Document (other than the occurrence of a Default or an Event of Default under this Note) that would constitute material non-public information regarding the Borrower or any of its Subsidiaries. At any time or from time to time, the Holder may deliver written notice (an “<U>Opt-In Notice</U>”) to the Borrower requesting that the Holder receive from the Borrower any such information required to be delivered that would constitute material non-public information regarding the Borrower or any of its Subsidiaries; <I>provided</I>, <I>however</I>, that the Holder may revoke any such Opt-In Notice in writing at any time. Following receipt of an Opt-In Notice from the Holder, the Borrower shall deliver such information to the Holder until the Opt-In Notice is subsequently revoked. To avoid doubt, prior to the receipt of any Opt-In Notice and at any time when all Opt-In Notices from the Holder have been revoked, the Borrower shall not be required to deliver any financial information pursuant to <U>Section 7(c)</U> of this Note.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0pt">8. <U>Consolidation, Merger, Sale, Conveyance and <FONT STYLE="letter-spacing: -0.1pt">Lease</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Borrower May Consolidate, Etc. on Certain Terms</U>. Subject to the provisions of Section 8(b), the Borrower shall not consolidate with, merge with or into, or sell, <FONT STYLE="letter-spacing: -0.1pt">convey, transfer or lease all or substantially all of its properties and assets to another Person, unless:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) the resulting, surviving or transferee Person (the “<U>Successor <FONT STYLE="letter-spacing: -0.1pt">Borrower</FONT></U><FONT STYLE="letter-spacing: -0.1pt">”), if not the Borrower, shall be a corporation organized and existing under </FONT>the laws of the United States of America, any state thereof or the District of Columbia, and the Successor Borrower (if not the Borrower) shall expressly assume all of the obligations of the Borrower under the Notes and the other Note Documents; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) immediately after giving effect to such transaction, no Default or Event of Default shall have occurred and be continuing.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For purposes of this Section 8(a), the sale, conveyance, transfer or lease of all or substantially all of the properties and assets of one or more Subsidiaries of the Borrower to another Person, which properties and assets, if held by the Borrower instead of such Subsidiaries, would constitute all or substantially all of the properties and assets of the Borrower on a consolidated basis, shall be deemed to be the sale, conveyance, transfer or lease of all or substantially all of the properties and assets of the Borrower to another Person.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Successor Borrower to Be Substituted</U>. In case of any such consolidation, merger, sale, conveyance, transfer or lease and upon the assumption by the Successor Borrower, by supplements or amendments to this Note and the other Note Documents, executed and delivered to the Collateral Agent, the Holder Representative and the holders of Notes, as applicable, satisfactory in form to the Collateral Agent, the Holder Representative (as to their respective rights, duties and obligations, as applicable) and the holders of Notes, of the due and punctual payment of the principal of and any accrued and unpaid interest on all of the Notes, the due and punctual delivery or payment, as the case may be, of any consideration due upon conversion of the Notes and the due and punctual performance of all of the covenants and conditions of this Note and <FONT STYLE="letter-spacing: -0.25pt">the </FONT>other Note Documents to be performed by the Borrower, such Successor Borrower (if not the Borrower) shall succeed to and, except in the case of a lease of all or substantially all of the Borrower’s properties and assets, shall be substituted for the Borrower, with the same effect as if it had been named herein as the party of the first part. Such Successor Borrower thereupon may cause to be signed, and may issue either in its own name or in the name of the Borrower any or all of the Notes issuable under the Purchase Agreement which theretofore shall not have been signed and delivered by the Borrower. All the Notes so issued shall in all respects have the same legal rank and benefit under the Purchase Agreement as the Notes theretofore or thereafter issued in accordance with the terms of the Purchase Agreement as though all of such Notes had been issued at the date of the execution of the Purchase Agreement. In the event of any such consolidation, merger, sale, conveyance or transfer (but not in the case of a lease), upon compliance with this Section 8 the Person named as the “Borrower” in the first paragraph of this Note (or any successor that shall thereafter have become such in the manner prescribed in this Section 8) may be dissolved, wound up and liquidated at any time thereafter and, except in the case of a lease, such Person shall be released from its liabilities as obligor and maker of the Notes and from its obligations under the Purchase Agreement and the Notes.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 61; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">In case of any such consolidation, merger, sale, conveyance, transfer or lease, such changes in phraseology and form (but not in substance) may be made in the Notes thereafter to be issued as may be appropriate.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Opinion of Counsel to Be Given to Holder Representative</U>. No such consolidation, merger, sale, conveyance, transfer or lease shall be effective unless the Holder Representative shall have received an opinion of counsel as conclusive evidence that any such consolidation, merger, sale, conveyance, transfer or lease and any such assumption complies with the provisions of this Section 8.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0pt">9. <FONT STYLE="letter-spacing: -0.1pt"><U>Guarantees</U>.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) Subject to this <U>Section 9</U> each of the Guarantors hereby, as a primary obligor and not merely as surety, jointly and severally, unconditionally guarantees to the Holder and its successors and assigns, irrespective of the validity and enforceability of this Note or the obligations of the Borrower hereunder or thereunder, that:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(i) the principal of, premium, if any, and interest on, this Note and such other Note Obligations will be promptly paid in full in cash when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on this Note, if any, if lawful, and all other obligations of the Borrower to the Holder hereunder will be promptly paid in full in cash or performed, all in accordance with the terms hereof and thereof; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 1in">(ii) in case of any extension of time of payment or renewal of this Note or any of such other obligations (including Note Obligations), that same will be promptly paid in full in cash when due or performed in accordance with the terms of the extension or renewal, whether at maturity, by acceleration or otherwise.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.9pt 0 59.95pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 62; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors will be jointly and severally obligated to pay the same immediately. Each Guarantor agrees that this is a guarantee of payment and not a guarantee of collection.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) The Guarantors hereby agree that their obligations hereunder are unconditional, irrespective of the validity, regularity or enforceability of this Note, the absence of any action to enforce the same, any amendment, waiver or consent by the Holder with respect to any provisions hereof or thereof, the recovery of any judgment against the Borrower or any other Guarantor, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a Guarantor. Each Guarantor hereby unconditionally and irrevocably waives and agrees not to assert any claim, defense, setoff or counterclaim based on diligence, promptness, presentment, requirements for any demand or notice hereunder including any of the following: (i) any demand for payment or performance and protest and notice of protest; (ii) any notice of acceptance; (iii) any presentment, demand, protest or further notice or other requirements of any kind with respect to any Note Obligation (including any accrued but unpaid interest thereon) becoming immediately due and payable; and (iv) any other notice in respect of any Note Obligation or any part thereof, and any defense arising by reason of any disability or other defense of the Borrower or any Guarantor. Each Guarantor further unconditionally and irrevocably agrees not to (x) enforce or otherwise exercise any right of subrogation or any right of reimbursement or contribution or similar right against the Borrower or any Guarantor or (y) assert any claim, defense, setoff or counterclaim it may have against the Borrower or any other Guarantor or set off any of its obligations to the Borrower or any other Guarantor against obligations of such Guarantor to the Borrower or such other Guarantor. No obligation of any Guarantor hereunder shall be discharged other than by complete performance. Each Guarantor further waives any right such Guarantor may have under any applicable requirement of law to require the Collateral Agent or the Holder to seek recourse first against the Borrower or any other Person as a condition precedent to enforcing such Guarantor’s liability and obligations under this <U>Section 9</U>.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) If the Holder is required by any court or otherwise to return any amount paid by the Borrower or any Guarantor, this Guarantee, to the extent theretofore discharged, will be reinstated in full force and effect.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) Each Guarantor agrees that it will not be entitled to any right of subrogation in relation to the Holder in respect of any obligations guaranteed hereby until payment in full in cash of all obligations (including the Note Obligations) guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors, on the one hand, and the Holder and the Collateral Agent, on the other hand, (1) the maturity of the obligations guaranteed hereby may be accelerated as provided in Section 12(b) for the purposes of this Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (2) in the event of any declaration of acceleration of such obligations as provided in Section 12(b), such obligations (whether or not due and payable) will forthwith become due and payable by the Guarantors for the purpose of this guarantee.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 63; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) Each Guarantor, and by its acceptance of the Note, the Holder, hereby confirms that it is the intention of all such parties that the guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of applicable Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to any guarantee. To effectuate the foregoing intention, the Holder and the Guarantors hereby irrevocably agree that the obligations of such Guarantor will be limited to the maximum amount that will, after giving effect to such maximum amount and all other contingent and fixed liabilities of such Guarantor that are relevant under such laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the obligations of such other Guarantor under this <U>Section 9</U>, result in the obligations of such Guarantor under its guarantee not constituting a fraudulent transfer or conveyance. Each Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by this Note and that its Guarantee, and the waivers set forth herein, are knowingly made in contemplation of such <FONT STYLE="letter-spacing: -0.1pt">benefits.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) To evidence a guarantee set forth in <U>Section 9(a)</U>, this Note will be executed on behalf of each Guarantor by one of its officers or authorized representatives and, with respect to any Guarantors providing a Guarantee after the date hereof, a Joinder Agreement will be executed on behalf of such Guarantor by one of its officers. Each Guarantor hereby agrees that its guarantee set forth in <U>Section 9(a)</U> will remain in full force and effect notwithstanding any failure to endorse on each Note a notation of such guarantee.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h) Except as otherwise provided in Section 9(i), a Guarantor may not, directly or indirectly, (1) consolidate with or merge with or into, or (2) sell, convey, transfer or lease all or substantially all of its properties and assets to (whether or not such Guarantor is the surviving Person), any other Person, other than the Borrower or another Guarantor, unless.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">(i) immediately after giving effect to that transaction, no Default or Event of Default has occurred and is continuing or would be caused thereby; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) the Person acquiring the property in any such sale or disposition or the Person formed by or surviving any such consolidation or merger (if other than the Borrower or another Guarantor) is an entity organized under the laws of the United States and otherwise reasonably acceptable to the Majority Holders and expressly assumes, by executing and delivering supplements and amendments to this Note and the other Note Documents that are satisfactory in form to the Collateral Agent, the Holder Representative (as to their respective rights, duties and obligations, as applicable) and the Majority Holders, all of the obligations of that Guarantor under its Guaranty, this Note and all other appropriate Note <FONT STYLE="letter-spacing: -0.1pt">Documents.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In case of any such consolidation, merger, sale, conveyance, transfer or lease and upon the assumption by the successor Person of the Guaranty of such Guarantor and the due and punctual performance of all of the covenants and conditions of this Note and the other Note Documents to be performed by such Guarantor, such successor Person will succeed to and be substituted for the Guarantor with the same effect as if it had been named herein as a Guarantor. Such successor Person thereupon may cause to be signed any or all of the Notes issuable under the Purchase Agreement which theretofore shall not have been signed and delivered by the Borrower; <I>provided</I>, <I>however</I>, that the Guaranty of such successor Person will remain in full force and effect notwithstanding any failure to endorse on each Note a notation of such Guaranty. All <FONT STYLE="letter-spacing: -0.25pt">the</FONT> Guaranties so issued will in all respects have the same legal rank and benefit under the Purchase Agreement as the Guaranties theretofore and thereafter issued in accordance with the terms of this Note and the other Note Documents as though all of such Guaranties had been issued at the date of the execution of the Purchase Agreement.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 64; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i) The Guaranty of any Guarantor, and the Collateral Agent’s Lien on the Collateral of such Guarantor, will be automatically released upon the liquidation or dissolution of such Guarantor following the Transfer of all of its assets to the Borrower or another Guarantor as permitted hereunder.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If the Guaranty of any Guarantor or all or substantially all of the assets of a Guarantor or the Capital Stock of any Guarantor are sold or disposed of in the manner described in this clause (i), and such Guarantor (or as the context may require, Collateral) is released, the Borrower shall deliver to the Collateral Agent and the Holder Representative a certificate of a Responsible Officer stating and certifying the identity of the released Guarantor (any/or the applicable Collateral), the basis for release in reasonable detail and that such release complies with this Note and the other Note Documents. Upon delivery by the Borrower to the Collateral Agent and the Holder Representative of a certificate of a Responsible Officer and an opinion of counsel to the effect that the conditions precedent to this clause (i) have been met with respect to a Guarantor (or such Collateral) in accordance with the provisions of this Note and the other Note Documents, the Collateral Agent and Holder Representative will execute any documents reasonably requested that are necessary or advisable in order to evidence the release of such Guarantor from its obligations under its Guaranty or the applicable Note Documents. Any Guarantor not released from its obligations under its Guaranty as provided in this Section 9(i) will remain liable for the full amount of principal of and interest and premium, if any, on the Notes and for the other obligations (including the Note Obligations) of any Guarantor under this Note and the other Note Documents as provided in this Section 9 notwithstanding the release of any other Guarantor.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(j) Each Guarantor hereby assumes responsibility for keeping itself informed of the financial condition of the Borrower, each other Guarantor and any other guarantor, maker or endorser of any Note Obligation or any part thereof, and of all other circumstances bearing upon the risk of nonpayment of any Note Obligation or any part thereof that diligent inquiry would reveal, and each Guarantor hereby agrees that the Holder shall not have any duty to advise any Guarantor of information known to it regarding such condition or any such circumstances. In the event the Holder, in its sole discretion, undertakes at any time or from time to time to provide any such information to any Guarantor, then the Holder shall be under no obligation to (a) undertake any investigation not a part of its regular business routine, (b) disclose any information that such Person, pursuant to accepted or reasonable commercial finance or banking practices, wishes to maintain confidential or (c) make any future disclosures of such information or any other information to any Guarantor.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: 0pt">10. <U>Creation of Security <FONT STYLE="letter-spacing: -0.1pt">Interest</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Grant of Security Interest</U>. To secure prompt payment of any and all of the principal of, premium, if any, and interest on, this Note and all other Note Obligations, and prompt performance by each Note Party of each of its covenants and duties under the Note Documents, each Note Party hereby grants to the Collateral Agent, for its benefit and for the benefit of the Holder Representative and holders of Notes, a continuing security interest (the “<U>Security Interest</U>”) in all of such Note Party’s right, title and interest in or to any and all of the following assets and properties, whether now owned or at any time hereafter created or acquired by such Note Party or in which such Note Party now has or at any time in the future may acquire any right, title or interest, and wherever located (collectively, the “<U>Article 9 Collateral</U>”):</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 65; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) all accounts (including health-care-insurance receivables), cash and Cash Equivalents, chattel paper (including tangible and electronic chattel paper), commercial tort claims, deposit accounts, securities accounts, documents (including negotiable documents), equipment (including all accessions and additions thereto), general intangibles (including payment intangibles, Intellectual Property and Licenses), goods (including fixtures), instruments (including promissory notes), Inventory (including all goods held for sale or lease or to be furnished under a contract of service, and including returns and repossessions), investment property (including securities and securities entitlements), letter-of- credit rights, money, fixtures, all books, records, ledger cards, files, correspondence, computer programs, tapes, disks and related data processing software (owned by such Note Party or in which it has an interest) that at any time evidence or contain information relating to any Article 9 Collateral or as are otherwise necessary or helpful in the collection thereof or realization thereupon;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) all real property interests (including leaseholds, mineral rights, timber, etc.); and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) any and all cash proceeds or noncash proceeds and products of any of the foregoing, including insurance proceeds, and all supporting obligations and the security and guarantees therefor or for any right to payment.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Such Security Interest constitutes a valid, first priority security interest in the presently existing Article 9 Collateral, and will constitute a valid, first priority security interest in Article 9 Collateral acquired after the date hereof, in each case, subject to Permitted Liens. This Note is intended by the parties to be a security agreement for purposes of the Code. Neither the Holder Representative nor the Collateral Agent shall be responsible for and make no representation as to the existence, genuineness, value or protection of any Collateral, for the legality, effectiveness or sufficiency of any Note Collateral Document, or for the creation, perfection, priority, sufficiency or protection of any Liens securing the Notes. By its acceptance of the Notes, the Holder will be deemed to accept the terms of, agree to be bound by and authorize and direct each of the Holder Representative and the Collateral Agent, as applicable, to enter into and perform its respective obligations under, the Note Collateral Documents. Neither the Holder Representative nor the Collateral Agent shall be responsible for (A) perfecting, maintaining, monitoring, preserving or protecting the Liens granted under this Note, the Note Collateral Documents or any agreement or instrument contemplated hereby or thereby, (B) the determination, filing, re-filing, recording, re-recording or continuing of any document, financing statement, financing change statement, registration, mortgage, assignment, notice, instrument of further assurance or other instrument in any public office at any time or times or (C) providing, maintaining, monitoring or preserving insurance on or the payment of taxes with respect to the Collateral. The actions described in items (A) through (C) shall be the sole responsibility of the Note Parties, as applicable.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.65pt 0 59.95pt; text-align: justify"> </P> <!-- Field: Page; Sequence: 66; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Notwithstanding the foregoing, in no event shall the Article 9 Collateral include: (A) any lease, license, contract, property rights or agreement to which a Note Party is a party or any of its rights or interests thereunder if and for so long as the grant of such Security Interest shall constitute or result in (I) the abandonment, invalidation or unenforceability of any right, title or interest of such Note Party therein or (II) a breach or termination pursuant to the terms of, or a default under, any such lease, license, contract, property rights or agreement (other than to the extent that any such term would be rendered ineffective pursuant to Sections 9406, 9407, 9408 or 9409 of the Code (or any successor provision or provisions) of any relevant jurisdiction or any other applicable Law (including Debtor Relief Laws) or principles of equity); <I>provided</I> that the Article 9 Collateral shall include and such Security Interest shall attach immediately (x) at such time as the condition causing such abandonment, invalidation or unenforceability shall be remedied and to the extent severable, shall attach immediately to any portion of such lease, license, contract, property rights or agreement that does not result in any of the consequences specified in (I) or (II) above and (y) to any all Proceeds, products, accessions, rents and profits of or in respect of any of the foregoing such leases, licenses, contracts, property rights or agreements; (B) any intent-to use Trademark applications prior to the filing of a “Statement of Use”, “Amendment to Allege Use” or similar filing with regard thereto, to the extent and solely during the period in which the grant of a security interest therein may impair the validity or enforceability of any Trademark that may issue from such intent to use Trademark application under applicable Law or (C) vehicles that may only be perfected by notifications on certificates of title (collectively, the “<U>Excluded Assets</U>”).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Authorization to File Financing Statements</U>. Each Note Party hereby irrevocably authorizes the Collateral Agent (but without obligation) for its benefit and the benefit of the Holder Representative and the holders of Notes at any time and from time to time to file, at such Note Party’s expense, in any relevant jurisdiction any financing statements with respect to the Article 9 Collateral or any part thereof and amendments thereto that (i) indicate the Article 9 Collateral as “all assets” whether now owned or hereafter acquired or “all personal property” whether now owned or hereafter acquired of such Note Party or words of similar effect as being of an equal or lesser scope or with greater detail and (ii) contain the information required by Article 9 of the Code or the analogous legislation of each applicable jurisdiction for the filing of any financing statement or amendment, including whether such Note Party is an organization, the type of organization and, if required, any organizational identification number issued to such Note Party. Each Note Party agrees to provide such information to the Collateral Agent promptly upon any reasonable request. Notwithstanding the foregoing or anything to the contrary herein or in any other Note Collateral Document, the Note Parties shall make all filings (including filings of continuation statements and amendments to financing statements that may be necessary to continue the effectiveness of such financing statements) necessary to maintain (at the sole cost and expense of the Note Parties) the security interest created by the Note Collateral Documents in the Collateral as a first priority perfected security interest to the extent perfection is required herein or by the Note Collateral Documents, and promptly provide evidence thereof to the Collateral <FONT STYLE="letter-spacing: -0.1pt">Agent.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>No Obligation</U>. The Security Interest is granted as security only and shall not subject the Collateral Agent or any holder of Notes to, or in any way alter or modify, any obligation or liability of any Note Party with respect to or arising out of the Article 9 Collateral.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Intellectual Property Filings</U>. The Collateral Agent is authorized (but without obligation) to file with the USPTO or the USCO (or any successor office) such documents as may be necessary or advisable for the purpose of perfecting, confirming, continuing, enforcing or protecting the Security Interest in United States Intellectual Property of each Note Party in which a security interest has been granted by such Note Party hereunder, with notice to such, and with or without the signature of any, Note Party, and naming any Note Party as debtor and the Collateral Agent as secured party. Notwithstanding the foregoing, such filings shall be the responsibility of the applicable Note Party, and such Note Party agrees to furnish evidence of any such filings and recordings to the Collateral Agent.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 67; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <U>Duration of Security Interest; <FONT STYLE="letter-spacing: -0.1pt">Release</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) The Collateral Agent’s Security Interest in the Article 9 Collateral shall continue until the payment in full in cash and the satisfaction of all Note Obligations (other than inchoate indemnity obligations or other obligations that expressly survive termination), whereupon such Security Interest shall terminate and the Collateral Agent shall, at the Note Parties’ sole cost and expense, promptly execute such further documents and take such further actions as may be necessary to effect the release contemplated by this Section 10(e)(i).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) Upon any Transfer by any Note Party of any Collateral that is permitted hereunder and under the other Note Documents (other than a Transfer to another Note Party), the security interest in such Collateral shall be automatically released and the Collateral Agent shall, at the Note Parties’ sole cost and expense, promptly execute such further documents and take such further actions as may be necessary to effect the release contemplated by this Section 10(e)(ii).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) <U>Possession of Article 9 Collateral</U>. So long as no Event of Default has occurred and is continuing, the Note Parties shall remain in full possession, enjoyment and control of the Article 9 Collateral (except only as may be otherwise required by the Majority Holders for perfection or protection of the Collateral Agent’s Security Interest therein) and shall be entitled to manage, operate and use the same and each part thereof with all the rights and franchises appertaining thereto; <I>provided</I>, <I>however</I>, that the possession, enjoyment, control and use of the Article 9 Collateral shall at all times be subject to the observance and performance of the terms of this Note and the other Note Documents.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) <U>Delivery of Additional Documentation Required</U>. Each Note Party shall from time to time execute and deliver to the Collateral Agent for its benefit and the benefit of the Holder Representative and the holders of Notes all Negotiable Collateral (having a value in excess of $100,000 in the aggregate) and other documents necessary or advisable to perfect and continue the perfection of the Collateral Agent’s Security Interest in the Article 9 Collateral and in order to fully consummate all of the transactions contemplated under the Note Documents. For the avoidance of doubt, if any Note Party acquires a Commercial Tort Claim (which could reasonably be expected to result in damages in excess of $100,000), such Note Party shall promptly notify the Collateral Agent in a writing signed by such Note Party of the general details thereof and such Note Party shall promptly, but in no event more than three (3) Business Days after such notice, agree to an amendment to the definition of Article 9 Collateral or the Code filings to include such Commercial Tort Claim, such amendment to be in form and substance as required by the Collateral Agent (acting at the direction of the Majority Holders). If at any time any Note Party shall take <FONT STYLE="letter-spacing: -0.5pt">a </FONT>security interest in any property of an Account Debtor or any other Person the value of which is in excess of $100,000 to secure payment and performance of an Account, such Note Party shall promptly notify the Collateral Agent and assign such security interest to the Collateral Agent for its benefit and the benefit of the holders of Notes. Such assignment need not be filed of public record unless necessary to continue the perfected status of the security interest against creditors of and transferees from the Account Debtor or other Person granting the security interest.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 68; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h) <U>Representations and Warranties</U>. Each Note Party represents and warrants, as to itself and the other Note Parties, to the Holder Representative, the Collateral Agent and the Holder that:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) Subject to Permitted Liens, each Note Party has good and valid rights in and title (except as otherwise permitted by the Note Documents) to (or the power to transfer rights in) the Article 9 Collateral (except with respect to title to Intellectual Property owned by a third party as to which such Note Party has been granted a License) with respect to which it has purported to grant a Security Interest hereunder, except for minor defects in title that do not materially interfere with its ability to conduct its business or to utilize such properties for their intended purposes and has full power and authority to grant to the Collateral Agent the Security Interest in such Article 9 Collateral pursuant hereto and to execute, deliver and perform its obligations in accordance with the terms of this Note and the other Note Documents, without the consent or approval of any other Person, other than any consent or approval that has been obtained and is in full force and effect.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(ii) </FONT>The Disclosure Letter has been duly prepared, completed and executed and the information set forth therein is correct and complete in all material respects (except that the information therein with respect to the exact legal name of each Note Party is correct and complete in all respects) as of the date hereof. The UCC financing statements or other appropriate filings, recordings or registrations prepared based upon the information provided to the Collateral Agent in the Disclosure Letter for filing by the Borrower in the applicable filing office, as required by the terms of this Note or the other Note Documents, are all the filings, recordings and registrations that are necessary to establish and preserve a legal, valid and perfected security interest in favor of the Collateral Agent (for its benefit and the benefit of the Holder Representative and the holders of Notes) in respect of all Article 9 Collateral in which the Security Interest may be perfected by filing, recording or registration in the United States (or any political subdivision thereof) and its territories and possessions pursuant to the Code, and no further or subsequent filing, re-filing, recording, rerecording, registration or re-registration is necessary in any such jurisdiction, except as provided under applicable Law with respect to the filing of continuation statements. Sections 5 and 6 of the Disclosure Letter set forth all Securities Accounts and Deposit Accounts maintained as of the date hereof by the Note Parties including (A) in the case of each Deposit Account, the depository bank and (B) in the case of each Securities Account, the Securities <FONT STYLE="letter-spacing: -0.1pt">Intermediary.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 132pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt"> </FONT></P> <!-- Field: Page; Sequence: 69; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.05pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(iii) </FONT>Each Note Party represents and warrants that Intellectual Property Security Agreements containing a description of all Article 9 Collateral consisting of (A) United States-registered Patents (and Patents for which United States applications are pending), (B) United States-registered Trademarks (and Trademarks for which United States applications for registration are pending) <FONT STYLE="letter-spacing: -0.25pt">and </FONT>(C) United States-registered Copyrights, respectively (other than, in each case, any Excluded Assets), in each case, as of the date hereof and listed in Section 9 of the Disclosure Letter, if any, have been prepared for recording by the USPTO and the USCO pursuant to 35 U.S.C. § 261, 15 U.S.C. § 1060 or 17 U.S.C. § 205 and the regulations thereunder, as applicable, in respect of all Article 9 Collateral consisting of United States registrations and applications for Patents, Trademarks and Copyrights. To the extent a security interest may be perfected by filing, recording or registration in the USPTO or USCO under the federal intellectual property laws, then no further or subsequent filing, re-filing, recording, rerecording, registration or re-registration is necessary (other than (x) such filings and actions as are necessary to perfect the Security Interest with respect to any Article 9 Collateral consisting of United States registrations and applications for Patents, Trademarks and Copyrights filed, acquired or developed by any Note Party after the date hereof and (y) the UCC financing and continuation statements contemplated in Section <FONT STYLE="letter-spacing: -0.1pt">10(h)(ii)).</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(iv) </FONT>The Security Interest constitutes (A) a legal and valid security interest in all the Article 9 Collateral securing the payment and performance in full of the Note Obligations and (B) subject to the filings described in Sections 9(h)(ii) and 10(h)(iii), a perfected security interest in all Article 9 Collateral in which a security interest may be perfected by filing, recording or registering a financing statement or analogous document in the United States (or any political subdivision thereof) and its territories and possessions pursuant to the Code. The Security Interest is prior to any other Lien on any of the Article 9 Collateral, subject to Permitted Liens.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(v) </FONT>The Article 9 Collateral (except with respect to Intellectual Property owned by a third party as to which a Note Party has been granted a License) is owned by the Note Parties free and clear of any Lien, except for Permitted Liens. None of the Note Parties has filed or consented to the filing of (A) any effective financing statement or analogous document under the Code or any other applicable <FONT STYLE="letter-spacing: -0.1pt">Laws covering any Article 9 Collateral, (B) any assignment in which any Note Party </FONT>assigns any Article 9 Collateral or any security agreement or similar instrument covering any Article 9 Collateral with the USPTO or the USCO or (C) any assignment in which any Note Party assigns any Article 9 Collateral or any security agreement or similar instrument covering any Article 9 Collateral with any foreign governmental, municipal or other office, which financing statement or analogous document, assignment, security agreement or similar instrument is still in effect, except, in each case under the foregoing clauses (A), (B) and (C), for Permitted <FONT STYLE="letter-spacing: -0.1pt">Liens.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.05pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(vi) </FONT>As of the date hereof, no Note Party has any Commercial Tort Claim which could reasonably be expected to result in damages in excess of $100,000, other than the Commercial Tort Claims listed in Section 7 of the Disclosure <FONT STYLE="letter-spacing: -0.1pt">Letter.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 70; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">11. <U>Pledge of <FONT STYLE="letter-spacing: -0.1pt">Securities</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Pledge</U>. To secure prompt payment of any and all of the principal of, premium, if any, and interest on, this Note and all other Note Obligations, and prompt performance by each Note Party of each of its covenants and duties under the Note Documents, each Note Party hereby assigns and pledges to the Collateral Agent, for its benefit and for the benefit of the Holder Representative and the holders of Notes, and hereby grants to the Collateral Agent, for its benefit and for the benefit of the Holder Representative and the holders of Notes, a continuing security interest in all of such Note Party’s right, title and interest in, to and under the following, whether now existing or hereafter from time to time acquired:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) all Capital Stock held by it that are listed in Section 8 of the Disclosure Letter and any other Capital Stock in any Subsidiary now owned or acquired in the future by such Note Party and all certificates (if any) representing all such Capital Stock (the “<U>Pledged Equity</U>”); <I>provided </I>that the Pledged Equity shall not include Capital Stock in excess of 65% of the issued and outstanding voting Capital Stock or 100% of the issued and outstanding non-voting Capital Stock directly owned by any Note Party in (A) any Subsidiary that is a CFC Holdco or (B) any Subsidiary that is a CFC.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) (A) the Indebtedness owned by it and listed opposite the name of such Note Party in Section 8 of the Disclosure Letter, (B) any other Indebtedness now owned or acquired in the future by such Note Party and (C) the debt securities, promissory notes and any other instruments evidencing such Indebtedness (collectively, the “Pledged Debt”);</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) all other property that may be delivered to and held by the Collateral Agent pursuant to the terms of this Section 11(a);</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv) subject to Section 11(f), all payments of principal or interest, dividends, cash, instruments and other property from time to time received, receivable or otherwise distributed in respect of, in exchange for or upon the conversion of, and all other Proceeds received in respect of, the securities and other property referred to in clauses (i), (ii) and (iii) above;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(v) subject to Section 11(f), all rights and privileges of such Note Party with respect to the securities and other property referred to in clauses (i), (ii), (iii) and (iv) above, including any claims, rights, powers, privileges, authority, options, security interests, liens and remedies (if any) under any corporate bylaws, limited liability company agreement or operating agreement, partnership agreement, or at law or otherwise; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 204pt; text-indent: -0.5in"> </P> <!-- Field: Page; Sequence: 71; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi) all Proceeds of any of the foregoing (the items referred to in <FONT STYLE="letter-spacing: -0.1pt">clauses </FONT></FONT>(i) through (vi) of this Section 11(a) being collectively referred to as the “<U>Pledged <FONT STYLE="letter-spacing: -0.1pt">Collateral</FONT></U><FONT STYLE="letter-spacing: -0.1pt">”);</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: justify">TO <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HAVE AND TO HOLD the Pledged Collateral, together with all right, title, interest, powers, privileges and preferences pertaining or incidental thereto, subject, however, to the terms, covenants and conditions hereinafter set forth.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Delivery of Pledged <FONT STYLE="letter-spacing: -0.1pt">Securities</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) Each Note Party agrees to deliver or cause to be delivered to the Collateral Agent, for its benefit and the benefit of the Holder Representative and the holders of Notes, on the date hereof, or if acquired after the date hereof, within fifteen (15) calendar days after receipt by such Note Party (or, in each case, such longer period as the Majority Holders may agree in their reasonable discretion), any and all (A) Pledged Equity to the extent consisting of certificated Capital Stock of any Subsidiary directly owned by such Note Party and (B) to the extent required to be delivered pursuant to Section 11(b)(ii), Pledged Debt.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) Each Note Party will cause any Indebtedness for borrowed money having an aggregate principal amount equal to or in excess of $100,000 owed to such Note Party by any Person (other than a Note Party) that is evidenced by a debt security, instrument or promissory note to be delivered to the Collateral Agent, for its benefit and the benefit of the Holder Representative and the holders of Notes, pursuant to the terms hereof.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) Upon delivery to the Collateral Agent, any Pledged Securities shall be accompanied by stock or security powers, as applicable, undated and duly executed in blank or other instruments of transfer reasonably satisfactory to the Majority Holders and by such other instruments and documents as the Majority Holders may reasonably request. Each delivery of Pledged Securities shall be accompanied by a schedule describing the securities, which schedule shall be deemed to supplement Section 8 of the Disclosure Letter and be made a part thereof; <I>provided</I> that failure to supplement such Section shall not affect the validity of such pledge of such Pledged Securities. Each schedule so delivered shall supplement any prior schedules so delivered.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Representations, Warranties and Covenants</U>. Each Note Party represents, warrants and covenants to the Collateral Agent, for its benefit and the benefit of the Holder Representative and the holders of Notes, that:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) as of the date hereof, Section 8 of the Disclosure Letter includes all Capital Stock, debt securities, instruments and promissory notes required to be pledged by such Note Party hereunder;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) the Pledged Equity issued by any Subsidiary of any Note Party has been duly and validly issued by the issuers thereof and is fully paid and non- assessable (other than Pledged Equity consisting of limited liability <FONT STYLE="letter-spacing: -0.1pt">company </FONT>interests or partnership interests which, pursuant to the relevant organizational or formation documents, cannot be fully paid and non-assessable);</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 72; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) except for the security interests granted hereunder, such Note <FONT STYLE="letter-spacing: -0.1pt">Party </FONT>(A) is, subject to any transfers, liquidations or dissolutions made in compliance with the terms of this Note and the other Note Documents, the direct owner, beneficially and of record, of the Pledged Equity indicated on Section 8 of the Disclosure Letter, (B) holds the same free and clear of all Liens, other than Liens created by the Note Documents and other Permitted Liens and (C) will use commercially reasonable efforts to defend its title or interest thereto or therein against any and all Liens (other than Permitted Liens), however arising, of all Persons whomsoever;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv) except for restrictions and limitations imposed or permitted by the Note Documents or securities laws generally, the Pledged Collateral is freely transferable and assignable, and none of the Pledged Collateral is subject to any option, right of first refusal, shareholders agreement, charter or by-law provisions or contractual restriction of any nature that would reasonably be expected to prohibit, impair, delay or otherwise affect in any manner material and adverse to the Collateral Agent or the holders of Notes the pledge of such Pledged Collateral hereunder, the sale or disposition thereof pursuant hereto or the exercise by the Collateral Agent or the holders of Notes of rights and remedies hereunder and under the other Note Documents;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(v) no material order, consent, license, authorization, action, notices, validation of, filing, registration with, exemption by or approval of any Governmental Authority, any securities exchange or any other Person was or is necessary for the validity of the pledge effected hereby, except for (A) filings and registrations necessary to perfect the Liens on the Collateral granted by the Note Parties in favor of the Collateral Agent and (B) the orders, consents, licenses, authorizations, actions, notices, validations, filings, registrations, exemptions and approvals that have been duly obtained, taken, given or made and are in full force and effect;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(vi) by virtue of the execution and delivery by each Note Party of this Note, and delivery of certificates (if any) representing the Pledged Equity and delivery of the debt securities, promissory notes and any other instruments (if any) evidencing the Pledged Debt to and continued possession thereof by the Collateral Agent in the State of New York, the Collateral Agent for its benefit and the benefit of the Holder Representative and the holders of Notes has a legal, valid and perfected Lien upon and security interest in such Pledged Securities as security for the payment and performance of the Note Obligations to the extent such perfection is governed by the Code, subject to no prior Lien;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(vii) the pledge effected hereby is effective to vest in the Collateral Agent, for its benefit and the benefit of the Holder Representative and the holders of Notes, the rights of a “secured party” (as defined in the Code) in the <FONT STYLE="letter-spacing: -0.1pt">Pledged </FONT>Collateral to the extent intended hereby, except as such enforceability may be <FONT STYLE="letter-spacing: -0.1pt">limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar </FONT>laws affecting the enforcement of creditors’ rights generally and by general equitable principles (whether enforcement is sought by proceedings in equity or at law); and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 73; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(viii) subject to the terms of this Note and to the extent permitted by applicable Law, each Note Party hereby agrees that if an Event of Default shall have occurred and be continuing and the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) shall have given the applicable Note Party written notice of its intent to exercise such rights, it will comply with instructions of the Collateral Agent with respect to the Capital Stock in such Note Party that constitute Pledged Equity hereunder that are not certificated without further consent by the applicable owner or holder of such Capital Stock.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Certification of Limited Liability Company and Limited Partnership Interests</U>. No interest in any limited liability company or limited partnership controlled by any Note Party that constitutes Pledged Equity shall be represented by a certificate unless (i) the limited liability company agreement or partnership agreement expressly provides that such interests shall be a “security” within the meaning of Article 8 of the Code of the applicable jurisdiction, (ii) such certificate bears a legend indicating such interest represented thereby is such a “security” and (iii) such certificate shall be delivered to the Collateral Agent in accordance with Section 11(b). Each Note Party further acknowledges and agrees that with respect to any interest in any limited liability company or limited partnership controlled on or after the date hereof by such Note Party and pledged hereunder that is not a “security” within the meaning of Article 8 of the Code, such Note Party shall at no time elect to treat any such interest as a “security” within the meaning of Article 8 of the Code, nor shall such interest be represented by a certificate, unless such election is made and such interest is thereafter represented by a certificate that is promptly delivered to the Collateral Agent pursuant to Sections 10(b)(i) and 10(b)(iii).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) <U>Registration in Nominee Name; Denominations</U>. If an Event of Default shall have occurred and be continuing and the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) shall have given the applicable Note Party written notice of its intent to exercise such rights, (i) the Collateral Agent, for its benefit and the benefit of the Holder Representative and the holders of Notes, shall have the right to hold the Pledged Securities in its own name as pledgee, the name of its nominee (as pledgee or as sub-agent) or the name of the applicable Note Party, endorsed or assigned in blank or in favor of the Collateral Agent and each Note Party will promptly give to the Collateral Agent copies of any written notices or other written communications received by it with respect to Pledged Equity registered in the name of such Note Party and (ii) the Collateral Agent shall have the right to exchange the certificates representing Pledged Equity for certificates of smaller or larger denominations for any purpose consistent with this Note and the other Note Documents, to the extent permitted by the documentation governing such Pledged Equity.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) The parties hereto expressly agree that, unless the Collateral Agent shall become the absolute owner of Pledged Equity consisting of any <FONT STYLE="letter-spacing: -0.1pt">limited </FONT>liability company interest or partnership interest pursuant hereto, neither this Note nor the other Note Documents shall be construed as creating a partnership or joint venture among the Collateral Agent, any holder of Notes, any Note Party or any other Person and the Collateral Agent shall have no duty, obligation or responsibility with respect to the Pledged Equity other than to hold the same in accordance with this Note.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 74; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) The Collateral Agent and the holders of Notes shall not be obligated to perform or discharge any obligation of any Note Parties solely as a result of the pledge effected hereby.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) <U>Voting Rights; Dividends and <FONT STYLE="letter-spacing: -0.1pt">Interest</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) Unless and until an Event of Default shall have occurred and be continuing and the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) shall have provided written notice to the applicable Note Party in accordance with Section 11(f)(iv) below that the rights of such Note Party under this Section 11(f) are being <FONT STYLE="letter-spacing: -0.1pt">suspended:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(A) </FONT>each Note Party shall be entitled to exercise any and all voting or other consensual rights and powers inuring to an owner of Pledged Equity or any part thereof and each Note Party agrees that it shall exercise such rights in a manner not prohibited by the terms of this Note or the other Note Documents;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(B) </FONT>the Collateral Agent shall promptly (after reasonable advance notice) execute and deliver (at the Note Parties’ sole cost and expense) to each Note Party, or cause to be executed and delivered to such Note Party, all such proxies, powers of attorney and other instruments prepared by such Note Party as such Note Party may reasonably request for the purpose of enabling such Note Party to exercise the voting or consensual rights and powers it is entitled to exercise pursuant to Section 11(f)(i)(A); <FONT STYLE="letter-spacing: -0.2pt">and</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="letter-spacing: -0.05pt">(C) </FONT>each Note Party shall be entitled to receive and retain any and all dividends, interest, principal and other distributions paid on or distributed in respect of the Pledged Securities to the extent and only to the extent that such dividends, interest, principal and other distributions are <FONT STYLE="letter-spacing: -0.1pt">permitted by, and otherwise paid or distributed in accordance with, the terms </FONT>and conditions of this Note, the other Note Documents and applicable Laws; <I>provided </I>that any noncash dividends, interest, principal or other distributions that would constitute Pledged Equity or Pledged Debt, whether resulting from a subdivision, combination or reclassification of the outstanding Capital Stock of the issuer of any Pledged Securities or received in exchange for Pledged Securities or any part thereof, or in redemption thereof, or as a result of any merger, consolidation, acquisition or <FONT STYLE="letter-spacing: -0.1pt">other </FONT>exchange of assets to which such issuer may be a party or otherwise, shall be and become part of the Pledged Collateral, and, if received by any Note Party, shall not be commingled by such Note Party with any of its other funds or property but shall be held separate and apart therefrom, shall be held in trust for the benefit of the Collateral Agent and the holders of Notes and shall be promptly (and in any event within five (5) Business Days or such longer period as the Majority Holders may agree in their reasonable discretion) delivered to the Collateral Agent in the same form as so received (with any necessary endorsement reasonably requested by the Majority Holders). So long as no Default or Event of Default has occurred and is continuing, the Collateral Agent shall promptly deliver to each Note Party any Pledged Securities in its possession if requested to be delivered to the issuer thereof in connection with any exchange or redemption of such Pledged Securities permitted by this Note and the other Note Documents in accordance with this Section 11(f)(i)(C).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 75; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) Upon the occurrence and during the continuance of an Event of Default after the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) shall have provided written notice to the applicable Note Party of the suspension of such Note Party’s rights under Section 11(f)(i)(C), then all rights of such Note Party to dividends, interest, principal or other distributions that such Note Party is authorized to receive pursuant to paragraph Section 11(f)(i)(C) shall cease and all such rights shall thereupon become vested in the Collateral Agent (on behalf of the holders of Notes), which shall have the sole and exclusive right and authority to receive and retain such dividends, interest, principal or other distributions in respect of the Pledged Equity. All dividends, interest, principal or other distributions received by any Note Party contrary to the provisions of this Section 11(f) shall be held in trust for the benefit of the Collateral Agent (for the benefit of the holders of Notes), shall be segregated from other property or funds of such Note Party and shall be promptly (and in any event within five (5) Business Days or such longer period as the Majority Holders may agree in their reasonable discretion) delivered to the Collateral Agent upon demand in the same form as so received (with any necessary endorsement reasonably requested by the Collateral Agent). Any and all money and other property paid over to or received by the Collateral Agent pursuant to the provisions of this paragraph (ii) shall be retained by the Collateral Agent in an account to be established by the Collateral Agent upon receipt of such money or other property and shall be applied in accordance with the provisions of <FONT STYLE="letter-spacing: -0.1pt">Section </FONT>11(c). After all Events of Default have been cured or waived and the Collateral Agent has received written notice from the Note Parties of such cure or waiver, the Collateral Agent shall promptly repay to each Note Party (without interest) all dividends, interest, principal or other distributions that such Note Party would otherwise be permitted to retain pursuant to the terms of paragraph Section 11(f)(i)(C) and that remain in such account, and such Note Party’s right to receive and retain any and all dividends, interest, principal and other distributions paid on or distributed in respect of the Pledged Securities shall be automatically <FONT STYLE="letter-spacing: -0.1pt">reinstated.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.7pt 0 132pt; text-align: justify"> </P> <!-- Field: Page; Sequence: 76; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) Upon the occurrence and during the continuance of an Event of Default, after the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) shall have provided the applicable Note Party with written notice of the suspension of such Note Party’s rights under paragraph Section 11(f)(i)(A), then all rights of such Note Party to exercise the voting and consensual rights and powers it is entitled to exercise pursuant to Section 11(f)(i)(A), and the obligations of the Collateral Agent under Section 11(f)(i)(B), shall cease, and all such rights in respect of the Pledged Securities shall thereupon become vested in the Collateral Agent (on behalf of the holders of Notes), which shall have the sole and exclusive right and authority to exercise such voting and consensual rights and powers. After all Events of Default have been cured or waived and the Collateral Agent has received written notice from the Note Parties of such cure or waiver, each Note Party shall immediately have the exclusive right to exercise the voting or consensual rights and powers that such Note Party would otherwise be entitled to exercise pursuant to the terms of Section 11(f)(i)(A) until such time as such rights are again suspended pursuant to this Section 11(f), and the obligations of the Collateral Agent under Section 11(f)(i)(B) shall be immediately reinstated.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) Any notice required to be given by the Collateral Agent to the Note Parties to suspend rights under Section 11(f) (A) shall be given in writing, (B) may be given with respect to one or more Note Parties at the same or different times <FONT STYLE="letter-spacing: -0.25pt">and </FONT></FONT>(C) may suspend the rights of the Note Parties under Section 11(f)(i)(A) or Section 11(f)(i)(C) in part without suspending all such rights (as specified by the Collateral Agent acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) and without waiving or otherwise affecting the Collateral Agent’s rights to give additional notices from time to time suspending other rights so long as an Event of Default has occurred and is continuing.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">12. <U>Defaults and <FONT STYLE="letter-spacing: -0.1pt">Remedies</FONT></U></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) <U>Events of Default</U>. Each of the following events shall be an “Event of Default” with respect to the Note (each, an “<U>Event of Default</U>”):</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) default in any payment of interest on this Note when due and payable, and the default continues for a period of thirty (30) days;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) default in the payment of principal of the Note when due and payable on the Maturity Date, on any Amortization Payment Date, upon any required repurchase or redemption, upon declaration of acceleration or otherwise;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) default by any Note Party or any Subsidiary of any Note Party with respect to any mortgage, agreement or other instrument under which there may be outstanding, or by which there may be secured or evidenced, any Indebtedness for money borrowed in excess of $500,000 (or its foreign currency equivalent) in the aggregate of such Note Party or of any such Subsidiary, whether such Indebtedness now exists or shall hereafter be created (but excluding the ABL Debt) (i) resulting in such Indebtedness becoming or being declared due and payable, (ii) enabling or permitting the holder or holders of such Indebtedness or any trustee or agent on its or their behalf to cause any such Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity or (iii) constituting a failure to pay the principal of any such debt when due and payable at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 77; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv) a final judgment or judgments for the payment of $100,000 (or its foreign currency equivalent) or more (excluding any amounts covered by insurance policies issued by insurers reasonably believed by the applicable Note Party in good faith to be credit-worthy) in the aggregate rendered against any Note Party or any Subsidiary of any Note Party, which judgment is not discharged or stayed within sixty (60) calendar days after (i) the date on which the right to appeal thereof has expired if no such appeal has commenced, or (ii) the date on which all rights to appeal have been extinguished;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(v) any Note Party or any Subsidiary of any Note Party shall commence a voluntary case or other proceeding seeking liquidation, reorganization or other relief with respect to such Note Party or any such Subsidiary or its debts under any Debtor Relief Law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, administrator, custodian or other similar official of any Note Party or any such Subsidiary or any substantial part of its property, or shall consent to any such relief or to the appointment of or taking possession by any such official in an involuntary case or other proceeding commenced against it, or shall make a general assignment for the benefit of <FONT STYLE="letter-spacing: -0.1pt">creditors;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(vi) an involuntary case or other proceeding shall be commenced against any Note Party or any Subsidiary seeking liquidation, reorganization or other relief with respect to such Note Party or such Subsidiary or its debts under any Debtor Relief Law now or hereafter in effect or seeking the appointment of a trustee, receiver, liquidator, administrator, custodian or other similar official of any Note Party or any such Subsidiary or any substantial part of its property, and such involuntary case or other proceeding shall remain undismissed and unstayed for a period of sixty (60) consecutive days;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(vii) any Guaranty ceases to be in full force and effect, other than in accordance with the terms of this Note, or any Guarantor denies or disaffirms its obligations under its Guaranty or gives notice to such effect;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(viii) any material provision of any Note Document, at any time after its execution and delivery and for any reason, other than as expressly permitted hereunder or thereunder or the satisfaction in full of all the Note Obligations, ceases to be in full force and effect, or any Note Party contests in writing the validity or enforceability of any provision of any Note Document or the validity or priority of any Lien as required hereby or thereby on a material portion of the Collateral or any Note Party denies in writing that it has any or further liability or obligation under any Note Document (other than as a result of repayment in full of the Note Obligations), or purports in writing to revoke or rescind any Note Document;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.7pt 0 96pt; text-align: justify; text-indent: 1in"> </P> <!-- Field: Page; Sequence: 78; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ix) (A) this Note or any other Note Document shall for any reason (other than pursuant to the terms hereof or thereof) cease to create a valid and perfected Lien, with the priority required hereby or thereby, on and security interest in any material portion of the Collateral purported to be covered thereby, subject to Permitted Liens or (B) any Lien created or purported to be created by this Note or any other Note Document shall cease to have the lien priority established or purported to be established by the applicable Intercreditor Agreement or Subordination Agreement;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(x) any provisions of any Subordination Agreement or Intercreditor Agreement or any agreement or instrument governing any Indebtedness thereunder shall for any reason be revoked or invalidated, or otherwise cease to be in full force and effect, or any Person shall contest in any manner the validity or enforceability thereof or deny that it has any further liability or obligation thereunder, or the Note Obligations or the Liens securing the Note Obligations for any reason shall not have the priority contemplated by this Note, the other Note Documents or any such Subordination Agreement or Intercreditor <FONT STYLE="letter-spacing: -0.1pt">Agreement;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(xi) (A) An ERISA Event occurs with respect to a Pension Plan or a Multiemployer Plan which has resulted or could reasonably be expected to result in liability of any Note Party or any Subsidiary under Title IV of ERISA to the Pension Plan, Multiemployer Plan or the PBGC in an aggregate amount in excess of $100,000 or (B) any Note Party or any ERISA Affiliate fails to pay when due, after the expiration of any applicable grace period, any installment payment with respect to its withdrawal liability under Section 4201 of ERISA under a Multiemployer Plan in an aggregate amount in excess of $100,000.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(xii) the Borrower or the Guarantor fails to observe or perform any other obligation or undertaking given by it under or in relation to this Note or the other Note Documents after written notice of such failure and a thirty (30) day period to cure;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(xiii) a default in the Borrower’s obligations under <U>Section <FONT STYLE="letter-spacing: -0.25pt">8</FONT></U><FONT STYLE="letter-spacing: -0.25pt">;</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(xiv) a default in the Company’s obligations in accordance with <U>Section 4</U> if such default is not cured within three (3) Business Days after its occurrence;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(xv) (i) any “Event of Default” (other than a payment default) under the ABL Debt occurs and continues beyond any applicable grace period, (ii) any principal payment “Event of Default” under the ABL Debt occurs or (iii) acceleration of the ABL Debt; or</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(xvi) the occurrence of an “Event of Default” under any other Note and continuance thereof beyond any applicable grace period.</P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"> </P> <!-- Field: Page; Sequence: 79; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) <U>Remedies</U>. If one or more Events of Default shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body), then:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) in each and every such case (other than an Event of Default specified in <U>Section 12(a)(v)</U> or <U>Section 12(a)(vi)</U> with respect to any Note Party or any of its Subsidiaries), unless the principal of all of the Notes shall have already become due and payable, either the Collateral Agent (at the direction of the Majority Holders) or the Majority Holders, by notice in writing to the Borrower (and to the Collateral Agent if given by the Majority Holders), may declare 100% of the principal of, and any accrued and unpaid interest on, all of the Notes, and all other amounts owing or payable hereunder or under the other Note Documents to be due and payable immediately, and upon any such declaration the same shall become and shall automatically be immediately due and payable, anything contained in this Note to the contrary notwithstanding. If an Event of Default specified in <U>Section 12(a)(v)</U> or <U>Section 12(a)(vi)</U> with respect to any Note Party or any of its Subsidiaries occurs and is continuing, 100% of the principal of, and accrued and unpaid interest, if any, on, all Notes, and all other amount owing or payable hereunder or under the other Notes Documents shall become and shall automatically be immediately due and payable; and</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) the Collateral Agent shall, at the request of the Majority Holders, exercise on behalf of itself and the holders of Notes any and all rights and remedies available to it and the holders of Notes under the Note Documents and any and all rights afforded to a “secured party” (as defined in the Code) with respect to the Note Obligations, including the Guaranty, under the Code or other applicable Law and also may (A) require each Note Party to, and each Note Party agrees that it will at its expense and upon request of the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with terms of the Note Documents), promptly assemble all or part of the Collateral as directed by the Collateral Agent and make it available to the Collateral Agent at a place and time to be reasonably designated by the Collateral Agent; (B) upon prior written notice, occupy any premises owned or, to the extent lawful and permitted, leased by any of the Note Parties where the Collateral or any part thereof is assembled or located for a reasonable period in order to effectuate its rights and remedies hereunder or under applicable Law, without obligation to such Note Party in respect of such occupation; (C) exercise any and all rights and remedies of any of the Note Parties under or in connection with the Collateral, or otherwise in respect of the <FONT STYLE="letter-spacing: -0.1pt">Collateral; </FONT>(D) subject to the mandatory requirements of applicable Law, sell, assign or otherwise dispose of all or any part of the Collateral, or direct such Note Party to sell, assign or otherwise dispose of all or any part of the Collateral without demand and without notice, advertisement, hearing or process of applicable Law, all of <FONT STYLE="letter-spacing: -0.1pt">which each Grantor hereby waives to the fullest extent permitted by applicable Law, </FONT>at any time or any place, at a public or private sale or at any broker’s board or on any securities exchange, for cash, upon credit or for future delivery as the Collateral Agent (acting at the direction of the Majority Holders) shall deem appropriate; <FONT STYLE="letter-spacing: -0.25pt">and </FONT></FONT>(E) to the extent of the Note Parties’ interest therein, take possession and control over all software and all associated servers, hardware and equipment, including domain name registrations and associated URLs, and each such Note Party shall provide to the Collateral Agent all access codes, transfer codes and verification codes and access to all other security measures and devices used or necessary <FONT STYLE="letter-spacing: -0.25pt">in</FONT> connection therewith. The Collateral Agent shall be authorized at any such sale of securities (if it deems it advisable to do so) to restrict the prospective bidders or purchasers to Persons who will represent and agree that they are purchasing the Collateral for their own account for investment and not with a view to the distribution or sale thereof, and upon consummation of any such sale the Collateral Agent shall have the right to assign, transfer and deliver to the purchaser or purchasers thereof the Collateral so sold. Each such purchaser at any sale of Collateral shall hold the property sold absolutely, free from any claim or right on the part of any Note Party, and each Note Party hereby waives (to the extent permitted by applicable Law) all rights of redemption, stay and appraisal that such Note Party now has or may at any time in the future have under any applicable Law now existing or hereafter enacted.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 80; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: justify; width: 1in"> </TD> <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent notice to the Note Parties is required under applicable Law, the Collateral Agent shall give the applicable Note Parties ten (10) calendar days’ prior written notice (which each Note Party agrees is reasonable notice within the meaning of Section 9611 of the Code or its equivalent in other jurisdictions) of the Collateral Agent’s intention to make any sale of Collateral. Such notice, in the case of a public sale, shall state the time and place for such sale and, in the case of a sale at a broker’s board or on a securities exchange, shall state the board or exchange at which such sale is to be made and the day on which the Collateral, or portion thereof, will first be offered for sale at such board or exchange. Any such public sale shall be held at such time or times within ordinary business hours and at such place or places as the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) may fix and state in the notice (if any) of such sale. At any such sale, the Collateral, or portion thereof, to be sold may be sold in one lot as an entirety or in separate parcels, as the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) may determine. The Collateral Agent shall not be obligated to make any sale of any Collateral if the Collateral Agent (acting at the direction of the Majority Holders) shall determine not to do so, regardless of the fact that notice of sale of such Collateral shall have been given. The Collateral Agent (acting at the direction of the Majority Holders or <FONT STYLE="letter-spacing: -0.1pt">otherwise in accordance with the terms of the Note Documents) may, without notice </FONT>or publication, adjourn any public or private sale or cause the same to be adjourned from time to time by announcement at the time and place fixed for sale, and such sale may, without further notice, be made at the time and place to which the same was so adjourned. In case any sale of all or any part of the Collateral is made on credit or for future delivery, the Collateral so sold may be retained by the Collateral Agent until the sale price is paid by the purchaser or purchasers thereof, but the Collateral Agent shall not incur any liability in case any such purchaser or purchasers shall fail to take up and pay for the Collateral so sold and, in case of any such failure, such Collateral may be sold again upon like notice. At any public (or, to the extent permitted by applicable Law, private) sale made pursuant to this Note or the other Note Documents, the Collateral Agent or any holder of Notes may bid for or purchase, free (to the extent permitted by applicable Law) from any right of redemption, stay, valuation or appraisal on the part of any Note Party (all said rights being also hereby waived and released to the extent permitted by applicable Law), the Collateral or any part thereof offered for sale and may make payment on account thereof by using any claim then due and payable to the Collateral Agent or such holder of Notes, as applicable, from any Note Party as a credit against the purchase price, and the Collateral Agent or such holder of Notes, as applicable, may, upon compliance with the terms of sale, hold, retain and dispose of such property without further accountability to any Note Party therefor. For purposes hereof, a binding written agreement to purchase the Collateral or any portion thereof shall be treated as a sale thereof, the Collateral Agent shall be free to carry out such sale pursuant to such agreement and no Note Party shall be entitled to the return of the Collateral or any portion thereof subject thereto, notwithstanding the fact that after the Collateral Agent shall have entered into such an agreement all Events of Default shall have been remedied and the Note Obligations paid in full. As an alternative to exercising the power of sale herein conferred upon it, the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) may proceed by a suit or suits at Law or in equity to foreclose this Note and the other Note Documents and to sell the Collateral or any portion thereof pursuant to a judgment or decree of a court or courts having competent jurisdiction or pursuant to a proceeding by a court-appointed receiver. Any sale pursuant to, and in accordance with, the provisions of this Section 12(b) shall be deemed to conform to the commercially reasonable standards as provided in Section 9610(b) of the Code or its equivalent in other jurisdictions.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 81; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: justify; width: 1in"> </TD> <TD STYLE="text-align: justify">Each <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Party irrevocably makes, constitutes and appoints the Collateral Agent (and all officers, employees or agents designated by the Collateral Agent) as such Note Party’s true and lawful agent (and attorney-in-fact) during the continuance of an Event of Default, for the purpose of (i) making, settling and adjusting claims in respect of Article 9 Collateral under policies of insurance, and endorsing the name of such Note Party on any check, draft, instrument or other item of payment for the proceeds of such policies of insurance, (ii) making all determinations and decisions with respect thereto and (iii) obtaining or maintaining the policies of insurance required hereby of by the other Note Documents or to pay any premium in whole or in part relating thereto; <I>provided </I>that to the extent any of the foregoing actions relate to the exercise of any rights or remedies in connection with the Capital Stock of any Note Party or Subsidiary thereof, including voting rights, the Collateral Agent shall provide written notice to the applicable Note Party. All sums disbursed by the Collateral Agent (for itself and on behalf of any of the Persons who are entitled to payment and reimbursement of costs and expenses under the Note Documents) in connection with this paragraph, including reasonable and documented out-of-pocket attorneys’ fees, court costs, expenses and other charges relating thereto, shall be payable by the Note Parties upon demand and shall be additional Note Obligations secured by the Collateral.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: justify; width: 1in"> </TD> <TD STYLE="text-align: justify">Each <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Party recognizes that the Collateral Agent may be unable to effect a public sale of any or all of the Pledged Equity or the Pledged Debt by reason of certain prohibitions contained in the Securities Act and applicable state securities laws or otherwise, and may be compelled to resort to one or more private <FONT STYLE="letter-spacing: -0.1pt">sales </FONT>thereof to a restricted group of purchasers which will be obliged to agree, among other things, to acquire such securities for their own account for investment and not with a view to the distribution or resale thereof. Each Note Party acknowledges and agrees that any such private sale may result in prices and other terms less favorable than if such sale were a public sale and, notwithstanding such circumstances, agrees that any such private sale shall be deemed to have been made in a commercially reasonable manner. The Collateral Agent shall be under no obligation to delay a sale of any of the Pledged Equity or the Pledged Debt for the period of time necessary to permit the issuer thereof to register such securities for public sale under the Securities Act or under applicable state securities laws, even if such issuer would agree to do so.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 82; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) <U>Application of Proceeds</U>. After the exercise of remedies provided for in Section 12(b) (or after the Note Obligations have automatically become immediately due and payable as set forth in Section 12(b)(i)), including in any proceeding under any Debtor Relief Law, any amounts received on account of the Note Obligations (whether as a result of a payment under a guarantee, any realization on the Collateral, any set-off rights, any distribution in connection with any proceeding under any Debtor Relief Law or otherwise and whether received in cash or otherwise, including all proceeds received by the Collateral Agent in respect of any sale, any collection from, or other realization upon all or any part of the Collateral but excluding the payment of current interest or interest paid as a form of adequate protection in any proceeding under any Debtor Relief Law) shall be applied by the Collateral Agent, subject to any Intercreditor Agreement then in effect, in the following order:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><I>First</I>, to payment of that portion of the Note Obligations constituting fees, indemnities, expenses and other amounts payable to the Collateral Agent and the Holder Representative, as applicable, in its capacities as such;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><I>Second</I>, to the payment of that portion of the Note Obligations constituting fees and indemnities (other than unasserted contingent indemnification obligations) and other amounts (other than principal and interest) payable to the holders of Notes, ratably among them in proportion to the respective amounts described in this clause Second payable to them, together with interest on each such amount at the highest rate then in effect under the Note Documents from and after the date such amount is due, owing or unpaid until paid in full;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><I>Third</I>, to the payment of that portion of the Note Obligations constituting accrued and unpaid interest on the Notes and other Note Obligations under the Note Documents (including, for the avoidance of doubt, interest which, but for the filing of a petition in bankruptcy with respect to any Note Party would have accrued on any such Note Obligation, whether or not a claim is allowed or allowable against any Note Party for such interest in the related bankruptcy proceeding), ratably among the holders of Notes in proportion to the respective amounts described in this clause Third payable to them;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 6.75pt 0 131.95pt; text-align: justify; text-indent: 0.5in"> </P> <!-- Field: Page; Sequence: 83; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I> </I></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><I>Fourth</I>, to the payment of that portion of the Note Obligations constituting unpaid principal of the Notes, ratably among the holders of Notes in proportion to the respective amounts described in this clause Fourth held by them;</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><I>Fifth</I>, to the payment of all other Note Obligations that are due and payable to the Collateral Agent and the holders of Notes on such date, ratably based upon the respective amounts described in this clause Fifth payable to them on such date; <FONT STYLE="letter-spacing: -0.2pt">and</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><I>Last</I>, the balance, if any, after all of the Note Obligations have been indefeasibly paid in full, to the Note Parties or as otherwise required by Law.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) shall have absolute discretion as to the time of application of any such proceeds, moneys or balances in accordance with this Note and the other Note Documents. Upon any sale of Collateral by the Collateral Agent (including pursuant to a power of sale granted by statute or under a judicial proceeding), the receipt of the Collateral Agent or of the officer making the sale shall be a sufficient discharge to the purchaser or purchasers of the Collateral so sold and such purchaser or purchasers shall not be obligated to see to the application <FONT STYLE="letter-spacing: -0.1pt">of any part of the purchase money paid over to the Collateral Agent or such officer or be answerable </FONT>in any way for the misapplication thereof.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0pt">The Collateral Agent shall have no liability to any holder of Notes for actions taken in reliance on information supplied to it as to the amounts of unpaid principal and interest and other amounts outstanding with respect to the Note Obligations. All distributions made by the Collateral Agent pursuant to this Section 12(c) shall be (subject to any decree of any court of competent jurisdiction) final (absent manifest error).</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) <U>Grant of License to Use Intellectual Property</U>. For the exclusive purpose of enabling the Collateral Agent to exercise rights and remedies under this Note and the other Note Documents at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies at any time after the occurrence and during the continuance of an Event of Default, each Note Party hereby grants to the Collateral Agent a non-exclusive, royalty-free, limited license (until the waiver or cure of all Events of Default) to use, license or sublicense any of the Intellectual Property and Licenses included in the Article 9 Collateral now owned or hereafter acquired by such Note Party, and wherever the same may be located, and including in such license reasonable access to all media in which any of the licensed items may be recorded or stored and to all computer software and programs used for the compilation or printout thereof to the extent of the applicable Note Party’s interest therein; <I>provided</I>, <I>however</I>, that (i) all of the foregoing rights of the Collateral Agent to use (to the extent permitted by the terms of such licenses and sublicenses) such licenses and sublicenses shall expire immediately upon the waiver or cure of all Events of Default and written notice by the applicable Note Party to the Collateral Agent of such waiver or cure, and shall be exercised by the Collateral Agent solely during the continuance of an Event of Default, and nothing in this Section 12(d) shall require the Note Parties to grant any license that is prohibited by any rule of Law or is prohibited by, or constitutes a breach or default under or results in the termination of, any contract, license, agreement, instrument or other document evidencing, giving rise to or theretofore granted, to the extent permitted by the Note Documents, with <FONT STYLE="letter-spacing: -0.1pt">respect </FONT>to, such property or otherwise unreasonably prejudices the value thereof to the relevant Note Party and (ii) such license and all of the foregoing rights related thereto shall automatically terminate upon the payment in full of all Note Obligations. Under the licenses to be granted by each Note Party under this <U>Section 12(d)</U>, both (A) the use of the Intellectual Property and Licenses included in the Article 9 Collateral by the Collateral Agent and (B) the licenses granted by the Collateral Agent to a third party shall (1) with respect to Trademarks, be subject to the maintenance of reasonable quality standards with respect to the goods and services on which such Trademarks are used sufficient to preserve the validity of such Trademarks; (2) with regard to trade secrets, be subject to the requirement that the secret status of the trade secrets be maintained and reasonable steps are taken to ensure that they are maintained; (3) with regard to Patents, be subject to the obligation to maintain the existence and enforceability of such Patents; (4) be subject to the use of reasonable patent, trademark, copyright and proprietary notices; and (5) be subject to the Collateral Agent having no greater rights than those of any such Note Party under any such license or sublicense; <I>provided</I>, <I>however</I>, that with respect to any uses, licenses, form licenses, or any other agreements or activities in effect on or prior to the occurrence of such Event of Default the requirements set forth in the foregoing clauses (1) through (5) shall be deemed satisfied. For the avoidance of doubt, the use of such license by the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) may be exercised only during the continuation of an Event of Default and until such time as all such Events of Default have been cured or waived in writing by the requisite holders of Notes in accordance with the Note Documents. Upon the occurrence and during the continuance of an Event of Default, the Collateral Agent (acting at the direction of the Majority Holders or otherwise in accordance with the terms of the Note Documents) may also exercise the rights afforded under Section 12(b)(ii) with respect to Intellectual Property and Licenses contained in the Article 9 Collateral.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 84; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Certain Rights on Acceleration</U>. It is understood and agreed that if this Note is accelerated or otherwise becomes due prior to its stated maturity, in each case, as a result of an Event of Default (including an Event of Default specified in <U>Section 12(a)(v) </U>or <U>Section 12(a)(vi)</U> (including the acceleration of any portion of the Indebtedness evidenced by the Notes by operation of law)), the Interest Make-Whole Payment shall also be due and payable in cash as though the Notes had been optionally converted and shall constitute part of the Note Obligations in view of the impracticability and difficulty of ascertaining actual damages and by mutual agreement of the parties as to a reasonable calculation of each Holder’s lost profits as a result thereof. If the Interest Make-Whole Payment becomes due and payable, it shall be deemed to be principal of this Note and interest shall accrue on the full principal amount of this Note (including the Interest Make- Whole Payment) from and after the applicable triggering event, including in connection with an Event of Default specified in <U>Section 12(a)(v)</U> or <U>Section 12(a)(vi)</U>. Any amounts payable above shall be presumed to be liquidated damages sustained by each Holder as the result of the acceleration of this Note and the Borrower and each Guarantor agrees that it is reasonable under the circumstances currently existing. The Interest Make-Whole Payment shall also be payable in the event this Note is satisfied, released or discharged through foreclosure, whether by judicial proceeding, deed in lieu of foreclosure or by any other means. THE BORROWER AND EACH <FONT STYLE="letter-spacing: -0.2pt">GUARANTOR EXPRESSLY WAIVES (TO THE FULLEST EXTENT THEY MAY LAWFULLY </FONT>DO SO) THE PROVISIONS OF ANY PRESENT OR FUTURE STATUTE OR LAW THAT PROHIBITS OR MAY PROHIBIT THE COLLECTION OF THE FOREGOING PREMIUM <FONT STYLE="letter-spacing: -0.25pt">IN </FONT></FONT>CONNECTION WITH ANY SUCH ACCELERATION. The Borrower and each Guarantor expressly agree (to the fullest extent it may lawfully do so) that: (A) the Interest Make-<FONT STYLE="letter-spacing: -0.2pt">Whole</FONT> Payment is reasonable and is the product of an arm’s length transaction between sophisticated business entities ably represented by counsel; (B) the Interest Make-Whole Payment shall be payable notwithstanding the then prevailing market rates at the time acceleration occurs; (C) there has been a course of conduct between the Holder and the Borrower and each Guarantor giving specific consideration in this transaction for such agreement to pay the Interest Make-Whole Payment; and (D) the Borrower and each Guarantor shall be estopped hereafter from claiming differently than as agreed to in this paragraph. The Borrower and each Guarantor expressly acknowledge that their agreement to pay the Interest Make-Whole Payment to holders as herein described is a material inducement to the Holder to purchase this Note.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 85; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) <U>Rights not Exclusive</U>. The rights and remedies provided for in this Note and the other Note Documents are cumulative and are not exclusive of any other rights, powers, privileges or remedies provided by Law or in equity, or under any other instrument, document or agreement now existing or hereafter arising.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) <U>Excess ABL Fee</U>. Without any limitation to any other rights and remedies or provisions in this Note, commencing with the fiscal month ending October 31, 2022, in the event Indebtedness in favor of the ABL Lenders arising under the ABL Debt Documents exceeds the amount set forth in clause (n) of the definition of Permitted Indebtedness as of the last day of such calendar month, the Borrower shall pay a fee in cash to Holder Representative, for pro rata distribution to each holder of the Notes, in an amount equal to ten percent (10%) of the amount by which the Indebtedness in favor of the ABL Lenders arising under the ABL Debt Documents exceeds the amount set forth in clause (n) of the definition of Permitted Indebtedness. Such fee shall be paid to the Holder Representative within two (2) business days following the last day of such fiscal month.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">13. <U>Miscellaneous <FONT STYLE="letter-spacing: -0.1pt">Provisions</FONT></U><FONT STYLE="letter-spacing: -0.1pt">.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(a) This Note and any provisions herein may be modified, amended and waived only with the written consent of the Borrower, the Majority Holders and the acknowledgement of the Holder Representative and the Collateral Agent, and any such modification, amendment or waiver shall be binding on the Holder and all holders of other Notes with respect to all the Notes. Notwithstanding the foregoing, no modification, amendment or waiver shall be made that affects the rights, duties or immunities of the Holder Representative and/or the Collateral Agent without its written consent, as applicable. Neither this Note nor any of the other Notes forming a series with this Note may be modified or amended, and no provisions of such other Notes may be waived, unless such modification, amendment or waiver applies to all of the Notes in the series.<SUP>3</SUP></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(b) After the date hereof, the Borrower agrees to pay all reasonable and documented fees, costs and expenses, including reasonable attorneys’ fees and expenses, incurred by the Majority Holders in collecting or attempting to collect the Obligations, whether or not any action or proceeding is commenced. None of the provisions hereof and none of the Holder’s rights or remedies under this Note on account of any past or future defaults shall be deemed to have been waived by the Collateral Agent’s or the Holder’s acceptance of any past due installments or by any indulgence granted by the Collateral Agent or the Holder to the Borrower.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"> </DIV></DIV><!-- Field: /Rule-Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P> <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <TR STYLE="vertical-align: top"> <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>3</SUP></FONT></TD> <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Second Amendment, notwithstanding anything in Section 13(a) of the Notes to the contrary, the terms of the Purchased Third Option Notes may be amended as set forth in Section 5 of the Second Amendment despite being part of the same series as all other Notes.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt"> </P> <!-- Field: Page; Sequence: 86; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(c) The Borrower hereby waives presentment, demand, diligence, protest and notice of every kind, and agrees that it shall remain liable for all amounts due under this Note notwithstanding any delay or failure by the Collateral Agent or the Holder to exercise any rights under this Note. Borrower hereby waives the right to plead any and all statutes of limitation as a defense to a demand under this Note to the full extent permitted by law.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(d) All notices, requests, demands, consents, instructions and other communications which are required or may be given under this Note shall be in writing and shall be deemed to have been duly given when received if personally delivered; when transmitted if transmitted by confirmed facsimile or other electronic transmission (including e-mail), except that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business on the next Business Day for the recipient; the Business Day after it is sent if sent for next day delivery to a domestic address by recognized overnight delivery service (e.g. Federal Express); and five (5) Business Days after the date mailed by certified or registered mail, postage prepaid, if sent by certified or registered mail, return receipt requested. In each case notice shall be sent to:</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD> </TD> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to the Holder Representative on behalf of the Holder, addressed <FONT STYLE="letter-spacing: -0.25pt">to:</FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="width: 0.5in"> </TD> <TD STYLE="width: 0.5in"> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilmington Savings Fund Society, FSB, as Holder Representative </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WSFS Bank Center</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">500 Delaware Avenue, 11th Floor </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilmington, DE 19801</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn: Global Capital Markets – Reed’s Inc </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: rgoldsborough@wsfsbank.com</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy (which shall not constitute notice) to: </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Winston & Strawn LLP</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200 Park Avenue New</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">York, NY 10166</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: (212) 294-6858 </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn: Bart Pisella</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: bpisella@winston.com</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to the Borrower, addressed to:</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reed’s, <FONT STYLE="letter-spacing: -0.2pt">Inc.</FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">201 Merritt 7 Corporate <FONT STYLE="letter-spacing: -0.2pt">Park,</FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norwalk, CT <FONT STYLE="letter-spacing: -0.1pt">06851</FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn: Norman E. Snyder, Jr, CEO </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: nsnyder@reedsinc.com</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to (which will not constitute <FONT STYLE="letter-spacing: -0.1pt">notice):</FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raines Feldman <FONT STYLE="letter-spacing: -0.25pt">LLP</FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18401 Vona Karman Avenue, Suite <FONT STYLE="letter-spacing: -0.25pt">360</FONT></FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Irvine, CA 92612 </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn: Ruba Qashu</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: <FONT STYLE="letter-spacing: -0.1pt">rqashu@raineslaw.com</FONT></FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 8.2pt 0 96pt"> </P> <TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"> <TR STYLE="vertical-align: top"> <TD STYLE="width: 0.5in"> </TD> <TD STYLE="text-align: justify">or <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to such other place and with such other copies as each party may designate as to itself by written notice to the others.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 87; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(e) The Holder hereby confirms the appointment of Wilmington Savings Fund Society, FSB as the Holder Representative and as the Collateral Agent for the benefit of the Holder under this Note and the other Note Documents to serve from the date hereof until the termination of this Note.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(i) Each Holder hereby irrevocably authorizes the Holder Representative and the Collateral Agent to take such action and to exercise such powers hereunder as provided herein or as requested in writing by the Holder or the Majority Holders, in accordance with the terms hereof, together with such powers as are reasonably incidental thereto and authorizes and directs the Collateral Agent to enter into each of the applicable Note Documents and perform its obligation and exercise its rights thereunder in accordance therewith, subject to the indemnification and other rights of the Collateral Agent set forth herein. Anything herein to the contrary notwithstanding, whenever reference is made in this Note to any action by, consent, designation, specification, requirement or approval of, notice, request or other communication from, or other direction given or action to be undertaken or to be (or not to be) suffered or omitted by the Collateral Agent or to any election, decision, opinion, acceptance, use of judgment, expression of satisfaction or other exercise of discretion, rights or remedies to be made (or not to be made) by the Collateral Agent, it is understood that in all cases the Collateral Agent shall be acting, giving, withholding, suffering, omitting, taking or otherwise undertaking and exercising the same (or shall not be undertaking and exercising the same) as directed by the Majority Holders. Each of the Holder Representative and the Collateral Agent may execute any of its duties hereunder by or through agents or employees and shall be entitled to request and act in reliance upon the advice of counsel concerning all matters pertaining to its duties hereunder and shall not be liable for any action taken or omitted to be taken by it in good faith in accordance therewith. Neither the Holder Representative nor the Collateral Agent will incur any liability of any kind with respect to any action or omission by the Holder <FONT STYLE="letter-spacing: -0.1pt">Representative or the Collateral Agent, as applicable, in connection with its services </FONT>pursuant to this Note and the other Note Documents, except in the event of liability directly resulting from its gross negligence or willful misconduct. The Holder will indemnify, defend and hold harmless the Holder Representative and the Collateral Agent from and against any and all losses, liabilities, damages, claims, penalties, fines, forfeitures, actions, fees, costs and expenses (including the fees and expenses of counsel and experts and their staffs and all expense of document location, duplication and shipment) and including the event of nonpayment by the Borrower under the Purchase Agreement (collectively, “<U>Representative Losses</U>”) arising <FONT STYLE="letter-spacing: -0.25pt">out </FONT>of or in connection with the Holder Representative’s or the Collateral Agent’s, as applicable, execution and performance of this Note and any other Note Documents, and the exercise or performance of their respective powers or duties hereunder (including any removal or remedial actions or other environmental claims), or in connection with any actual or alleged presence of hazardous materials in the air, surface water or groundwater or on the surface or subsurface of any real property at any time owned, leased or operated by the Borrower, the generation, storage, transportation, handling or disposal of hazardous materials by the Borrower or any of its Subsidiaries at any location, whether or not owned, leased or operated by the Borrower or any of its Subsidiaries, the non-compliance by the Borrower or any of its Subsidiaries with any environmental laws, or any environmental claim asserted against the Borrower, any of its Subsidiaries or any real property at any time owned, leased or operated by the Borrower or any of its Subsidiaries, in each case as such Representative Loss is suffered or incurred, including the enforcement of this Section 13(e)(i); <I>provided</I>, that no such indemnification shall be provided in the event that any such Representative Loss is finally adjudicated to have been directly caused by the gross negligence or willful misconduct of the Holder Representative or the Collateral Agent, as applicable.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 88; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(ii) Each of the Holder Representative and the Collateral Agent may resign at any time upon 10 days’ notice to the Borrower, the Holder and the other holders of Notes, and the Majority Holders may remove or replace the Holder <FONT STYLE="letter-spacing: -0.1pt">Representative or the Collateral Agent at any time upon 10 days’ notice by notifying </FONT>the Borrower and the holders of the Notes. Upon any such resignation or replacement, the Majority Holders shall have the right to appoint a successor holder representative or collateral agent, as applicable, in consultation with the Borrower. Upon the acceptance of its appointment as Holder Representative or Collateral Agent, as applicable, hereunder by a successor, such successor shall succeed to and become vested with all the rights, powers, privileges and duties of the retiring Holder Representative or Collateral Agent, as applicable, and the retiring, replaced or removed Holder Representative or Collateral Agent, as applicable, shall be discharged from its duties and obligations hereunder. If no successor Holder Representative or Collateral Agent, as applicable, shall have been appointed and shall have accepted such appointment, then on such 10<SUP>th</SUP> day (a) the retiring Holder Representative’s or Collateral Agent’s, as applicable, resignation, replacement or removal shall become effective, (b) the retiring, replaced or removed Holder Representative or Collateral Agent, as applicable, shall thereupon be discharged from its duties and obligations hereunder and (c) the Majority Holders shall thereafter perform all duties of the Holder Representative or the Collateral Agent, as applicable, hereunder and under the other Note Documents until such time, if any, as the Majority Holders appoint a successor Holder Representative or Collateral Agent, as applicable, in consultation with the Borrower. The Holder Representative and Collateral Agent, as applicable, shall have no liability or responsibility for any action or inaction of any successor Holder Representative or successor Collateral Agent, as applicable. Notwithstanding replacement of the Holder Representative or the Collateral Agent, as applicable, pursuant to this Section 13(e)(ii), the Holder’s obligations under Section 13(e)(i) hereof will continue for the benefit of the retiring Holder Representative or Collateral Agent, as applicable.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 89; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iii) The Holder agrees that any action taken by the Collateral Agent in accordance with the provision of this Note and the Note Collateral Documents, and the exercise by the Collateral Agent of any rights or remedies set forth herein and therein shall be authorized and binding upon the Holder. Notwithstanding any provision to the contrary contained elsewhere in this Note and the Note Collateral Documents, the duties of the Collateral Agent shall be ministerial and administrative in nature, and the Collateral Agent shall not have any duties or responsibilities, except those expressly set forth herein and in the other documents to which the Collateral Agent is a party, nor shall the Collateral Agent have or be deemed to have any trust or other fiduciary relationship with the Holder Representative, any Holder or any Note Party, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Note and the Note Collateral Documents or otherwise exist against the Collateral Agent, and the Collateral Agent shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Note Collateral Documents that the Collateral Agent is required to exercise as directed in writing by the Majority Holders. Without limiting the generality of the foregoing sentence, the use of the term “agent” in this Note with reference to the Collateral Agent is not intended to <FONT STYLE="letter-spacing: -0.1pt">connote any fiduciary or other implied (or express) obligations arising under agency </FONT>doctrine of any applicable law regardless of whether an Event of Default has occurred and is continuing. Instead, such term is used merely as a matter of market custom and is intended to create or reflect only an administrative relationship between independent contracting parties.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(iv) The parties hereto and the Holder hereby agree and acknowledge that the Collateral Agent shall not assume, be responsible for or otherwise be obligated for any liabilities, claims, causes of action, suits, losses, allegations, requests, demands, penalties, fines, settlements, damages (including foreseeable and unforeseeable), judgments, expenses and costs (including but not limited to, any remediation, corrective action, response, removal or remedial action, or investigation, operations and maintenance or monitoring costs, for personal injury or property damages, real or personal) of any kind whatsoever, pursuant to any environmental law as a result of this Note, the Note Collateral Documents or any actions taken pursuant hereto or thereto. Further, the parties hereto and the Holder hereby agree and acknowledge that in the exercise of its rights under this Note and the Note Collateral Documents, the Collateral Agent may hold or obtain indicia of ownership primarily to protect the security interest of the Collateral Agent in the Collateral and that any such actions taken by the Collateral Agent shall not be construed as or otherwise constitute any participation in the management of such <FONT STYLE="letter-spacing: -0.1pt">Collateral.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">(v) No provision of this Note or any Note Collateral Document shall require the Collateral Agent to expend or risk its own funds or otherwise incur <FONT STYLE="letter-spacing: -0.25pt">any </FONT>financial liability in the performance of any of its duties hereunder or thereunder or to take or omit to take any action hereunder or thereunder or take any action at the request or direction of the holders of Notes unless it shall have received indemnity satisfactory to the Collateral Agent against potential costs and liabilities incurred by the Collateral Agent relating thereto. Notwithstanding anything to the contrary contained in this Note or the Note Collateral Documents, in the event the Collateral Agent is entitled or required to commence an action to foreclose or otherwise exercise its remedies to acquire control or possession of the Collateral, the Collateral Agent shall not be required to commence any such action or exercise any remedy or to inspect or conduct any studies of any property under the Mortgages or take any such other action if the Collateral Agent has determined that the Collateral Agent may incur personal liability as a result of the presence at, or release on or from, the Collateral or such property, of any hazardous materials. The Collateral Agent shall at any time be entitled to cease taking any action described in this clause if it no longer reasonably deems any indemnity, security or undertaking from the Note Parties or the Holder to be sufficient.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 90; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(f) In the event that any one or more provisions of this Note shall be held to be illegal, invalid or otherwise unenforceable, the same shall not affect any other provision of this Note and the remaining provisions of this Note shall remain in full force and effect.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(g) Neither this Note nor any beneficial interest in this Note may be assigned or transferred by the Borrower; <I>provided</I>, this Note shall be transferrable by the Holder upon prior written notice to the Collateral Agent and the Borrower and subject to applicable securities laws and completion and execution of the Assignment and Assumption Agreement in the form attached to the Purchase Agreement.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(h) All questions concerning the construction, validity, enforcement and interpretation of the Note Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings (as defined in the Purchase Agreement) concerning the interpretations, enforcement and defense of the transactions contemplated by the Notes and any other Note Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Note Documents), and hereby irrevocably waives, and agrees not to assert in any Action (as defined in the Purchase Agreement) or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to <FONT STYLE="letter-spacing: -0.1pt">serve </FONT>process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Note Documents, then, in addition to the obligations of the Borrower under Section 4.7 of the Purchase Agreement, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 91; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(i) <B>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE <FONT STYLE="letter-spacing: -0.1pt">PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, </FONT>IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B> </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(j) The headings herein are for convenience only, do not constitute a part of this Note and shall not be deemed to limit or affect any of the provisions hereof. Unless the context otherwise requires, any reference in this Note to a “Section” or “clause” refers to a Section or clause, as the case may be, of this Note, and the words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Note as a whole and not to any particular Section or other subdivision. Unless the context otherwise requires, any reference to a statute, rule or regulation refers to the same (including any successor statute, rule or regulation thereto) as it may be amended from time to time, and the word “including” shall be deemed to be followed by the words “without limitation.”</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(k) THE BORROWER MAY, TO THE EXTENT PERMITTED BY LAW, AND DIRECTLY OR INDIRECTLY (REGARDLESS OF WHETHER SUCH NOTES ARE SURRENDERED TO THE BORROWER), REPURCHASE NOTES OR PORTIONS OF INDEBTEDNESS OUTSTANDING UNDER THE NOTES IN THE OPEN MARKET OR <FONT STYLE="letter-spacing: -0.1pt">OTHERWISE, WHETHER BY THE BORROWER OR ITS SUBSIDIARIES. THE BORROWER </FONT>SHALL CAUSE ANY SUCH NOTES OR PORTIONS OF INDEBTEDNESS OUTSTANDING <FONT STYLE="letter-spacing: -0.1pt">UNDER THE NOTES SO REPURCHASED TO BE CANCELLED AND SUCH NOTES SHALL </FONT>NO LONGER BE CONSIDERED OUTSTANDING UPON THEIR REPURCHASE.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">(l) In no event shall the Holder Representative or the Collateral Agent be responsible or liable for any failure or delay in the performance of their respective obligations hereunder arising out of or caused by, directly or indirectly, forces beyond their respective control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, epidemics and pandemics, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services; it being understood that the Holder Representative or Collateral Agent shall use reasonable efforts which are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) The parties hereto acknowledge that in accordance with Section 326 of <FONT STYLE="letter-spacing: -0.25pt">the </FONT></FONT>U.S.A. PATRIOT Act, the Holder Representative and the Collateral Agent, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Holder Representative and the Collateral Agent. <FONT STYLE="letter-spacing: -0.25pt">The </FONT>parties to this Note agree that they will provide the Holder Representative and the Collateral Agent with such information as it may request in order for the Holder Representative and the Collateral Agent to satisfy the requirements of the U.S.A. PATRIOT Act.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">[<I>Signature Page <FONT STYLE="letter-spacing: -0.1pt">Follows</FONT></I><FONT STYLE="letter-spacing: -0.1pt">]</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 5pt"><FONT STYLE="letter-spacing: -0.1pt"> </FONT></P> <!-- Field: Page; Sequence: 92; Value: 1 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="letter-spacing: -0.1pt"> </FONT></P> <P STYLE="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, Borrower and each Guarantor has caused this Note to be duly executed the day and year first above written.</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD> </TD> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REED’S, INC., as Borrower </FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware corporation</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="width: 50%"> </TD> <TD STYLE="width: 5%"> </TD> <TD STYLE="width: 45%"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="padding-bottom: 1.5pt"> </TD> <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD> <TD STYLE="border-bottom: Black 1.5pt solid"> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman E. Snyder, Jr</FONT></TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</FONT></TD></TR> </TABLE> <P STYLE="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0 283.75pt 0 96pt"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0.5pt; margin-bottom: 0">[Signature Page to Promissory <FONT STYLE="letter-spacing: -0.1pt">Note]</FONT></P> <P STYLE="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0 283.75pt 0 96pt"> </P> <!-- Field: Page; Sequence: 93 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"> </TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="color: #010101; font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">AGREED AND ACCEPTED: </FONT></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="width: 5%"> </TD> <TD STYLE="width: 45%"> </TD> <TD STYLE="width: 50%"> </TD></TR> <TR STYLE="vertical-align: top"> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOLDER REPRESENTATIVE</FONT></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilmington Savings Fund Society, <FONT STYLE="letter-spacing: -0.2pt">FSB,</FONT></FONT></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">solely in its capacity as the Holder <FONT STYLE="letter-spacing: -0.1pt">Representative</FONT></FONT></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD> <TD STYLE="border-bottom: Black 1.5pt solid"> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD> <TD>Raye Goldsborough</TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Title</FONT></TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice <FONT STYLE="letter-spacing: -0.1pt">President</FONT></FONT></TD> <TD> </TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="vertical-align: top"> <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">COLLATERAL <FONT STYLE="letter-spacing: -0.1pt">AGENT</FONT></FONT></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD COLSPAN="2"> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD COLSPAN="2"> <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">Wilmington Savings Fund Society, FSB,</P> <P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">solely in its capacity as the Collateral Agent</P></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="width: 5%"> </TD> <TD STYLE="width: 45%"> </TD> <TD STYLE="width: 50%"> </TD></TR> <TR STYLE="vertical-align: top"> <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD> <TD STYLE="border-bottom: Black 1.5pt solid"> </TD> <TD STYLE="padding-bottom: 1.5pt"> </TD></TR> <TR STYLE="vertical-align: top"> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">Name:</FONT></TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raye Goldsborough</FONT></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Title</FONT></TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President</FONT></TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD> </TD> <TD> </TD> <TD> </TD></TR> <TR STYLE="vertical-align: top"> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD> <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 10, <FONT STYLE="letter-spacing: -0.2pt">2023</FONT></FONT></TD> <TD> </TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">[Signature Page to Promissory <FONT STYLE="letter-spacing: -0.1pt">Note]</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 94 --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"> </TD></TR></TABLE></DIV> <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt"> </P></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><B>[Exhibit A, Exhibit B, Exhibit C, Annex A, Annex B, Annex C, and Schedule 1 have been omitted]</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <!-- Field: Page; Sequence: 101; Options: Last --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"> </TD></TR></TABLE></DIV> <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-31.1 <SEQUENCE>3 <FILENAME>ex31-1.htm <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT 31.1</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I, Norman E. Snyder, Jr., certify that:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Quarterly Report on Form 10-Q of Reed’s, Inc.;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 1, 2023</FONT></TD> <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Norman E. Snyder, Jr.</I></FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman E. Snyder, Jr.</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif"> <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 15; Options: Last --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"> </TD></TR></TABLE></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> </B></FONT></P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-31.2 <SEQUENCE>4 <FILENAME>ex31-2.htm <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT 31.2</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I, Joann Tinnelly, certify that:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have reviewed this Quarterly Report on Form 10-Q of Reed’s, Inc.;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 1, 2023</FONT></TD> <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Joann Tinnelly</I></FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joann Tinnelly</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chief Financial Officer</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer)</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 16; Options: Last --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"> </TD></TR></TABLE></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B> </B></FONT></P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-32.1 <SEQUENCE>5 <FILENAME>ex32-1.htm <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT 32.1</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Quarterly Report on Form 10-Q of Reed’s, Inc., a Delaware corporation (the “Company”) for the period ending March 31, 2023 as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), Norman E. Snyder, Jr., Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge and belief:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REED’S, INC.</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 1, 2023</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD> <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Norman E. Snyder, Jr.</I></FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Norman E. Snyder, Jr.</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 17; Options: Last --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"> </TD></TR></TABLE></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-32.2 <SEQUENCE>6 <FILENAME>ex32-2.htm <TEXT> <HTML> <HEAD> <TITLE></TITLE> </HEAD> <BODY STYLE="font: 10pt Times New Roman, Times, Serif"> <P STYLE="margin: 0"> </P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT 32.2</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Quarterly Report on Form 10-Q of Reed’s, Inc., a Delaware corporation (the “Company”) for the period ending March 31, 2023 as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), Thomas J. Spisak, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of her knowledge and belief:</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REED’S, INC.</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: June 1, 2023</FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD> <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Joann Tinnelly</I></FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joann Tinnelly</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chief Financial Officer</FONT></TD></TR> <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD> <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial Officer)</FONT></TD></TR> </TABLE> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <!-- Field: Page; Sequence: 18; Options: Last --> <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"> </TD></TR></TABLE></DIV> <!-- Field: /Page --> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></P> </BODY> </HTML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>7 <FILENAME>reed-20230331.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" ?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaiB2bP9z5Z86ekhvWB0bXn6PyYoqtsXvSPBX4qm0dAN --> <schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:REED="http://drinkreeds.com/20230331" elementFormDefault="qualified" targetNamespace="http://drinkreeds.com/20230331"> <annotation> <appinfo> <link:roleType roleURI="http://drinkreeds.com/role/Cover" id="Cover"> <link:definition>00000001 - Document - Cover</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/BalanceSheets" id="BalanceSheets"> <link:definition>00000002 - Statement - Condensed Balance Sheets</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical"> <link:definition>00000003 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StatementsOfOperations" id="StatementsOfOperations"> <link:definition>00000004 - Statement - Condensed Statements of Operations (Unaudited)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" id="StatementsOfChangesInStockholdersEquityDeficitUnauditied"> <link:definition>00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows"> <link:definition>00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies"> <link:definition>00000007 - Disclosure - Summary of Significant Accounting Policies</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/Inventory" id="Inventory"> <link:definition>00000008 - Disclosure - Inventory</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/PropertyAndEquipment" id="PropertyAndEquipment"> <link:definition>00000009 - Disclosure - Property and Equipment</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/IntangibleAssets" id="IntangibleAssets"> <link:definition>00000010 - Disclosure - Intangible Assets</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/LineOfCredit" id="LineOfCredit"> <link:definition>00000011 - Disclosure - Line of Credit</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayable" id="SecuredConvertibleNotesPayable"> <link:definition>00000012 - Disclosure - Secured Convertible Notes Payable</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/LeasesLiabilities" id="LeasesLiabilities"> <link:definition>00000013 - Disclosure - Leases Liabilities</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StockholdersEquity" id="StockholdersEquity"> <link:definition>00000014 - Disclosure - Stockholder’s Equity</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/Stock-basedCompensation" id="Stock-basedCompensation"> <link:definition>00000015 - Disclosure - Stock-Based Compensation</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StockWarrants" id="StockWarrants"> <link:definition>00000016 - Disclosure - Stock Warrants</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" id="TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty"> <link:definition>00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies"> <link:definition>00000018 - Disclosure - Commitments and Contingencies</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SubsequentEvents" id="SubsequentEvents"> <link:definition>00000019 - Disclosure - Subsequent Events</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies"> <link:definition>00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables"> <link:definition>00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/InventoryTables" id="InventoryTables"> <link:definition>00000022 - Disclosure - Inventory (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables"> <link:definition>00000023 - Disclosure - Property and Equipment (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables"> <link:definition>00000024 - Disclosure - Intangible Assets (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/LineOfCreditTables" id="LineOfCreditTables"> <link:definition>00000025 - Disclosure - Line of Credit (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" id="SecuredConvertibleNotesPayableTables"> <link:definition>00000026 - Disclosure - Secured Convertible Notes Payable (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/Stock-basedCompensationTables" id="Stock-basedCompensationTables"> <link:definition>00000027 - Disclosure - Stock-Based Compensation (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StockWarrantsTables" id="StockWarrantsTables"> <link:definition>00000028 - Disclosure - Stock Warrants (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" id="TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables"> <link:definition>00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" id="ScheduleOfPotentiallyDilutiveSecuritiesDetails"> <link:definition>00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative"> <link:definition>00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfInventoryDetails" id="ScheduleOfInventoryDetails"> <link:definition>00000032 - Disclosure - Schedule of Inventory (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails"> <link:definition>00000033 - Disclosure - Schedule of Property and Equipment (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative"> <link:definition>00000034 - Disclosure - Property and Equipment (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" id="SummaryOfIntangibleAssetsDetails"> <link:definition>00000035 - Disclosure - Summary of Intangible Assets (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" id="ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails"> <link:definition>00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfDebtDetails" id="ScheduleOfDebtDetails"> <link:definition>00000037 - Disclosure - Schedule of Debt (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/LineOfCreditDetailsNarrative" id="LineOfCreditDetailsNarrative"> <link:definition>00000038 - Disclosure - Line of Credit (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" id="SecuredConvertibleNotesPayableDetailsNarrative"> <link:definition>00000039 - Disclosure - Secured Convertible Notes Payable (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" id="LeasesLiabilitiesDetailsNarrative"> <link:definition>00000040 - Disclosure - Leases Liabilities (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative"> <link:definition>00000041 - Disclosure - Stockholder’s Equity (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" id="SummaryOfNon-vestedRestrictedStockActivityDetails"> <link:definition>00000042 - Disclosure - Summary of Non-vested Restricted Stock Activity (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" id="ScheduleOfStockOptionActivityDetails"> <link:definition>00000043 - Disclosure - Schedule of Stock Option Activity (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" id="Stock-basedCompensationDetailsNarrative"> <link:definition>00000044 - Disclosure - Stock-Based Compensation (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" id="ScheduleOfWarrantActivityDetails"> <link:definition>00000045 - Disclosure - Schedule of Warrant Activity (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/StockWarrantsDetailsNarrative" id="StockWarrantsDetailsNarrative"> <link:definition>00000046 - Disclosure - Stock Warrants (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" id="ScheduleOfRelatedPartiesDetails"> <link:definition>00000047 - Disclosure - Schedule of Related Parties (Details)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" id="ScheduleOfRelatedPartiesDetailsParenthetical"> <link:definition>00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" id="TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative"> <link:definition>00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative"> <link:definition>00000050 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:roleType roleURI="http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative"> <link:definition>00000051 - Disclosure - Subsequent Events (Details Narrative)</link:definition> <link:usedOn>link:presentationLink</link:usedOn> <link:usedOn>link:calculationLink</link:usedOn> <link:usedOn>link:definitionLink</link:usedOn> </link:roleType> <link:linkbaseRef xlink:type="simple" xlink:href="reed-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" /> <link:linkbaseRef xlink:type="simple" xlink:href="reed-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" /> <link:linkbaseRef xlink:type="simple" xlink:href="reed-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" /> <link:linkbaseRef xlink:type="simple" xlink:href="reed-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" /> </appinfo> </annotation> <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" /> <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" /> <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" /> <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" /> <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" /> <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" /> <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" /> <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" /> <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" /> <element id="REED_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_ChristopherJReedMember" name="ChristopherJReedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_CaliforniaCustomBeverageLLCMember" name="CaliforniaCustomBeverageLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_VendorOneMember" name="VendorOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_UnvestedRestrictedCommonStockMember" name="UnvestedRestrictedCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" name="CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_RightOfUseAssetsUnderOperatingLeasesMember" name="RightOfUseAssetsUnderOperatingLeasesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_ComputerHardwareAndSoftwareMember" name="ComputerHardwareAndSoftwareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_AlternaCapitalSolutionsMember" name="AlternaCapitalSolutionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_NotePurchaseAgreementMember" name="NotePurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_SeptemberTwoThousandTwentyTwoNotesMember" name="SeptemberTwoThousandTwentyTwoNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_OptionNotesMember" name="OptionNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_FebruaryTwoThousandTwentyThreeNotesMember" name="FebruaryTwoThousandTwentyThreeNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_LimitedWaiverAndDeferralAgreementMember" name="LimitedWaiverAndDeferralAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_HoldersMember" name="HoldersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_TwoThousandTwentyEquityIncentivePlanMember" name="TwoThousandTwentyEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_BoardOfDirectorsMember" name="BoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_StockWarrantsMember" name="StockWarrantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_ChrisReedMember" name="ChrisReedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_DDSourceofLifeHoldingLtdMember" name="DDSourceofLifeHoldingLtdMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" /> <element id="REED_DeliveryAndHandlingExpense" name="DeliveryAndHandlingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" name="AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_FairValueOfVestedOptions" name="FairValueOfVestedOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" name="FairValueOfVestedRestrictedSharesGrantedToOfficers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_FairValueOfCommonSharesIssuedAsFinancingCosts" name="FairValueOfCommonSharesIssuedAsFinancingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_AccrualOfInterestOnConvertibleNote" name="AccrualOfInterestOnConvertibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets" name="IncreaseDecreaseInAmortizationOfRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_DisclosureLeasesLiabilitiesAbstract" name="DisclosureLeasesLiabilitiesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" /> <element id="REED_DisclosureStockWarrantsAbstract" name="DisclosureStockWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" /> <element id="REED_StockWarrantsTextBlock" name="StockWarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" /> <element id="REED_GoingConcernPoliciesTextBlock" name="GoingConcernPoliciesTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" /> <element id="REED_CovidNineteenConsiderationPolicyTextBlock" name="CovidNineteenConsiderationPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" /> <element id="REED_ReverseStockSplitPolicyTextBlock" name="ReverseStockSplitPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" /> <element id="REED_CarryingCostPropertyAndExplorationRights" name="CarryingCostPropertyAndExplorationRights" nillable="true" xbrli:periodType="duration" type="xbrli:decimalItemType" substitutionGroup="xbrli:item" /> <element id="REED_PercentageOfCoPackersProducts" name="PercentageOfCoPackersProducts" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" /> <element id="REED_LineOfCreditMonitoringFee" name="LineOfCreditMonitoringFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_AmortizationOfLineOfCreditPeriod" name="AmortizationOfLineOfCreditPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" /> <element id="REED_DebtInstrumentRemainingUnamortizedDiscount" name="DebtInstrumentRemainingUnamortizedDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_PercentageOfRepurchasePrice" name="PercentageOfRepurchasePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" /> <element id="REED_PercentageForDeferredPayment" name="PercentageForDeferredPayment" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" /> <element id="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" /> <element id="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" /> <element id="REED_FairValueOfVestedStockOption" name="FairValueOfVestedStockOption" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" name="ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" name="ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" name="ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted" name="ClassOfWarrantOrRightNumberOfSecuritiesGranted" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" name="ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" name="ClassOfWarrantOrRightNumberOfSecuritiesExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" name="ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" name="ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" name="ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" name="ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" name="ClassOfWarrantOrRightNumberOfSecuritieExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" name="ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" name="ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" /> <element id="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" name="ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_ProvisionForReceivableWithFormerRelatedParty" name="ProvisionForReceivableWithFormerRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_RoyaltyPercentage" name="RoyaltyPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" /> <element id="REED_RoyaltyReceivable" name="RoyaltyReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> <element id="REED_CopackingFees" name="CopackingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" /> </schema> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.CAL <SEQUENCE>8 <FILENAME>reed-20230331_cal.xml <DESCRIPTION>XBRL CALCULATION FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://drinkreeds.com/role/Cover" xlink:href="reed-20230331.xsd#Cover" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/BalanceSheets" xlink:href="reed-20230331.xsd#BalanceSheets" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/BalanceSheetsParenthetical" xlink:href="reed-20230331.xsd#BalanceSheetsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfOperations" xlink:href="reed-20230331.xsd#StatementsOfOperations" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:href="reed-20230331.xsd#StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfCashFlows" xlink:href="reed-20230331.xsd#StatementsOfCashFlows" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Inventory" xlink:href="reed-20230331.xsd#Inventory" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipment" xlink:href="reed-20230331.xsd#PropertyAndEquipment" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/IntangibleAssets" xlink:href="reed-20230331.xsd#IntangibleAssets" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCredit" xlink:href="reed-20230331.xsd#LineOfCredit" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayable" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayable" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LeasesLiabilities" xlink:href="reed-20230331.xsd#LeasesLiabilities" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockholdersEquity" xlink:href="reed-20230331.xsd#StockholdersEquity" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensation" xlink:href="reed-20230331.xsd#Stock-basedCompensation" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrants" xlink:href="reed-20230331.xsd#StockWarrants" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/CommitmentsAndContingencies" xlink:href="reed-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SubsequentEvents" xlink:href="reed-20230331.xsd#SubsequentEvents" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/InventoryTables" xlink:href="reed-20230331.xsd#InventoryTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipmentTables" xlink:href="reed-20230331.xsd#PropertyAndEquipmentTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/IntangibleAssetsTables" xlink:href="reed-20230331.xsd#IntangibleAssetsTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCreditTables" xlink:href="reed-20230331.xsd#LineOfCreditTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayableTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensationTables" xlink:href="reed-20230331.xsd#Stock-basedCompensationTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrantsTables" xlink:href="reed-20230331.xsd#StockWarrantsTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfInventoryDetails" xlink:href="reed-20230331.xsd#ScheduleOfInventoryDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="reed-20230331.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="reed-20230331.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" xlink:href="reed-20230331.xsd#SummaryOfIntangibleAssetsDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfDebtDetails" xlink:href="reed-20230331.xsd#ScheduleOfDebtDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCreditDetailsNarrative" xlink:href="reed-20230331.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayableDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" xlink:href="reed-20230331.xsd#LeasesLiabilitiesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" xlink:href="reed-20230331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:href="reed-20230331.xsd#SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="reed-20230331.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="reed-20230331.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" xlink:href="reed-20230331.xsd#ScheduleOfWarrantActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrantsDetailsNarrative" xlink:href="reed-20230331.xsd#StockWarrantsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" xlink:href="reed-20230331.xsd#ScheduleOfRelatedPartiesDetailsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="reed-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" xlink:href="reed-20230331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Cover" xlink:title="00000001 - Document - Cover" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" /> <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" /> <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" /> <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" /> <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" /> <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" /> <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations (Unaudited)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DeliveryAndHandlingExpense" xlink:label="loc_REEDDeliveryAndHandlingExpense" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_REEDDeliveryAndHandlingExpense" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:title="00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" /> <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedOptions" xlink:label="loc_REEDFairValueOfVestedOptions" /> <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_REEDFairValueOfVestedOptions" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:label="loc_REEDFairValueOfVestedRestrictedSharesGrantedToOfficers" /> <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_REEDFairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfCommonSharesIssuedAsFinancingCosts" xlink:label="loc_REEDFairValueOfCommonSharesIssuedAsFinancingCosts" /> <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_REEDFairValueOfCommonSharesIssuedAsFinancingCosts" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" /> <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" /> <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AccrualOfInterestOnConvertibleNote" xlink:label="loc_REEDAccrualOfInterestOnConvertibleNote" /> <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_REEDAccrualOfInterestOnConvertibleNote" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" /> <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" /> <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" /> <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets" xlink:label="loc_REEDIncreaseDecreaseInAmortizationOfRightOfUseAssets" /> <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_REEDIncreaseDecreaseInAmortizationOfRightOfUseAssets" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" /> <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" /> <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" /> <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" /> <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" /> <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" weight="-1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" /> <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Summary of Significant Accounting Policies" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Inventory" xlink:title="00000008 - Disclosure - Inventory" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipment" xlink:title="00000009 - Disclosure - Property and Equipment" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/IntangibleAssets" xlink:title="00000010 - Disclosure - Intangible Assets" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCredit" xlink:title="00000011 - Disclosure - Line of Credit" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayable" xlink:title="00000012 - Disclosure - Secured Convertible Notes Payable" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LeasesLiabilities" xlink:title="00000013 - Disclosure - Leases Liabilities" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockholdersEquity" xlink:title="00000014 - Disclosure - Stockholder’s Equity" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensation" xlink:title="00000015 - Disclosure - Stock-Based Compensation" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrants" xlink:title="00000016 - Disclosure - Stock Warrants" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:title="00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - Commitments and Contingencies" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - Subsequent Events" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/InventoryTables" xlink:title="00000022 - Disclosure - Inventory (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/IntangibleAssetsTables" xlink:title="00000024 - Disclosure - Intangible Assets (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCreditTables" xlink:title="00000025 - Disclosure - Line of Credit (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" xlink:title="00000026 - Disclosure - Secured Convertible Notes Payable (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensationTables" xlink:title="00000027 - Disclosure - Stock-Based Compensation (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrantsTables" xlink:title="00000028 - Disclosure - Stock Warrants (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:title="00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:title="00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfInventoryDetails" xlink:title="00000032 - Disclosure - Schedule of Inventory (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000033 - Disclosure - Schedule of Property and Equipment (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000034 - Disclosure - Property and Equipment (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" xlink:title="00000035 - Disclosure - Summary of Intangible Assets (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaapIndefiniteLivedTradeNames" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="loc_us-gaapIndefiniteLivedTradeNames" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="loc_us-gaapIndefiniteLivedTrademarks" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="loc_us-gaapIndefiniteLivedTrademarks" xlink:type="arc" weight="1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:title="00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfDebtDetails" xlink:title="00000037 - Disclosure - Schedule of Debt (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt" /> <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapConvertibleNotesPayable" xlink:to="loc_us-gaapSecuredDebt" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" /> <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapConvertibleNotesPayable" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" weight="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" /> <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapConvertibleNotesPayable" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" weight="-1" /> </link:calculationLink> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCreditDetailsNarrative" xlink:title="00000038 - Disclosure - Line of Credit (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" xlink:title="00000039 - Disclosure - Secured Convertible Notes Payable (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" xlink:title="00000040 - Disclosure - Leases Liabilities (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000041 - Disclosure - Stockholder’s Equity (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:title="00000042 - Disclosure - Summary of Non-vested Restricted Stock Activity (Details)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000043 - Disclosure - Schedule of Stock Option Activity (Details)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="00000044 - Disclosure - Stock-Based Compensation (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" xlink:title="00000045 - Disclosure - Schedule of Warrant Activity (Details)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrantsDetailsNarrative" xlink:title="00000046 - Disclosure - Stock Warrants (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000047 - Disclosure - Schedule of Related Parties (Details)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" xlink:title="00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:title="00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000050 - Disclosure - Commitments and Contingencies (Details Narrative)" /> <link:calculationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000051 - Disclosure - Subsequent Events (Details Narrative)" /> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.DEF <SEQUENCE>9 <FILENAME>reed-20230331_def.xml <DESCRIPTION>XBRL DEFINITION FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://drinkreeds.com/role/Cover" xlink:href="reed-20230331.xsd#Cover" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/BalanceSheets" xlink:href="reed-20230331.xsd#BalanceSheets" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/BalanceSheetsParenthetical" xlink:href="reed-20230331.xsd#BalanceSheetsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfOperations" xlink:href="reed-20230331.xsd#StatementsOfOperations" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:href="reed-20230331.xsd#StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfCashFlows" xlink:href="reed-20230331.xsd#StatementsOfCashFlows" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Inventory" xlink:href="reed-20230331.xsd#Inventory" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipment" xlink:href="reed-20230331.xsd#PropertyAndEquipment" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/IntangibleAssets" xlink:href="reed-20230331.xsd#IntangibleAssets" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCredit" xlink:href="reed-20230331.xsd#LineOfCredit" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayable" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayable" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LeasesLiabilities" xlink:href="reed-20230331.xsd#LeasesLiabilities" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockholdersEquity" xlink:href="reed-20230331.xsd#StockholdersEquity" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensation" xlink:href="reed-20230331.xsd#Stock-basedCompensation" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrants" xlink:href="reed-20230331.xsd#StockWarrants" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/CommitmentsAndContingencies" xlink:href="reed-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SubsequentEvents" xlink:href="reed-20230331.xsd#SubsequentEvents" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/InventoryTables" xlink:href="reed-20230331.xsd#InventoryTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipmentTables" xlink:href="reed-20230331.xsd#PropertyAndEquipmentTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/IntangibleAssetsTables" xlink:href="reed-20230331.xsd#IntangibleAssetsTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCreditTables" xlink:href="reed-20230331.xsd#LineOfCreditTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayableTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensationTables" xlink:href="reed-20230331.xsd#Stock-basedCompensationTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrantsTables" xlink:href="reed-20230331.xsd#StockWarrantsTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfInventoryDetails" xlink:href="reed-20230331.xsd#ScheduleOfInventoryDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="reed-20230331.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="reed-20230331.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" xlink:href="reed-20230331.xsd#SummaryOfIntangibleAssetsDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfDebtDetails" xlink:href="reed-20230331.xsd#ScheduleOfDebtDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCreditDetailsNarrative" xlink:href="reed-20230331.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayableDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" xlink:href="reed-20230331.xsd#LeasesLiabilitiesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" xlink:href="reed-20230331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:href="reed-20230331.xsd#SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="reed-20230331.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="reed-20230331.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" xlink:href="reed-20230331.xsd#ScheduleOfWarrantActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrantsDetailsNarrative" xlink:href="reed-20230331.xsd#StockWarrantsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" xlink:href="reed-20230331.xsd#ScheduleOfRelatedPartiesDetailsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="reed-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" xlink:href="reed-20230331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" /> <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Cover" xlink:title="00000001 - Document - Cover" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:to="loc_us-gaapRelatedPartyMember_20" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAssetsAbstract_50" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapAssetsCurrentAbstract_50" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapCash_50" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_50" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapInventoryNet_50" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapOtherReceivablesNetCurrent_50" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_50" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_50" xlink:to="loc_us-gaapAssetsCurrent_50" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_50" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_50" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_50" xlink:to="loc_us-gaapAssets_50" xlink:type="arc" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:type="arc" order="12" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapAccountsPayableCurrent_50" xlink:type="arc" order="13" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_50" xlink:type="arc" order="14" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapLinesOfCreditCurrent_50" xlink:type="arc" order="15" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_50" xlink:type="arc" order="16" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent_50" xlink:type="arc" order="17" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_50" xlink:type="arc" order="18" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_50" xlink:to="loc_us-gaapLiabilitiesCurrent_50" xlink:type="arc" order="19" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable_50" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_50" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilities_50" xlink:type="arc" order="22" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapStockholdersEquityAbstract_50" xlink:type="arc" order="23" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapPreferredStockValue_50" xlink:type="arc" order="24" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapCommonStockValue_50" xlink:type="arc" order="25" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapAdditionalPaidInCapital_50" xlink:type="arc" order="26" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_50" xlink:type="arc" order="27" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_50" xlink:to="loc_us-gaapStockholdersEquity_50" xlink:type="arc" order="28" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract_50" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_50" xlink:type="arc" order="29" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations (Unaudited)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:title="00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_10" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" xlink:label="loc_REEDAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_REEDAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_60" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_60" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_60" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_60" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_60" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_60" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="12" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Summary of Significant Accounting Policies" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Inventory" xlink:title="00000008 - Disclosure - Inventory" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipment" xlink:title="00000009 - Disclosure - Property and Equipment" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/IntangibleAssets" xlink:title="00000010 - Disclosure - Intangible Assets" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCredit" xlink:title="00000011 - Disclosure - Line of Credit" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayable" xlink:title="00000012 - Disclosure - Secured Convertible Notes Payable" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LeasesLiabilities" xlink:title="00000013 - Disclosure - Leases Liabilities" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockholdersEquity" xlink:title="00000014 - Disclosure - Stockholder’s Equity" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensation" xlink:title="00000015 - Disclosure - Stock-Based Compensation" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrants" xlink:title="00000016 - Disclosure - Stock Warrants" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:title="00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - Commitments and Contingencies" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - Subsequent Events" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/InventoryTables" xlink:title="00000022 - Disclosure - Inventory (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/IntangibleAssetsTables" xlink:title="00000024 - Disclosure - Intangible Assets (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCreditTables" xlink:title="00000025 - Disclosure - Line of Credit (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" xlink:title="00000026 - Disclosure - Secured Convertible Notes Payable (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensationTables" xlink:title="00000027 - Disclosure - Stock-Based Compensation (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrantsTables" xlink:title="00000028 - Disclosure - Stock Warrants (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:title="00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:title="00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember_20" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_40" xlink:type="arc" order="41" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_UnvestedRestrictedCommonStockMember" xlink:label="loc_REEDUnvestedRestrictedCommonStockMember_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_REEDUnvestedRestrictedCommonStockMember_60" xlink:type="arc" order="61" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" xlink:label="loc_REEDCommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_REEDCommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_80" xlink:type="arc" order="81" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_130" xlink:type="arc" order="0" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapScheduleOfProductInformationTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_30" xlink:type="arc" order="31" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CustomerOneMember" xlink:label="loc_REEDCustomerOneMember_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_REEDCustomerOneMember_60" xlink:type="arc" order="61" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CustomerTwoMember" xlink:label="loc_REEDCustomerTwoMember_70" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_REEDCustomerTwoMember_70" xlink:type="arc" order="71" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_VendorOneMember" xlink:label="loc_REEDVendorOneMember_150" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_REEDVendorOneMember_150" xlink:type="arc" order="151" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_60" xlink:type="arc" order="62" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_100" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_100" xlink:type="arc" order="102" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember_60" xlink:type="arc" order="63" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_100" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_100" xlink:type="arc" order="103" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChristopherJReedMember" xlink:label="loc_REEDChristopherJReedMember_140" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDChristopherJReedMember_140" xlink:type="arc" order="141" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember_140" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember_140" xlink:type="arc" order="142" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetIncomeLoss_180" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquity_180" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash_180" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_180" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_180" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CarryingCostPropertyAndExplorationRights" xlink:label="loc_REEDCarryingCostPropertyAndExplorationRights_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_REEDCarryingCostPropertyAndExplorationRights_180" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_180" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_180" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense_180" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_180" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageOfCoPackersProducts" xlink:label="loc_REEDPercentageOfCoPackersProducts_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_REEDPercentageOfCoPackersProducts_180" xlink:type="arc" order="10" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfInventoryDetails" xlink:title="00000032 - Disclosure - Schedule of Inventory (Details)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000033 - Disclosure - Schedule of Property and Equipment (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RightOfUseAssetsUnderOperatingLeasesMember" xlink:label="loc_REEDRightOfUseAssetsUnderOperatingLeasesMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_REEDRightOfUseAssetsUnderOperatingLeasesMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ComputerHardwareAndSoftwareMember" xlink:label="loc_REEDComputerHardwareAndSoftwareMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_REEDComputerHardwareAndSoftwareMember_20" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember_40" xlink:type="arc" order="41" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="2" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000034 - Disclosure - Property and Equipment (Details Narrative)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" xlink:title="00000035 - Disclosure - Summary of Intangible Assets (Details)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:title="00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AlternaCapitalSolutionsMember" xlink:label="loc_REEDAlternaCapitalSolutionsMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_REEDAlternaCapitalSolutionsMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent_50" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_us-gaapDeferredFinanceCostsCurrentNet_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsCurrentNet_50" xlink:type="arc" order="1" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfDebtDetails" xlink:title="00000037 - Disclosure - Schedule of Debt (Details)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCreditDetailsNarrative" xlink:title="00000038 - Disclosure - Line of Credit (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AlternaCapitalSolutionsMember" xlink:label="loc_REEDAlternaCapitalSolutionsMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_REEDAlternaCapitalSolutionsMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_60" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity_60" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_60" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity_60" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription_60" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCredit_60" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_LineOfCreditMonitoringFee" xlink:label="loc_REEDLineOfCreditMonitoringFee_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_REEDLineOfCreditMonitoringFee_60" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DirectOperatingCosts" xlink:label="loc_us-gaapDirectOperatingCosts_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDirectOperatingCosts_60" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AmortizationOfLineOfCreditPeriod" xlink:label="loc_REEDAmortizationOfLineOfCreditPeriod_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_REEDAmortizationOfLineOfCreditPeriod_60" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_60" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DebtInstrumentRemainingUnamortizedDiscount" xlink:label="loc_REEDDebtInstrumentRemainingUnamortizedDiscount_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_REEDDebtInstrumentRemainingUnamortizedDiscount_60" xlink:type="arc" order="10" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" xlink:title="00000039 - Disclosure - Secured Convertible Notes Payable (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_NotePurchaseAgreementMember" xlink:label="loc_REEDNotePurchaseAgreementMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_REEDNotePurchaseAgreementMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_LimitedWaiverAndDeferralAgreementMember" xlink:label="loc_REEDLimitedWaiverAndDeferralAgreementMember_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_REEDLimitedWaiverAndDeferralAgreementMember_130" xlink:type="arc" order="131" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SeptemberTwoThousandTwentyTwoNotesMember" xlink:label="loc_REEDSeptemberTwoThousandTwentyTwoNotesMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDSeptemberTwoThousandTwentyTwoNotesMember_20" xlink:type="arc" order="22" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_OptionNotesMember" xlink:label="loc_REEDOptionNotesMember_90" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDOptionNotesMember_90" xlink:type="arc" order="91" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FebruaryTwoThousandTwentyThreeNotesMember" xlink:label="loc_REEDFebruaryTwoThousandTwentyThreeNotesMember_110" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDFebruaryTwoThousandTwentyThreeNotesMember_110" xlink:type="arc" order="111" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember_180" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember_180" xlink:type="arc" order="181" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_HoldersMember" xlink:label="loc_REEDHoldersMember_230" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDHoldersMember_230" xlink:type="arc" order="231" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSecuredDebt_250" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms_250" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_250" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt_250" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_250" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_250" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_250" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt_250" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCash_250" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_250" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCommonStockValue_250" xlink:type="arc" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_250" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_250" xlink:type="arc" order="12" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageOfRepurchasePrice" xlink:label="loc_REEDPercentageOfRepurchasePrice_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_REEDPercentageOfRepurchasePrice_250" xlink:type="arc" order="13" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_250" xlink:type="arc" order="14" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageForDeferredPayment" xlink:label="loc_REEDPercentageForDeferredPayment_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_REEDPercentageForDeferredPayment_250" xlink:type="arc" order="15" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaapInterestExpenseDebtExcludingAmortization_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebtExcludingAmortization_250" xlink:type="arc" order="16" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_250" xlink:type="arc" order="17" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_250" xlink:type="arc" order="18" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpense_250" xlink:type="arc" order="19" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_250" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_250" xlink:type="arc" order="21" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentType" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentType_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentType_250" xlink:type="arc" order="22" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_250" xlink:type="arc" order="23" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_250" xlink:type="arc" order="24" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet_250" xlink:type="arc" order="25" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_250" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_250" xlink:type="arc" order="26" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" xlink:title="00000040 - Disclosure - Leases Liabilities (Details Narrative)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000041 - Disclosure - Stockholder’s Equity (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficerMember" xlink:label="loc_srtOfficerMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtOfficerMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_20" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_20" xlink:type="arc" order="1" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:title="00000042 - Disclosure - Summary of Non-vested Restricted Stock Activity (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_40" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_40" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_40" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_40" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_40" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_40" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_40" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_40" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_40" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_40" xlink:type="arc" order="10" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_40" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_40" xlink:type="arc" order="12" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" xlink:type="arc" order="13" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_40" xlink:type="arc" order="14" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_40" xlink:type="arc" order="15" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000043 - Disclosure - Schedule of Stock Option Activity (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapOffsettingAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_40" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_40" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_40" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_40" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_40" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_40" xlink:type="arc" order="10" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_40" xlink:type="arc" order="14" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_40" xlink:type="arc" order="16" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_40" xlink:type="arc" order="17" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_40" xlink:type="arc" order="18" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_40" xlink:type="arc" order="19" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="00000044 - Disclosure - Stock-Based Compensation (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_90" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_90" xlink:type="arc" order="91" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_REEDTwoThousandTwentyEquityIncentivePlanMember_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_REEDTwoThousandTwentyEquityIncentivePlanMember_30" xlink:type="arc" order="31" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_EmployeesMember" xlink:label="loc_REEDEmployeesMember_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDEmployeesMember_40" xlink:type="arc" order="42" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_BoardOfDirectorsMember" xlink:label="loc_REEDBoardOfDirectorsMember_60" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDBoardOfDirectorsMember_60" xlink:type="arc" order="61" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_130" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_130" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan_130" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_130" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_130" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_130" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_130" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_130" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice_130" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_130" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_130" xlink:type="arc" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_130" xlink:type="arc" order="11" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedStockOption" xlink:label="loc_REEDFairValueOfVestedStockOption_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDFairValueOfVestedStockOption_130" xlink:type="arc" order="12" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" xlink:title="00000045 - Disclosure - Schedule of Warrant Activity (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_40" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_40" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_40" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGranted_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGranted_40" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_40" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercised_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercised_40" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_40" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_40" xlink:type="arc" order="8" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_40" xlink:type="arc" order="9" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_40" xlink:type="arc" order="12" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisable_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisable_40" xlink:type="arc" order="14" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_40" xlink:type="arc" order="15" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_40" xlink:type="arc" order="16" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_40" xlink:type="arc" order="17" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrantsDetailsNarrative" xlink:title="00000046 - Disclosure - Stock Warrants (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_StockWarrantsMember" xlink:label="loc_REEDStockWarrantsMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_REEDStockWarrantsMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_20" xlink:type="arc" order="0" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000047 - Disclosure - Schedule of Related Parties (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivablesNetCurrent_30" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_30" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables_30" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivables_30" xlink:type="arc" order="2" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" xlink:title="00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical)" /> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:title="00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChristopherJReedMember" xlink:label="loc_REEDChristopherJReedMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDChristopherJReedMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember_0" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:to="loc_us-gaapRelatedPartyMember_10" xlink:type="arc" order="13" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember_80" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember_80" xlink:type="arc" order="81" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RoyaltyPercentage" xlink:label="loc_REEDRoyaltyPercentage_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_REEDRoyaltyPercentage_130" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayable_130" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapReceivablesNetCurrent_130" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RoyaltyReceivable" xlink:label="loc_REEDRoyaltyReceivable_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_REEDRoyaltyReceivable_130" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CopackingFees" xlink:label="loc_REEDCopackingFees_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_REEDCopackingFees_130" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivables_130" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="7" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000050 - Disclosure - Commitments and Contingencies (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChrisReedMember" xlink:label="loc_REEDChrisReedMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDChrisReedMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember_0" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapSecurityDeposit_40" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_40" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_40" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_40" xlink:type="arc" order="2" /> </link:definitionLink> <link:definitionLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000051 - Disclosure - Subsequent Events (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SecuritiesPurchaseAgreementMember" xlink:label="loc_REEDSecuritiesPurchaseAgreementMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_REEDSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DDSourceofLifeHoldingLtdMember" xlink:label="loc_REEDDDSourceofLifeHoldingLtdMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDDDSourceofLifeHoldingLtdMember_0" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_OptionNotesMember" xlink:label="loc_REEDOptionNotesMember_20" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDOptionNotesMember_20" xlink:type="arc" order="22" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_50" xlink:type="arc" order="1" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice_50" xlink:type="arc" order="2" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_50" xlink:type="arc" order="3" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_50" xlink:type="arc" order="4" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_50" xlink:type="arc" order="5" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_50" xlink:type="arc" order="6" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_50" xlink:type="arc" order="7" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_50" /> <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_50" xlink:type="arc" order="8" /> </link:definitionLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>10 <FILENAME>reed-20230331_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" /> <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" /> <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:label="us-gaap_RelatedAndNonrelatedPartyStatusAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:to="us-gaap_RelatedAndNonrelatedPartyStatusAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedAndNonrelatedPartyStatusAxis_lbl" xml:lang="en-US">Related and Nonrelated Party Status [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CustomerOneMember" xlink:label="REED_CustomerOneMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CustomerOneMember" xlink:to="REED_CustomerOneMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="us-gaap_ProductConcentrationRiskMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductConcentrationRiskMember" xlink:to="us-gaap_ProductConcentrationRiskMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductConcentrationRiskMember_lbl" xml:lang="en-US">Product Concentration Risk [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CustomerTwoMember" xlink:label="REED_CustomerTwoMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CustomerTwoMember" xlink:to="REED_CustomerTwoMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChristopherJReedMember" xlink:label="REED_ChristopherJReedMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ChristopherJReedMember" xlink:to="REED_ChristopherJReedMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ChristopherJReedMember_lbl" xml:lang="en-US">Christopher J. Reed [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="REED_CaliforniaCustomBeverageLLCMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CaliforniaCustomBeverageLLCMember" xlink:to="REED_CaliforniaCustomBeverageLLCMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_CaliforniaCustomBeverageLLCMember_lbl" xml:lang="en-US">California Custom Beverage, LLC [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_VendorOneMember" xlink:label="REED_VendorOneMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_VendorOneMember" xlink:to="REED_VendorOneMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_VendorOneMember_lbl" xml:lang="en-US">Vendor One [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="us-gaap_ConvertibleNotesPayableMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible Notes Payable [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_UnvestedRestrictedCommonStockMember" xlink:label="REED_UnvestedRestrictedCommonStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_UnvestedRestrictedCommonStockMember" xlink:to="REED_UnvestedRestrictedCommonStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_UnvestedRestrictedCommonStockMember_lbl" xml:lang="en-US">Unvested Restricted Common Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" xlink:label="REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" xlink:to="REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_lbl" xml:lang="en-US">Common Stock Equivalent Of Series A Convertible Preferred Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RightOfUseAssetsUnderOperatingLeasesMember" xlink:label="REED_RightOfUseAssetsUnderOperatingLeasesMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_RightOfUseAssetsUnderOperatingLeasesMember" xlink:to="REED_RightOfUseAssetsUnderOperatingLeasesMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_RightOfUseAssetsUnderOperatingLeasesMember_lbl" xml:lang="en-US">Right Of Use Assets Under Operating Leases [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ComputerHardwareAndSoftwareMember" xlink:label="REED_ComputerHardwareAndSoftwareMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ComputerHardwareAndSoftwareMember" xlink:to="REED_ComputerHardwareAndSoftwareMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ComputerHardwareAndSoftwareMember_lbl" xml:lang="en-US">Computer Hardware And Software [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="us-gaap_MachineryAndEquipmentMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MachineryAndEquipmentMember" xlink:to="us-gaap_MachineryAndEquipmentMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MachineryAndEquipmentMember_lbl" xml:lang="en-US">Machinery and Equipment [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xml:lang="en-US">Lender Name [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AlternaCapitalSolutionsMember" xlink:label="REED_AlternaCapitalSolutionsMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AlternaCapitalSolutionsMember" xlink:to="REED_AlternaCapitalSolutionsMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_AlternaCapitalSolutionsMember_lbl" xml:lang="en-US">Alterna Capital Solutions [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_NotePurchaseAgreementMember" xlink:label="REED_NotePurchaseAgreementMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_NotePurchaseAgreementMember" xlink:to="REED_NotePurchaseAgreementMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_NotePurchaseAgreementMember_lbl" xml:lang="en-US">Note Purchase Agreement [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SeptemberTwoThousandTwentyTwoNotesMember" xlink:label="REED_SeptemberTwoThousandTwentyTwoNotesMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SeptemberTwoThousandTwentyTwoNotesMember" xlink:to="REED_SeptemberTwoThousandTwentyTwoNotesMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SeptemberTwoThousandTwentyTwoNotesMember_lbl" xml:lang="en-US">September Two Thousand Twenty Two Notes [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_OptionNotesMember" xlink:label="REED_OptionNotesMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_OptionNotesMember" xlink:to="REED_OptionNotesMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_OptionNotesMember_lbl" xml:lang="en-US">Option Notes [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FebruaryTwoThousandTwentyThreeNotesMember" xlink:label="REED_FebruaryTwoThousandTwentyThreeNotesMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FebruaryTwoThousandTwentyThreeNotesMember" xlink:to="REED_FebruaryTwoThousandTwentyThreeNotesMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_FebruaryTwoThousandTwentyThreeNotesMember_lbl" xml:lang="en-US">February Two Thousand Twenty Three Notes [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_LimitedWaiverAndDeferralAgreementMember" xlink:label="REED_LimitedWaiverAndDeferralAgreementMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_LimitedWaiverAndDeferralAgreementMember" xlink:to="REED_LimitedWaiverAndDeferralAgreementMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_LimitedWaiverAndDeferralAgreementMember_lbl" xml:lang="en-US">Limited Waiver And Deferral Agreement [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_HoldersMember" xlink:label="REED_HoldersMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_HoldersMember" xlink:to="REED_HoldersMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_HoldersMember_lbl" xml:lang="en-US">Holders [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficerMember" xlink:label="srt_OfficerMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OfficerMember" xlink:to="srt_OfficerMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OfficerMember_lbl" xml:lang="en-US">Officer [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="REED_TwoThousandTwentyEquityIncentivePlanMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="REED_TwoThousandTwentyEquityIncentivePlanMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_TwoThousandTwentyEquityIncentivePlanMember_lbl" xml:lang="en-US">2020 Equity Incentive Plan [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_EmployeesMember" xlink:label="REED_EmployeesMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_EmployeesMember" xlink:to="REED_EmployeesMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_BoardOfDirectorsMember" xlink:label="REED_BoardOfDirectorsMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_BoardOfDirectorsMember" xlink:to="REED_BoardOfDirectorsMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_BoardOfDirectorsMember_lbl" xml:lang="en-US">Board of Directors [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xml:lang="en-US">Derivative Instrument [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_StockWarrantsMember" xlink:label="REED_StockWarrantsMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_StockWarrantsMember" xlink:to="REED_StockWarrantsMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_StockWarrantsMember_lbl" xml:lang="en-US">Stock Warrants [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChrisReedMember" xlink:label="REED_ChrisReedMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ChrisReedMember" xlink:to="REED_ChrisReedMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ChrisReedMember_lbl" xml:lang="en-US">Chris Reed [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SecuritiesPurchaseAgreementMember" xlink:label="REED_SecuritiesPurchaseAgreementMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SecuritiesPurchaseAgreementMember" xlink:to="REED_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DDSourceofLifeHoldingLtdMember" xlink:label="REED_DDSourceofLifeHoldingLtdMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DDSourceofLifeHoldingLtdMember" xlink:to="REED_DDSourceofLifeHoldingLtdMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_DDSourceofLifeHoldingLtdMember_lbl" xml:lang="en-US">DD Source of Life Holding Ltd [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net of allowance of $213 and $252, respectively</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xml:lang="en-US">Receivable from former related party</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net of accumulated depreciation of $867 and $787, respectively</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS’ DEFICIT</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xml:lang="en-US">Revolving line of credit, net of capitalized financing costs of $322 and $363, respectively</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Payable to former related party</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Current portion of convertible notes payable, net of debt discount of $670 and $414, respectively</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of lease liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xml:lang="en-US">Convertible note payable, net of debt discount of $484 and $562, respectively, less current portion</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Lease liabilities, less current portion</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders’ deficit:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $.0001 par value, 180,000,000 shares authorized; 2,602,399 and 2,519,485 shares issued and outstanding, respectively</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders’ deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders’ deficit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Accounts receivable, net of allowance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="us-gaap_DeferredFinanceCostsCurrentNet" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsCurrentNet" xlink:to="us-gaap_DeferredFinanceCostsCurrentNet_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsCurrentNet_lbl" xml:lang="en-US">Capitalized financing costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xml:lang="en-US">Debt discount current</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_lbl" xml:lang="en-US">Debt discount, noncurrent</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Series A convertible preferred stock, par value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Series A convertible preferred stock, shares authorized</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Series A convertible preferred stock, shares issued</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Series A convertible preferred stock, shares outstanding</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Net Sales</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of goods sold</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DeliveryAndHandlingExpense" xlink:label="REED_DeliveryAndHandlingExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DeliveryAndHandlingExpense" xlink:to="REED_DeliveryAndHandlingExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_DeliveryAndHandlingExpense_lbl" xml:lang="en-US">Delivery and handling expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net loss per share – basic and diluted</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares outstanding – basic and diluted</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" xlink:label="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" xlink:to="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_lbl" xml:lang="en-US">Fair value of vested options</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Fair value of vested restricted shares granted to officers</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Fair value of vested restricted shares granted to officers, shares</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Repurchase of common stock</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Repurchase of common stock, shares</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Common shares issued for financing costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Common shares issued for financing costs, shares</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Common shares issued for cash, net of offering costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Common shares issued for cash, net of offering costs, shares</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Amortization of prepaid financing costs</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedOptions" xlink:label="REED_FairValueOfVestedOptions" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedOptions" xlink:to="REED_FairValueOfVestedOptions_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="REED_FairValueOfVestedOptions_lbl" xml:lang="en-US">Fair value of vested options</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:label="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:to="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers_lbl" xml:lang="en-US">Fair value of vested restricted shares granted to officers</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfCommonSharesIssuedAsFinancingCosts" xlink:label="REED_FairValueOfCommonSharesIssuedAsFinancingCosts" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfCommonSharesIssuedAsFinancingCosts" xlink:to="REED_FairValueOfCommonSharesIssuedAsFinancingCosts_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_FairValueOfCommonSharesIssuedAsFinancingCosts_lbl" xml:lang="en-US">Fair value of common shares issued as financing costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Change in allowance for doubtful accounts</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Inventory write-downs</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AccrualOfInterestOnConvertibleNote" xlink:label="REED_AccrualOfInterestOnConvertibleNote" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AccrualOfInterestOnConvertibleNote" xlink:to="REED_AccrualOfInterestOnConvertibleNote_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_AccrualOfInterestOnConvertibleNote_lbl" xml:lang="en-US">Accrued interest</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other assets</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets" xlink:label="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets" xlink:to="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets_lbl" xml:lang="en-US">Decrease in right of use assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Accrued expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Lease liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Proceeds from line of credit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLinesOfCredit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_lbl" xml:lang="en-US">Payments on line of credit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from convertible note payable, net of expenses</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Repurchase of common stock</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Amounts from former related party, net</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in cash</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash at beginning of period</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash at end of period</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">Line of Credit</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Secured Convertible Notes Payable</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureLeasesLiabilitiesAbstract" xlink:label="REED_DisclosureLeasesLiabilitiesAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DisclosureLeasesLiabilitiesAbstract" xlink:to="REED_DisclosureLeasesLiabilitiesAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_DisclosureLeasesLiabilitiesAbstract_lbl" xml:lang="en-US">Leases Liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases Liabilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholder’s Equity</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock-Based Compensation</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureStockWarrantsAbstract" xlink:label="REED_DisclosureStockWarrantsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DisclosureStockWarrantsAbstract" xlink:to="REED_DisclosureStockWarrantsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_DisclosureStockWarrantsAbstract_lbl" xml:lang="en-US">Stock Warrants</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_StockWarrantsTextBlock" xlink:label="REED_StockWarrantsTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_StockWarrantsTextBlock" xlink:to="REED_StockWarrantsTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="REED_StockWarrantsTextBlock_lbl" xml:lang="en-US">Stock Warrants</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Transactions with California Custom Beverage, LLC, former related party</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_GoingConcernPoliciesTextBlock" xlink:label="REED_GoingConcernPoliciesTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_GoingConcernPoliciesTextBlock" xlink:to="REED_GoingConcernPoliciesTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_GoingConcernPoliciesTextBlock_lbl" xml:lang="en-US">Going Concern</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CovidNineteenConsiderationPolicyTextBlock" xlink:label="REED_CovidNineteenConsiderationPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CovidNineteenConsiderationPolicyTextBlock" xlink:to="REED_CovidNineteenConsiderationPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_CovidNineteenConsiderationPolicyTextBlock_lbl" xml:lang="en-US">Recent Trends - Market Conditions</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ReverseStockSplitPolicyTextBlock" xlink:label="REED_ReverseStockSplitPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ReverseStockSplitPolicyTextBlock" xlink:to="REED_ReverseStockSplitPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ReverseStockSplitPolicyTextBlock_lbl" xml:lang="en-US">Reverse Stock Split</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss per Common Share</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock Compensation Expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Potentially Dilutive Securities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Summary of Intangible Assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xml:lang="en-US">Schedule of Amount Outstanding Under Credit Facilities</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Debt</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Non-vested Restricted Stock Activity</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrant Activity</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Related Parties</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="us-gaap_ScheduleOfProductInformationTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfProductInformationTable" xlink:to="us-gaap_ScheduleOfProductInformationTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfProductInformationTable_lbl" xml:lang="en-US">Schedule of Product Information [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="us-gaap_ProductInformationLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductInformationLineItems" xlink:to="us-gaap_ProductInformationLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductInformationLineItems_lbl" xml:lang="en-US">Product Information [Line Items]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net income loss</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xml:lang="en-US">Line of credit facility, borrowing capacity</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xml:lang="en-US">Line of credit facility, additional borrowing capacity</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CarryingCostPropertyAndExplorationRights" xlink:label="REED_CarryingCostPropertyAndExplorationRights" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CarryingCostPropertyAndExplorationRights" xlink:to="REED_CarryingCostPropertyAndExplorationRights_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_CarryingCostPropertyAndExplorationRights_lbl" xml:lang="en-US">Shipping and handling costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock par value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="us-gaap_AdvertisingExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingExpense" xlink:to="us-gaap_AdvertisingExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingExpense_lbl" xml:lang="en-US">Advertising costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Percentage of sale accounted to customer</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageOfCoPackersProducts" xlink:label="REED_PercentageOfCoPackersProducts" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_PercentageOfCoPackersProducts" xlink:to="REED_PercentageOfCoPackersProducts_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_PercentageOfCoPackersProducts_lbl" xml:lang="en-US">Percentage of co-packers products</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials and packaging</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished products</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Total cost</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated depreciation and amortization</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Net book value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of right-of-use assets</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="us-gaap_IndefiniteLivedTradeNames" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedTradeNames" xlink:to="us-gaap_IndefiniteLivedTradeNames_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedTradeNames_lbl" xml:lang="en-US">Brand names</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="us-gaap_IndefiniteLivedTrademarks" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedTrademarks" xlink:to="us-gaap_IndefiniteLivedTrademarks_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedTrademarks_lbl" xml:lang="en-US">Trademarks</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Total</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xml:lang="en-US">Line of Credit Facility [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LinesOfCreditCurrent_2_lbl" xml:lang="en-US">Total</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsCurrentNet" xlink:to="us-gaap_DeferredFinanceCostsCurrentNet_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredFinanceCostsCurrentNet_2_lbl" xml:lang="en-US">Capitalized financing costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebt" xlink:label="us-gaap_SecuredDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="us-gaap_SecuredDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecuredDebt_lbl" xml:lang="en-US">Secured Convertible Note Payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Capitalized financing costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Total</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_2_lbl" xml:lang="en-US">Current portion</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_2_lbl" xml:lang="en-US">Long term portion</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Debt instrument, term</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2_lbl" xml:lang="en-US">Line of credit facility, borrowing capacity</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_lbl" xml:lang="en-US">Line of credit facility, maximum amount outstanding during period</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xml:lang="en-US">Line of credit facility, interest rate description</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_LineOfCreditMonitoringFee" xlink:label="REED_LineOfCreditMonitoringFee" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_LineOfCreditMonitoringFee" xlink:to="REED_LineOfCreditMonitoringFee_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_LineOfCreditMonitoringFee_lbl" xml:lang="en-US">Line of credit monitoring fee</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DirectOperatingCosts" xlink:label="us-gaap_DirectOperatingCosts" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DirectOperatingCosts" xlink:to="us-gaap_DirectOperatingCosts_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DirectOperatingCosts_lbl" xml:lang="en-US">Direct operating costs</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AmortizationOfLineOfCreditPeriod" xlink:label="REED_AmortizationOfLineOfCreditPeriod" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AmortizationOfLineOfCreditPeriod" xlink:to="REED_AmortizationOfLineOfCreditPeriod_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_AmortizationOfLineOfCreditPeriod_lbl" xml:lang="en-US">Amortization of line of credit period</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DebtInstrumentRemainingUnamortizedDiscount" xlink:label="REED_DebtInstrumentRemainingUnamortizedDiscount" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DebtInstrumentRemainingUnamortizedDiscount" xlink:to="REED_DebtInstrumentRemainingUnamortizedDiscount_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_DebtInstrumentRemainingUnamortizedDiscount_lbl" xml:lang="en-US">Remaining unamortized debt discount amount</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecuredDebt" xlink:to="us-gaap_SecuredDebt_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SecuredDebt_2_lbl" xml:lang="en-US">Secured convertible promissory notes</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="us-gaap_DebtInstrumentInterestRateTerms" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateTerms" xlink:to="us-gaap_DebtInstrumentInterestRateTerms_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateTerms_lbl" xml:lang="en-US">Debt instrument rate terms</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt instrument maturity date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfSecuredDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfSecuredDebt_lbl" xml:lang="en-US">Proceeds from issuance of notes</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">New issuance of common stock</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Monthly payment</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xml:lang="en-US">Weighted average interest</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="us-gaap_RepaymentsOfSecuredDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfSecuredDebt" xlink:to="us-gaap_RepaymentsOfSecuredDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfSecuredDebt_lbl" xml:lang="en-US">Principal payment</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of common stock issued</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common stock value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt instrument rate</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageOfRepurchasePrice" xlink:label="REED_PercentageOfRepurchasePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_PercentageOfRepurchasePrice" xlink:to="REED_PercentageOfRepurchasePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_PercentageOfRepurchasePrice_lbl" xml:lang="en-US">Percentage of repurchase price</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Options to purchase</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageForDeferredPayment" xlink:label="REED_PercentageForDeferredPayment" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_PercentageForDeferredPayment" xlink:to="REED_PercentageForDeferredPayment_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_PercentageForDeferredPayment_lbl" xml:lang="en-US">Percentage for deferred payment</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebtExcludingAmortization_lbl" xml:lang="en-US">Amortization of interest</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Maturity date</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest expense</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest on the notes</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Whole interest</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentType" xlink:label="us-gaap_DebtConversionConvertedInstrumentType" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentType" xlink:to="us-gaap_DebtConversionConvertedInstrumentType_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentType_lbl" xml:lang="en-US">Debt instrument conversion, description</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt conversion into shares</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Unamortized debt discount amount</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_2_lbl" xml:lang="en-US">Direct costs</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Lease cost</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Operating leases liability</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Payments of operating lease liability</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted average remaining lease term for operating lease</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted average discount rate for operating lease</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable_lbl" xml:lang="en-US">Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems_lbl" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Stock repurchased, shares</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Stock repurchased, value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Unvested Shares, beginning balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_lbl" xml:lang="en-US">Issuable Shares, beginning balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_lbl" xml:lang="en-US">Fair Value at Date of Issuance, beginning balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Unvested, beginning balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_lbl" xml:lang="en-US">Unvested Shares, Granted</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_lbl" xml:lang="en-US">Issuable Shares, Granted</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_lbl" xml:lang="en-US">Fair Value at Date of Issuance, Granted</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Unvested Shares, Vested</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_lbl" xml:lang="en-US">Issuable Shares, Vested</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Fair Value at Date of Issuance, Vested</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Unvested Shares, Forfeited</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_lbl" xml:lang="en-US">Issuable Shares, Forfeited</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_lbl" xml:lang="en-US">Fair Value at Date of Issuance, Forfeited</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Unvested Shares, Issued</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_lbl" xml:lang="en-US">Issuable Shares, Issued</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_lbl" xml:lang="en-US">Fair Value at Date of Issuance, Issued</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Unvested Shares, ending balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_2_lbl" xml:lang="en-US">Issuable Shares, ending balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_2_lbl" xml:lang="en-US">Fair Value at Date of Issuance, ending balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Unvested, ending balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="us-gaap_OffsettingAssetsTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsTable" xlink:to="us-gaap_OffsettingAssetsTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsTable_lbl" xml:lang="en-US">Offsetting Assets [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="us-gaap_OffsettingAssetsLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffsettingAssetsLineItems" xlink:to="us-gaap_OffsettingAssetsLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OffsettingAssetsLineItems_lbl" xml:lang="en-US">Offsetting Assets [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Shares Outstanding, Beginning balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding, Beginning</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Shares Outstanding, Beginning</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Shares, Granted</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Granted</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Shares, Exercised</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Exercised</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Shares, Unvested forfeited</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Unvested forfeited</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Shares, Vested forfeited</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Vested forfeited</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Shares Outstanding, Ending Balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding, Ending</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_lbl" xml:lang="en-US">Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Shares Outstanding, Ending</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Shares, Exercisable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Exercisable Ending Balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Ending balance</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted shares, value</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Aggregate value of unvested compensation</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock issued during period shares employee benefit plan</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Number of stock option shares vested</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xml:lang="en-US">Stock options exercisable price</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Expiration years</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_lbl" xml:lang="en-US">Options grant date</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Stock price</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Volatility</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend rate</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Weighted average risk-free interest rate</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedStockOption" xlink:label="REED_FairValueOfVestedStockOption" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedStockOption" xlink:to="REED_FairValueOfVestedStockOption_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_FairValueOfVestedStockOption_lbl" xml:lang="en-US">Fair value of vested stock option</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Shares Outstanding, Beginning Balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding Beginning Balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Beginning</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted_lbl" xml:lang="en-US">Shares, Granted</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Granted</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised_lbl" xml:lang="en-US">Shares, Exercised</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Exercised</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_lbl" xml:lang="en-US">Shares, Forfeited</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Forfeited</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2_lbl" xml:lang="en-US">Shares Outstanding, Ending Balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding Ending Balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_lbl" xml:lang="en-US">Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Ending</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable_lbl" xml:lang="en-US">Shares Exercisable, Ending Balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Exercisable Ending Balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Share price</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherReceivablesNetCurrent_2_lbl" xml:lang="en-US">Accounts receivable, net of provision of $538 and $538 at March 31, 2023 and December 31, 2022, respectively</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accounts payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="us-gaap_OtherReceivables" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OtherReceivables_lbl" xml:lang="en-US">Net (payable) receivable</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ProvisionForReceivableWithFormerRelatedParty" xlink:label="REED_ProvisionForReceivableWithFormerRelatedParty" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ProvisionForReceivableWithFormerRelatedParty" xlink:to="REED_ProvisionForReceivableWithFormerRelatedParty_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ProvisionForReceivableWithFormerRelatedParty_lbl" xml:lang="en-US">Provision for disputed receivable with former related party</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RoyaltyPercentage" xlink:label="REED_RoyaltyPercentage" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_RoyaltyPercentage" xlink:to="REED_RoyaltyPercentage_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_RoyaltyPercentage_lbl" xml:lang="en-US">Royalty percentage</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Copacking fees</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="us-gaap_ReceivablesNetCurrent" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xml:lang="en-US">Receivables</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RoyaltyReceivable" xlink:label="REED_RoyaltyReceivable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_RoyaltyReceivable" xlink:to="REED_RoyaltyReceivable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_RoyaltyReceivable_lbl" xml:lang="en-US">Royalty receivable</link:label> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CopackingFees" xlink:label="REED_CopackingFees" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CopackingFees" xlink:to="REED_CopackingFees_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="REED_CopackingFees_lbl" xml:lang="en-US">Copacking fees</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherReceivables_2_lbl" xml:lang="en-US">Net receivable</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_3_lbl" xml:lang="en-US">Accounts payable</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Deposit of security with lessor</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Number of common stock value placed</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Value of stock placed</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants to purchase stock</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Proceeds from issuance of private placement</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrant term</link:label> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" /> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price of warrants</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2_lbl" xml:lang="en-US">Common shares issued on exercise of options</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Debt instrument, maturity date</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DeliveryAndHandlingExpense" xlink:to="REED_DeliveryAndHandlingExpense_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_DeliveryAndHandlingExpense_doc" xml:lang="en-US">Delivery and handling expense.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" xlink:to="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested_doc" xml:lang="en-US">Adjustments to additional paid in capital share based compensation stock options vested.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedOptions" xlink:to="REED_FairValueOfVestedOptions_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_FairValueOfVestedOptions_doc" xml:lang="en-US">Fair value of vested options.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:to="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers_doc" xml:lang="en-US">Fair value of vested restricted shares granted to officers.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfCommonSharesIssuedAsFinancingCosts" xlink:to="REED_FairValueOfCommonSharesIssuedAsFinancingCosts_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_FairValueOfCommonSharesIssuedAsFinancingCosts_doc" xml:lang="en-US">Fair value of common shares issued as financing costs.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AccrualOfInterestOnConvertibleNote" xlink:to="REED_AccrualOfInterestOnConvertibleNote_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_AccrualOfInterestOnConvertibleNote_doc" xml:lang="en-US">Accrual of interest on convertible note.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets" xlink:to="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets_doc" xml:lang="en-US">Amortization of right of use of asset.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_GoingConcernPoliciesTextBlock" xlink:to="REED_GoingConcernPoliciesTextBlock_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_GoingConcernPoliciesTextBlock_doc" xml:lang="en-US">Going Concern Policies [Text Block]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CovidNineteenConsiderationPolicyTextBlock" xlink:to="REED_CovidNineteenConsiderationPolicyTextBlock_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_CovidNineteenConsiderationPolicyTextBlock_doc" xml:lang="en-US">Covid 19 Consideration [Policy Text Block]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CarryingCostPropertyAndExplorationRights" xlink:to="REED_CarryingCostPropertyAndExplorationRights_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_CarryingCostPropertyAndExplorationRights_doc" xml:lang="en-US">Carrying cost property and exploration rights.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ReverseStockSplitPolicyTextBlock" xlink:to="REED_ReverseStockSplitPolicyTextBlock_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ReverseStockSplitPolicyTextBlock_doc" xml:lang="en-US">Reverse Stock Split [PolicyText Block]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CustomerOneMember" xlink:to="REED_CustomerOneMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CustomerTwoMember" xlink:to="REED_CustomerTwoMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AlternaCapitalSolutionsMember" xlink:to="REED_AlternaCapitalSolutionsMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_AlternaCapitalSolutionsMember_doc" xml:lang="en-US">Alterna Capital Solutions [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_LineOfCreditMonitoringFee" xlink:to="REED_LineOfCreditMonitoringFee_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_LineOfCreditMonitoringFee_doc" xml:lang="en-US">Monitoring fee.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_AmortizationOfLineOfCreditPeriod" xlink:to="REED_AmortizationOfLineOfCreditPeriod_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_AmortizationOfLineOfCreditPeriod_doc" xml:lang="en-US">Amortization of line of credit period.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DebtInstrumentRemainingUnamortizedDiscount" xlink:to="REED_DebtInstrumentRemainingUnamortizedDiscount_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_DebtInstrumentRemainingUnamortizedDiscount_doc" xml:lang="en-US">Debt instrument remaining unamortized discount.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_NotePurchaseAgreementMember" xlink:to="REED_NotePurchaseAgreementMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_NotePurchaseAgreementMember_doc" xml:lang="en-US">Note Purchase Agreement [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non-vested grants in period, gross.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non-vested, number of issuable shares.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non-vested issuable shares grants in period, gross.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options vested number of issuable shares.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options nonvested number of issuable shares forfeited in period gross.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non-vested shares issued in period, gross.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non-vested fair value.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non-vested granted.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_doc" xml:lang="en-US">Fair Value, Forfeited.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non-vested issued.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options vested forfeitures and expirations in period.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options vested forfeiture and expirations in period, weighted average grant date fair value.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_doc" xml:lang="en-US">Share-based compensation arrangement by share-based payment award options outstanding weighted average remaining contractual term ending.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_TwoThousandTwentyEquityIncentivePlanMember" xlink:to="REED_TwoThousandTwentyEquityIncentivePlanMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_TwoThousandTwentyEquityIncentivePlanMember_doc" xml:lang="en-US">2020 Equity Incentive Plan [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_EmployeesMember" xlink:to="REED_EmployeesMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_BoardOfDirectorsMember" xlink:to="REED_BoardOfDirectorsMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_BoardOfDirectorsMember_doc" xml:lang="en-US">Board of Directors [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedStockOption" xlink:to="REED_FairValueOfVestedStockOption_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_FairValueOfVestedStockOption_doc" xml:lang="en-US">Fair value of vested stock option.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_StockWarrantsTextBlock" xlink:to="REED_StockWarrantsTextBlock_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_StockWarrantsTextBlock_doc" xml:lang="en-US">Stock Warrants [Text Block]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted_doc" xml:lang="en-US">Class of warrant or right number of securities granted.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised_doc" xml:lang="en-US">Class of warrant or right number of securities exercised.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_doc" xml:lang="en-US">Class of warrant or right number of securities forfeited or expired.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable_doc" xml:lang="en-US">Number of warrants or rights exercisable.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Class of warrant or right number of securities outstanding weighted average exercise price per share.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_doc" xml:lang="en-US">Class of warrant or right number of securities granted weighted average exercise price.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_doc" xml:lang="en-US">Class of warrant or right number of securities exercised weighted average exercise price.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_doc" xml:lang="en-US">Class of warrant or right number of securities forfeited weighted average exercise price.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_doc" xml:lang="en-US">Class of warrant or right number of securities exercisable weighted average exercise price.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Remaining term of warrant oustanding.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_doc" xml:lang="en-US">Remaining term of warrant oustanding.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Class of warrant or right number of securitie exercisable weighted average remaining contractual terms.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_doc" xml:lang="en-US">Class of warrant or right number of securities outstanding aggregate intrinsic value.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_doc" xml:lang="en-US">Class of warrant or right number of securities exercisable aggregate intrinsic value.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_StockWarrantsMember" xlink:to="REED_StockWarrantsMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_StockWarrantsMember_doc" xml:lang="en-US">Stock Warrants [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_RoyaltyPercentage" xlink:to="REED_RoyaltyPercentage_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_RoyaltyPercentage_doc" xml:lang="en-US">Royalty percentage</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ChristopherJReedMember" xlink:to="REED_ChristopherJReedMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ChristopherJReedMember_doc" xml:lang="en-US">Christopher J. Reed [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CaliforniaCustomBeverageLLCMember" xlink:to="REED_CaliforniaCustomBeverageLLCMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_CaliforniaCustomBeverageLLCMember_doc" xml:lang="en-US">California Custom Beverage, LLC [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_RoyaltyReceivable" xlink:to="REED_RoyaltyReceivable_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_RoyaltyReceivable_doc" xml:lang="en-US">Royalty receivable.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CopackingFees" xlink:to="REED_CopackingFees_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_CopackingFees_doc" xml:lang="en-US">Copacking fees.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ProvisionForReceivableWithFormerRelatedParty" xlink:to="REED_ProvisionForReceivableWithFormerRelatedParty_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ProvisionForReceivableWithFormerRelatedParty_doc" xml:lang="en-US">Provision for receivable with former related party.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ChrisReedMember" xlink:to="REED_ChrisReedMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_ChrisReedMember_doc" xml:lang="en-US">Chris Reed [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_PercentageOfCoPackersProducts" xlink:to="REED_PercentageOfCoPackersProducts_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_PercentageOfCoPackersProducts_doc" xml:lang="en-US">Percentage of co-packers products.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_VendorOneMember" xlink:to="REED_VendorOneMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_VendorOneMember_doc" xml:lang="en-US">Vendor One [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_PercentageOfRepurchasePrice" xlink:to="REED_PercentageOfRepurchasePrice_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_PercentageOfRepurchasePrice_doc" xml:lang="en-US">Percentage of repurchase price.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_OptionNotesMember" xlink:to="REED_OptionNotesMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_OptionNotesMember_doc" xml:lang="en-US">Option Notes [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_PercentageForDeferredPayment" xlink:to="REED_PercentageForDeferredPayment_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_PercentageForDeferredPayment_doc" xml:lang="en-US">Percentage for deferred payment.</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_HoldersMember" xlink:to="REED_HoldersMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_HoldersMember_doc" xml:lang="en-US">Holders [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_LimitedWaiverAndDeferralAgreementMember" xlink:to="REED_LimitedWaiverAndDeferralAgreementMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_LimitedWaiverAndDeferralAgreementMember_doc" xml:lang="en-US">Limited Waiver And Deferral Agreement [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SeptemberTwoThousandTwentyTwoNotesMember" xlink:to="REED_SeptemberTwoThousandTwentyTwoNotesMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SeptemberTwoThousandTwentyTwoNotesMember_doc" xml:lang="en-US">September Two Thousand Twenty Two Notes [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FebruaryTwoThousandTwentyThreeNotesMember" xlink:to="REED_FebruaryTwoThousandTwentyThreeNotesMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_FebruaryTwoThousandTwentyThreeNotesMember_doc" xml:lang="en-US">February Two Thousand Twenty Three Notes [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SecuritiesPurchaseAgreementMember" xlink:to="REED_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_DDSourceofLifeHoldingLtdMember" xlink:to="REED_DDSourceofLifeHoldingLtdMember_doc" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="REED_DDSourceofLifeHoldingLtdMember_doc" xml:lang="en-US">DD Source of Life Holding Ltd [Member]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_5_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_5_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedOptions" xlink:to="REED_FairValueOfVestedOptions_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_FairValueOfVestedOptions_3_lbl" xml:lang="en-US">FairValueOfVestedOptions</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:to="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_FairValueOfVestedRestrictedSharesGrantedToOfficers_3_lbl" xml:lang="en-US">FairValueOfVestedRestrictedSharesGrantedToOfficers</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfLinesOfCredit_2_lbl" xml:lang="en-US">Repayments of Lines of Credit</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_StockWarrantsTextBlock" xlink:to="REED_StockWarrantsTextBlock_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_StockWarrantsTextBlock_3_lbl" xml:lang="en-US">StockWarrantsTextBlock</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_2_lbl" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Interest Payable</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_2_lbl" xml:lang="en-US">Convertible Notes Payable</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_4_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_4_lbl" xml:lang="en-US">Fair Value Unvested, beginning balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_4_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_4_lbl" xml:lang="en-US">Fair Value, Unvested, ending balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_3_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" xlink:to="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_3_lbl" xml:lang="en-US">Number of Issuable Shares, Issued</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" xlink:to="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_3_lbl" xml:lang="en-US">Fair Value, Issued</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_3_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding Beginning Balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_4_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_4_lbl" xml:lang="en-US">Aggregate Intrinsic Value Shares Outstanding Ending</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Granted [Default Label]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised_3_lbl" xml:lang="en-US">Shares, Exercised [Default Label]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Exercised [Default Label]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable_3_lbl" xml:lang="en-US">Shares Exercisable, Ending Balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted-Average Exercise Price, Exercisable Ending Balance</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_3_lbl" xml:lang="en-US">Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance [Default Label]</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" xlink:to="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_3_lbl" xml:lang="en-US">Class of warrant or right number of securities exercisable aggregate intrinsic value</link:label> <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="REED_CopackingFees" xlink:to="REED_CopackingFees_3_lbl" xlink:type="arc" /> <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="REED_CopackingFees_3_lbl" xml:lang="en-US">CopackingFees</link:label> </link:labelLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>11 <FILENAME>reed-20230331_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> <XBRL> <?xml version="1.0" encoding="US-ASCII" standalone="no"?> <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b --> <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com --> <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 --> <link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"> <link:roleRef roleURI="http://drinkreeds.com/role/Cover" xlink:href="reed-20230331.xsd#Cover" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/BalanceSheets" xlink:href="reed-20230331.xsd#BalanceSheets" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/BalanceSheetsParenthetical" xlink:href="reed-20230331.xsd#BalanceSheetsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfOperations" xlink:href="reed-20230331.xsd#StatementsOfOperations" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:href="reed-20230331.xsd#StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StatementsOfCashFlows" xlink:href="reed-20230331.xsd#StatementsOfCashFlows" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Inventory" xlink:href="reed-20230331.xsd#Inventory" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipment" xlink:href="reed-20230331.xsd#PropertyAndEquipment" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/IntangibleAssets" xlink:href="reed-20230331.xsd#IntangibleAssets" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCredit" xlink:href="reed-20230331.xsd#LineOfCredit" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayable" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayable" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LeasesLiabilities" xlink:href="reed-20230331.xsd#LeasesLiabilities" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockholdersEquity" xlink:href="reed-20230331.xsd#StockholdersEquity" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensation" xlink:href="reed-20230331.xsd#Stock-basedCompensation" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrants" xlink:href="reed-20230331.xsd#StockWarrants" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/CommitmentsAndContingencies" xlink:href="reed-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SubsequentEvents" xlink:href="reed-20230331.xsd#SubsequentEvents" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/InventoryTables" xlink:href="reed-20230331.xsd#InventoryTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipmentTables" xlink:href="reed-20230331.xsd#PropertyAndEquipmentTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/IntangibleAssetsTables" xlink:href="reed-20230331.xsd#IntangibleAssetsTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCreditTables" xlink:href="reed-20230331.xsd#LineOfCreditTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayableTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensationTables" xlink:href="reed-20230331.xsd#Stock-basedCompensationTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrantsTables" xlink:href="reed-20230331.xsd#StockWarrantsTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="reed-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfInventoryDetails" xlink:href="reed-20230331.xsd#ScheduleOfInventoryDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="reed-20230331.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="reed-20230331.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" xlink:href="reed-20230331.xsd#SummaryOfIntangibleAssetsDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfDebtDetails" xlink:href="reed-20230331.xsd#ScheduleOfDebtDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LineOfCreditDetailsNarrative" xlink:href="reed-20230331.xsd#LineOfCreditDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" xlink:href="reed-20230331.xsd#SecuredConvertibleNotesPayableDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" xlink:href="reed-20230331.xsd#LeasesLiabilitiesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" xlink:href="reed-20230331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:href="reed-20230331.xsd#SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="reed-20230331.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" xlink:href="reed-20230331.xsd#Stock-basedCompensationDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" xlink:href="reed-20230331.xsd#ScheduleOfWarrantActivityDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/StockWarrantsDetailsNarrative" xlink:href="reed-20230331.xsd#StockWarrantsDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" xlink:href="reed-20230331.xsd#ScheduleOfRelatedPartiesDetails" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" xlink:href="reed-20230331.xsd#ScheduleOfRelatedPartiesDetailsParenthetical" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:href="reed-20230331.xsd#TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="reed-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" /> <link:roleRef roleURI="http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" xlink:href="reed-20230331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" /> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Cover" xlink:title="00000001 - Document - Cover"> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" /> <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" /> <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" /> <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" /> <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" /> <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" /> <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" /> <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" /> <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" /> <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" /> <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" /> <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" /> <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" /> <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" /> <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" /> <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" /> <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" /> <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" /> <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" /> <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" /> <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" /> <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" /> <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" /> <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" /> <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" /> <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" /> <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" /> <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" /> <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" /> <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" /> <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" /> <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" /> <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" /> <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" /> <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" /> <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" /> <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" /> <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" /> <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Balance Sheets"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" /> <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" /> <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" /> <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" /> <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" /> <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" /> <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" /> <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" /> <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" /> <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Balance Sheets (Parenthetical)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_us-gaapDeferredFinanceCostsCurrentNet" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDeferredFinanceCostsCurrentNet" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountNoncurrent" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountNoncurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Statements of Operations (Unaudited)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DeliveryAndHandlingExpense" xlink:label="loc_REEDDeliveryAndHandlingExpense" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_REEDDeliveryAndHandlingExpense" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" xlink:title="00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" xlink:label="loc_REEDAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_REEDAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedOptions" xlink:label="loc_REEDFairValueOfVestedOptions" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_REEDFairValueOfVestedOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:label="loc_REEDFairValueOfVestedRestrictedSharesGrantedToOfficers" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_REEDFairValueOfVestedRestrictedSharesGrantedToOfficers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfCommonSharesIssuedAsFinancingCosts" xlink:label="loc_REEDFairValueOfCommonSharesIssuedAsFinancingCosts" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_REEDFairValueOfCommonSharesIssuedAsFinancingCosts" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AccrualOfInterestOnConvertibleNote" xlink:label="loc_REEDAccrualOfInterestOnConvertibleNote" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_REEDAccrualOfInterestOnConvertibleNote" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets" xlink:label="loc_REEDIncreaseDecreaseInAmortizationOfRightOfUseAssets" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_REEDIncreaseDecreaseInAmortizationOfRightOfUseAssets" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" /> <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" /> <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" /> <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" /> <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" /> <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaapRepaymentsOfLinesOfCredit" /> <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfLinesOfCredit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" /> <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" /> <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfCommonStock" /> <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" /> <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" /> <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" /> <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" /> <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" /> <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" /> <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" /> <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Summary of Significant Accounting Policies"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Inventory" xlink:title="00000008 - Disclosure - Inventory"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipment" xlink:title="00000009 - Disclosure - Property and Equipment"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/IntangibleAssets" xlink:title="00000010 - Disclosure - Intangible Assets"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCredit" xlink:title="00000011 - Disclosure - Line of Credit"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayable" xlink:title="00000012 - Disclosure - Secured Convertible Notes Payable"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LeasesLiabilities" xlink:title="00000013 - Disclosure - Leases Liabilities"> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureLeasesLiabilitiesAbstract" xlink:label="loc_REEDDisclosureLeasesLiabilitiesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureLeasesLiabilitiesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockholdersEquity" xlink:title="00000014 - Disclosure - Stockholder’s Equity"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensation" xlink:title="00000015 - Disclosure - Stock-Based Compensation"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrants" xlink:title="00000016 - Disclosure - Stock Warrants"> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureStockWarrantsAbstract" xlink:label="loc_REEDDisclosureStockWarrantsAbstract" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_StockWarrantsTextBlock" xlink:label="loc_REEDStockWarrantsTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureStockWarrantsAbstract" xlink:to="loc_REEDStockWarrantsTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" xlink:title="00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/CommitmentsAndContingencies" xlink:title="00000018 - Disclosure - Commitments and Contingencies"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - Subsequent Events"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_GoingConcernPoliciesTextBlock" xlink:label="loc_REEDGoingConcernPoliciesTextBlock" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_REEDGoingConcernPoliciesTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CovidNineteenConsiderationPolicyTextBlock" xlink:label="loc_REEDCovidNineteenConsiderationPolicyTextBlock" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_REEDCovidNineteenConsiderationPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ReverseStockSplitPolicyTextBlock" xlink:label="loc_REEDReverseStockSplitPolicyTextBlock" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_REEDReverseStockSplitPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/InventoryTables" xlink:title="00000022 - Disclosure - Inventory (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipmentTables" xlink:title="00000023 - Disclosure - Property and Equipment (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/IntangibleAssetsTables" xlink:title="00000024 - Disclosure - Intangible Assets (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCreditTables" xlink:title="00000025 - Disclosure - Line of Credit (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" xlink:title="00000026 - Disclosure - Secured Convertible Notes Payable (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfDebtTableTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDebtTableTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensationTables" xlink:title="00000027 - Disclosure - Stock-Based Compensation (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="loc_us-gaapNonvestedRestrictedStockSharesActivityTableTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapNonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrantsTables" xlink:title="00000028 - Disclosure - Stock Warrants (Tables)"> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureStockWarrantsAbstract" xlink:label="loc_REEDDisclosureStockWarrantsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureStockWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" xlink:title="00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" xlink:title="00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_UnvestedRestrictedCommonStockMember" xlink:label="loc_REEDUnvestedRestrictedCommonStockMember" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_REEDUnvestedRestrictedCommonStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" xlink:label="loc_REEDCommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_REEDCommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable" xlink:label="loc_us-gaapScheduleOfProductInformationTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfProductInformationTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems" xlink:label="loc_us-gaapProductInformationLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapProductInformationLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtStatementScenarioAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtMajorCustomersAxis" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CustomerOneMember" xlink:label="loc_REEDCustomerOneMember" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_REEDCustomerOneMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CustomerTwoMember" xlink:label="loc_REEDCustomerTwoMember" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_REEDCustomerTwoMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_VendorOneMember" xlink:label="loc_REEDVendorOneMember" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_REEDVendorOneMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductConcentrationRiskMember" xlink:label="loc_us-gaapProductConcentrationRiskMember" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapProductConcentrationRiskMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="50" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChristopherJReedMember" xlink:label="loc_REEDChristopherJReedMember" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDChristopherJReedMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfProductInformationTable" xlink:to="loc_deiLegalEntityAxis" order="60" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CarryingCostPropertyAndExplorationRights" xlink:label="loc_REEDCarryingCostPropertyAndExplorationRights" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_REEDCarryingCostPropertyAndExplorationRights" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense" xlink:label="loc_us-gaapAdvertisingExpense" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapAdvertisingExpense" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageOfCoPackersProducts" xlink:label="loc_REEDPercentageOfCoPackersProducts" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapProductInformationLineItems" xlink:to="loc_REEDPercentageOfCoPackersProducts" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfInventoryDetails" xlink:title="00000032 - Disclosure - Schedule of Inventory (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000033 - Disclosure - Schedule of Property and Equipment (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RightOfUseAssetsUnderOperatingLeasesMember" xlink:label="loc_REEDRightOfUseAssetsUnderOperatingLeasesMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_REEDRightOfUseAssetsUnderOperatingLeasesMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ComputerHardwareAndSoftwareMember" xlink:label="loc_REEDComputerHardwareAndSoftwareMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_REEDComputerHardwareAndSoftwareMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaapMachineryAndEquipmentMember" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapMachineryAndEquipmentMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000034 - Disclosure - Property and Equipment (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" xlink:title="00000035 - Disclosure - Summary of Intangible Assets (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTradeNames" xlink:label="loc_us-gaapIndefiniteLivedTradeNames" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIndefiniteLivedTradeNames" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedTrademarks" xlink:label="loc_us-gaapIndefiniteLivedTrademarks" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIndefiniteLivedTrademarks" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" xlink:title="00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AlternaCapitalSolutionsMember" xlink:label="loc_REEDAlternaCapitalSolutionsMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_REEDAlternaCapitalSolutionsMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaapLinesOfCreditCurrent" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLinesOfCreditCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsCurrentNet" xlink:label="loc_us-gaapDeferredFinanceCostsCurrentNet" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsCurrentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfDebtDetails" xlink:title="00000037 - Disclosure - Schedule of Debt (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapSecuredDebt" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LineOfCreditDetailsNarrative" xlink:title="00000038 - Disclosure - Line of Credit (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="loc_us-gaapLineOfCreditFacilityTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLineOfCreditFacilityTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="loc_us-gaapLineOfCreditFacilityLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaapLineOfCreditFacilityAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityTable" xlink:to="loc_us-gaapLineOfCreditFacilityAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaapLineOfCreditFacilityLenderDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityAxis" xlink:to="loc_us-gaapLineOfCreditFacilityLenderDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AlternaCapitalSolutionsMember" xlink:label="loc_REEDAlternaCapitalSolutionsMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLenderDomain" xlink:to="loc_REEDAlternaCapitalSolutionsMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDescription" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDescription" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_LineOfCreditMonitoringFee" xlink:label="loc_REEDLineOfCreditMonitoringFee" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_REEDLineOfCreditMonitoringFee" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DirectOperatingCosts" xlink:label="loc_us-gaapDirectOperatingCosts" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapDirectOperatingCosts" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_AmortizationOfLineOfCreditPeriod" xlink:label="loc_REEDAmortizationOfLineOfCreditPeriod" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_REEDAmortizationOfLineOfCreditPeriod" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DebtInstrumentRemainingUnamortizedDiscount" xlink:label="loc_REEDDebtInstrumentRemainingUnamortizedDiscount" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLineOfCreditFacilityLineItems" xlink:to="loc_REEDDebtInstrumentRemainingUnamortizedDiscount" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" xlink:title="00000039 - Disclosure - Secured Convertible Notes Payable (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_NotePurchaseAgreementMember" xlink:label="loc_REEDNotePurchaseAgreementMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_REEDNotePurchaseAgreementMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_LimitedWaiverAndDeferralAgreementMember" xlink:label="loc_REEDLimitedWaiverAndDeferralAgreementMember" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_REEDLimitedWaiverAndDeferralAgreementMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SeptemberTwoThousandTwentyTwoNotesMember" xlink:label="loc_REEDSeptemberTwoThousandTwentyTwoNotesMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDSeptemberTwoThousandTwentyTwoNotesMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_OptionNotesMember" xlink:label="loc_REEDOptionNotesMember" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDOptionNotesMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FebruaryTwoThousandTwentyThreeNotesMember" xlink:label="loc_REEDFebruaryTwoThousandTwentyThreeNotesMember" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDFebruaryTwoThousandTwentyThreeNotesMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaapConvertibleNotesPayableMember" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_us-gaapConvertibleNotesPayableMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_HoldersMember" xlink:label="loc_REEDHoldersMember" /> <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDHoldersMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecuredDebt" xlink:label="loc_us-gaapSecuredDebt" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSecuredDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateTerms" xlink:label="loc_us-gaapDebtInstrumentInterestRateTerms" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateTerms" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfSecuredDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfSecuredDebt" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaapRepaymentsOfSecuredDebt" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapRepaymentsOfSecuredDebt" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCash" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageOfRepurchasePrice" xlink:label="loc_REEDPercentageOfRepurchasePrice" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_REEDPercentageOfRepurchasePrice" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_PercentageForDeferredPayment" xlink:label="loc_REEDPercentageForDeferredPayment" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_REEDPercentageForDeferredPayment" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaapInterestExpenseDebtExcludingAmortization" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebtExcludingAmortization" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" /> <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" /> <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentType" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentType" /> <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentType" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" /> <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" /> <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" /> <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" /> <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" xlink:title="00000040 - Disclosure - Leases Liabilities (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureLeasesLiabilitiesAbstract" xlink:label="loc_REEDDisclosureLeasesLiabilitiesAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost" xlink:label="loc_us-gaapLeaseCost" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureLeasesLiabilitiesAbstract" xlink:to="loc_us-gaapLeaseCost" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureLeasesLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureLeasesLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureLeasesLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureLeasesLiabilitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000041 - Disclosure - Stockholder’s Equity (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OfficerMember" xlink:label="loc_srtOfficerMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtOfficerMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" xlink:title="00000042 - Disclosure - Summary of Non-vested Restricted Stock Activity (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_2" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_2" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000043 - Disclosure - Schedule of Stock Option Activity (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsTable" xlink:label="loc_us-gaapOffsettingAssetsTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapOffsettingAssetsTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OffsettingAssetsLineItems" xlink:label="loc_us-gaapOffsettingAssetsLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapOffsettingAssetsLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaapDerivativeInstrumentRiskAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsTable" xlink:to="loc_us-gaapDerivativeInstrumentRiskAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaapDerivativeContractTypeDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentRiskAxis" xlink:to="loc_us-gaapDerivativeContractTypeDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeContractTypeDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_REEDShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" xlink:label="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_REEDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" /> <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" /> <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOffsettingAssetsLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="00000044 - Disclosure - Stock-Based Compensation (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_TwoThousandTwentyEquityIncentivePlanMember" xlink:label="loc_REEDTwoThousandTwentyEquityIncentivePlanMember" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_REEDTwoThousandTwentyEquityIncentivePlanMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_EmployeesMember" xlink:label="loc_REEDEmployeesMember" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDEmployeesMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_BoardOfDirectorsMember" xlink:label="loc_REEDBoardOfDirectorsMember" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDBoardOfDirectorsMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_FairValueOfVestedStockOption" xlink:label="loc_REEDFairValueOfVestedStockOption" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_REEDFairValueOfVestedStockOption" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" xlink:title="00000045 - Disclosure - Schedule of Warrant Activity (Details)"> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureStockWarrantsAbstract" xlink:label="loc_REEDDisclosureStockWarrantsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureStockWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGranted" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGranted" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercised" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2" /> <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_2" /> <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" /> <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_2" /> <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisable" /> <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" /> <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" /> <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" xlink:label="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" /> <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_REEDClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/StockWarrantsDetailsNarrative" xlink:title="00000046 - Disclosure - Stock Warrants (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DisclosureStockWarrantsAbstract" xlink:label="loc_REEDDisclosureStockWarrantsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_REEDDisclosureStockWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_StockWarrantsMember" xlink:label="loc_REEDStockWarrantsMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_REEDStockWarrantsMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" xlink:title="00000047 - Disclosure - Schedule of Related Parties (Details)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="loc_us-gaapOtherReceivablesNetCurrent" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivablesNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" xlink:title="00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ProvisionForReceivableWithFormerRelatedParty" xlink:label="loc_REEDProvisionForReceivableWithFormerRelatedParty" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_REEDProvisionForReceivableWithFormerRelatedParty" xlink:type="arc" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" xlink:title="00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChristopherJReedMember" xlink:label="loc_REEDChristopherJReedMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDChristopherJReedMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_deiLegalEntityAxis" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusAxis" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedAndNonrelatedPartyStatusDomain" xlink:label="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusAxis" xlink:to="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedAndNonrelatedPartyStatusDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="40" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember_2" /> <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember_2" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RoyaltyPercentage" xlink:label="loc_REEDRoyaltyPercentage" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_REEDRoyaltyPercentage" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapReceivablesNetCurrent" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_RoyaltyReceivable" xlink:label="loc_REEDRoyaltyReceivable" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_REEDRoyaltyReceivable" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CopackingFees" xlink:label="loc_REEDCopackingFees" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_REEDCopackingFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherReceivables" xlink:label="loc_us-gaapOtherReceivables" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherReceivables" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000050 - Disclosure - Commitments and Contingencies (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:label="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:label="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_ChrisReedMember" xlink:label="loc_REEDChrisReedMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_REEDChrisReedMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable" xlink:to="loc_deiLegalEntityAxis" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_CaliforniaCustomBeverageLLCMember" xlink:label="loc_REEDCaliforniaCustomBeverageLLCMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDCaliforniaCustomBeverageLLCMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" /> </link:presentationLink> <link:presentationLink xlink:type="extended" xlink:role="http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000051 - Disclosure - Subsequent Events (Details Narrative)"> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_SecuritiesPurchaseAgreementMember" xlink:label="loc_REEDSecuritiesPurchaseAgreementMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_REEDSecuritiesPurchaseAgreementMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_deiLegalEntityAxis" order="20" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_DDSourceofLifeHoldingLtdMember" xlink:label="loc_REEDDDSourceofLifeHoldingLtdMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_REEDDDSourceofLifeHoldingLtdMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="40" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" /> <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" /> <link:loc xlink:type="locator" xlink:href="reed-20230331.xsd#REED_OptionNotesMember" xlink:label="loc_REEDOptionNotesMember" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_REEDOptionNotesMember" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" /> <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" /> <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" /> <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" /> <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" /> <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" /> <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" /> <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" /> <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" /> <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" /> <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" /> </link:presentationLink> </link:linkbase> </XBRL> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208230955088"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>May 15, 2023</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td> <td class="text">10-Q<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td> <td class="text">Mar. 31, 2023<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td> <td class="text">Q1<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td> <td class="text">2023<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td> <td class="text">--12-31<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td> <td class="text">001-32501<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td> <td class="text">REED’S, INC.<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td> <td class="text">0001140215<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td> <td class="text">35-2177773<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td> <td class="text">DE<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td> <td class="text">201 Merritt 7<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td> <td class="text">Norwalk<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td> <td class="text">CT<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td> <td class="text">06851<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td> <td class="text">(800)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td> <td class="text">997-3337<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td> <td class="text">Yes<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td> <td class="text">Yes<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td> <td class="text">Non-accelerated Filer<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td> <td class="text">true<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td> <td class="text">false<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td> <td class="text"> <span></span> </td> <td class="nump">2,602,399<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_AmendmentFlag</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CityAreaCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CoverAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:gMonthDayItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:fiscalPeriodItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:gYearItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:dateItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentTransitionReport</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_DocumentType</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:submissionTypeItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:stateOrProvinceItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCentralIndexKey</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:centralIndexKeyItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityFileNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:fileNumberItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityFilerCategory</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:filerCategoryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:edgarStateCountryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:yesNoItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityRegistrantName</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityShellCompany</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntitySmallBusiness</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:booleanItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dei:employerIdItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_LocalPhoneNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>dei_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:normalizedStringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>R2.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208232300512"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td> <td class="nump">$ 467<span></span> </td> <td class="nump">$ 533<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance of $213 and $252, respectively</a></td> <td class="nump">4,665<span></span> </td> <td class="nump">5,671<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td> <td class="nump">15,301<span></span> </td> <td class="nump">16,175<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td> <td class="nump">601<span></span> </td> <td class="nump">939<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td> <td class="nump">21,811<span></span> </td> <td class="nump">24,095<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation of $867 and $787, respectively</a></td> <td class="nump">686<span></span> </td> <td class="nump">766<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td> <td class="nump">626<span></span> </td> <td class="nump">626<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td> <td class="nump">23,123<span></span> </td> <td class="nump">25,487<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td> <td class="nump">11,165<span></span> </td> <td class="nump">9,805<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td> <td class="nump">467<span></span> </td> <td class="nump">233<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Revolving line of credit, net of capitalized financing costs of $322 and $363, respectively</a></td> <td class="nump">7,593<span></span> </td> <td class="nump">10,974<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Current portion of convertible notes payable, net of debt discount of $670 and $414, respectively</a></td> <td class="nump">5,485<span></span> </td> <td class="nump">2,434<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease liabilities</a></td> <td class="nump">194<span></span> </td> <td class="nump">187<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td> <td class="nump">26,763<span></span> </td> <td class="nump">25,658<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible note payable, net of debt discount of $484 and $562, respectively, less current portion</a></td> <td class="nump">8,526<span></span> </td> <td class="nump">8,092<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, less current portion</a></td> <td class="nump">156<span></span> </td> <td class="nump">207<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td> <td class="nump">35,445<span></span> </td> <td class="nump">33,957<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders’ deficit:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding</a></td> <td class="nump">94<span></span> </td> <td class="nump">94<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $.0001 par value, 180,000,000 shares authorized; 2,602,399 and 2,519,485 shares issued and outstanding, respectively</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td> <td class="nump">115,140<span></span> </td> <td class="nump">114,635<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td> <td class="num">(127,556)<span></span> </td> <td class="num">(123,199)<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders’ deficit</a></td> <td class="num">(12,322)<span></span> </td> <td class="num">(8,470)<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders’ deficit</a></td> <td class="nump">23,123<span></span> </td> <td class="nump">25,487<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Receivable from former related party</a></td> <td class="nump">777<span></span> </td> <td class="nump">777<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Payable to former related party</a></td> <td class="nump">$ 1,859<span></span> </td> <td class="nump">$ 2,025<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Assets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AssetsCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Cash</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Liabilities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>R3.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228010560"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, net of allowance</a></td> <td class="nump">$ 213<span></span> </td> <td class="nump">$ 252<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Property and equipment, accumulated depreciation</a></td> <td class="nump">867<span></span> </td> <td class="nump">787<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsCurrentNet', window );">Capitalized financing costs</a></td> <td class="nump">322<span></span> </td> <td class="nump">363<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt discount current</a></td> <td class="nump">670<span></span> </td> <td class="nump">414<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent', window );">Debt discount, noncurrent</a></td> <td class="nump">$ 484<span></span> </td> <td class="nump">$ 562<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Series A convertible preferred stock, par value</a></td> <td class="nump">$ 10<span></span> </td> <td class="nump">$ 10<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Series A convertible preferred stock, shares authorized</a></td> <td class="nump">500,000<span></span> </td> <td class="nump">500,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Series A convertible preferred stock, shares issued</a></td> <td class="nump">9,411<span></span> </td> <td class="nump">9,411<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Series A convertible preferred stock, shares outstanding</a></td> <td class="nump">9,411<span></span> </td> <td class="nump">9,411<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td> <td class="nump">$ 0.0001<span></span> </td> <td class="nump">$ 0.0001<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td> <td class="nump">180,000,000<span></span> </td> <td class="nump">180,000,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td> <td class="nump">2,602,399<span></span> </td> <td class="nump">2,519,485<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td> <td class="nump">2,602,399<span></span> </td> <td class="nump">2,519,485<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsCurrentNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsCurrentNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>15 <FILENAME>R4.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228298640"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net Sales</a></td> <td class="nump">$ 11,157<span></span> </td> <td class="nump">$ 12,182<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of goods sold</a></td> <td class="nump">8,459<span></span> </td> <td class="nump">9,250<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td> <td class="nump">2,698<span></span> </td> <td class="nump">2,932<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_DeliveryAndHandlingExpense', window );">Delivery and handling expense</a></td> <td class="nump">2,120<span></span> </td> <td class="nump">2,812<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing expense</a></td> <td class="nump">1,447<span></span> </td> <td class="nump">2,178<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td> <td class="nump">1,709<span></span> </td> <td class="nump">2,121<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td> <td class="nump">5,276<span></span> </td> <td class="nump">7,111<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td> <td class="num">(2,578)<span></span> </td> <td class="num">(4,179)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td> <td class="num">(1,779)<span></span> </td> <td class="num">(801)<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="num">$ (4,357)<span></span> </td> <td class="num">$ (4,980)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share – basic and diluted</a></td> <td class="num">$ (1.70)<span></span> </td> <td class="num">$ (2.56)<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding – basic and diluted</a></td> <td class="nump">2,559,855<span></span> </td> <td class="nump">1,947,548<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_DeliveryAndHandlingExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Delivery and handling expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_DeliveryAndHandlingExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GrossProfit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingExpenses</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>16 <FILENAME>R5.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228394448"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Common Stock [Member]</div></th> <th class="th"><div>Preferred Stock [Member]</div></th> <th class="th"><div>Additional Paid-in Capital [Member]</div></th> <th class="th"><div>Retained Earnings [Member]</div></th> <th class="th"><div>Total</div></th> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 94<span></span> </td> <td class="nump">$ 107,246<span></span> </td> <td class="num">$ (103,137)<span></span> </td> <td class="nump">$ 4,203<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td> <td class="nump">1,874,680<span></span> </td> <td class="nump">9,411<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested', window );">Fair value of vested options</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">225<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">225<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Fair value of vested restricted shares granted to officers</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">66<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">66<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Fair value of vested restricted shares granted to officers, shares</a></td> <td class="nump">2,732<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">(2)<span></span> </td> <td class="text"> <span></span> </td> <td class="num">(2)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock, shares</a></td> <td class="num">(265)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Common shares issued for financing costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">37<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">37<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Common shares issued for financing costs, shares</a></td> <td class="nump">2,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">(4,980)<span></span> </td> <td class="num">(4,980)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common shares issued for cash, net of offering costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">5,067<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">5,067<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common shares issued for cash, net of offering costs, shares</a></td> <td class="nump">371,891<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 94<span></span> </td> <td class="nump">112,639<span></span> </td> <td class="num">(108,117)<span></span> </td> <td class="nump">4,616<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2022</a></td> <td class="nump">2,251,038<span></span> </td> <td class="nump">9,411<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 94<span></span> </td> <td class="nump">107,246<span></span> </td> <td class="num">(103,137)<span></span> </td> <td class="nump">4,203<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2021</a></td> <td class="nump">1,874,680<span></span> </td> <td class="nump">9,411<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 94<span></span> </td> <td class="nump">114,635<span></span> </td> <td class="num">(123,199)<span></span> </td> <td class="num">(8,470)<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2022</a></td> <td class="nump">2,519,485<span></span> </td> <td class="nump">9,411<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested', window );">Fair value of vested options</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">229<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">229<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Fair value of vested restricted shares granted to officers</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">4<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">4<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Fair value of vested restricted shares granted to officers, shares</a></td> <td class="nump">750<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">(1)<span></span> </td> <td class="text"> <span></span> </td> <td class="num">(1)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock, shares</a></td> <td class="num">(274)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Common shares issued for financing costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">273<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">273<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Common shares issued for financing costs, shares</a></td> <td class="nump">82,438<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="num">(4,357)<span></span> </td> <td class="num">(4,357)<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 94<span></span> </td> <td class="nump">$ 115,140<span></span> </td> <td class="num">$ (127,556)<span></span> </td> <td class="num">$ (12,322)<span></span> </td> </tr> <tr class="rc"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2023</a></td> <td class="nump">2,602,399<span></span> </td> <td class="nump">9,411<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital share based compensation stock options vested.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharesOutstanding</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>17 <FILENAME>R6.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228506576"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td> <td class="num">$ (4,357)<span></span> </td> <td class="num">$ (4,980)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation</a></td> <td class="nump">47<span></span> </td> <td class="nump">25<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td> <td class="nump">281<span></span> </td> <td class="nump">65<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of prepaid financing costs</a></td> <td class="text"> <span></span> </td> <td class="nump">431<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_FairValueOfVestedOptions', window );">Fair value of vested options</a></td> <td class="nump">229<span></span> </td> <td class="nump">225<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_FairValueOfVestedRestrictedSharesGrantedToOfficers', window );">Fair value of vested restricted shares granted to officers</a></td> <td class="nump">4<span></span> </td> <td class="nump">66<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_FairValueOfCommonSharesIssuedAsFinancingCosts', window );">Fair value of common shares issued as financing costs</a></td> <td class="text"> <span></span> </td> <td class="nump">37<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Change in allowance for doubtful accounts</a></td> <td class="num">(39)<span></span> </td> <td class="nump">62<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-downs</a></td> <td class="num">(228)<span></span> </td> <td class="nump">10<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_AccrualOfInterestOnConvertibleNote', window );">Accrued interest</a></td> <td class="nump">1,113<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td> <td class="nump">1,044<span></span> </td> <td class="num">(40)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td> <td class="nump">1,102<span></span> </td> <td class="num">(3,810)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td> <td class="nump">338<span></span> </td> <td class="num">(617)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets', window );">Decrease in right of use assets</a></td> <td class="nump">32<span></span> </td> <td class="nump">27<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td> <td class="nump">1,360<span></span> </td> <td class="nump">5,926<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td> <td class="nump">235<span></span> </td> <td class="nump">403<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Lease liabilities</a></td> <td class="num">(44)<span></span> </td> <td class="num">(37)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td> <td class="nump">1,117<span></span> </td> <td class="num">(2,207)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from line of credit</a></td> <td class="nump">8,699<span></span> </td> <td class="nump">14,508<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on line of credit</a></td> <td class="num">(12,120)<span></span> </td> <td class="num">(17,212)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible note payable, net of expenses</a></td> <td class="nump">2,405<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock</a></td> <td class="text"> <span></span> </td> <td class="nump">5,067<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td> <td class="num">(1)<span></span> </td> <td class="num">(2)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Amounts from former related party, net</a></td> <td class="num">(166)<span></span> </td> <td class="num">(81)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td> <td class="num">(1,183)<span></span> </td> <td class="nump">2,280<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash</a></td> <td class="num">(66)<span></span> </td> <td class="nump">73<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at beginning of period</a></td> <td class="nump">533<span></span> </td> <td class="nump">49<span></span> </td> <td class="nump">$ 49<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at end of period</a></td> <td class="nump">467<span></span> </td> <td class="nump">122<span></span> </td> <td class="nump">$ 533<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td> <td class="nump">$ 390<span></span> </td> <td class="nump">$ 256<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_AccrualOfInterestOnConvertibleNote"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrual of interest on convertible note.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_AccrualOfInterestOnConvertibleNote</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_FairValueOfCommonSharesIssuedAsFinancingCosts"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of common shares issued as financing costs.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_FairValueOfCommonSharesIssuedAsFinancingCosts</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_FairValueOfVestedOptions"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested options.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_FairValueOfVestedOptions</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_FairValueOfVestedRestrictedSharesGrantedToOfficers"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested restricted shares granted to officers.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_FairValueOfVestedRestrictedSharesGrantedToOfficers</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of right of use of asset.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestPaidNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483080/330-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>18 <FILENAME>R7.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237421024"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td> <td class="text"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zC5sNFhQheBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_822_zEyCKqV7mUzi">Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zWaZuAbLpBJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zx6bm5chSKie">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on May 15, 2023. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2023, and the results of its operations and its cash flows for the three months ended March 31, 2023 and 2022. The balance sheet as of December 31, 2022 is derived from the Company’s audited financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--GoingConcernPoliciesTextBlock_zspy2yQKkutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_ziCBtRErE2Ll">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the three months ended March 31, 2023, the Company recorded a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20230101__20230331_zSZndycwUAX7" title="Net income loss">4,357</span>, and at March 31, 2023, had a stockholders’ deficit of $<span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20230331_z4rTTYrnyWhi">12,322</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2022, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, we had a cash balance of $<span id="xdx_90A_eus-gaap--Cash_iI_pn3n3_c20230331_z1RfR6k1KJ07" title="Cash">467</span>, with $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331_zkYNTPLx70ti" title="Line of credit facility, borrowing capacity">62</span> of current availability, and $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331_zbG85NCkH8nc" title="Line of credit facility, additional borrowing capacity">5,084</span> of additional borrowing capacity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--CovidNineteenConsiderationPolicyTextBlock_zr2RZDKAtlub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zoQsuS6IQL42">Recent Trends - Market Conditions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2022, the COVID-19 pandemic continued to impact our operating results and the Company anticipates a residual effect for the balance of the year. In addition, the pandemic could cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively affects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow during the first quarter of 2023, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations. We expect the inflationary trends and supply chain pressures to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended March 31, 2023, the Company experienced moderation from the elevated freight costs experienced in 2022. The average cost of shipping and handling for the period ended March 31, 2023, was $<span id="xdx_90A_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20230101__20230331_z9PPrSfmlsDd" title="Shipping and handling costs">3.46</span> per case, as compared to $<span id="xdx_90B_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20220101__20220331_zr3s93VrjdA3" title="Shipping and handling costs">3.90</span> per case for the period ended March 31, 2022. Although the Company has experienced decreases in freight costs over the last three quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. Although, the Company has been negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company has experienced moderation in inflation and anticipates this to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and protect our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through March 31, 2023, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part to be responsible to our employees and business partners in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--ReverseStockSplitPolicyTextBlock_zcJIb3XlkaX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrnwZGZVIuLb">Reverse Stock Split</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At a special meeting of shareholders held on January 24, 2023, the Company’s shareholders granted the Company’s board of directors the discretion to effect a reverse stock split of the common stock through an amendment to the Company’s Certificate of Incorporation, as amended, at a ratio of any ratio not less than <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20240122__20240124__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGXsDvSvofih" title="Reverse stock split">1-for-6 and not more than 1-for-50</span>, at any time on or prior to January 24, 2024, with the exact ratio to be set at a whole number within this range by the board of directors in its sole discretion. On January 25, 2023, the Company announced that its board of directors approved a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230123__20230125_zX0vqkPDiiTa" title="Reverse stock split">1-for-50 reverse stock split</span> of the Company’s issued and outstanding shares of common stock, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230125_zk1kPlWomdYg" title="Common stock par value">0.0001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized number of shares of common stock were not affected by the reverse stock split. No fractional shares were issued in connection with the reverse stock split, as all fractional shares were rounded up to the next whole share. Accordingly, all share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the above-described reverse stock split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zIV9whzmHNF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWsVc4Z17RCi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zRPXtDWYnH8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zKLte9A4xSoa">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztBZdn4dRhzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zFtoNpuLA6J6">Loss per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the periods ended March 31, 2023 and 2022, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:</span></p> <p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zb1wya13MRa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zkdPk4CYZAyk" style="display: none">Schedule of Potentially Dilutive Securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPEXumPr24Ai" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220331_zFlbhz4U0Wpb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQfXVgvmSk67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">276,715</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_ztEgUXlVNqIk" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">174,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,904</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zwYMiz0YzYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,257,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zarSidTOZeKj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_z5xumX8PAtmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock equivalent of Series A Convertible Preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,669,360</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">487,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zVOct0kq03V8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfLjV5frfB7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zcYAl67biuub">Stock Compensation Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation</i> whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zPqvbZHo5Mn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zMHSPY5jtJQb">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $<span id="xdx_90F_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zlyI0xGE7sIe" title="Advertising costs">55</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20220331_zVRPF0CL1DTf" title="Advertising costs">312</span> for the three months ended March 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zSJNEYtSF8th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zzuqbLkSRs0c">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the three months ended March 31, 2023, the Company’s two largest customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zhjWD7A0vtC3" title="Concentration risk percentage">18</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z8PY15ZIt8F7" title="Concentration risk percentage">13</span>% of net sales, respectively. During the three months ended March 31, 2022, the Company’s two largest customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zQRhjXHwYAJe" title="Concentration risk percentage">18</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zu6OK4kd7j5e" title="Concentration risk percentage">12</span>% of net sales, respectively. No other customers exceeded 10% of net sales in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2023, the Company had accounts receivable from two customers which comprised <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkZGEPpt3xm" title="Concentration risk, percentage">18</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFMIAIE4P3W7" title="Concentration risk, percentage">11</span>% of its gross accounts receivable. As of December 31, 2022, the Company had accounts receivable from two customers which comprised <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPU0rP4JquH2" title="Concentration risk, percentage">19</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzI3sj3WGlrl" title="Concentration risk, percentage">11</span>% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and the year ended December 31, 2022, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company utilizes co-packers to produce <span id="xdx_90A_ecustom--PercentageOfCoPackersProducts_pid_dp_uPure_c20230101__20230331_zRozQ453RjIh" title="Percentage of co-packers products">100</span>% of its products. The Company has long-standing relationships with two different co-packers, and in conjunction with the sale of its manufacturing plant we entered into a third co-packing agreement with California Custom Beverage LLC (“CCB”), the purchaser of the plant (see Note 11). CCB is <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zBn8F4bDgPEg" title="Concentration risk, percentage">100</span>% owned by Chris Reed, founder of the Company and formerly Chief Executive Officer, Chairman, director, and most recently, Chief Innovation Officer. Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zPrrhxezrSk2" title="Percentage of sale accounted to customer">11</span>% of all purchases. During the three months ended March 31, 2022, the Company’s largest vendor accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zXFarhHr1lO4" title="Percentage of sale accounted to customer">13</span>% of all purchases. No other vendors exceeded 10% of all purchases in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zf0Pma4juc5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zdPV50cba8i5">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIVAdhofeuV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z0cRHst8Nmt8">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04 “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation— Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815- 40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). ASU 2021-04 provides guidance as to how an issuer should account for a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option (i.e., a warrant) that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument. An issuer should measure the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company adopted ASU 2021-04 effective January 1, 2022. The adoption of ASU 2021-04 did not have any impact on the Company’s financial statement presentation or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2016, the FASB issued ASU 2016-13, <i>Measurement of Credit Losses on Financial Instruments</i>. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company adopted this standard effective January 1, 2023 and there was no material impact of adopting this standard on the Company’s financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.</span></p> <p id="xdx_85C_zgmVICqzkfB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>19 <FILENAME>R8.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208230922368"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td> <td class="text"><p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_znmEgHHFV5ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_826_zWee98NzAJwb">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrOqFredCLSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z2ZtBxxqOpyd" style="display: none">Schedule of Inventory</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zafOs6QsMgCb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zJVVw8c0UK01" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz4dt_zAVtgXZcRXP7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Raw materials and packaging</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,178</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,526</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz4dt_zKLsmCp6fM91" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Finished products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,649</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz4dt_z0neJrSoJwdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,301</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,175</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zrUMUCeUdGZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>20 <FILENAME>R9.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228322288"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td> <td class="text"><p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z2S1mUTouBI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_828_zbvglWbZ06zf">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_ztP0RtqFosQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zaqMbEpbSude" style="display: none">Schedule of Property and Equipment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331_zu3MX6JniaP1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zBfjOndsQvSc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsUnderOperatingLeasesMember_zuRJaL5Vb8qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Right-of-use assets under operating leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerHardwareAndSoftwareMember_zSRTFox0Qpcj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Computer hardware and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zC2U319Ct8tc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Machinery and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzorg_z2DlSRSuHwT" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzorg_zKqyPsJM7rF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(867</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(787</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzorg_zUbv2WIz6c36" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Net book value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">686</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_ziALRRfNGQo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months ended March 31, 2023 and 2022 was $<span id="xdx_90C_eus-gaap--Depreciation_pn3n3_c20230101__20230331_zEJDRS9wj7sd" title="Depreciation expense">47</span> and $<span id="xdx_902_eus-gaap--Depreciation_pn3n3_c20220101__20220331_z4e9May3G9z2" title="Depreciation expense">25</span>, respectively, and amortization of right-of-use assets for the three months ended March 31, 2022 and 2021 was $<span id="xdx_90D_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20230101__20230331_zotzQKuBMKmf" title="Amortization of right-of-use assets">32</span> and $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20220101__20220331_zN7dzsquaIZi" title="Amortization of right-of-use assets">27</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>21 <FILENAME>R10.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228322160"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td> <td class="text"><p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_z37xqau2dXG7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82D_z2MZ2ZzwSKmd">Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_z6t8G3PlNVMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zA3mQEGNTkea" style="display: none">Summary of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230331_zFYV6NsNhhj3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zlOzhmua1Czg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--IndefiniteLivedTradeNames_iI_pn3n3_maILIAEzdvn_zckpm6vOo64j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Brand names</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IndefiniteLivedTrademarks_iI_pn3n3_maILIAEzdvn_zNNb6IH2Kp66" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Trademarks</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzdvn_z7Kr9ehUn2ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zomCzP7KgdJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>22 <FILENAME>R11.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237580352"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Line of Credit<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">Line of Credit</a></td> <td class="text"><p id="xdx_80A_eus-gaap--ShortTermDebtTextBlock_zNJOqn5RLmY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_828_zr1aGtU0Kzp1">Line of Credit</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zodfXAcYmQgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under the Company’s credit facilities are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_z6xvmyYxVxo4" style="display: none">Schedule of Amount Outstanding Under Credit Facilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Line of credit – Alterna Capital Solutions</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zmBayIASHv3k" style="width: 16%; text-align: right" title="Total">7,915</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zurvFg2UTC3f" style="width: 16%; text-align: right" title="Total">11,337</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20230331_zyGgKRWEV9Q" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(322</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20221231_zPKbkmNkCOxc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(363</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331_zJItTVBCb83l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">7,593</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231_zdYYMKYCGB6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">10,974</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zfUiBbex1h8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Alterna Capital Solutions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 28, 2022, the Company entered into a financing agreement with Alterna Capital Solutions (“ACS”), for a line of credit to replace its existing credit facility. The ACS line of credit is for a term of <span id="xdx_906_eus-gaap--DebtInstrumentTerm_dtY_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ztGlDaQPT36" title="Debt instrument, term">3</span> years, provides for borrowings of up to $<span id="xdx_901_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z8e70GoXRY1e" title="Line of credit facility, maximum borrowing capacity">13,000</span>, and is secured by eligible accounts receivable and inventory. An over advance rider provides for up to $<span id="xdx_904_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_pn3n3_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ze5QVlZC2MZe" title="Line of credit facility, maximum amount outstanding during period">400</span> of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zoBV64UPchxc" title="Line of credit facility, maximum borrowing capacity">13,000</span>. At March 31, 2023, $<span id="xdx_903_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zHsDEiNJHOZb" title="Line of credit facility, borrowing capacity">62</span> of current availability and $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zJgOPAv2gQ5c" title="Line of credit facility, borrowing capacity">5,084</span> of borrowing capacity was available under the financing agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zhbBKtNJwtsa" title="Line of credit facility, interest rate description">Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (12.75% at March 31, 2023 and 12.25% at December 31, 2022). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.40% at March 31, 2023 and 12.90% at December 31, 2022). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2023 and 18.00% at December 31, 2022). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility</span>. A loan balance of less than $<span id="xdx_90F_eus-gaap--LineOfCredit_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zG2b2rsFNHY2" title="Line of credit">1,500</span> will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $<span id="xdx_909_ecustom--LineOfCreditMonitoringFee_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zZXoKlI3BwF8" title="Line of credit monitoring fee">1</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred $<span id="xdx_90C_eus-gaap--DirectOperatingCosts_pn3n3_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zrXQgnPUeqlh" title="Direct operating costs">483</span> of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the <span id="xdx_907_ecustom--AmortizationOfLineOfCreditPeriod_dtY_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_znsxkhOE7iE2" title="Amortization of line of credit period">3</span>-year life of the ACS agreement. The unamortized debt discount balance was $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20220101__20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zf8QBh5MRms6" title="Amortization of debt discount">363</span> at December 31, 2022. For the three months ended March 31, 2023, amortization of debt discount was $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20230101__20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ztgKHckHYA8k" title="Amortization of debt discount">41</span>, and as of March 31, 2023, the remaining unamortized debt discount balance is $<span id="xdx_904_ecustom--DebtInstrumentRemainingUnamortizedDiscount_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zMx18RJxVbdg" title="Remaining unamortized debt discount amount">322</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>23 <FILENAME>R12.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237493856"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Secured Convertible Notes Payable<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Secured Convertible Notes Payable</a></td> <td class="text"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zxQVGmiUI6S5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_829_z7pSKLZYqBhj">Secured Convertible Notes Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zoZWIjZuktb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under secured convertible notes payable are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zNi9ZTxIlOl9" style="display: none">Schedule of Debt</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230331_zbgWjfKK4fK3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_ztfZ23A4fGK7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--SecuredDebt_iI_pn3n3_maCNPzwQW_zgEzJGrRTW47" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Secured Convertible Note Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,450</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_maCNPzwQW_zgRe811erj94" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,052</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredFinanceCostsNet_iNI_pn3n3_di_msCNPzwQW_zN8aolXsBwHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(976</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ConvertibleNotesPayable_iTI_pn3n3_mtCNPzwQW_zm8UYqldvhYb" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,011</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iNI_pn3n3_di_zsXNfAVxRjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,485</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,434</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_z59erWFtAdA8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,526</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,092</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zVJAbGfUC4y6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Secured Convertible Note Payable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, the Company entered into a note purchase agreement and agreed to issue $<span id="xdx_909_eus-gaap--SecuredDebt_iI_pn3n3_c20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zFU3sHUMxkW7" title="Secured convertible promissory notes">11,250</span> of secured convertible promissory notes (the “Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateTerms_pp0d_c20220508__20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_ze54X7u3cIfi" title="Debt instrument rate terms">The Notes bear interest at a rate of 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the Notes)</span>. The Notes are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with ACS, the Company’s existing secured lender (see Note 5). The Notes mature on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20220508__20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z4d4XtN6XGxf" title="Debt instrument maturity date">May 9, 2025</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 9, 2022, the Company issued $<span id="xdx_905_eus-gaap--SecuredDebt_iI_pn3n3_c20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zzl8HUigHIPh" title="Secured convertible promissory notes">11,250</span> of Notes to Whitebox. In September 2022, the Company issued an additional $<span id="xdx_90F_eus-gaap--SecuredDebt_iI_pn3n3_c20220930__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_zxwjDChC0Rw3" title="Secured convertible promissory notes">2,500</span> of Notes to Whitebox (the “September 2022 Notes”). The net proceeds from the issuance of the Notes and September 2022 Notes, after deducting placement agent fees and other debt issuance costs, was approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_c20220901__20220930__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_z8uvXtVIVNia" title="Proceeds from issuance of notes">12,430</span>. In November 2022, the Company paid off the $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_dd_c20221101__20221130__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_zMTJK7UpYgle" title="Common stock paid, value">2,500</span> of September 2022 Notes in cash. Beginning in August 2022, $<span id="xdx_908_eus-gaap--SecuredDebt_iI_pn3n3_c20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z3jtOEwG93q1" title="Secured convertible promissory notes">11,250</span> of the Notes have an amortization feature which requires the Company to make monthly payments of principal of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zlfuhkXjAYu1" title="Monthly payment">200</span> plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company. Amortization payments that are paid in shares are priced at <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zwHlbqaoaRTa" title="Weighted average interest">90</span>% of the average of the daily volume weighted average prices of the Company’s common stock during the five trading days prior to the date of amortization payment. During the year ended December 31, 2022, the Company made monthly amortization principal payments aggregating $<span id="xdx_90A_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYQOLANw0jQ5" title="Principal payment">800</span>, made up of $<span id="xdx_905_eus-gaap--Cash_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zagOV5Q8WJha" title="Cash">600</span> in cash, and the issuance of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_dd_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zbw9kcUfYoef" title="Common stock paid, shares">32,362</span> shares of common stock valued at $<span id="xdx_909_eus-gaap--CommonStockValue_iI_pn3n3_dd_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zRPHtNJAcVTh" title="Common stock value">200</span>. At December 31, 2022, the principal balance of the Notes was $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zeEn0iBL3Ryj" title="Principal balance">10,450</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2023, the Company entered into a Partial Option Exercise and Second Amendment to the <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zDPv79bHi9A8" title="Debt instrument rate">10</span>% Convertible Notes with Whitebox. The Notes were amended so if the Company experiences a fundamental change as defined, the holders of the notes have the right to require the Company to repurchase the notes for cash at a repurchase price equal to <span id="xdx_90F_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20230209__20230210__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYrD31geg427" title="Percentage of repurchase price">110</span>% (amended from <span id="xdx_909_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_znNwRJvdDj44" title="Percentage of repurchase price">100</span>%) of the principal amount, plus accrued interest. In addition, Whitebox exercised a partial option to purchase $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_c20230209__20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_zUa3qDJZrB9l" title="Options to purchase">2,550</span> of additional notes (the “February 2023 Notes”) from the Company. The February 2023 Notes bear interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_z3wCC1BCdqu8" title="Debt instrument rate">10</span>% per annum. payable in cash and mature on June 20, 2023. No amortization payments (as defined in the Notes) are payable on the February 2023 Notes, and the February 2023 Notes may be prepaid without premium or penalty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 13, 2023, the Company entered into a Limited Waiver and Deferral Agreement with Whitebox. Whitebox waived the Company’s covenant violation of its Excess ABL Amount at November 30, 2022, December 31, 2022, and January 31, 2023, and deferred payment of the <span id="xdx_906_ecustom--PercentageForDeferredPayment_iI_pid_dp_uPure_c20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zHo30icII6ma" title="Percentage for deferred payment">10</span>% fee for the Excess ABL Amount until June 2023. In addition, Whitebox also temporarily waived any requirement that the Company repurchase the Notes in the event of fundamental change (as defined in the Notes), through April 1, 2023, subject to the terms and conditions contained therein. As an inducement, the Company issued an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230213__20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zxe2LFj0Nol7" title="Number of common stock issued">82,438</span> shares of common stock to the holders with a fair value of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230213__20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zmpJX8b6wm3g" title="Number of common stock issued, value">273</span>. These costs have been capitalized and are being amortized over the term of the waiver. For the three months ended March 31, 2023, amortization of interest was $<span id="xdx_907_eus-gaap--InterestExpenseDebtExcludingAmortization_pn3n3_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zAhBHyduL0O6" title="Amortization of interest">96</span>. The shares issued and the shares of common stock issuable upon conversion of the Option Notes are registrable and subject to that certain Registration Rights Agreement dated May 9, 2023. At March 31, 2023, the principal balance of the Notes and February 2023 Notes was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_z3uULc1L2IWg" title="Principal balance">13,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon conversion, holders of the Note are entitled to receive an interest make-whole payment, as defined. The make-whole amount is equal to the sum of the remaining scheduled payments of interest on the Notes to be converted that would be due if such notes matured <span id="xdx_905_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20230213__20230213_z5diV9UAXNj4" title="Maturity date">May 9, 2025</span>, payable, at the Company’s option in cash or in shares of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the balance of accrued interest was $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zvowSmVx3IN7" title="Accrued interest">1,052</span>. During the three months ended March 31, 2023, the Company recorded interest of $<span id="xdx_90B_eus-gaap--InterestExpense_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z9TsBWmE827e" title="Interest expense">1,113</span>, made up of $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zgtqbHI9rKg8" title="Interest on the notes">366</span> of interest on the Notes, and $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSyDe3jWCuVk" title="Whole interest">747</span> related to the excess line of credit debt fee. At March 31, 2023, the balance of accrued interest was $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_znZSVlAE8VR4" title="Accrued interest">2,165</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentType_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zvpgoObs8zmc" title="Debt instrument conversion, description">The initial conversion rate of the Notes is 0.08306 shares of the Company’s common stock per one dollar of principal converted, or approximately $12.04 per share, subject to customary anti-dilution adjustments. In addition, if certain corporate events occur that constitute a make-whole fundamental change as defined, then the note holders are, under certain circumstances, are entitled to an increase in the conversion rate, limited to 0.12155 shares of Common Stock per one dollar of principal, or approximately $8.23 per share</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to settle conversions and make amortization payments and interest make-whole payments using shares of the Company’s common stock is subject to certain limitations set forth in the Notes. If the Company experiences a fundamental change as defined, the holders of the notes have the right to require the Company to repurchase the notes for cash at a repurchase price equal to <span id="xdx_904_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zMWnY49bF8Ah" title="Percentage of repurchase price">100</span>% of the principal amount, plus accrued interest thereon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023, the Notes, including accrued interest, are convertible into <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z69rYm3BuGq5" title="Debt conversion into shares">1,257,491</span> shares of the Company’s common stock pursuant to a share conversion cap limit as defined in the Notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unamortized debt discount was $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zAY7MMM0t0Jk" title="Unamortized debt discount amount">976</span> at December 31, 2022. During the three months ended March 31, 2023, the Company incurred $<span id="xdx_907_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zWZlZxGE0KX9" title="Direct costs">145</span> of direct costs of the transactions, consisting primarily of placement agent fees and other offering expenses and the issuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--HoldersMember_zOZvKpsijZt7" title="Number of common stock issued">82,438</span> valued at $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--HoldersMember_zc5oVFlabMYk" title="New issuance of common stock">273</span> as inducement for the aforementioned waiver. These costs have been capitalized and are being amortized over the term of the Notes and waiver period. For the three months ended March 31, 2023, amortization of debt discount was $<span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zEAmjzHnVOUi" title="Amortization of debt discount">240</span>, and as of March 31, 2023, the remaining unamortized debt discount balance is $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zkEp0BRbktOh" title="Unamortized debt discount amount">1,154</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>24 <FILENAME>R13.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237505776"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Liabilities<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_DisclosureLeasesLiabilitiesAbstract', window );"><strong>Leases Liabilities</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases Liabilities</a></td> <td class="text"><p id="xdx_804_eus-gaap--LesseeOperatingLeasesTextBlock_zPYP6birGRs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_829_zJFAa3M0l19j">Leases Liabilities</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, lease costs totaled $<span id="xdx_90F_eus-gaap--LeaseCost_pn3n3_c20230101__20230331_zjYQox5l5S0k" title="Lease cost">32</span> and $<span id="xdx_90F_eus-gaap--LeaseCost_pn3n3_c20220101__20220331_ztt1tK7AkWGh" title="Lease cost">27</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, operating lease liabilities totaled $<span id="xdx_909_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20221231_z8M19u1X83Nb" title="Operating leases liability">394</span>. During the three months ended March 31, 2023, the Company made payments of $<span id="xdx_909_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20230331_zd8R4pDfSWp6" title="Payments of operating lease liability">44</span> towards its operating lease liability. As of March 31, 2023, operating lease liabilities totaled $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20230331_z8Ai7jRRC1Hc" title="Operating leases liability">350</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the weighted average remaining lease terms for an operating lease are <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331_zEJZHrfoJUBc" title="Weighted average remaining lease term for operating lease">1.76</span> years. As of March 31, 2023, the weighted average discount rate on the operating lease is <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zmwmr4X2epW8" title="Weighted average discount rate for operating lease">12.60</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_DisclosureLeasesLiabilitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_DisclosureLeasesLiabilitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>25 <FILENAME>R14.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228572576"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder’s Equity<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholder’s Equity</a></td> <td class="text"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ze8eFSXJhFwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_827_z8jqMLZVZi49">Stockholder’s Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company repurchased <span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20230331__srt--TitleOfIndividualAxis__srt--OfficerMember_zfXCwokrrJw6" title="Stock repurchased, shares">274</span> shares of common stock from an officer for $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__srt--OfficerMember_zLWlAQbS37Ac" title="Stock repurchased, value">1</span> based on the market value of share on the date repurchased. The Company retired the shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EquityAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>26 <FILENAME>R15.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228572576"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td> <td class="text"><p id="xdx_80F_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z6zshYg2zRA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_82B_zM6GBH2EBPp9">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Restricted common stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zsFwyY3jB2c4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes restricted stock activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zP5XnOXUCWj1" style="display: none">Summary of Non-vested Restricted Stock Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Issuable<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value<br/> at Date of<br/> Issuance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> Average <br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Balance, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhYwL9dgtte" style="width: 12%; text-align: right" title="Unvested Shares, beginning balance">1,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKAygSFawnc3" style="width: 12%; text-align: right" title="Issuable Shares, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iS_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjmeN6GaKck1" style="width: 12%; text-align: right" title="Fair Value at Date of Issuance, beginning balance">26.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhxsnUtxjUd" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, beginning balance">44.75</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPOTajjURMtg" style="text-align: right" title="Unvested Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0794">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zTAfL3JeBBUd" style="text-align: right" title="Issuable Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziUSxI8gRGz5" style="text-align: right" title="Fair Value at Date of Issuance, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0798">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjS4kUDx2o99" style="text-align: right" title="Unvested Shares, Vested">(750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zysKmil7Odh7" style="text-align: right" title="Issuable Shares, Vested">750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoMYZGIy99m2" style="text-align: right" title="Fair Value at Date of Issuance, Vested"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSiZbyHdPTgb" style="text-align: right" title="Unvested Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zq5W7F6eoxX4" style="font-size: 11pt; text-align: right" title="Issuable Shares, Forfeited"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></span></td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9dcnj3qlqu" style="text-align: right" title="Fair Value at Date of Issuance, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z0InI5dTzM5a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unvested Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zIHWuo5JdpD1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Issuable Shares, Issued">(750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBd6N9SH05ma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value at Date of Issuance, Issued">(6.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zyKUsCOXHnk6" style="border-bottom: Black 2.5pt double; text-align: right" title="Unvested Shares, ending balance">710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoWWvVlsSbr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Issuable Shares, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iE_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSDcwkdf21Ki" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value at Date of Issuance, ending balance">20.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhGBB8xjbMO6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, ending balance">44.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zWnPAZCnuHDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total fair value of restricted common stock vesting during the three months ended March 31, 2023 and 2022, was $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zsRgMCXHOCF9" title="Number of restricted shares, value">4</span> and $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKepQwqMJnC1" title="Number of restricted shares, value">66</span>, respectively, and is included in general and administrative expenses in the accompanying statements of operations. As of March 31, 2023, the amount of unvested compensation related to issuances of restricted common stock was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z4DoB3z18R11" title="Aggregate value of unvested compensation">20</span>, which will be recognized as an expense in future periods as the shares vest. When calculating basic loss per share, these shares are included in weighted average common shares outstanding from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares outstanding as of their grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock options</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zBpYMW1oi4fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes stock option activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zVc2uhVTtMa1" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms <br/> (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2SNl00YKn1c" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning balance">164,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuUJaWCYKwP" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning">48.90</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSd9kSxrgQsc" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning">7.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9EmoXyXsnDe" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0840">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVoZWFJp3EHb" style="text-align: right" title="Shares, Granted">10,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvW0t2ZWOY98" style="text-align: right" title="Weighted-Average Exercise Price, Granted">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAF94qZxbk5" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvMl2ST4FSa" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkX6XQbtmmOc" style="text-align: right" title="Shares, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9YTMEtHPXIc" style="text-align: right" title="Weighted-Average Exercise Price, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vested forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxhyAq7UYtMj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvEDp1qr8MMa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zokyJJjusar5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">174,460</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIjfxCeyd1Ak" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending">46.34</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z273mWlE5KT" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending">7.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFRVpb2VdES" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Ending"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIwpHC2j7xjj" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Exercisable">102,520</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsHxWcMvpyqa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">54.41</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z63qbKqbFRPf" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">6.86</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znmhvM4p4fUk" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zxEMRl2eldLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company approved options exercisable into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember_zV0MmXgXXbv6" title="Options exercisable">10,037</span> shares to be issued pursuant to Reed’s 2020 Equity Incentive Plan. <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_za5WHnlcwQp5" title="Stock issued during period shares employee benefit plan">10,037</span> options were issued to employees, <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20230331_zVuH69qFVCRf" title="Number of stock option shares vested">5,016</span> options vesting annually over a <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zT4pCJzx1Tv7" title="Vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0880">four</span></span>-year vesting period, and <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z373V8tAnIs" title="Number of stock option shares vested">5,021</span> options vesting based on performance criteria to be established by the board of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The stock options are exercisable at a price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20230331_zsCtKT0ar9Lb" title="Stock options exercisable price">4.50</span> per share and expire in <span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dc_c20230101__20230331_zHo5iTH38Ob5" title="Expiration years">ten years</span>. The total fair value of these options at grant date was approximately $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20220101__20221231_z5zmpSbHz3Qi" title="Options grant date">32</span>, which was determined using a Black-Scholes-Merton option pricing model with the following average assumption: stock price of $<span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20230331_zi0S3GVSDUDd" title="Stock price">4.50</span> share, expected term of six years, volatility of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230331_zDSpvmuhEGUd" title="Volatility">82</span>%, dividend rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230331_zge1amAGgO13" title="Dividend rate">0</span>%, and weighted average risk-free interest rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230331_zQoY9q1yNYUl" title="Weighted average risk-free interest rate">3.59</span>%. The expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future; and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, the Company recognized $<span id="xdx_908_ecustom--FairValueOfVestedStockOption_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zC2nFxDUjdZg" title="Fair value of vested stock option">229</span> and $<span id="xdx_90D_ecustom--FairValueOfVestedStockOption_pn3n3_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zOvXuRUIkVbg" title="Fair value of vested stock option">225</span> of compensation expense relating to vested stock options. As of March 31, 2023, the aggregate amount of unvested compensation related to stock options was approximately $<span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z6Yt9Fc6m78d" title="Aggregate value of unvested compensation">1,039</span> which will be recognized as an expense as the options vest in future periods through March 28, 2027.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2023, which was $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdVPz8v6Nh1c" title="Stock price">3.45</span>, and the exercise price of the outstanding stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>27 <FILENAME>R16.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208233856768"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_DisclosureStockWarrantsAbstract', window );"><strong>Stock Warrants</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_StockWarrantsTextBlock', window );">Stock Warrants</a></td> <td class="text"><p id="xdx_805_ecustom--StockWarrantsTextBlock_zVk03cY1LBbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_82A_zRMkiE0Cjlha">Stock Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zkE55migrDKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s warrant activity during the three months ended March 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zedw11Hunbfi" style="display: none">Schedule of Warrant Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Remaining Contractual Terms (Years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBkeF3h1MYT4" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning Balance">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znnHiATgbCa" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding Beginning Balance">16.99</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z40a4hORR28" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance">4.20</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zEifyPmGoDOk" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGranted_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSzD7jaCcudj" style="text-align: right" title="Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zN0IwnPs5pNb" style="text-align: right" title="Weighted-Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercised_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zA8vUHqIWXZe" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z7dQrzo0QdOh" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw8mzZ4x5VX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zvA6Dbjp5ff3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUJtEiWUMC4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zikpFePQ6DK7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znJ4KgsFTRZi" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zuFQBiv9kFna" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisable_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_ziurI0G7Vyo2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Exercisable, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUnbOsyAA1q5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90C_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zdFeJPoEKYE9" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zc2ArIYcTpDf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zLT6poeJt3dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2023, which was $<span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--StockWarrantsMember_zffRYNkZXNGf" title="Share price">3.45</span>, and the exercise price of the Company’s warrants to purchase common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_DisclosureStockWarrantsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_DisclosureStockWarrantsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_StockWarrantsTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Warrants [Text Block]</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_StockWarrantsTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>28 <FILENAME>R17.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208233856768"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions with California Custom Beverage, LLC, former related party<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Transactions with California Custom Beverage, LLC, former related party</a></td> <td class="text"><p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zm66y4MsHNVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_82A_zpGKqtA0piea">Transactions with California Custom Beverage, LLC, former related party</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a <span id="xdx_906_ecustom--RoyaltyPercentage_iI_dp_uPure_c20181231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zmUY9VeOlmb" title="Royalty percentage">5</span>% royalty through 2021 on certain private label sales made by CCB.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, the Company incurred co-packing fees due to CCB of $<span id="xdx_90F_eus-gaap--OtherLiabilities_iI_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z0tzYQyOBWF1" title="Copacking fees">428</span> and $<span id="xdx_901_eus-gaap--OtherLiabilities_iI_pn3n3_c20220331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z6TPwRSHF008" title="Copacking fees">636</span>, respectively. As of March 31, 2023 and 2022, the aggregate of co-packing fees payable to CCB were $<span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zlRtYXBO9zlg" title="Notes payable">1,859</span> and $<span id="xdx_904_eus-gaap--NotesPayable_iI_pn3n3_c20220331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zdPQTTiu7kW8" title="Notes payable">2,025</span>, respectively. At March 31, 2023 and December 31, 2022, the Company had also recorded receivables from CCB of $<span id="xdx_907_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zTNBmUEcepnb" title="Receivables">1,315</span> and $<span id="xdx_90C_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zfLN8yIbAP6e" title="Receivables">1,315</span>, respectively, including royalty receivable of $<span id="xdx_906_ecustom--RoyaltyReceivable_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_ztskNONfrZb4" title="Royalty receivable">297</span> and $<span id="xdx_904_ecustom--RoyaltyReceivable_pn3n3_c20220101__20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zvNJyuUxZ9vj" title="Royalty receivable">297</span>, and charge backs of certain costs management determined were permittable under the co-packing agreement of $<span id="xdx_906_ecustom--CopackingFees_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_z4CaJcCnff4g" title="Copacking fees">1,018</span> and $<span id="xdx_907_ecustom--CopackingFees_c20220101__20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zZxQnappjeaa" title="Copacking fees">1,018</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zI3er1dz0J0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and December 31, 2022, accounts receivable due from and accounts payable due to CCB were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zaAiCH0xULVi" style="display: none">Schedule of Related Parties</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230331_zPRgkv1i2kF8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zmFe2ByAZxVg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zjiuF2a3bxie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable, net of provision of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zYDQzmCb14z" title="Net of provision">538</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_z28BqdJay44f" title="Net of provision">538</span> at March 31, 2023 and December 31, 2022, respectively</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zirQLj82PSE1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,859</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,025</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--OtherReceivables_iNTI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zidqRkyQ4hR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Net (payable) receivable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,082</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,248</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A8_zuD1eWdZmN6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, CCB disputes that it owes $<span id="xdx_903_eus-gaap--OtherReceivables_iI_pn3n3_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zBFPQjliW6jh" title="Net receivable">1,043</span> of the $<span id="xdx_905_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember_zcS1McDftvbe" title="Receivables">1,315</span> recorded as receivable by the Company. The Company believes that it will prevail in this dispute, however, as of March 31, 2023 and December 31, 2022, due to the uncertainty about the ultimate amount that will be settled, the Company has provided a reserve for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zVhnGQpx7Ua6" title="Provision for disputed receivable with former related party"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_zN8A9YOtUhF2" title="Provision for disputed receivable with former related party">538</span></span> based on management’s estimate. In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $<span id="xdx_904_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_c20230331__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zsimglxOnxTh" title="Accounts payable">1,859</span> and $<span id="xdx_900_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_c20221231__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zbVBV0lAURm7" title="Accounts payable">2,025</span> outstanding at March 31, 2023 and December 31, 2022, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>29 <FILENAME>R18.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208326367056"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td> <td class="text"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z4RN0Cr9Ct8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_821_zVxSF3Q4vw3d">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $<span id="xdx_90C_eus-gaap--SecurityDeposit_iI_pn3n3_c20181231__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zaG3wFUZUpel" title="Deposit of security with lessor">1,200</span> of security with the lessor. As of March 31, 2023, $<span id="xdx_900_eus-gaap--SecurityDeposit_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zehoWZTXv85i" title="Deposit of security with lessor">800</span> has been deposited with the lessor and Chris J. Reed has placed approximately <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zzN9rQusiVt7" title="Number of common stock value placed">7,260</span> shares of the Company’s common stock valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zjarPTJku753" title="Value of stock placed">25</span> that remain in escrow with the lessor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that there are no material litigation matters at the current time. Although the results of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>30 <FILENAME>R19.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237632080"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td> <td class="text"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z4OLh4ufw67c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13. <span id="xdx_829_zwLFW44aNbn5">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2023, the Company entered into a Securities Purchase Agreement with D&D Source of Life Holding Ltd., as the lead investor, and certain of Reed’s affiliates pursuant to which the investors agreed to purchase an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230524__20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3JgqRecybr7" title="Common shares issued for cash">1,566,732</span> shares of Reed’s common stock and warrants to purchase <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6YwIWhJHuo9" title="Warrants to purchase stock">313,346</span> shares of Common Stock. The purchase price per share of Common Stock and associated warrant was $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zeSZDbXbFnge" title="Share price">2.585</span>. The gross proceeds to the Company, before deducting offering expenses, are approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230524__20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrOGiRggY4dl" title="Proceeds from issuance of private placement">4,100</span>. <span style="background-color: white"> </span>The warrants are exercisable for a term of <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUnuwl9lVJ98" title="Warrant term">three years</span> at a per share exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0eUaZB4p7l8" title="Exercise price of warrants">2.50</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2023, in order to induce the lead investor to subscribe, the Company granted the lead investor certain preemptive rights and agreed to support the lead investor’s nomination of two board designees, one of which shall be an independent director.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 30, 2023, the Company entered into a Partial Option Exercise and Third Amendment to 10% Convertible Notes (the Notes, see Note 6) with Whitebox a Limited Waiver and Deferral Agreement. Whitebox exercised a partial option to purchase an aggregate of approximately $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20230529__20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zbslHR74Vc96" title="Common shares issued on exercise of options">1,500</span> of additional notes (the “Option Notes”) from the Company. The Option Notes bear interest at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zXpt7Rrt22Xg" title="Debt instrument rate">10</span>% per annum. payable in cash and mature on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20230529__20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zbpmT8nzpQK1" title="Debt instrument, maturity date">September 29, 2023</span>. No amortization payments (as defined in the Notes) are payable on the Option Notes, and the Option Notes may be prepaid without premium or penalty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares issued and the shares of common stock issuable upon conversion of the Option Notes are registrable and subject to that certain Registration Rights Agreement dated May 25, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>31 <FILENAME>R20.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231012656"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td> <td class="text"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zWaZuAbLpBJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zx6bm5chSKie">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on May 15, 2023. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2023, and the results of its operations and its cash flows for the three months ended March 31, 2023 and 2022. The balance sheet as of December 31, 2022 is derived from the Company’s audited financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_GoingConcernPoliciesTextBlock', window );">Going Concern</a></td> <td class="text"><p id="xdx_84C_ecustom--GoingConcernPoliciesTextBlock_zspy2yQKkutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_ziCBtRErE2Ll">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the three months ended March 31, 2023, the Company recorded a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20230101__20230331_zSZndycwUAX7" title="Net income loss">4,357</span>, and at March 31, 2023, had a stockholders’ deficit of $<span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20230331_z4rTTYrnyWhi">12,322</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2022, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, we had a cash balance of $<span id="xdx_90A_eus-gaap--Cash_iI_pn3n3_c20230331_z1RfR6k1KJ07" title="Cash">467</span>, with $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331_zkYNTPLx70ti" title="Line of credit facility, borrowing capacity">62</span> of current availability, and $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331_zbG85NCkH8nc" title="Line of credit facility, additional borrowing capacity">5,084</span> of additional borrowing capacity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_CovidNineteenConsiderationPolicyTextBlock', window );">Recent Trends - Market Conditions</a></td> <td class="text"><p id="xdx_84F_ecustom--CovidNineteenConsiderationPolicyTextBlock_zr2RZDKAtlub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zoQsuS6IQL42">Recent Trends - Market Conditions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2022, the COVID-19 pandemic continued to impact our operating results and the Company anticipates a residual effect for the balance of the year. In addition, the pandemic could cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively affects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow during the first quarter of 2023, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations. We expect the inflationary trends and supply chain pressures to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended March 31, 2023, the Company experienced moderation from the elevated freight costs experienced in 2022. The average cost of shipping and handling for the period ended March 31, 2023, was $<span id="xdx_90A_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20230101__20230331_z9PPrSfmlsDd" title="Shipping and handling costs">3.46</span> per case, as compared to $<span id="xdx_90B_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20220101__20220331_zr3s93VrjdA3" title="Shipping and handling costs">3.90</span> per case for the period ended March 31, 2022. Although the Company has experienced decreases in freight costs over the last three quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. Although, the Company has been negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company has experienced moderation in inflation and anticipates this to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and protect our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through March 31, 2023, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part to be responsible to our employees and business partners in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ReverseStockSplitPolicyTextBlock', window );">Reverse Stock Split</a></td> <td class="text"><p id="xdx_842_ecustom--ReverseStockSplitPolicyTextBlock_zcJIb3XlkaX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrnwZGZVIuLb">Reverse Stock Split</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At a special meeting of shareholders held on January 24, 2023, the Company’s shareholders granted the Company’s board of directors the discretion to effect a reverse stock split of the common stock through an amendment to the Company’s Certificate of Incorporation, as amended, at a ratio of any ratio not less than <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20240122__20240124__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGXsDvSvofih" title="Reverse stock split">1-for-6 and not more than 1-for-50</span>, at any time on or prior to January 24, 2024, with the exact ratio to be set at a whole number within this range by the board of directors in its sole discretion. On January 25, 2023, the Company announced that its board of directors approved a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230123__20230125_zX0vqkPDiiTa" title="Reverse stock split">1-for-50 reverse stock split</span> of the Company’s issued and outstanding shares of common stock, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230125_zk1kPlWomdYg" title="Common stock par value">0.0001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized number of shares of common stock were not affected by the reverse stock split. No fractional shares were issued in connection with the reverse stock split, as all fractional shares were rounded up to the next whole share. Accordingly, all share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the above-described reverse stock split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td> <td class="text"><p id="xdx_848_eus-gaap--UseOfEstimates_zIV9whzmHNF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWsVc4Z17RCi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td> <td class="text"><p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zRPXtDWYnH8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zKLte9A4xSoa">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss per Common Share</a></td> <td class="text"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztBZdn4dRhzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zFtoNpuLA6J6">Loss per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the periods ended March 31, 2023 and 2022, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:</span></p> <p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zb1wya13MRa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zkdPk4CYZAyk" style="display: none">Schedule of Potentially Dilutive Securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPEXumPr24Ai" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220331_zFlbhz4U0Wpb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQfXVgvmSk67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">276,715</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_ztEgUXlVNqIk" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">174,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,904</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zwYMiz0YzYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,257,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zarSidTOZeKj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_z5xumX8PAtmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock equivalent of Series A Convertible Preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,669,360</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">487,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zVOct0kq03V8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Compensation Expense</a></td> <td class="text"><p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfLjV5frfB7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zcYAl67biuub">Stock Compensation Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation</i> whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td> <td class="text"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zPqvbZHo5Mn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zMHSPY5jtJQb">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $<span id="xdx_90F_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zlyI0xGE7sIe" title="Advertising costs">55</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20220331_zVRPF0CL1DTf" title="Advertising costs">312</span> for the three months ended March 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td> <td class="text"><p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zSJNEYtSF8th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zzuqbLkSRs0c">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the three months ended March 31, 2023, the Company’s two largest customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zhjWD7A0vtC3" title="Concentration risk percentage">18</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z8PY15ZIt8F7" title="Concentration risk percentage">13</span>% of net sales, respectively. During the three months ended March 31, 2022, the Company’s two largest customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zQRhjXHwYAJe" title="Concentration risk percentage">18</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zu6OK4kd7j5e" title="Concentration risk percentage">12</span>% of net sales, respectively. No other customers exceeded 10% of net sales in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2023, the Company had accounts receivable from two customers which comprised <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkZGEPpt3xm" title="Concentration risk, percentage">18</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFMIAIE4P3W7" title="Concentration risk, percentage">11</span>% of its gross accounts receivable. As of December 31, 2022, the Company had accounts receivable from two customers which comprised <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPU0rP4JquH2" title="Concentration risk, percentage">19</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzI3sj3WGlrl" title="Concentration risk, percentage">11</span>% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and the year ended December 31, 2022, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company utilizes co-packers to produce <span id="xdx_90A_ecustom--PercentageOfCoPackersProducts_pid_dp_uPure_c20230101__20230331_zRozQ453RjIh" title="Percentage of co-packers products">100</span>% of its products. The Company has long-standing relationships with two different co-packers, and in conjunction with the sale of its manufacturing plant we entered into a third co-packing agreement with California Custom Beverage LLC (“CCB”), the purchaser of the plant (see Note 11). CCB is <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zBn8F4bDgPEg" title="Concentration risk, percentage">100</span>% owned by Chris Reed, founder of the Company and formerly Chief Executive Officer, Chairman, director, and most recently, Chief Innovation Officer. Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zPrrhxezrSk2" title="Percentage of sale accounted to customer">11</span>% of all purchases. During the three months ended March 31, 2022, the Company’s largest vendor accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zXFarhHr1lO4" title="Percentage of sale accounted to customer">13</span>% of all purchases. No other vendors exceeded 10% of all purchases in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td> <td class="text"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zf0Pma4juc5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zdPV50cba8i5">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td> <td class="text"><p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIVAdhofeuV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z0cRHst8Nmt8">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04 “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation— Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815- 40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). ASU 2021-04 provides guidance as to how an issuer should account for a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option (i.e., a warrant) that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument. An issuer should measure the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company adopted ASU 2021-04 effective January 1, 2022. The adoption of ASU 2021-04 did not have any impact on the Company’s financial statement presentation or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2016, the FASB issued ASU 2016-13, <i>Measurement of Credit Losses on Financial Instruments</i>. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company adopted this standard effective January 1, 2023 and there was no material impact of adopting this standard on the Company’s financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.</span></p> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_CovidNineteenConsiderationPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Covid 19 Consideration [Policy Text Block]</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_CovidNineteenConsiderationPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_GoingConcernPoliciesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Going Concern Policies [Text Block]</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_GoingConcernPoliciesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ReverseStockSplitPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse Stock Split [PolicyText Block]</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ReverseStockSplitPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_UseOfEstimates</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>32 <FILENAME>R21.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237606144"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Securities</a></td> <td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zb1wya13MRa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zkdPk4CYZAyk" style="display: none">Schedule of Potentially Dilutive Securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPEXumPr24Ai" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220331_zFlbhz4U0Wpb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQfXVgvmSk67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">276,715</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_ztEgUXlVNqIk" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">174,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,904</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zwYMiz0YzYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,257,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zarSidTOZeKj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_z5xumX8PAtmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock equivalent of Series A Convertible Preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,669,360</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">487,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>33 <FILENAME>R22.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231061088"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td> <td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrOqFredCLSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z2ZtBxxqOpyd" style="display: none">Schedule of Inventory</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zafOs6QsMgCb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zJVVw8c0UK01" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz4dt_zAVtgXZcRXP7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Raw materials and packaging</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,178</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,526</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz4dt_zKLsmCp6fM91" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Finished products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,649</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz4dt_z0neJrSoJwdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,301</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,175</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>34 <FILENAME>R23.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237635600"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td> <td class="text"><p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_ztP0RtqFosQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zaqMbEpbSude" style="display: none">Schedule of Property and Equipment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331_zu3MX6JniaP1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zBfjOndsQvSc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsUnderOperatingLeasesMember_zuRJaL5Vb8qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Right-of-use assets under operating leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerHardwareAndSoftwareMember_zSRTFox0Qpcj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Computer hardware and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zC2U319Ct8tc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Machinery and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzorg_z2DlSRSuHwT" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzorg_zKqyPsJM7rF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(867</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(787</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzorg_zUbv2WIz6c36" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Net book value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">686</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>35 <FILENAME>R24.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208326327552"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of Intangible Assets</a></td> <td class="text"><p id="xdx_896_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_z6t8G3PlNVMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zA3mQEGNTkea" style="display: none">Summary of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230331_zFYV6NsNhhj3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zlOzhmua1Czg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--IndefiniteLivedTradeNames_iI_pn3n3_maILIAEzdvn_zckpm6vOo64j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Brand names</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IndefiniteLivedTrademarks_iI_pn3n3_maILIAEzdvn_zNNb6IH2Kp66" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Trademarks</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzdvn_z7Kr9ehUn2ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>36 <FILENAME>R25.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208326352912"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Line of Credit (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Amount Outstanding Under Credit Facilities</a></td> <td class="text"><p id="xdx_89F_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zodfXAcYmQgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under the Company’s credit facilities are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_z6xvmyYxVxo4" style="display: none">Schedule of Amount Outstanding Under Credit Facilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Line of credit – Alterna Capital Solutions</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zmBayIASHv3k" style="width: 16%; text-align: right" title="Total">7,915</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zurvFg2UTC3f" style="width: 16%; text-align: right" title="Total">11,337</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20230331_zyGgKRWEV9Q" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(322</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20221231_zPKbkmNkCOxc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(363</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331_zJItTVBCb83l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">7,593</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231_zdYYMKYCGB6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">10,974</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>37 <FILENAME>R26.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237439296"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Secured Convertible Notes Payable (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td> <td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zoZWIjZuktb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under secured convertible notes payable are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zNi9ZTxIlOl9" style="display: none">Schedule of Debt</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230331_zbgWjfKK4fK3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_ztfZ23A4fGK7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--SecuredDebt_iI_pn3n3_maCNPzwQW_zgEzJGrRTW47" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Secured Convertible Note Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,450</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_maCNPzwQW_zgRe811erj94" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,052</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredFinanceCostsNet_iNI_pn3n3_di_msCNPzwQW_zN8aolXsBwHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(976</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ConvertibleNotesPayable_iTI_pn3n3_mtCNPzwQW_zm8UYqldvhYb" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,011</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iNI_pn3n3_di_zsXNfAVxRjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,485</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,434</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_z59erWFtAdA8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,526</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,092</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>38 <FILENAME>R27.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237462240"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Summary of Non-vested Restricted Stock Activity</a></td> <td class="text"><p id="xdx_89A_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zsFwyY3jB2c4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes restricted stock activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zP5XnOXUCWj1" style="display: none">Summary of Non-vested Restricted Stock Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Issuable<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value<br/> at Date of<br/> Issuance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> Average <br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Balance, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhYwL9dgtte" style="width: 12%; text-align: right" title="Unvested Shares, beginning balance">1,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKAygSFawnc3" style="width: 12%; text-align: right" title="Issuable Shares, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iS_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjmeN6GaKck1" style="width: 12%; text-align: right" title="Fair Value at Date of Issuance, beginning balance">26.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhxsnUtxjUd" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, beginning balance">44.75</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPOTajjURMtg" style="text-align: right" title="Unvested Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0794">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zTAfL3JeBBUd" style="text-align: right" title="Issuable Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziUSxI8gRGz5" style="text-align: right" title="Fair Value at Date of Issuance, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0798">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjS4kUDx2o99" style="text-align: right" title="Unvested Shares, Vested">(750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zysKmil7Odh7" style="text-align: right" title="Issuable Shares, Vested">750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoMYZGIy99m2" style="text-align: right" title="Fair Value at Date of Issuance, Vested"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSiZbyHdPTgb" style="text-align: right" title="Unvested Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zq5W7F6eoxX4" style="font-size: 11pt; text-align: right" title="Issuable Shares, Forfeited"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></span></td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9dcnj3qlqu" style="text-align: right" title="Fair Value at Date of Issuance, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z0InI5dTzM5a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unvested Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zIHWuo5JdpD1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Issuable Shares, Issued">(750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBd6N9SH05ma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value at Date of Issuance, Issued">(6.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zyKUsCOXHnk6" style="border-bottom: Black 2.5pt double; text-align: right" title="Unvested Shares, ending balance">710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoWWvVlsSbr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Issuable Shares, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iE_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSDcwkdf21Ki" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value at Date of Issuance, ending balance">20.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhGBB8xjbMO6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, ending balance">44.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td> <td class="text"><p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zBpYMW1oi4fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes stock option activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zVc2uhVTtMa1" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms <br/> (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2SNl00YKn1c" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning balance">164,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuUJaWCYKwP" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning">48.90</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSd9kSxrgQsc" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning">7.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9EmoXyXsnDe" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0840">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVoZWFJp3EHb" style="text-align: right" title="Shares, Granted">10,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvW0t2ZWOY98" style="text-align: right" title="Weighted-Average Exercise Price, Granted">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAF94qZxbk5" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvMl2ST4FSa" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkX6XQbtmmOc" style="text-align: right" title="Shares, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9YTMEtHPXIc" style="text-align: right" title="Weighted-Average Exercise Price, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vested forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxhyAq7UYtMj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvEDp1qr8MMa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zokyJJjusar5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">174,460</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIjfxCeyd1Ak" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending">46.34</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z273mWlE5KT" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending">7.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFRVpb2VdES" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Ending"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIwpHC2j7xjj" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Exercisable">102,520</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsHxWcMvpyqa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">54.41</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z63qbKqbFRPf" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">6.86</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znmhvM4p4fUk" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>39 <FILENAME>R28.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237606144"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_DisclosureStockWarrantsAbstract', window );"><strong>Stock Warrants</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrant Activity</a></td> <td class="text"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zkE55migrDKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s warrant activity during the three months ended March 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zedw11Hunbfi" style="display: none">Schedule of Warrant Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Remaining Contractual Terms (Years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBkeF3h1MYT4" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning Balance">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znnHiATgbCa" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding Beginning Balance">16.99</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z40a4hORR28" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance">4.20</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zEifyPmGoDOk" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGranted_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSzD7jaCcudj" style="text-align: right" title="Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zN0IwnPs5pNb" style="text-align: right" title="Weighted-Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercised_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zA8vUHqIWXZe" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z7dQrzo0QdOh" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw8mzZ4x5VX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zvA6Dbjp5ff3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUJtEiWUMC4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zikpFePQ6DK7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znJ4KgsFTRZi" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zuFQBiv9kFna" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisable_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_ziurI0G7Vyo2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Exercisable, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUnbOsyAA1q5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90C_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zdFeJPoEKYE9" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zc2ArIYcTpDf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_DisclosureStockWarrantsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_DisclosureStockWarrantsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>40 <FILENAME>R29.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231061088"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions with California Custom Beverage, LLC, former related party (Tables)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"><div>Mar. 31, 2023</div></th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Related Parties</a></td> <td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zI3er1dz0J0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and December 31, 2022, accounts receivable due from and accounts payable due to CCB were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zaAiCH0xULVi" style="display: none">Schedule of Related Parties</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230331_zPRgkv1i2kF8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zmFe2ByAZxVg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zjiuF2a3bxie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable, net of provision of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zYDQzmCb14z" title="Net of provision">538</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_z28BqdJay44f" title="Net of provision">538</span> at March 31, 2023 and December 31, 2022, respectively</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zirQLj82PSE1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,859</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,025</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--OtherReceivables_iNTI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zidqRkyQ4hR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Net (payable) receivable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,082</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,248</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:textBlockItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>41 <FILENAME>R30.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208227861920"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Potentially Dilutive Securities (Details) - shares<br> shares in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td> <td class="nump">1,669,360<span></span> </td> <td class="nump">487,898<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td> <td class="nump">235,946<span></span> </td> <td class="nump">276,715<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td> <td class="nump">174,460<span></span> </td> <td class="nump">202,904<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td> <td class="nump">1,257,491<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=REED_UnvestedRestrictedCommonStockMember', window );">Unvested Restricted Common Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td> <td class="nump">710<span></span> </td> <td class="nump">7,526<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember', window );">Common Stock Equivalent Of Series A Convertible Preferred Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total</a></td> <td class="nump">753<span></span> </td> <td class="nump">753<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleNotesPayableMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=REED_UnvestedRestrictedCommonStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=REED_UnvestedRestrictedCommonStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>42 <FILENAME>R31.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228601440"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative)<br> $ / shares in Units, $ in Thousands</strong></div></th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Jan. 24, 2024</div></th> <th class="th"> <div>Jan. 25, 2023 </div> <div>$ / shares</div> </th> <th class="th"> <div>Mar. 31, 2023 </div> <div>USD ($) </div> <div>$ / shares</div> </th> <th class="th"> <div>Mar. 31, 2022 </div> <div>USD ($)</div> </th> <th class="th"> <div>Dec. 31, 2022 </div> <div>USD ($) </div> <div>$ / shares</div> </th> <th class="th"> <div>Dec. 31, 2021 </div> <div>USD ($)</div> </th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income loss</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 4,357<span></span> </td> <td class="nump">$ 4,980<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Equity, Attributable to Parent</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">12,322<span></span> </td> <td class="num">$ (4,616)<span></span> </td> <td class="nump">$ 8,470<span></span> </td> <td class="num">$ (4,203)<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">467<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 533<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">62<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, additional borrowing capacity</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 5,084<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_CarryingCostPropertyAndExplorationRights', window );">Shipping and handling costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">3.46<span></span> </td> <td class="nump">3.90<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td> <td class="text"> <span></span> </td> <td class="text">1-for-50 reverse stock split<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value | $ / shares</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 0.0001<span></span> </td> <td class="nump">$ 0.0001<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 0.0001<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 55<span></span> </td> <td class="nump">$ 312<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_PercentageOfCoPackersProducts', window );">Percentage of co-packers products</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">100.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Product Concentration Risk [Member] | Christopher J. Reed [Member] | California Custom Beverage, LLC [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of sale accounted to customer</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">100.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=REED_CustomerOneMember', window );">Customer One [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of sale accounted to customer</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">18.00%<span></span> </td> <td class="nump">18.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=REED_CustomerOneMember', window );">Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of sale accounted to customer</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">18.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">19.00%<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=REED_CustomerTwoMember', window );">Customer Two [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of sale accounted to customer</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">13.00%<span></span> </td> <td class="nump">12.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=REED_CustomerTwoMember', window );">Customer Two [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of sale accounted to customer</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">11.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">11.00%<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=REED_VendorOneMember', window );">Vendor One [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of sale accounted to customer</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">11.00%<span></span> </td> <td class="nump">13.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td> <td class="text">1-for-6 and not more than 1-for-50<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_CarryingCostPropertyAndExplorationRights"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying cost property and exploration rights.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_CarryingCostPropertyAndExplorationRights</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:decimalItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_PercentageOfCoPackersProducts"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of co-packers products.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_PercentageOfCoPackersProducts</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Cash</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=REED_ChristopherJReedMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=REED_ChristopherJReedMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=REED_CaliforniaCustomBeverageLLCMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_LegalEntityAxis=REED_CaliforniaCustomBeverageLLCMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=REED_CustomerOneMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_MajorCustomersAxis=REED_CustomerOneMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=REED_CustomerTwoMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_MajorCustomersAxis=REED_CustomerTwoMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=REED_VendorOneMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_MajorCustomersAxis=REED_VendorOneMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>43 <FILENAME>R32.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228531696"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials and packaging</a></td> <td class="nump">$ 7,178<span></span> </td> <td class="nump">$ 8,526<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished products</a></td> <td class="nump">8,123<span></span> </td> <td class="nump">7,649<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td> <td class="nump">$ 15,301<span></span> </td> <td class="nump">$ 16,175<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>44 <FILENAME>R33.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208232218752"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td> <td class="nump">$ 1,553<span></span> </td> <td class="nump">$ 1,553<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td> <td class="num">(867)<span></span> </td> <td class="num">(787)<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net book value</a></td> <td class="nump">686<span></span> </td> <td class="nump">766<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=REED_RightOfUseAssetsUnderOperatingLeasesMember', window );">Right Of Use Assets Under Operating Leases [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td> <td class="nump">724<span></span> </td> <td class="nump">724<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=REED_ComputerHardwareAndSoftwareMember', window );">Computer Hardware And Software [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td> <td class="nump">400<span></span> </td> <td class="nump">400<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td> <td class="nump">$ 429<span></span> </td> <td class="nump">$ 429<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=REED_RightOfUseAssetsUnderOperatingLeasesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=REED_RightOfUseAssetsUnderOperatingLeasesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=REED_ComputerHardwareAndSoftwareMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=REED_ComputerHardwareAndSoftwareMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>45 <FILENAME>R34.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231085840"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td> <td class="nump">$ 47<span></span> </td> <td class="nump">$ 25<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td> <td class="nump">$ 32<span></span> </td> <td class="nump">$ 27<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Depreciation</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>46 <FILENAME>R35.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208233828160"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTradeNames', window );">Brand names</a></td> <td class="nump">$ 576<span></span> </td> <td class="nump">$ 576<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Trademarks</a></td> <td class="nump">50<span></span> </td> <td class="nump">50<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Total</a></td> <td class="nump">$ 626<span></span> </td> <td class="nump">$ 626<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTradeNames"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IndefiniteLivedTradeNames</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTrademarks"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_IndefiniteLivedTrademarks</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>47 <FILENAME>R36.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231517184"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Amount Outstanding Under Credit Facilities (Details) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Total</a></td> <td class="nump">$ 7,593<span></span> </td> <td class="nump">$ 10,974<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsCurrentNet', window );">Capitalized financing costs</a></td> <td class="num">(322)<span></span> </td> <td class="num">(363)<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=REED_AlternaCapitalSolutionsMember', window );">Alterna Capital Solutions [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Total</a></td> <td class="nump">$ 7,915<span></span> </td> <td class="nump">$ 11,337<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsCurrentNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsCurrentNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=REED_AlternaCapitalSolutionsMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=REED_AlternaCapitalSolutionsMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>48 <FILENAME>R37.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208227862080"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Convertible Note Payable</a></td> <td class="nump">$ 13,000<span></span> </td> <td class="nump">$ 10,450<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td> <td class="nump">2,165<span></span> </td> <td class="nump">1,052<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Capitalized financing costs</a></td> <td class="num">(1,154)<span></span> </td> <td class="num">(976)<span></span> </td> </tr> <tr class="reu"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Total</a></td> <td class="nump">14,011<span></span> </td> <td class="nump">10,526<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Current portion</a></td> <td class="num">(5,485)<span></span> </td> <td class="num">(2,434)<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Long term portion</a></td> <td class="nump">$ 8,526<span></span> </td> <td class="nump">$ 8,092<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SecuredDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>49 <FILENAME>R38.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208227633136"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Line of Credit (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="1"></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 28, 2022</div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 5,084<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td> <td class="text"> <span></span> </td> <td class="nump">62<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td> <td class="text"> <span></span> </td> <td class="nump">281<span></span> </td> <td class="nump">$ 65<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=REED_AlternaCapitalSolutionsMember', window );">Alterna Capital Solutions [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td> <td class="text">3 years<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td> <td class="nump">$ 13,000<span></span> </td> <td class="nump">5,084<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod', window );">Line of credit facility, maximum amount outstanding during period</a></td> <td class="nump">$ 400<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Line of credit facility, borrowing capacity</a></td> <td class="text"> <span></span> </td> <td class="nump">62<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDescription', window );">Line of credit facility, interest rate description</a></td> <td class="text">Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (12.75% at March 31, 2023 and 12.25% at December 31, 2022). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.40% at March 31, 2023 and 12.90% at December 31, 2022). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2023 and 18.00% at December 31, 2022). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td> <td class="nump">$ 1,500<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_LineOfCreditMonitoringFee', window );">Line of credit monitoring fee</a></td> <td class="nump">1<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectOperatingCosts', window );">Direct operating costs</a></td> <td class="nump">$ 483<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_AmortizationOfLineOfCreditPeriod', window );">Amortization of line of credit period</a></td> <td class="text">3 years<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td> <td class="text"> <span></span> </td> <td class="nump">41<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 363<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_DebtInstrumentRemainingUnamortizedDiscount', window );">Remaining unamortized debt discount amount</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 322<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_AmortizationOfLineOfCreditPeriod"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of line of credit period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_AmortizationOfLineOfCreditPeriod</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_DebtInstrumentRemainingUnamortizedDiscount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument remaining unamortized discount.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_DebtInstrumentRemainingUnamortizedDiscount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_LineOfCreditMonitoringFee"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monitoring fee.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_LineOfCreditMonitoringFee</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectOperatingCosts"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate direct operating costs incurred during the reporting period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DirectOperatingCosts</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCredit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDescription"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDescription</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount borrowed under the credit facility at any time during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=REED_AlternaCapitalSolutionsMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=REED_AlternaCapitalSolutionsMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>50 <FILENAME>R39.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208225991776"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Secured Convertible Notes Payable (Details Narrative) - USD ($)<br></strong></div></th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> <th class="th" colspan="3">1 Months Ended</th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr> <th class="th"><div>Feb. 13, 2023</div></th> <th class="th"><div>Feb. 10, 2023</div></th> <th class="th"><div>May 09, 2022</div></th> <th class="th"><div>Nov. 30, 2022</div></th> <th class="th"><div>Sep. 30, 2022</div></th> <th class="th"><div>Aug. 31, 2022</div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured convertible promissory notes</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 13,000,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 10,450,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">New issuance of common stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 5,067,000<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">467,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">533,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Maturity date</a></td> <td class="text">May 09, 2025<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">2,165,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,052,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,779,000<span></span> </td> <td class="nump">801,000<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Direct costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,154,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">976,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">281,000<span></span> </td> <td class="nump">$ 65,000<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=REED_HoldersMember', window );">Holders [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">New issuance of common stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 273,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">82,438<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 2,165,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,052,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,113,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest on the notes</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">366,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Whole interest</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 747,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=REED_OptionNotesMember', window );">Option Notes [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument rate</a></td> <td class="text"> <span></span> </td> <td class="nump">10.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=REED_FebruaryTwoThousandTwentyThreeNotesMember', window );">February Two Thousand Twenty Three Notes [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument rate</a></td> <td class="text"> <span></span> </td> <td class="nump">10.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options to purchase</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 2,550,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=REED_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured convertible promissory notes</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 11,250,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 11,250,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateTerms', window );">Debt instrument rate terms</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text">The Notes bear interest at a rate of 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the Notes)<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text">May 09, 2025<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Monthly payment</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 200,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Weighted average interest</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">90.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Principal payment</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">800,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 600,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">32,362<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 200,000<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal balance</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 10,450,000<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_PercentageOfRepurchasePrice', window );">Percentage of repurchase price</a></td> <td class="text"> <span></span> </td> <td class="nump">110.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">100.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">100.00%<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentType', window );">Debt instrument conversion, description</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text">The initial conversion rate of the Notes is 0.08306 shares of the Company’s common stock per one dollar of principal converted, or approximately $12.04 per share, subject to customary anti-dilution adjustments. In addition, if certain corporate events occur that constitute a make-whole fundamental change as defined, then the note holders are, under certain circumstances, are entitled to an increase in the conversion rate, limited to 0.12155 shares of Common Stock per one dollar of principal, or approximately $8.23 per share<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion into shares</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">1,257,491<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount amount</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 1,154,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 976,000<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Direct costs</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">145,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">240,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=REED_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member] | September Two Thousand Twenty Two Notes [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured convertible promissory notes</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 2,500,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt', window );">Proceeds from issuance of notes</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 12,430,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">New issuance of common stock</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 2,500,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=REED_NotePurchaseAgreementMember', window );">Note Purchase Agreement [Member] | February Two Thousand Twenty Three Notes [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal balance</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">13,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=REED_LimitedWaiverAndDeferralAgreementMember', window );">Limited Waiver And Deferral Agreement [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">New issuance of common stock</a></td> <td class="nump">$ 273,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td> <td class="nump">82,438<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_PercentageForDeferredPayment', window );">Percentage for deferred payment</a></td> <td class="nump">10.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Amortization of interest</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 96,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_PercentageForDeferredPayment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for deferred payment.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_PercentageForDeferredPayment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_PercentageOfRepurchasePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of repurchase price.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_PercentageOfRepurchasePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_Cash</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_CommonStockValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentType"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of the financial instrument that the original debt is being converted into (for example, new debt, common stock, preferred stock, etc.) in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentType</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateTerms"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateTerms</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:dateItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestExpense</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:dateItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSecuredDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSecuredDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SecuredDebt</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=REED_HoldersMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=REED_HoldersMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=REED_OptionNotesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=REED_OptionNotesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=REED_FebruaryTwoThousandTwentyThreeNotesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=REED_FebruaryTwoThousandTwentyThreeNotesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=REED_NotePurchaseAgreementMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=REED_NotePurchaseAgreementMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=REED_SeptemberTwoThousandTwentyTwoNotesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=REED_SeptemberTwoThousandTwentyTwoNotesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=REED_LimitedWaiverAndDeferralAgreementMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=REED_LimitedWaiverAndDeferralAgreementMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>51 <FILENAME>R40.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208230942064"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases Liabilities (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_DisclosureLeasesLiabilitiesAbstract', window );"><strong>Leases Liabilities</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease cost</a></td> <td class="nump">$ 32<span></span> </td> <td class="nump">$ 27<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating leases liability</a></td> <td class="nump">350<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 394<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Payments of operating lease liability</a></td> <td class="nump">$ 44<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term for operating lease</a></td> <td class="text">1 year 9 months 3 days<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate for operating lease</a></td> <td class="nump">12.60%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_DisclosureLeasesLiabilitiesAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_DisclosureLeasesLiabilitiesAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_LeaseCost</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>52 <FILENAME>R41.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208236736192"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder’s Equity (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased, value</a></td> <td class="nump">$ 1<span></span> </td> <td class="nump">$ 2<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_OfficerMember', window );">Officer [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchased, shares</a></td> <td class="nump">274<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased, value</a></td> <td class="nump">$ 1<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>53 <FILENAME>R42.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208227751024"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Non-vested Restricted Stock Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th> <th class="th" colspan="1">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Unvested Shares, Vested</a></td> <td class="num">(5,016)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair Value at Date of Issuance, Vested</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 32<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested Shares, beginning balance</a></td> <td class="nump">1,460<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares', window );">Issuable Shares, beginning balance</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue', window );">Fair Value at Date of Issuance, beginning balance</a></td> <td class="nump">$ 26<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Unvested, beginning balance</a></td> <td class="nump">$ 44.75<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross', window );">Unvested Shares, Granted</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross', window );">Issuable Shares, Granted</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted', window );">Fair Value at Date of Issuance, Granted</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Unvested Shares, Vested</a></td> <td class="num">(750)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares', window );">Issuable Shares, Vested</a></td> <td class="nump">750<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair Value at Date of Issuance, Vested</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Unvested Shares, Forfeited</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross', window );">Issuable Shares, Forfeited</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited', window );">Fair Value at Date of Issuance, Forfeited</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Unvested Shares, Issued</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross', window );">Issuable Shares, Issued</a></td> <td class="num">(750)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued', window );">Fair Value at Date of Issuance, Issued</a></td> <td class="num">$ (6)<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested Shares, ending balance</a></td> <td class="nump">710<span></span> </td> <td class="nump">1,460<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares', window );">Issuable Shares, ending balance</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue', window );">Fair Value at Date of Issuance, ending balance</a></td> <td class="nump">$ 20<span></span> </td> <td class="nump">$ 26<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Unvested, ending balance</a></td> <td class="nump">$ 44.75<span></span> </td> <td class="nump">$ 44.75<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non-vested grants in period, gross.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options nonvested number of issuable shares forfeited in period gross.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non-vested issuable shares grants in period, gross.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non-vested shares issued in period, gross.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non-vested fair value.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Forfeited.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non-vested granted.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non-vested issued.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non-vested, number of issuable shares.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested number of issuable shares.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>54 <FILENAME>R43.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231134576"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock Option Activity (Details) - Equity Option [Member]<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"> <div>Mar. 31, 2023 </div> <div>USD ($) </div> <div>$ / shares </div> <div>shares</div> </th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Outstanding, Beginning balance | shares</a></td> <td class="nump">164,423<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding, Beginning | $ / shares</a></td> <td class="nump">$ 48.90<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning</a></td> <td class="text">7 years 6 months 29 days<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Shares Outstanding, Beginning | $</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, Granted | shares</a></td> <td class="nump">10,037<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Granted | $ / shares</a></td> <td class="nump">$ 4.50<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised | shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercised | $ / shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Unvested forfeited | shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted-Average Exercise Price, Unvested forfeited | $ / shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod', window );">Shares, Vested forfeited | shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Vested forfeited | $ / shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Outstanding, Ending Balance | shares</a></td> <td class="nump">174,460<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding, Ending | $ / shares</a></td> <td class="nump">$ 46.34<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1', window );">Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending</a></td> <td class="text">7 years 5 months 19 days<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Shares Outstanding, Ending | $</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable | shares</a></td> <td class="nump">102,520<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercisable Ending Balance | $ / shares</a></td> <td class="nump">$ 54.41<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance</a></td> <td class="text">6 years 10 months 9 days<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Ending balance | $</a></td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested forfeitures and expirations in period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested forfeiture and expirations in period, weighted average grant date fair value.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award options outstanding weighted average remaining contractual term ending.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_StockOptionMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>55 <FILENAME>R44.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231391984"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock option shares vested</a></td> <td class="nump">5,016<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock options exercisable price</a></td> <td class="nump">$ 4.50<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Expiration years</a></td> <td class="text">10 years<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Options grant date</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 32<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price</a></td> <td class="nump">$ 4.50<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td> <td class="nump">82.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend rate</a></td> <td class="nump">0.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted average risk-free interest rate</a></td> <td class="nump">3.59%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=REED_BoardOfDirectorsMember', window );">Board of Directors [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock option shares vested</a></td> <td class="nump">5,021<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=REED_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued during period shares employee benefit plan</a></td> <td class="nump">10,037<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=REED_TwoThousandTwentyEquityIncentivePlanMember', window );">2020 Equity Incentive Plan [Member] | Employees [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Stock issued during period shares employee benefit plan</a></td> <td class="nump">10,037<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td> <td class="text">4 years<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Number of restricted shares, value</a></td> <td class="nump">$ 4<span></span> </td> <td class="nump">$ 66<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Aggregate value of unvested compensation</a></td> <td class="nump">$ 20<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of stock option shares vested</a></td> <td class="nump">750<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Options grant date</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Aggregate value of unvested compensation</a></td> <td class="nump">$ 1,039<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock price</a></td> <td class="nump">$ 3.45<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_FairValueOfVestedStockOption', window );">Fair value of vested stock option</a></td> <td class="nump">$ 229<span></span> </td> <td class="nump">$ 225<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_FairValueOfVestedStockOption"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock option.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_FairValueOfVestedStockOption</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=REED_BoardOfDirectorsMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=REED_BoardOfDirectorsMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=REED_TwoThousandTwentyEquityIncentivePlanMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_PlanNameAxis=REED_TwoThousandTwentyEquityIncentivePlanMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=REED_EmployeesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=REED_EmployeesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>56 <FILENAME>R45.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208227881104"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warrant Activity (Details) - Warrant [Member]<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> </tr> <tr><th class="th"> <div>Mar. 31, 2023 </div> <div>USD ($) </div> <div>$ / shares </div> <div>shares</div> </th></tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Shares Outstanding, Beginning Balance | shares</a></td> <td class="nump">235,946<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding Beginning Balance | $ / shares</a></td> <td class="nump">$ 16.99<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance</a></td> <td class="text">4 years 2 months 12 days<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning | $</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted', window );">Shares, Granted | shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Granted | $ / shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised', window );">Shares, Exercised | shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercised | $ / shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired', window );">Shares, Forfeited | shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Forfeited | $ / shares</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Shares Outstanding, Ending Balance | shares</a></td> <td class="nump">235,946<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding Ending Balance | $ / shares</a></td> <td class="nump">$ 16.99<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1', window );">Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance</a></td> <td class="text">4 years 2 months 12 days<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending | $</a></td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable', window );">Shares Exercisable, Ending Balance | shares</a></td> <td class="nump">235,946<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercisable Ending Balance | $ / shares</a></td> <td class="nump">$ 16.99<span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance</a></td> <td class="text">4 years 2 months 12 days<span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Exercisable | $</a></td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights exercisable.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities exercisable aggregate intrinsic value.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securitie exercisable weighted average remaining contractual terms.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities outstanding aggregate intrinsic value.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining term of warrant oustanding.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining term of warrant oustanding.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities exercisable weighted average exercise price.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities exercised.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities exercised weighted average exercise price.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities forfeited weighted average exercise price.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities forfeited or expired.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities granted.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities granted weighted average exercise price.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of warrant or right number of securities outstanding weighted average exercise price per share.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>57 <FILENAME>R46.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208237726384"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stock Warrants (Details Narrative)<br></strong></div></th> <th class="th"> <div>Mar. 31, 2023 </div> <div>$ / shares</div> </th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td> <td class="nump">$ 4.50<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=REED_StockWarrantsMember', window );">Stock Warrants [Member]</a></td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td> <td class="nump">$ 3.45<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=REED_StockWarrantsMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=REED_StockWarrantsMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>58 <FILENAME>R47.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208230995392"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Related Parties (Details) - Related Party [Member] - USD ($)<br> $ in Thousands</strong></div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Accounts receivable, net of provision of $538 and $538 at March 31, 2023 and December 31, 2022, respectively</a></td> <td class="nump">$ 777<span></span> </td> <td class="nump">$ 777<span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Accounts payable</a></td> <td class="num">(1,859)<span></span> </td> <td class="num">(2,025)<span></span> </td> </tr> <tr class="rou"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Net (payable) receivable</a></td> <td class="num">$ (1,082)<span></span> </td> <td class="num">$ (1,248)<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherReceivables</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>59 <FILENAME>R48.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231533456"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Related Parties (Details) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="1">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_ProvisionForReceivableWithFormerRelatedParty', window );">Provision for disputed receivable with former related party</a></td> <td class="nump">$ 538<span></span> </td> <td class="nump">$ 538<span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_ProvisionForReceivableWithFormerRelatedParty"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision for receivable with former related party.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_ProvisionForReceivableWithFormerRelatedParty</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>60 <FILENAME>R49.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208228282368"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Transactions with California Custom Beverage, LLC, former related party (Details Narrative) - USD ($)<br></strong></div></th> <th class="th" colspan="1">3 Months Ended</th> <th class="th" colspan="1">12 Months Ended</th> <th class="th" colspan="1"></th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Dec. 31, 2022</div></th> <th class="th"><div>Mar. 31, 2022</div></th> <th class="th"><div>Dec. 31, 2018</div></th> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=REED_CaliforniaCustomBeverageLLCMember', window );">California Custom Beverage, LLC [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 1,315,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Net receivable</a></td> <td class="nump">$ 1,082,000<span></span> </td> <td class="nump">1,248,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Accounts payable</a></td> <td class="nump">1,859,000<span></span> </td> <td class="nump">2,025,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member] | California Custom Beverage, LLC [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Net receivable</a></td> <td class="text"> <span></span> </td> <td class="nump">1,043,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=REED_ChristopherJReedMember', window );">Christopher J. Reed [Member] | California Custom Beverage, LLC [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_RoyaltyPercentage', window );">Royalty percentage</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">5.00%<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td> <td class="nump">1,859,000<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 2,025,000<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td> <td class="nump">1,315,000<span></span> </td> <td class="nump">1,315,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_RoyaltyReceivable', window );">Royalty receivable</a></td> <td class="nump">297,000<span></span> </td> <td class="nump">297,000<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_REED_CopackingFees', window );">Copacking fees</a></td> <td class="nump">1,018<span></span> </td> <td class="nump">$ 1,018<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=REED_ChristopherJReedMember', window );">Christopher J. Reed [Member] | California Custom Beverage, LLC [Member] | Related Party [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Copacking fees</a></td> <td class="nump">$ 428<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 636,000<span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_CopackingFees"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Copacking fees.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_CopackingFees</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_RoyaltyPercentage"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty percentage</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_RoyaltyPercentage</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_REED_RoyaltyReceivable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty receivable.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">REED_RoyaltyReceivable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>REED_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_NotesPayable</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherLiabilities</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_OtherReceivables</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=REED_CaliforniaCustomBeverageLLCMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=REED_CaliforniaCustomBeverageLLCMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_RelatedAndNonrelatedPartyStatusAxis=us-gaap_RelatedPartyMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=REED_ChristopherJReedMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=REED_ChristopherJReedMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=REED_CaliforniaCustomBeverageLLCMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_LegalEntityAxis=REED_CaliforniaCustomBeverageLLCMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>61 <FILENAME>R50.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231125152"> <tr> <th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th> <th class="th" colspan="2">3 Months Ended</th> <th class="th" colspan="1"></th> </tr> <tr> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Mar. 31, 2022</div></th> <th class="th"><div>Dec. 31, 2018</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock placed</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 5,067<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=REED_ChrisReedMember', window );">Chris Reed [Member] | California Custom Beverage, LLC [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems', window );"><strong>Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Deposit of security with lessor</a></td> <td class="nump">$ 800<span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 1,200<span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock value placed</a></td> <td class="nump">7,260<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Value of stock placed</a></td> <td class="nump">$ 25<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SecurityDeposit</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=REED_ChrisReedMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">srt_TitleOfIndividualAxis=REED_ChrisReedMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=REED_CaliforniaCustomBeverageLLCMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_LegalEntityAxis=REED_CaliforniaCustomBeverageLLCMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>62 <FILENAME>R51.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <html> <head> <title></title> <link rel="stylesheet" type="text/css" href="include/report.css"> <script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript"> function toggleNextSibling (e) { if (e.nextSibling.style.display=='none') { e.nextSibling.style.display='block'; } else { e.nextSibling.style.display='none'; } }</script> </head> <body> <span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140208231380896"> <tr> <th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th> <th class="th"><div>May 30, 2023</div></th> <th class="th"><div>May 25, 2023</div></th> <th class="th"><div>Mar. 31, 2023</div></th> <th class="th"><div>Feb. 10, 2023</div></th> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">$ 4.50<span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=REED_OptionNotesMember', window );">Option Notes [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument rate</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="nump">10.00%<span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Option Notes [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Common shares issued on exercise of options</a></td> <td class="nump">$ 1,500<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument rate</a></td> <td class="nump">10.00%<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td> <td class="text">Sep. 29, 2023<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="rh"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=REED_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | DD Source of Life Holding Ltd [Member] | Subsequent Event [Member]</a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common shares issued for cash, net of offering costs, shares</a></td> <td class="text"> <span></span> </td> <td class="nump">1,566,732<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase stock</a></td> <td class="text"> <span></span> </td> <td class="nump">313,346<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 2.585<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from issuance of private placement</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 4,100<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="re"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td> <td class="text"> <span></span> </td> <td class="text">3 years<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> <tr class="ro"> <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td> <td class="text"> <span></span> </td> <td class="nump">$ 2.50<span></span> </td> <td class="text"> <span></span> </td> <td class="text"> <span></span> </td> </tr> </table> <div style="display: none;"> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:percentItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:dateItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>debit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SharePrice</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>dtr-types:perShareItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:sharesItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:monetaryItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>credit</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:stringItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>duration</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td>us-gaap_</td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>xbrli:durationItemType</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Period Type:</strong></td> <td>instant</td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=REED_OptionNotesMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=REED_OptionNotesMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=REED_SecuritiesPurchaseAgreementMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=REED_SecuritiesPurchaseAgreementMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=REED_DDSourceofLifeHoldingLtdMember"> <tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr> <tr><td><div class="body" style="padding: 2px;"> <a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0"> <tr> <td><strong> Name:</strong></td> <td style="white-space:nowrap;">dei_LegalEntityAxis=REED_DDSourceofLifeHoldingLtdMember</td> </tr> <tr> <td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td> <td></td> </tr> <tr> <td><strong> Data Type:</strong></td> <td>na</td> </tr> <tr> <td><strong> Balance Type:</strong></td> <td></td> </tr> <tr> <td><strong> Period Type:</strong></td> <td></td> </tr> </table></div> </div></td></tr> </table> </div> </body> </html> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>63 <FILENAME>form10-q_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <XML> <?xml version="1.0" encoding="utf-8"?> <xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:REED="http://drinkreeds.com/20230331" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <link:schemaRef xlink:href="reed-20230331.xsd" xlink:type="simple"/> <context id="From2023-01-01to2023-03-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2023-05-15"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <instant>2023-05-15</instant> </period> </context> <context id="AsOf2023-03-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-03-31_us-gaap_RelatedPartyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31_us-gaap_RelatedPartyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2022-01-012022-03-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="AsOf2022-12-31_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_us-gaap_PreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_us-gaap_PreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_PreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_PreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2023-03-31_us-gaap_PreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-03-31_us-gaap_CommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-03-31</instant> </period> </context> <context id="AsOf2022-03-31_us-gaap_PreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-03-31</instant> </period> </context> <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-03-31</instant> </period> </context> <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-03-31</instant> </period> </context> <context id="AsOf2022-03-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <instant>2022-03-31</instant> </period> </context> <context id="From2024-01-222024-01-24_srt_ScenarioForecastMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2024-01-22</startDate> <endDate>2024-01-24</endDate> </period> </context> <context id="From2023-01-232023-01-25"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <startDate>2023-01-23</startDate> <endDate>2023-01-25</endDate> </period> </context> <context id="AsOf2023-01-25"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <instant>2023-01-25</instant> </period> </context> <context id="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:CustomerTwoMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_ProductConcentrationRiskMember_us-gaap_SalesRevenueNetMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:VendorOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">REED:VendorOneMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_WarrantMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_WarrantMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_StockOptionMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_StockOptionMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_ConvertibleNotesPayableMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_UnvestedRestrictedCommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_custom_UnvestedRestrictedCommonStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">REED:CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_custom_RightOfUseAssetsUnderOperatingLeasesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:RightOfUseAssetsUnderOperatingLeasesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_RightOfUseAssetsUnderOperatingLeasesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:RightOfUseAssetsUnderOperatingLeasesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-03-31_custom_ComputerHardwareAndSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_ComputerHardwareAndSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">REED:ComputerHardwareAndSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-03-31_us-gaap_MachineryAndEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_AlternaCapitalSolutionsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-03-27</startDate> <endDate>2022-03-28</endDate> </period> </context> <context id="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-03-28</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_AlternaCapitalSolutionsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_AlternaCapitalSolutionsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">REED:AlternaCapitalSolutionsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2022-05-09_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-05-09</instant> </period> </context> <context id="From2022-05-082022-05-09_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-05-08</startDate> <endDate>2022-05-09</endDate> </period> </context> <context id="AsOf2022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:SeptemberTwoThousandTwentyTwoNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-09-30</instant> </period> </context> <context id="From2022-09-012022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:SeptemberTwoThousandTwentyTwoNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-09-01</startDate> <endDate>2022-09-30</endDate> </period> </context> <context id="From2022-11-012022-11-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:SeptemberTwoThousandTwentyTwoNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-11-01</startDate> <endDate>2022-11-30</endDate> </period> </context> <context id="AsOf2022-08-31_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-08-31</instant> </period> </context> <context id="From2022-08-012022-08-31_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-08-01</startDate> <endDate>2022-08-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-02-10_custom_OptionNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:OptionNotesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-02-10</instant> </period> </context> <context id="From2023-02-092023-02-10_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-02-09</startDate> <endDate>2023-02-10</endDate> </period> </context> <context id="From2023-02-092023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:FebruaryTwoThousandTwentyThreeNotesMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-02-09</startDate> <endDate>2023-02-10</endDate> </period> </context> <context id="AsOf2023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:FebruaryTwoThousandTwentyThreeNotesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-02-10</instant> </period> </context> <context id="AsOf2023-02-13_custom_LimitedWaiverAndDeferralAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:LimitedWaiverAndDeferralAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-02-13</instant> </period> </context> <context id="From2023-02-132023-02-13_custom_LimitedWaiverAndDeferralAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:LimitedWaiverAndDeferralAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-02-13</startDate> <endDate>2023-02-13</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_LimitedWaiverAndDeferralAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:LimitedWaiverAndDeferralAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_custom_NotePurchaseAgreementMember_custom_FebruaryTwoThousandTwentyThreeNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:FebruaryTwoThousandTwentyThreeNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="From2023-02-132023-02-13"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <startDate>2023-02-13</startDate> <endDate>2023-02-13</endDate> </period> </context> <context id="AsOf2022-12-31_us-gaap_ConvertibleNotesPayableMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_us-gaap_ConvertibleNotesPayableMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_custom_NotePurchaseAgreementMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:NotePurchaseAgreementMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="From2023-01-012023-03-31_custom_HoldersMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:HoldersMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_srt_OfficerMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2022-12-31_us-gaap_RestrictedStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_RestrictedStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_us-gaap_RestrictedStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_RestrictedStockMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">REED:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember_custom_EmployeesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:EmployeesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">REED:TwoThousandTwentyEquityIncentivePlanMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_custom_BoardOfDirectorsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:BoardOfDirectorsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_EmployeeStockOptionMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-03-31_us-gaap_EmployeeStockOptionMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_us-gaap_EmployeeStockOptionMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31_us-gaap_StockOptionMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="AsOf2023-03-31_us-gaap_StockOptionMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:StockOptionMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-12-31_us-gaap_WarrantMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-03-31_us-gaap_WarrantMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2023-03-31_custom_StockWarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">REED:StockWarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2018-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2018-12-31</instant> </period> </context> <context id="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-03-31</instant> </period> </context> <context id="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-03-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChristopherJReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:RelatedAndNonrelatedPartyStatusAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2018-12-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChrisReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2018-12-31</instant> </period> </context> <context id="AsOf2023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChrisReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-03-31</instant> </period> </context> <context id="From2023-01-012023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">REED:ChrisReedMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:CaliforniaCustomBeverageLLCMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-03-31</endDate> </period> </context> <context id="From2023-05-242023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:DDSourceofLifeHoldingLtdMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-05-24</startDate> <endDate>2023-05-25</endDate> </period> </context> <context id="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">REED:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">REED:DDSourceofLifeHoldingLtdMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-05-25</instant> </period> </context> <context id="From2023-05-292023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:OptionNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-05-29</startDate> <endDate>2023-05-30</endDate> </period> </context> <context id="AsOf2023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001140215</identifier> <segment> <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">REED:OptionNotesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-05-30</instant> </period> </context> <unit id="USD"> <measure>iso4217:USD</measure> </unit> <unit id="Shares"> <measure>shares</measure> </unit> <unit id="USDPShares"> <divide> <unitNumerator> <measure>iso4217:USD</measure> </unitNumerator> <unitDenominator> <measure>shares</measure> </unitDenominator> </divide> </unit> <unit id="Pure"> <measure>pure</measure> </unit> <unit id="Segment"> <measure>REED:Segment</measure> </unit> <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-03-31">0001140215</dei:EntityCentralIndexKey> <dei:AmendmentFlag contextRef="From2023-01-01to2023-03-31">false</dei:AmendmentFlag> <dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-03-31">Q1</dei:DocumentFiscalPeriodFocus> <dei:CurrentFiscalYearEndDate contextRef="From2023-01-01to2023-03-31">--12-31</dei:CurrentFiscalYearEndDate> <us-gaap:CommonStockValue contextRef="AsOf2023-03-31" id="xdx2ixbrl0147" unitRef="USD" xsi:nil="true"/> <us-gaap:CommonStockValue contextRef="AsOf2022-12-31" id="xdx2ixbrl0148" unitRef="USD" xsi:nil="true"/> <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0217" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2023-01-012023-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0258" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0259" unitRef="USD" xsi:nil="true"/> <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0263" unitRef="USD" xsi:nil="true"/> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0273" unitRef="USD" xsi:nil="true"/> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0283" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0332" unitRef="USD" xsi:nil="true"/> <us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0333" unitRef="USD" xsi:nil="true"/> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0337" unitRef="USD" xsi:nil="true"/> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0347" unitRef="USD" xsi:nil="true"/> <us-gaap:AmortizationOfFinancingCosts contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0372" unitRef="USD" xsi:nil="true"/> <REED:FairValueOfCommonSharesIssuedAsFinancingCosts contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0381" unitRef="USD" xsi:nil="true"/> <REED:AccrualOfInterestOnConvertibleNote contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0391" unitRef="USD" xsi:nil="true"/> <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0423" unitRef="USD" xsi:nil="true"/> <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0424" unitRef="USD" xsi:nil="true"/> <us-gaap:ProceedsFromConvertibleDebt contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0436" unitRef="USD" xsi:nil="true"/> <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2023-01-01to2023-03-31" id="xdx2ixbrl0438" unitRef="USD" xsi:nil="true"/> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-03-31_us-gaap_ConvertibleNotesPayableMember" id="xdx2ixbrl0509" unitRef="Shares" xsi:nil="true"/> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0788" unitRef="Shares" xsi:nil="true"/> <REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0794" unitRef="Shares" xsi:nil="true"/> <REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0796" unitRef="Shares" xsi:nil="true"/> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0798" unitRef="USD" xsi:nil="true"/> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0804" unitRef="USD" xsi:nil="true"/> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0806" unitRef="Shares" xsi:nil="true"/> <REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0808" unitRef="Shares" xsi:nil="true"/> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0810" unitRef="USD" xsi:nil="true"/> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0812" unitRef="Shares" xsi:nil="true"/> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" id="xdx2ixbrl0820" unitRef="Shares" xsi:nil="true"/> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" id="xdx2ixbrl0840" unitRef="USD" xsi:nil="true"/> <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0846" unitRef="Shares" xsi:nil="true"/> <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0848" unitRef="USDPShares" xsi:nil="true"/> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0850" unitRef="Shares" xsi:nil="true"/> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0852" unitRef="USDPShares" xsi:nil="true"/> <REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0854" unitRef="Shares" xsi:nil="true"/> <REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" id="xdx2ixbrl0856" unitRef="USDPShares" xsi:nil="true"/> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="xdx2ixbrl0864" unitRef="USD" xsi:nil="true"/> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" id="xdx2ixbrl0872" unitRef="USD" xsi:nil="true"/> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember_custom_EmployeesMember" id="xdx2ixbrl0880">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1> <REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue contextRef="AsOf2022-12-31_us-gaap_WarrantMember" id="xdx2ixbrl0916" unitRef="USD" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritiesGranted contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0918" unitRef="Shares" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0920" unitRef="USDPShares" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritiesExercised contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0922" unitRef="Shares" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0924" unitRef="USDPShares" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0926" unitRef="Shares" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0928" unitRef="USDPShares" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue contextRef="AsOf2023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0936" unitRef="USD" xsi:nil="true"/> <REED:ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue contextRef="AsOf2023-03-31_us-gaap_WarrantMember" id="xdx2ixbrl0944" unitRef="USD" xsi:nil="true"/> <dei:DocumentType contextRef="From2023-01-01to2023-03-31">10-Q</dei:DocumentType> <dei:DocumentQuarterlyReport contextRef="From2023-01-01to2023-03-31">true</dei:DocumentQuarterlyReport> <dei:DocumentPeriodEndDate contextRef="From2023-01-01to2023-03-31">2023-03-31</dei:DocumentPeriodEndDate> <dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-03-31">2023</dei:DocumentFiscalYearFocus> <dei:DocumentTransitionReport contextRef="From2023-01-01to2023-03-31">false</dei:DocumentTransitionReport> <dei:EntityFileNumber contextRef="From2023-01-01to2023-03-31">001-32501</dei:EntityFileNumber> <dei:EntityRegistrantName contextRef="From2023-01-01to2023-03-31">REED’S, INC.</dei:EntityRegistrantName> <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-03-31">DE</dei:EntityIncorporationStateCountryCode> <dei:EntityTaxIdentificationNumber contextRef="From2023-01-01to2023-03-31">35-2177773</dei:EntityTaxIdentificationNumber> <dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-03-31">201 Merritt 7</dei:EntityAddressAddressLine1> <dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-03-31">Norwalk</dei:EntityAddressCityOrTown> <dei:EntityAddressStateOrProvince contextRef="From2023-01-01to2023-03-31">CT</dei:EntityAddressStateOrProvince> <dei:EntityAddressPostalZipCode contextRef="From2023-01-01to2023-03-31">06851</dei:EntityAddressPostalZipCode> <dei:CityAreaCode contextRef="From2023-01-01to2023-03-31">(800)</dei:CityAreaCode> <dei:LocalPhoneNumber contextRef="From2023-01-01to2023-03-31">997-3337</dei:LocalPhoneNumber> <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-05-15" decimals="INF" unitRef="Shares">2602399</dei:EntityCommonStockSharesOutstanding> <dei:EntityCurrentReportingStatus contextRef="From2023-01-01to2023-03-31">Yes</dei:EntityCurrentReportingStatus> <dei:EntityInteractiveDataCurrent contextRef="From2023-01-01to2023-03-31">Yes</dei:EntityInteractiveDataCurrent> <dei:EntityFilerCategory contextRef="From2023-01-01to2023-03-31">Non-accelerated Filer</dei:EntityFilerCategory> <dei:EntitySmallBusiness contextRef="From2023-01-01to2023-03-31">true</dei:EntitySmallBusiness> <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-03-31">false</dei:EntityEmergingGrowthCompany> <dei:EntityShellCompany contextRef="From2023-01-01to2023-03-31">false</dei:EntityShellCompany> <us-gaap:Cash contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">467000</us-gaap:Cash> <us-gaap:Cash contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">533000</us-gaap:Cash> <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">213000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent> <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">252000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent> <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">4665000</us-gaap:AccountsReceivableNetCurrent> <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">5671000</us-gaap:AccountsReceivableNetCurrent> <us-gaap:InventoryNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">15301000</us-gaap:InventoryNet> <us-gaap:InventoryNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">16175000</us-gaap:InventoryNet> <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">777000</us-gaap:OtherReceivablesNetCurrent> <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">777000</us-gaap:OtherReceivablesNetCurrent> <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">601000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent> <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">939000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent> <us-gaap:AssetsCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">21811000</us-gaap:AssetsCurrent> <us-gaap:AssetsCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">24095000</us-gaap:AssetsCurrent> <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">867000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">787000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">686000</us-gaap:PropertyPlantAndEquipmentNet> <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">766000</us-gaap:PropertyPlantAndEquipmentNet> <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">626000</us-gaap:IntangibleAssetsNetExcludingGoodwill> <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">626000</us-gaap:IntangibleAssetsNetExcludingGoodwill> <us-gaap:Assets contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">23123000</us-gaap:Assets> <us-gaap:Assets contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">25487000</us-gaap:Assets> <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">11165000</us-gaap:AccountsPayableCurrent> <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">9805000</us-gaap:AccountsPayableCurrent> <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">467000</us-gaap:AccruedLiabilitiesCurrent> <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">233000</us-gaap:AccruedLiabilitiesCurrent> <us-gaap:DeferredFinanceCostsCurrentNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">322000</us-gaap:DeferredFinanceCostsCurrentNet> <us-gaap:DeferredFinanceCostsCurrentNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">363000</us-gaap:DeferredFinanceCostsCurrentNet> <us-gaap:LinesOfCreditCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">7593000</us-gaap:LinesOfCreditCurrent> <us-gaap:LinesOfCreditCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">10974000</us-gaap:LinesOfCreditCurrent> <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">1859000</us-gaap:OtherLiabilitiesCurrent> <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">2025000</us-gaap:OtherLiabilitiesCurrent> <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">670000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent> <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">414000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent> <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">5485000</us-gaap:ConvertibleNotesPayableCurrent> <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">2434000</us-gaap:ConvertibleNotesPayableCurrent> <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">194000</us-gaap:OperatingLeaseLiabilityCurrent> <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">187000</us-gaap:OperatingLeaseLiabilityCurrent> <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">26763000</us-gaap:LiabilitiesCurrent> <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">25658000</us-gaap:LiabilitiesCurrent> <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">484000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent> <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">562000</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent> <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">8526000</us-gaap:ConvertibleLongTermNotesPayable> <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">8092000</us-gaap:ConvertibleLongTermNotesPayable> <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">156000</us-gaap:OperatingLeaseLiabilityNoncurrent> <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">207000</us-gaap:OperatingLeaseLiabilityNoncurrent> <us-gaap:Liabilities contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">35445000</us-gaap:Liabilities> <us-gaap:Liabilities contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">33957000</us-gaap:Liabilities> <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2023-03-31" decimals="INF" unitRef="USDPShares">10</us-gaap:PreferredStockParOrStatedValuePerShare> <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares">10</us-gaap:PreferredStockParOrStatedValuePerShare> <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2023-03-31" decimals="INF" unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized> <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">500000</us-gaap:PreferredStockSharesAuthorized> <us-gaap:PreferredStockSharesIssued contextRef="AsOf2023-03-31" decimals="INF" unitRef="Shares">9411</us-gaap:PreferredStockSharesIssued> <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2023-03-31" decimals="INF" unitRef="Shares">9411</us-gaap:PreferredStockSharesOutstanding> <us-gaap:PreferredStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">9411</us-gaap:PreferredStockSharesIssued> <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">9411</us-gaap:PreferredStockSharesOutstanding> <us-gaap:PreferredStockValue contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">94000</us-gaap:PreferredStockValue> <us-gaap:PreferredStockValue contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">94000</us-gaap:PreferredStockValue> <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2023-03-31" decimals="INF" unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare> <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2022-12-31" decimals="INF" unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare> <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2023-03-31" decimals="INF" unitRef="Shares">180000000</us-gaap:CommonStockSharesAuthorized> <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">180000000</us-gaap:CommonStockSharesAuthorized> <us-gaap:CommonStockSharesIssued contextRef="AsOf2023-03-31" decimals="INF" unitRef="Shares">2602399</us-gaap:CommonStockSharesIssued> <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2023-03-31" decimals="INF" unitRef="Shares">2602399</us-gaap:CommonStockSharesOutstanding> <us-gaap:CommonStockSharesIssued contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">2519485</us-gaap:CommonStockSharesIssued> <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2022-12-31" decimals="INF" unitRef="Shares">2519485</us-gaap:CommonStockSharesOutstanding> <us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">115140000</us-gaap:AdditionalPaidInCapital> <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">114635000</us-gaap:AdditionalPaidInCapital> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-127556000</us-gaap:RetainedEarningsAccumulatedDeficit> <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-123199000</us-gaap:RetainedEarningsAccumulatedDeficit> <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-12322000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-8470000</us-gaap:StockholdersEquity> <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">23123000</us-gaap:LiabilitiesAndStockholdersEquity> <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">25487000</us-gaap:LiabilitiesAndStockholdersEquity> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">11157000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">12182000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax> <us-gaap:CostOfGoodsAndServicesSold contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">8459000</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:CostOfGoodsAndServicesSold contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">9250000</us-gaap:CostOfGoodsAndServicesSold> <us-gaap:GrossProfit contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">2698000</us-gaap:GrossProfit> <us-gaap:GrossProfit contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">2932000</us-gaap:GrossProfit> <REED:DeliveryAndHandlingExpense contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">2120000</REED:DeliveryAndHandlingExpense> <REED:DeliveryAndHandlingExpense contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">2812000</REED:DeliveryAndHandlingExpense> <us-gaap:SellingAndMarketingExpense contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1447000</us-gaap:SellingAndMarketingExpense> <us-gaap:SellingAndMarketingExpense contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">2178000</us-gaap:SellingAndMarketingExpense> <us-gaap:GeneralAndAdministrativeExpense contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1709000</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:GeneralAndAdministrativeExpense contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">2121000</us-gaap:GeneralAndAdministrativeExpense> <us-gaap:OperatingExpenses contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">5276000</us-gaap:OperatingExpenses> <us-gaap:OperatingExpenses contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">7111000</us-gaap:OperatingExpenses> <us-gaap:OperatingIncomeLoss contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-2578000</us-gaap:OperatingIncomeLoss> <us-gaap:OperatingIncomeLoss contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-4179000</us-gaap:OperatingIncomeLoss> <us-gaap:InterestExpense contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1779000</us-gaap:InterestExpense> <us-gaap:InterestExpense contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">801000</us-gaap:InterestExpense> <us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-4357000</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-4980000</us-gaap:NetIncomeLoss> <us-gaap:EarningsPerShareBasic contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="USDPShares">-1.70</us-gaap:EarningsPerShareBasic> <us-gaap:EarningsPerShareBasic contextRef="From2022-01-012022-03-31" decimals="INF" unitRef="USDPShares">-2.56</us-gaap:EarningsPerShareBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="Shares">2559855</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2022-01-012022-03-31" decimals="INF" unitRef="Shares">1947548</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic> <us-gaap:SharesOutstanding contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">2519485</us-gaap:SharesOutstanding> <us-gaap:SharesOutstanding contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" decimals="INF" unitRef="Shares">9411</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_PreferredStockMember" decimals="-3" unitRef="USD">94000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">114635000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-123199000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">-8470000</us-gaap:StockholdersEquity> <REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">229000</REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested> <REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">229000</REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested> <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">750</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures> <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures> <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">274</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">1000</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1000</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">82438</us-gaap:StockIssuedDuringPeriodSharesOther> <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">273000</us-gaap:StockIssuedDuringPeriodValueOther> <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">273000</us-gaap:StockIssuedDuringPeriodValueOther> <us-gaap:NetIncomeLoss contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-4357000</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-4357000</us-gaap:NetIncomeLoss> <us-gaap:SharesOutstanding contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">2602399</us-gaap:SharesOutstanding> <us-gaap:SharesOutstanding contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" decimals="INF" unitRef="Shares">9411</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" decimals="-3" unitRef="USD">94000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">115140000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-127556000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-12322000</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">1874680</us-gaap:SharesOutstanding> <us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" decimals="INF" unitRef="Shares">9411</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" decimals="-3" unitRef="USD">94000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">107246000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-103137000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4203000</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">1874680</us-gaap:SharesOutstanding> <us-gaap:SharesOutstanding contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" decimals="INF" unitRef="Shares">9411</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" decimals="-3" unitRef="USD">94000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">107246000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-103137000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">4203000</us-gaap:StockholdersEquity> <REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">225000</REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested> <REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">225000</REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested> <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">2732</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures> <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">66000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures> <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">66000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">265</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">2000</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">2000</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">2000</us-gaap:StockIssuedDuringPeriodSharesOther> <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">37000</us-gaap:StockIssuedDuringPeriodValueOther> <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">37000</us-gaap:StockIssuedDuringPeriodValueOther> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">371891</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">5067000</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">5067000</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-4980000</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-4980000</us-gaap:NetIncomeLoss> <us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">2251038</us-gaap:SharesOutstanding> <us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" decimals="INF" unitRef="Shares">9411</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" decimals="-3" unitRef="USD">94000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">112639000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-108117000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="-3" unitRef="USD">4616000</us-gaap:StockholdersEquity> <us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" decimals="INF" unitRef="Shares">2251038</us-gaap:SharesOutstanding> <us-gaap:SharesOutstanding contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" decimals="INF" unitRef="Shares">9411</us-gaap:SharesOutstanding> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_PreferredStockMember" decimals="-3" unitRef="USD">94000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" unitRef="USD">112639000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" decimals="-3" unitRef="USD">-108117000</us-gaap:StockholdersEquity> <us-gaap:StockholdersEquity contextRef="AsOf2022-03-31" decimals="-3" unitRef="USD">4616000</us-gaap:StockholdersEquity> <us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-4357000</us-gaap:NetIncomeLoss> <us-gaap:NetIncomeLoss contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-4980000</us-gaap:NetIncomeLoss> <us-gaap:DepreciationDepletionAndAmortization contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">47000</us-gaap:DepreciationDepletionAndAmortization> <us-gaap:DepreciationDepletionAndAmortization contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">25000</us-gaap:DepreciationDepletionAndAmortization> <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">281000</us-gaap:AmortizationOfDebtDiscountPremium> <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">65000</us-gaap:AmortizationOfDebtDiscountPremium> <us-gaap:AmortizationOfFinancingCosts contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">431000</us-gaap:AmortizationOfFinancingCosts> <REED:FairValueOfVestedOptions contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-229000</REED:FairValueOfVestedOptions> <REED:FairValueOfVestedOptions contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-225000</REED:FairValueOfVestedOptions> <REED:FairValueOfVestedRestrictedSharesGrantedToOfficers contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-4000</REED:FairValueOfVestedRestrictedSharesGrantedToOfficers> <REED:FairValueOfVestedRestrictedSharesGrantedToOfficers contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-66000</REED:FairValueOfVestedRestrictedSharesGrantedToOfficers> <REED:FairValueOfCommonSharesIssuedAsFinancingCosts contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">37000</REED:FairValueOfCommonSharesIssuedAsFinancingCosts> <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-39000</us-gaap:ProvisionForDoubtfulAccounts> <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">62000</us-gaap:ProvisionForDoubtfulAccounts> <us-gaap:InventoryWriteDown contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-228000</us-gaap:InventoryWriteDown> <us-gaap:InventoryWriteDown contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">10000</us-gaap:InventoryWriteDown> <REED:AccrualOfInterestOnConvertibleNote contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1113000</REED:AccrualOfInterestOnConvertibleNote> <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-1044000</us-gaap:IncreaseDecreaseInAccountsReceivable> <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">40000</us-gaap:IncreaseDecreaseInAccountsReceivable> <us-gaap:IncreaseDecreaseInInventories contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-1102000</us-gaap:IncreaseDecreaseInInventories> <us-gaap:IncreaseDecreaseInInventories contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">3810000</us-gaap:IncreaseDecreaseInInventories> <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-338000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets> <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">617000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets> <REED:IncreaseDecreaseInAmortizationOfRightOfUseAssets contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">32000</REED:IncreaseDecreaseInAmortizationOfRightOfUseAssets> <REED:IncreaseDecreaseInAmortizationOfRightOfUseAssets contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">27000</REED:IncreaseDecreaseInAmortizationOfRightOfUseAssets> <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1360000</us-gaap:IncreaseDecreaseInAccountsPayable> <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">5926000</us-gaap:IncreaseDecreaseInAccountsPayable> <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">235000</us-gaap:IncreaseDecreaseInAccruedLiabilities> <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">403000</us-gaap:IncreaseDecreaseInAccruedLiabilities> <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-44000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability> <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-37000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1117000</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-2207000</us-gaap:NetCashProvidedByUsedInOperatingActivities> <us-gaap:ProceedsFromLinesOfCredit contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">8699000</us-gaap:ProceedsFromLinesOfCredit> <us-gaap:ProceedsFromLinesOfCredit contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">14508000</us-gaap:ProceedsFromLinesOfCredit> <us-gaap:RepaymentsOfLinesOfCredit contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">12120000</us-gaap:RepaymentsOfLinesOfCredit> <us-gaap:RepaymentsOfLinesOfCredit contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">17212000</us-gaap:RepaymentsOfLinesOfCredit> <us-gaap:ProceedsFromConvertibleDebt contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">2405000</us-gaap:ProceedsFromConvertibleDebt> <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">5067000</us-gaap:ProceedsFromIssuanceOfCommonStock> <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">1000</us-gaap:PaymentsForRepurchaseOfCommonStock> <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">2000</us-gaap:PaymentsForRepurchaseOfCommonStock> <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-166000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt> <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">-81000</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt> <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-1183000</us-gaap:NetCashProvidedByUsedInFinancingActivities> <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">2280000</us-gaap:NetCashProvidedByUsedInFinancingActivities> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-66000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">73000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">533000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">49000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">467000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations> <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2022-03-31" decimals="-3" unitRef="USD">122000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations> <us-gaap:InterestPaidNet contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">390000</us-gaap:InterestPaidNet> <us-gaap:InterestPaidNet contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">256000</us-gaap:InterestPaidNet> <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zC5sNFhQheBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_822_zEyCKqV7mUzi">Summary of Significant Accounting Policies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zWaZuAbLpBJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zx6bm5chSKie">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on May 15, 2023. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2023, and the results of its operations and its cash flows for the three months ended March 31, 2023 and 2022. The balance sheet as of December 31, 2022 is derived from the Company’s audited financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--GoingConcernPoliciesTextBlock_zspy2yQKkutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_ziCBtRErE2Ll">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the three months ended March 31, 2023, the Company recorded a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20230101__20230331_zSZndycwUAX7" title="Net income loss">4,357</span>, and at March 31, 2023, had a stockholders’ deficit of $<span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20230331_z4rTTYrnyWhi">12,322</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2022, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, we had a cash balance of $<span id="xdx_90A_eus-gaap--Cash_iI_pn3n3_c20230331_z1RfR6k1KJ07" title="Cash">467</span>, with $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331_zkYNTPLx70ti" title="Line of credit facility, borrowing capacity">62</span> of current availability, and $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331_zbG85NCkH8nc" title="Line of credit facility, additional borrowing capacity">5,084</span> of additional borrowing capacity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--CovidNineteenConsiderationPolicyTextBlock_zr2RZDKAtlub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zoQsuS6IQL42">Recent Trends - Market Conditions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2022, the COVID-19 pandemic continued to impact our operating results and the Company anticipates a residual effect for the balance of the year. In addition, the pandemic could cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively affects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow during the first quarter of 2023, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations. We expect the inflationary trends and supply chain pressures to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended March 31, 2023, the Company experienced moderation from the elevated freight costs experienced in 2022. The average cost of shipping and handling for the period ended March 31, 2023, was $<span id="xdx_90A_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20230101__20230331_z9PPrSfmlsDd" title="Shipping and handling costs">3.46</span> per case, as compared to $<span id="xdx_90B_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20220101__20220331_zr3s93VrjdA3" title="Shipping and handling costs">3.90</span> per case for the period ended March 31, 2022. Although the Company has experienced decreases in freight costs over the last three quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. Although, the Company has been negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company has experienced moderation in inflation and anticipates this to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and protect our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through March 31, 2023, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part to be responsible to our employees and business partners in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--ReverseStockSplitPolicyTextBlock_zcJIb3XlkaX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrnwZGZVIuLb">Reverse Stock Split</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At a special meeting of shareholders held on January 24, 2023, the Company’s shareholders granted the Company’s board of directors the discretion to effect a reverse stock split of the common stock through an amendment to the Company’s Certificate of Incorporation, as amended, at a ratio of any ratio not less than <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20240122__20240124__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGXsDvSvofih" title="Reverse stock split">1-for-6 and not more than 1-for-50</span>, at any time on or prior to January 24, 2024, with the exact ratio to be set at a whole number within this range by the board of directors in its sole discretion. On January 25, 2023, the Company announced that its board of directors approved a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230123__20230125_zX0vqkPDiiTa" title="Reverse stock split">1-for-50 reverse stock split</span> of the Company’s issued and outstanding shares of common stock, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230125_zk1kPlWomdYg" title="Common stock par value">0.0001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized number of shares of common stock were not affected by the reverse stock split. No fractional shares were issued in connection with the reverse stock split, as all fractional shares were rounded up to the next whole share. Accordingly, all share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the above-described reverse stock split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zIV9whzmHNF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWsVc4Z17RCi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zRPXtDWYnH8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zKLte9A4xSoa">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztBZdn4dRhzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zFtoNpuLA6J6">Loss per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the periods ended March 31, 2023 and 2022, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:</span></p> <p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zb1wya13MRa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zkdPk4CYZAyk" style="display: none">Schedule of Potentially Dilutive Securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPEXumPr24Ai" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220331_zFlbhz4U0Wpb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQfXVgvmSk67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">276,715</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_ztEgUXlVNqIk" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">174,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,904</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zwYMiz0YzYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,257,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zarSidTOZeKj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_z5xumX8PAtmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock equivalent of Series A Convertible Preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,669,360</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">487,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zVOct0kq03V8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfLjV5frfB7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zcYAl67biuub">Stock Compensation Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation</i> whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zPqvbZHo5Mn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zMHSPY5jtJQb">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $<span id="xdx_90F_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zlyI0xGE7sIe" title="Advertising costs">55</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20220331_zVRPF0CL1DTf" title="Advertising costs">312</span> for the three months ended March 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zSJNEYtSF8th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zzuqbLkSRs0c">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the three months ended March 31, 2023, the Company’s two largest customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zhjWD7A0vtC3" title="Concentration risk percentage">18</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z8PY15ZIt8F7" title="Concentration risk percentage">13</span>% of net sales, respectively. During the three months ended March 31, 2022, the Company’s two largest customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zQRhjXHwYAJe" title="Concentration risk percentage">18</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zu6OK4kd7j5e" title="Concentration risk percentage">12</span>% of net sales, respectively. No other customers exceeded 10% of net sales in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2023, the Company had accounts receivable from two customers which comprised <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkZGEPpt3xm" title="Concentration risk, percentage">18</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFMIAIE4P3W7" title="Concentration risk, percentage">11</span>% of its gross accounts receivable. As of December 31, 2022, the Company had accounts receivable from two customers which comprised <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPU0rP4JquH2" title="Concentration risk, percentage">19</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzI3sj3WGlrl" title="Concentration risk, percentage">11</span>% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and the year ended December 31, 2022, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company utilizes co-packers to produce <span id="xdx_90A_ecustom--PercentageOfCoPackersProducts_pid_dp_uPure_c20230101__20230331_zRozQ453RjIh" title="Percentage of co-packers products">100</span>% of its products. The Company has long-standing relationships with two different co-packers, and in conjunction with the sale of its manufacturing plant we entered into a third co-packing agreement with California Custom Beverage LLC (“CCB”), the purchaser of the plant (see Note 11). CCB is <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zBn8F4bDgPEg" title="Concentration risk, percentage">100</span>% owned by Chris Reed, founder of the Company and formerly Chief Executive Officer, Chairman, director, and most recently, Chief Innovation Officer. Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zPrrhxezrSk2" title="Percentage of sale accounted to customer">11</span>% of all purchases. During the three months ended March 31, 2022, the Company’s largest vendor accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zXFarhHr1lO4" title="Percentage of sale accounted to customer">13</span>% of all purchases. No other vendors exceeded 10% of all purchases in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zf0Pma4juc5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zdPV50cba8i5">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIVAdhofeuV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z0cRHst8Nmt8">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04 “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation— Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815- 40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). ASU 2021-04 provides guidance as to how an issuer should account for a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option (i.e., a warrant) that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument. An issuer should measure the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company adopted ASU 2021-04 effective January 1, 2022. The adoption of ASU 2021-04 did not have any impact on the Company’s financial statement presentation or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2016, the FASB issued ASU 2016-13, <i>Measurement of Credit Losses on Financial Instruments</i>. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company adopted this standard effective January 1, 2023 and there was no material impact of adopting this standard on the Company’s financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.</span></p> <p id="xdx_85C_zgmVICqzkfB3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:SignificantAccountingPoliciesTextBlock> <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zWaZuAbLpBJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zx6bm5chSKie">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed financial statements of Reed’s, Inc. (the “Company”, “we”, “us”, or “our”), have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. We believe that the disclosures contained in these condensed financial statements are adequate to make the information presented herein not misleading. These condensed financial statements should be read in conjunction with the financial statements contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on May 15, 2023. The accompanying condensed financial statements are unaudited, but in the opinion of management contain all adjustments, including normal recurring adjustments, necessary to present fairly the Company’s financial position as of March 31, 2023, and the results of its operations and its cash flows for the three months ended March 31, 2023 and 2022. The balance sheet as of December 31, 2022 is derived from the Company’s audited financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:BasisOfAccountingPolicyPolicyTextBlock> <REED:GoingConcernPoliciesTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_84C_ecustom--GoingConcernPoliciesTextBlock_zspy2yQKkutj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_ziCBtRErE2Ll">Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying financial statements, for the three months ended March 31, 2023, the Company recorded a net loss of $<span id="xdx_90F_eus-gaap--NetIncomeLoss_iN_pn3n3_di_c20230101__20230331_zSZndycwUAX7" title="Net income loss">4,357</span>, and at March 31, 2023, had a stockholders’ deficit of $<span id="xdx_90D_eus-gaap--StockholdersEquity_iNI_pn3n3_di_c20230331_z4rTTYrnyWhi">12,322</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2022, financial statements, raised substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, we had a cash balance of $<span id="xdx_90A_eus-gaap--Cash_iI_pn3n3_c20230331_z1RfR6k1KJ07" title="Cash">467</span>, with $<span id="xdx_906_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331_zkYNTPLx70ti" title="Line of credit facility, borrowing capacity">62</span> of current availability, and $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331_zbG85NCkH8nc" title="Line of credit facility, additional borrowing capacity">5,084</span> of additional borrowing capacity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically, we have financed our operations through public and private sales of common stock, issuance of preferred and common stock, convertible debt instruments, term loans and credit lines from financial institutions, and cash generated from operations. To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity, mezzanine or debt securities, through arrangements with strategic partners or through obtaining credit from financial institutions. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the debt and equity capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have also taken decisive action to improve our margins, including fully outsourcing our manufacturing process, streamlining our product portfolio, negotiating improved vendor contracts and restructuring our selling prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </REED:GoingConcernPoliciesTextBlock> <us-gaap:NetIncomeLoss contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">-4357000</us-gaap:NetIncomeLoss> <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-12322000</us-gaap:StockholdersEquity> <us-gaap:Cash contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">467000</us-gaap:Cash> <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">62000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity> <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">5084000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> <REED:CovidNineteenConsiderationPolicyTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_84F_ecustom--CovidNineteenConsiderationPolicyTextBlock_zr2RZDKAtlub" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zoQsuS6IQL42">Recent Trends - Market Conditions</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended December 31, 2022, the COVID-19 pandemic continued to impact our operating results and the Company anticipates a residual effect for the balance of the year. In addition, the pandemic could cause reduced demand for our products if, for example, the pandemic results in a recessionary economic environment which negatively affects the consumers who purchase our products. Based on the recent increase in demand for our products, we believe that over the long term, there will continue to be strong demand for our products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the U.S. economy continued to grow during the first quarter of 2023, the higher inflation, the actions by the Federal Reserve to address inflation, and rising energy prices create uncertainty about the future economic environment which will continue to evolve and may impact our business in future periods. We have experienced supply chain challenges, including increased lead times, as well as inflation of raw materials, logistics and labor costs due to availability constraints and high demand. Although we regularly monitor companies in our supply chain, and use alternative suppliers when necessary and available, supply chain constraints could cause a disruption in our ability to obtain raw materials required to manufacture our products and adversely affect our operations. We expect the inflationary trends and supply chain pressures to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the period ended March 31, 2023, the Company experienced moderation from the elevated freight costs experienced in 2022. The average cost of shipping and handling for the period ended March 31, 2023, was $<span id="xdx_90A_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20230101__20230331_z9PPrSfmlsDd" title="Shipping and handling costs">3.46</span> per case, as compared to $<span id="xdx_90B_ecustom--CarryingCostPropertyAndExplorationRights_pid_uPure_c20220101__20220331_zr3s93VrjdA3" title="Shipping and handling costs">3.90</span> per case for the period ended March 31, 2022. Although the Company has experienced decreases in freight costs over the last three quarters, in the Company’s opinion there remains a volatile environment and the Company will continue to monitor pricing and availability in transportation. Mitigation plans have been implemented to manage this risk. Although, the Company has been negatively impacted by supply chain challenges impacting our ability to benefit from strong demand for, and increased sales of our product. The disruption caused by labor shortages, significant raw material cost inflation, logistics issues and increased freight costs, and ongoing port congestion, resulted in suppressed margins and net income. The Company has experienced moderation in inflation and anticipates this to continue throughout 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to operate without significant incremental negative operational impact from the COVID-19 pandemic will in part depend on our ability to protect our employees and protect our supply chain. The Company has endeavored to follow the recommended actions of government and health authorities to protect our employees. Since the inception of the COVID-19 pandemic and through March 31, 2023, we maintained the consistency of our operations during the onset of the COVID-19 pandemic. We will continue to innovate in managing our business, coordinating with our employees and suppliers to do our part to be responsible to our employees and business partners in responding to our customers and suppliers. However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain (for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively impact our operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have not observed any material impairments of our assets or a significant change in the fair value of our assets due to the COVID-19 pandemic.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </REED:CovidNineteenConsiderationPolicyTextBlock> <REED:CarryingCostPropertyAndExplorationRights contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="Pure">3.46</REED:CarryingCostPropertyAndExplorationRights> <REED:CarryingCostPropertyAndExplorationRights contextRef="From2022-01-012022-03-31" decimals="INF" unitRef="Pure">3.90</REED:CarryingCostPropertyAndExplorationRights> <REED:ReverseStockSplitPolicyTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_842_ecustom--ReverseStockSplitPolicyTextBlock_zcJIb3XlkaX1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrnwZGZVIuLb">Reverse Stock Split</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At a special meeting of shareholders held on January 24, 2023, the Company’s shareholders granted the Company’s board of directors the discretion to effect a reverse stock split of the common stock through an amendment to the Company’s Certificate of Incorporation, as amended, at a ratio of any ratio not less than <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20240122__20240124__srt--StatementScenarioAxis__srt--ScenarioForecastMember_zGXsDvSvofih" title="Reverse stock split">1-for-6 and not more than 1-for-50</span>, at any time on or prior to January 24, 2024, with the exact ratio to be set at a whole number within this range by the board of directors in its sole discretion. On January 25, 2023, the Company announced that its board of directors approved a <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230123__20230125_zX0vqkPDiiTa" title="Reverse stock split">1-for-50 reverse stock split</span> of the Company’s issued and outstanding shares of common stock, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230125_zk1kPlWomdYg" title="Common stock par value">0.0001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authorized number of shares of common stock were not affected by the reverse stock split. No fractional shares were issued in connection with the reverse stock split, as all fractional shares were rounded up to the next whole share. Accordingly, all share and per share amounts presented herein with respect to common stock have been retroactively adjusted to reflect the above-described reverse stock split for all periods presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </REED:ReverseStockSplitPolicyTextBlock> <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2024-01-222024-01-24_srt_ScenarioForecastMember">1-for-6 and not more than 1-for-50</us-gaap:StockholdersEquityReverseStockSplit> <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2023-01-232023-01-25">1-for-50 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit> <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2023-01-25" decimals="INF" unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare> <us-gaap:UseOfEstimates contextRef="From2023-01-01to2023-03-31"><p id="xdx_848_eus-gaap--UseOfEstimates_zIV9whzmHNF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zWsVc4Z17RCi">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for credit loss reserves for accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:UseOfEstimates> <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_847_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zRPXtDWYnH8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zKLte9A4xSoa">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, <i>Revenue from Contracts with Customers</i> (“ASC 606”). Revenue and costs of sales are recognized when control of the products transfers to our customer, which generally occurs upon shipment from our facilities. The Company’s performance obligations are satisfied at that time. The Company does not have any significant contracts with customers requiring performance beyond delivery, and contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. Shipping and handling activities are performed before the customer obtains control of the goods and therefore represent a fulfilment activity rather than a promised service to the customer. All of the Company’s products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not allow for returns, except for damaged products when the damage occurred pre-fulfilment. Damaged product returns have historically been insignificant. Because of this, the stand-alone nature of our products, and our assessment of performance obligations and transaction pricing for our sales contracts, we do not currently maintain a contract asset or liability balance for obligations. We assess our contracts and the reasonableness of our conclusions on a quarterly basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:RevenueFromContractWithCustomerPolicyTextBlock> <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_ztBZdn4dRhzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zFtoNpuLA6J6">Loss per Common Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic earnings (loss) per share is computed by dividing the net income (loss) applicable to common stockholders by the weighted average number of shares of common stock outstanding during the year, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings (loss) per share is computed by dividing the net income applicable to common stockholders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the periods ended March 31, 2023 and 2022, the calculations of basic and diluted loss per share are the same because potential dilutive securities would have had an anti-dilutive effect. The potentially dilutive securities consisted of the following:</span></p> <p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zb1wya13MRa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zkdPk4CYZAyk" style="display: none">Schedule of Potentially Dilutive Securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPEXumPr24Ai" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220331_zFlbhz4U0Wpb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQfXVgvmSk67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">276,715</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_ztEgUXlVNqIk" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">174,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,904</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zwYMiz0YzYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,257,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zarSidTOZeKj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_z5xumX8PAtmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock equivalent of Series A Convertible Preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,669,360</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">487,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zVOct0kq03V8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:EarningsPerSharePolicyTextBlock> <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89D_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zb1wya13MRa8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zkdPk4CYZAyk" style="display: none">Schedule of Potentially Dilutive Securities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230331_zPEXumPr24Ai" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220331_zFlbhz4U0Wpb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQfXVgvmSk67" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 14%; text-align: right">276,715</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_ztEgUXlVNqIk" style="vertical-align: bottom; background-color: White"> <td>Options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">174,460</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">202,904</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zwYMiz0YzYW5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Convertible note payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,257,491</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--UnvestedRestrictedCommonStockMember_zarSidTOZeKj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested restricted common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember_z5xumX8PAtmg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Common stock equivalent of Series A Convertible Preferred stock</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">753</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">1,669,360</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">487,898</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember" decimals="-3" unitRef="Shares">235946000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-03-31_us-gaap_WarrantMember" decimals="-3" unitRef="Shares">276715000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember" decimals="-3" unitRef="Shares">174460000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-03-31_us-gaap_StockOptionMember" decimals="-3" unitRef="Shares">202904000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember" decimals="-3" unitRef="Shares">1257491000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2023-01-012023-03-31_custom_UnvestedRestrictedCommonStockMember" decimals="-3" unitRef="Shares">710000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-03-31_custom_UnvestedRestrictedCommonStockMember" decimals="-3" unitRef="Shares">7526000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2023-01-012023-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" decimals="-3" unitRef="Shares">753000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-03-31_custom_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember" decimals="-3" unitRef="Shares">753000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="Shares">1669360000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="Shares">487898000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount> <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2023-01-01to2023-03-31"><p id="xdx_844_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zfLjV5frfB7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zcYAl67biuub">Stock Compensation Expense</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company periodically issues stock options and restricted stock awards to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for such grants issued and vesting based on ASC 718, <i>Compensation-Stock Compensation</i> whereby the value of the award is measured on the date of grant and recognized for employees as compensation expense on the straight-line basis over the vesting period. Recognition of compensation expense for non-employees is in the same period and manner as if the Company had paid cash for the services. The Company recognizes the fair value of stock-based compensation within its Statements of Operations with classification depending on the nature of the services rendered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy> <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_84D_eus-gaap--AdvertisingCostsPolicyTextBlock_zPqvbZHo5Mn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zMHSPY5jtJQb">Advertising Costs</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are expensed as incurred and are included in selling and marketing expense. Advertising costs aggregated $<span id="xdx_90F_eus-gaap--AdvertisingExpense_pn3n3_c20230101__20230331_zlyI0xGE7sIe" title="Advertising costs">55</span> and $<span id="xdx_906_eus-gaap--AdvertisingExpense_pn3n3_c20220101__20220331_zVRPF0CL1DTf" title="Advertising costs">312</span> for the three months ended March 31, 2023 and 2022, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:AdvertisingCostsPolicyTextBlock> <us-gaap:AdvertisingExpense contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">55000</us-gaap:AdvertisingExpense> <us-gaap:AdvertisingExpense contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">312000</us-gaap:AdvertisingExpense> <us-gaap:ConcentrationRiskCreditRisk contextRef="From2023-01-01to2023-03-31"><p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zSJNEYtSF8th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zzuqbLkSRs0c">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net sales.</i> During the three months ended March 31, 2023, the Company’s two largest customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zhjWD7A0vtC3" title="Concentration risk percentage">18</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_z8PY15ZIt8F7" title="Concentration risk percentage">13</span>% of net sales, respectively. During the three months ended March 31, 2022, the Company’s two largest customers accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zQRhjXHwYAJe" title="Concentration risk percentage">18</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zu6OK4kd7j5e" title="Concentration risk percentage">12</span>% of net sales, respectively. No other customers exceeded 10% of net sales in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of March 31, 2023, the Company had accounts receivable from two customers which comprised <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zkZGEPpt3xm" title="Concentration risk, percentage">18</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zFMIAIE4P3W7" title="Concentration risk, percentage">11</span>% of its gross accounts receivable. As of December 31, 2022, the Company had accounts receivable from two customers which comprised <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zPU0rP4JquH2" title="Concentration risk, percentage">19</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zzI3sj3WGlrl" title="Concentration risk, percentage">11</span>% of its gross accounts receivable, respectively. No other customers exceeded 10% of gross accounts receivable in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and the year ended December 31, 2022, the Company utilized six separate co-packers for most its production and bottling of beverage products in the United States. The Company utilizes co-packers to produce <span id="xdx_90A_ecustom--PercentageOfCoPackersProducts_pid_dp_uPure_c20230101__20230331_zRozQ453RjIh" title="Percentage of co-packers products">100</span>% of its products. The Company has long-standing relationships with two different co-packers, and in conjunction with the sale of its manufacturing plant we entered into a third co-packing agreement with California Custom Beverage LLC (“CCB”), the purchaser of the plant (see Note 11). CCB is <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zBn8F4bDgPEg" title="Concentration risk, percentage">100</span>% owned by Chris Reed, founder of the Company and formerly Chief Executive Officer, Chairman, director, and most recently, Chief Innovation Officer. Although there are other packers, a change in co-packers may cause a delay in the production process, which could ultimately affect operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the three months ended March 31, 2023, the Company’s largest vendor accounted for approximately <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zPrrhxezrSk2" title="Percentage of sale accounted to customer">11</span>% of all purchases. During the three months ended March 31, 2022, the Company’s largest vendor accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220331__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember_zXFarhHr1lO4" title="Percentage of sale accounted to customer">13</span>% of all purchases. No other vendors exceeded 10% of all purchases in either period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:ConcentrationRiskCreditRisk> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" decimals="INF" unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" decimals="INF" unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" decimals="INF" unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" decimals="INF" unitRef="Pure">0.12</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-03-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" decimals="INF" unitRef="Pure">0.18</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-03-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" decimals="INF" unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_custom_CustomerOneMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" decimals="INF" unitRef="Pure">0.19</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-12-31_custom_CustomerTwoMember_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember" decimals="INF" unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1> <REED:PercentageOfCoPackersProducts contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="Pure">1</REED:PercentageOfCoPackersProducts> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_ProductConcentrationRiskMember_us-gaap_SalesRevenueNetMember" decimals="INF" unitRef="Pure">1</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2023-01-012023-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" decimals="INF" unitRef="Pure">0.11</us-gaap:ConcentrationRiskPercentage1> <us-gaap:ConcentrationRiskPercentage1 contextRef="From2022-01-012022-03-31_custom_VendorOneMember_us-gaap_SalesRevenueNetMember_us-gaap_ProductConcentrationRiskMember" decimals="INF" unitRef="Pure">0.13</us-gaap:ConcentrationRiskPercentage1> <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-01-01to2023-03-31"><p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zf0Pma4juc5b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zdPV50cba8i5">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses various inputs in determining the fair value of its financial assets and liabilities and measures these assets on a recurring basis. Financial assets recorded at fair value are categorized by the level of subjectivity associated with the inputs used to measure their fair value. ASC 820 defines the following levels of subjectivity associated with the inputs:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3—Unobservable inputs based on the Company’s assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of financial assets and liabilities, such as cash and cash equivalents, accounts receivable, short-term bank loans, accounts payable, notes payable and other payables, approximate their fair values because of the short maturity of these instruments. The carrying values of capital lease obligations and long-term financing obligations approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:FairValueOfFinancialInstrumentsPolicy> <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zIVAdhofeuV7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z0cRHst8Nmt8">Recent Accounting Pronouncements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the FASB issued ASU 2021-04 “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation— Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815- 40) Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). ASU 2021-04 provides guidance as to how an issuer should account for a modification of the terms or conditions or an exchange of a freestanding equity-classified written call option (i.e., a warrant) that remains equity classified after modification or exchange as an exchange of the original instrument for a new instrument. An issuer should measure the effect of a modification or exchange as the difference between the fair value of the modified or exchanged warrant and the fair value of that warrant immediately before modification or exchange and then apply a recognition model that comprises four categories of transactions and the corresponding accounting treatment for each category (equity issuance, debt origination, debt modification, and modifications unrelated to equity issuance and debt origination or modification). ASU 2021-04 is effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the guidance provided in ASU 2021-04 prospectively to modifications or exchanges occurring on or after the effective date. The Company adopted ASU 2021-04 effective January 1, 2022. The adoption of ASU 2021-04 did not have any impact on the Company’s financial statement presentation or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In September 2016, the FASB issued ASU 2016-13, <i>Measurement of Credit Losses on Financial Instruments</i>. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company adopted this standard effective January 1, 2023 and there was no material impact of adopting this standard on the Company’s financial statements and related disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting pronouncements and guidance issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.</span></p> </us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock> <us-gaap:InventoryDisclosureTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_80D_eus-gaap--InventoryDisclosureTextBlock_znmEgHHFV5ma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2. <span id="xdx_826_zWee98NzAJwb">Inventory</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrOqFredCLSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z2ZtBxxqOpyd" style="display: none">Schedule of Inventory</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zafOs6QsMgCb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zJVVw8c0UK01" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz4dt_zAVtgXZcRXP7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Raw materials and packaging</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,178</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,526</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz4dt_zKLsmCp6fM91" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Finished products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,649</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz4dt_z0neJrSoJwdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,301</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,175</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zrUMUCeUdGZa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:InventoryDisclosureTextBlock> <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89A_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zrOqFredCLSf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory is valued at the lower of cost (first-in, first-out) or net realizable value, net of write downs, and is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B8_z2ZtBxxqOpyd" style="display: none">Schedule of Inventory</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20230331_zafOs6QsMgCb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20221231_zJVVw8c0UK01" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryRawMaterials_iI_pn3n3_maINz4dt_zAVtgXZcRXP7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Raw materials and packaging</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">7,178</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,526</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pn3n3_maINz4dt_zKLsmCp6fM91" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Finished products</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,123</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,649</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryNet_iTI_pn3n3_mtINz4dt_z0neJrSoJwdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15,301</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,175</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfInventoryCurrentTableTextBlock> <us-gaap:InventoryRawMaterials contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">7178000</us-gaap:InventoryRawMaterials> <us-gaap:InventoryRawMaterials contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">8526000</us-gaap:InventoryRawMaterials> <us-gaap:InventoryFinishedGoods contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">8123000</us-gaap:InventoryFinishedGoods> <us-gaap:InventoryFinishedGoods contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">7649000</us-gaap:InventoryFinishedGoods> <us-gaap:InventoryNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">15301000</us-gaap:InventoryNet> <us-gaap:InventoryNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">16175000</us-gaap:InventoryNet> <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_804_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z2S1mUTouBI6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3. <span id="xdx_828_zbvglWbZ06zf">Property and Equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_ztP0RtqFosQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zaqMbEpbSude" style="display: none">Schedule of Property and Equipment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331_zu3MX6JniaP1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zBfjOndsQvSc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsUnderOperatingLeasesMember_zuRJaL5Vb8qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Right-of-use assets under operating leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerHardwareAndSoftwareMember_zSRTFox0Qpcj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Computer hardware and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zC2U319Ct8tc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Machinery and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzorg_z2DlSRSuHwT" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzorg_zKqyPsJM7rF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(867</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(787</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzorg_zUbv2WIz6c36" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Net book value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">686</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_ziALRRfNGQo2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the three months ended March 31, 2023 and 2022 was $<span id="xdx_90C_eus-gaap--Depreciation_pn3n3_c20230101__20230331_zEJDRS9wj7sd" title="Depreciation expense">47</span> and $<span id="xdx_902_eus-gaap--Depreciation_pn3n3_c20220101__20220331_z4e9May3G9z2" title="Depreciation expense">25</span>, respectively, and amortization of right-of-use assets for the three months ended March 31, 2022 and 2021 was $<span id="xdx_90D_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20230101__20230331_zotzQKuBMKmf" title="Amortization of right-of-use assets">32</span> and $<span id="xdx_908_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_pn3n3_c20220101__20220331_zN7dzsquaIZi" title="Amortization of right-of-use assets">27</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock> <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89D_eus-gaap--PropertyPlantAndEquipmentTextBlock_ztP0RtqFosQj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is comprised of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zaqMbEpbSude" style="display: none">Schedule of Property and Equipment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230331_zu3MX6JniaP1" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_zBfjOndsQvSc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--RightOfUseAssetsUnderOperatingLeasesMember_zuRJaL5Vb8qg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Right-of-use assets under operating leases</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">724</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerHardwareAndSoftwareMember_zSRTFox0Qpcj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Computer hardware and software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">400</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zC2U319Ct8tc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Machinery and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">429</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_pn3n3_maPPAENzorg_z2DlSRSuHwT" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total cost</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,553</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pn3n3_di_msPPAENzorg_zKqyPsJM7rF1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(867</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(787</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pn3n3_mtPPAENzorg_zUbv2WIz6c36" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Net book value</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">686</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">766</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:PropertyPlantAndEquipmentTextBlock> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2023-03-31_custom_RightOfUseAssetsUnderOperatingLeasesMember" decimals="-3" unitRef="USD">724000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31_custom_RightOfUseAssetsUnderOperatingLeasesMember" decimals="-3" unitRef="USD">724000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2023-03-31_custom_ComputerHardwareAndSoftwareMember" decimals="-3" unitRef="USD">400000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31_custom_ComputerHardwareAndSoftwareMember" decimals="-3" unitRef="USD">400000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2023-03-31_us-gaap_MachineryAndEquipmentMember" decimals="-3" unitRef="USD">429000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31_us-gaap_MachineryAndEquipmentMember" decimals="-3" unitRef="USD">429000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1553000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1553000</us-gaap:PropertyPlantAndEquipmentGross> <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">867000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">787000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment> <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">686000</us-gaap:PropertyPlantAndEquipmentNet> <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">766000</us-gaap:PropertyPlantAndEquipmentNet> <us-gaap:Depreciation contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">47000</us-gaap:Depreciation> <us-gaap:Depreciation contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">25000</us-gaap:Depreciation> <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">32000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense> <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">27000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense> <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_z37xqau2dXG7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4. <span id="xdx_82D_z2MZ2ZzwSKmd">Intangible Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_z6t8G3PlNVMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zA3mQEGNTkea" style="display: none">Summary of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230331_zFYV6NsNhhj3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zlOzhmua1Czg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--IndefiniteLivedTradeNames_iI_pn3n3_maILIAEzdvn_zckpm6vOo64j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Brand names</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IndefiniteLivedTrademarks_iI_pn3n3_maILIAEzdvn_zNNb6IH2Kp66" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Trademarks</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzdvn_z7Kr9ehUn2ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zomCzP7KgdJh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:IntangibleAssetsDisclosureTextBlock> <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_896_eus-gaap--ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_z6t8G3PlNVMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B3_zA3mQEGNTkea" style="display: none">Summary of Intangible Assets</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230331_zFYV6NsNhhj3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20221231_zlOzhmua1Czg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_403_eus-gaap--IndefiniteLivedTradeNames_iI_pn3n3_maILIAEzdvn_zckpm6vOo64j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Brand names</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">576</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IndefiniteLivedTrademarks_iI_pn3n3_maILIAEzdvn_zNNb6IH2Kp66" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Trademarks</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--IndefiniteLivedIntangibleAssetsExcludingGoodwill_iTI_pn3n3_mtILIAEzdvn_z7Kr9ehUn2ia" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">626</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock> <us-gaap:IndefiniteLivedTradeNames contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">576000</us-gaap:IndefiniteLivedTradeNames> <us-gaap:IndefiniteLivedTradeNames contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">576000</us-gaap:IndefiniteLivedTradeNames> <us-gaap:IndefiniteLivedTrademarks contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">50000</us-gaap:IndefiniteLivedTrademarks> <us-gaap:IndefiniteLivedTrademarks contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">50000</us-gaap:IndefiniteLivedTrademarks> <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">626000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill> <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">626000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill> <us-gaap:ShortTermDebtTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_80A_eus-gaap--ShortTermDebtTextBlock_zNJOqn5RLmY1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5. <span id="xdx_828_zr1aGtU0Kzp1">Line of Credit</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zodfXAcYmQgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under the Company’s credit facilities are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_z6xvmyYxVxo4" style="display: none">Schedule of Amount Outstanding Under Credit Facilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Line of credit – Alterna Capital Solutions</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zmBayIASHv3k" style="width: 16%; text-align: right" title="Total">7,915</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zurvFg2UTC3f" style="width: 16%; text-align: right" title="Total">11,337</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20230331_zyGgKRWEV9Q" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(322</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20221231_zPKbkmNkCOxc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(363</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331_zJItTVBCb83l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">7,593</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231_zdYYMKYCGB6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">10,974</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zfUiBbex1h8g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Alterna Capital Solutions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 28, 2022, the Company entered into a financing agreement with Alterna Capital Solutions (“ACS”), for a line of credit to replace its existing credit facility. The ACS line of credit is for a term of <span id="xdx_906_eus-gaap--DebtInstrumentTerm_dtY_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ztGlDaQPT36" title="Debt instrument, term">3</span> years, provides for borrowings of up to $<span id="xdx_901_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_z8e70GoXRY1e" title="Line of credit facility, maximum borrowing capacity">13,000</span>, and is secured by eligible accounts receivable and inventory. An over advance rider provides for up to $<span id="xdx_904_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_pn3n3_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ze5QVlZC2MZe" title="Line of credit facility, maximum amount outstanding during period">400</span> of additional borrowing above the collateralized base (the “Over Advance”) up to a total borrowing of $<span id="xdx_90F_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zoBV64UPchxc" title="Line of credit facility, maximum borrowing capacity">13,000</span>. At March 31, 2023, $<span id="xdx_903_eus-gaap--LineOfCreditFacilityCurrentBorrowingCapacity_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zHsDEiNJHOZb" title="Line of credit facility, borrowing capacity">62</span> of current availability and $<span id="xdx_90C_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zJgOPAv2gQ5c" title="Line of credit facility, borrowing capacity">5,084</span> of borrowing capacity was available under the financing agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--LineOfCreditFacilityInterestRateDescription_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zhbBKtNJwtsa" title="Line of credit facility, interest rate description">Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (12.75% at March 31, 2023 and 12.25% at December 31, 2022). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.40% at March 31, 2023 and 12.90% at December 31, 2022). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2023 and 18.00% at December 31, 2022). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility</span>. A loan balance of less than $<span id="xdx_90F_eus-gaap--LineOfCredit_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zG2b2rsFNHY2" title="Line of credit">1,500</span> will bear interest at a rate in line with account receivables advances plus the monthly monitoring fee of $<span id="xdx_909_ecustom--LineOfCreditMonitoringFee_iI_pn3n3_c20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zZXoKlI3BwF8" title="Line of credit monitoring fee">1</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred $<span id="xdx_90C_eus-gaap--DirectOperatingCosts_pn3n3_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zrXQgnPUeqlh" title="Direct operating costs">483</span> of direct costs of the transaction, consisting primarily of broker, bank and legal fees. These costs have been capitalized and are being amortized over the <span id="xdx_907_ecustom--AmortizationOfLineOfCreditPeriod_dtY_c20220327__20220328__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_znsxkhOE7iE2" title="Amortization of line of credit period">3</span>-year life of the ACS agreement. The unamortized debt discount balance was $<span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20220101__20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zf8QBh5MRms6" title="Amortization of debt discount">363</span> at December 31, 2022. For the three months ended March 31, 2023, amortization of debt discount was $<span id="xdx_90D_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20230101__20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_ztgKHckHYA8k" title="Amortization of debt discount">41</span>, and as of March 31, 2023, the remaining unamortized debt discount balance is $<span id="xdx_904_ecustom--DebtInstrumentRemainingUnamortizedDiscount_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zMx18RJxVbdg" title="Remaining unamortized debt discount amount">322</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:ShortTermDebtTextBlock> <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89F_eus-gaap--ScheduleOfLineOfCreditFacilitiesTextBlock_zodfXAcYmQgg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under the Company’s credit facilities are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_z6xvmyYxVxo4" style="display: none">Schedule of Amount Outstanding Under Credit Facilities</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Line of credit – Alterna Capital Solutions</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zmBayIASHv3k" style="width: 16%; text-align: right" title="Total">7,915</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231__us-gaap--LineOfCreditFacilityAxis__custom--AlternaCapitalSolutionsMember_zurvFg2UTC3f" style="width: 16%; text-align: right" title="Total">11,337</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20230331_zyGgKRWEV9Q" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(322</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredFinanceCostsCurrentNet_iNI_pn3n3_di0_c20221231_zPKbkmNkCOxc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Capitalized financing costs">(363</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20230331_zJItTVBCb83l" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">7,593</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--LinesOfCreditCurrent_iI_pn3n3_c20221231_zdYYMKYCGB6" style="border-bottom: Black 2.5pt double; text-align: right" title="Total">10,974</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock> <us-gaap:LinesOfCreditCurrent contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">7915000</us-gaap:LinesOfCreditCurrent> <us-gaap:LinesOfCreditCurrent contextRef="AsOf2022-12-31_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">11337000</us-gaap:LinesOfCreditCurrent> <us-gaap:DeferredFinanceCostsCurrentNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">322000</us-gaap:DeferredFinanceCostsCurrentNet> <us-gaap:DeferredFinanceCostsCurrentNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">363000</us-gaap:DeferredFinanceCostsCurrentNet> <us-gaap:LinesOfCreditCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">7593000</us-gaap:LinesOfCreditCurrent> <us-gaap:LinesOfCreditCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">10974000</us-gaap:LinesOfCreditCurrent> <us-gaap:DebtInstrumentTerm contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember">P3Y</us-gaap:DebtInstrumentTerm> <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">13000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">400000</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod> <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">13000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">62000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity> <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">5084000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity> <us-gaap:LineOfCreditFacilityInterestRateDescription contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember">Borrowings based on receivables bears an interest of prime plus 4.75% but not less than 8.0% (12.75% at March 31, 2023 and 12.25% at December 31, 2022). Borrowings based on inventory bears an interest of prime plus 5.25% but not less than 8.5% (13.40% at March 31, 2023 and 12.90% at December 31, 2022). The additional over advance rider bears a rate of prime plus 12.75%, but not less than 16.00% (18.00% at March 31, 2023 and 18.00% at December 31, 2022). Additionally, the line of credit is subject to monthly monitoring fee of $1 with a minimum usage requirement on the credit facility</us-gaap:LineOfCreditFacilityInterestRateDescription> <us-gaap:LineOfCredit contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">1500000</us-gaap:LineOfCredit> <REED:LineOfCreditMonitoringFee contextRef="AsOf2022-03-28_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">1000</REED:LineOfCreditMonitoringFee> <us-gaap:DirectOperatingCosts contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">483000</us-gaap:DirectOperatingCosts> <REED:AmortizationOfLineOfCreditPeriod contextRef="From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember">P3Y</REED:AmortizationOfLineOfCreditPeriod> <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2022-01-012022-12-31_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">363000</us-gaap:AmortizationOfDebtDiscountPremium> <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2023-01-012023-03-31_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">41000</us-gaap:AmortizationOfDebtDiscountPremium> <REED:DebtInstrumentRemainingUnamortizedDiscount contextRef="AsOf2023-03-31_custom_AlternaCapitalSolutionsMember" decimals="-3" unitRef="USD">322000</REED:DebtInstrumentRemainingUnamortizedDiscount> <us-gaap:DebtDisclosureTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zxQVGmiUI6S5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_829_z7pSKLZYqBhj">Secured Convertible Notes Payable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zoZWIjZuktb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under secured convertible notes payable are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zNi9ZTxIlOl9" style="display: none">Schedule of Debt</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230331_zbgWjfKK4fK3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_ztfZ23A4fGK7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--SecuredDebt_iI_pn3n3_maCNPzwQW_zgEzJGrRTW47" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Secured Convertible Note Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,450</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_maCNPzwQW_zgRe811erj94" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,052</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredFinanceCostsNet_iNI_pn3n3_di_msCNPzwQW_zN8aolXsBwHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(976</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ConvertibleNotesPayable_iTI_pn3n3_mtCNPzwQW_zm8UYqldvhYb" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,011</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iNI_pn3n3_di_zsXNfAVxRjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,485</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,434</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_z59erWFtAdA8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,526</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,092</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zVJAbGfUC4y6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Secured Convertible Note Payable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, the Company entered into a note purchase agreement and agreed to issue $<span id="xdx_909_eus-gaap--SecuredDebt_iI_pn3n3_c20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zFU3sHUMxkW7" title="Secured convertible promissory notes">11,250</span> of secured convertible promissory notes (the “Notes”) to entities affiliated with Whitebox Advisors, LLC (collectively, “Whitebox”). <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateTerms_pp0d_c20220508__20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_ze54X7u3cIfi" title="Debt instrument rate terms">The Notes bear interest at a rate of 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the Notes)</span>. The Notes are secured by substantially all of the Company’s assets (including all of its intellectual property) and are subject to a collateral sharing agreement with ACS, the Company’s existing secured lender (see Note 5). The Notes mature on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20220508__20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z4d4XtN6XGxf" title="Debt instrument maturity date">May 9, 2025</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 9, 2022, the Company issued $<span id="xdx_905_eus-gaap--SecuredDebt_iI_pn3n3_c20220509__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zzl8HUigHIPh" title="Secured convertible promissory notes">11,250</span> of Notes to Whitebox. In September 2022, the Company issued an additional $<span id="xdx_90F_eus-gaap--SecuredDebt_iI_pn3n3_c20220930__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_zxwjDChC0Rw3" title="Secured convertible promissory notes">2,500</span> of Notes to Whitebox (the “September 2022 Notes”). The net proceeds from the issuance of the Notes and September 2022 Notes, after deducting placement agent fees and other debt issuance costs, was approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfSecuredDebt_pn3n3_c20220901__20220930__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_z8uvXtVIVNia" title="Proceeds from issuance of notes">12,430</span>. In November 2022, the Company paid off the $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_dd_c20221101__20221130__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--SeptemberTwoThousandTwentyTwoNotesMember_zMTJK7UpYgle" title="Common stock paid, value">2,500</span> of September 2022 Notes in cash. Beginning in August 2022, $<span id="xdx_908_eus-gaap--SecuredDebt_iI_pn3n3_c20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z3jtOEwG93q1" title="Secured convertible promissory notes">11,250</span> of the Notes have an amortization feature which requires the Company to make monthly payments of principal of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_pn3n3_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zlfuhkXjAYu1" title="Monthly payment">200</span> plus accrued interest, payable in cash or in shares of the Company’s common stock at the option of the Company. Amortization payments that are paid in shares are priced at <span id="xdx_906_eus-gaap--DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_pid_dp_uPure_c20220801__20220831__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zwHlbqaoaRTa" title="Weighted average interest">90</span>% of the average of the daily volume weighted average prices of the Company’s common stock during the five trading days prior to the date of amortization payment. During the year ended December 31, 2022, the Company made monthly amortization principal payments aggregating $<span id="xdx_90A_eus-gaap--RepaymentsOfSecuredDebt_pn3n3_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYQOLANw0jQ5" title="Principal payment">800</span>, made up of $<span id="xdx_905_eus-gaap--Cash_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zagOV5Q8WJha" title="Cash">600</span> in cash, and the issuance of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_dd_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zbw9kcUfYoef" title="Common stock paid, shares">32,362</span> shares of common stock valued at $<span id="xdx_909_eus-gaap--CommonStockValue_iI_pn3n3_dd_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zRPHtNJAcVTh" title="Common stock value">200</span>. At December 31, 2022, the principal balance of the Notes was $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zeEn0iBL3Ryj" title="Principal balance">10,450</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2023, the Company entered into a Partial Option Exercise and Second Amendment to the <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zDPv79bHi9A8" title="Debt instrument rate">10</span>% Convertible Notes with Whitebox. The Notes were amended so if the Company experiences a fundamental change as defined, the holders of the notes have the right to require the Company to repurchase the notes for cash at a repurchase price equal to <span id="xdx_90F_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20230209__20230210__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zYrD31geg427" title="Percentage of repurchase price">110</span>% (amended from <span id="xdx_909_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_znNwRJvdDj44" title="Percentage of repurchase price">100</span>%) of the principal amount, plus accrued interest. In addition, Whitebox exercised a partial option to purchase $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_pn3n3_c20230209__20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_zUa3qDJZrB9l" title="Options to purchase">2,550</span> of additional notes (the “February 2023 Notes”) from the Company. The February 2023 Notes bear interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230210__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_z3wCC1BCdqu8" title="Debt instrument rate">10</span>% per annum. payable in cash and mature on June 20, 2023. No amortization payments (as defined in the Notes) are payable on the February 2023 Notes, and the February 2023 Notes may be prepaid without premium or penalty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 13, 2023, the Company entered into a Limited Waiver and Deferral Agreement with Whitebox. Whitebox waived the Company’s covenant violation of its Excess ABL Amount at November 30, 2022, December 31, 2022, and January 31, 2023, and deferred payment of the <span id="xdx_906_ecustom--PercentageForDeferredPayment_iI_pid_dp_uPure_c20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zHo30icII6ma" title="Percentage for deferred payment">10</span>% fee for the Excess ABL Amount until June 2023. In addition, Whitebox also temporarily waived any requirement that the Company repurchase the Notes in the event of fundamental change (as defined in the Notes), through April 1, 2023, subject to the terms and conditions contained therein. As an inducement, the Company issued an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230213__20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zxe2LFj0Nol7" title="Number of common stock issued">82,438</span> shares of common stock to the holders with a fair value of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230213__20230213__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zmpJX8b6wm3g" title="Number of common stock issued, value">273</span>. These costs have been capitalized and are being amortized over the term of the waiver. For the three months ended March 31, 2023, amortization of interest was $<span id="xdx_907_eus-gaap--InterestExpenseDebtExcludingAmortization_pn3n3_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--LimitedWaiverAndDeferralAgreementMember_zAhBHyduL0O6" title="Amortization of interest">96</span>. The shares issued and the shares of common stock issuable upon conversion of the Option Notes are registrable and subject to that certain Registration Rights Agreement dated May 9, 2023. At March 31, 2023, the principal balance of the Notes and February 2023 Notes was $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember__us-gaap--DebtInstrumentAxis__custom--FebruaryTwoThousandTwentyThreeNotesMember_z3uULc1L2IWg" title="Principal balance">13,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon conversion, holders of the Note are entitled to receive an interest make-whole payment, as defined. The make-whole amount is equal to the sum of the remaining scheduled payments of interest on the Notes to be converted that would be due if such notes matured <span id="xdx_905_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20230213__20230213_z5diV9UAXNj4" title="Maturity date">May 9, 2025</span>, payable, at the Company’s option in cash or in shares of common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the balance of accrued interest was $<span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20221231__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zvowSmVx3IN7" title="Accrued interest">1,052</span>. During the three months ended March 31, 2023, the Company recorded interest of $<span id="xdx_90B_eus-gaap--InterestExpense_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_z9TsBWmE827e" title="Interest expense">1,113</span>, made up of $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zgtqbHI9rKg8" title="Interest on the notes">366</span> of interest on the Notes, and $<span id="xdx_902_eus-gaap--DebtInstrumentPeriodicPaymentPrincipal_pn3n3_c20230101__20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_zSyDe3jWCuVk" title="Whole interest">747</span> related to the excess line of credit debt fee. At March 31, 2023, the balance of accrued interest was $<span id="xdx_909_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_c20230331__us-gaap--ShortTermDebtTypeAxis__us-gaap--ConvertibleNotesPayableMember_znZSVlAE8VR4" title="Accrued interest">2,165</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentType_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zvpgoObs8zmc" title="Debt instrument conversion, description">The initial conversion rate of the Notes is 0.08306 shares of the Company’s common stock per one dollar of principal converted, or approximately $12.04 per share, subject to customary anti-dilution adjustments. In addition, if certain corporate events occur that constitute a make-whole fundamental change as defined, then the note holders are, under certain circumstances, are entitled to an increase in the conversion rate, limited to 0.12155 shares of Common Stock per one dollar of principal, or approximately $8.23 per share</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s ability to settle conversions and make amortization payments and interest make-whole payments using shares of the Company’s common stock is subject to certain limitations set forth in the Notes. If the Company experiences a fundamental change as defined, the holders of the notes have the right to require the Company to repurchase the notes for cash at a repurchase price equal to <span id="xdx_904_ecustom--PercentageOfRepurchasePrice_pid_dp_uPure_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zMWnY49bF8Ah" title="Percentage of repurchase price">100</span>% of the principal amount, plus accrued interest thereon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023, the Notes, including accrued interest, are convertible into <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_pid_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_z69rYm3BuGq5" title="Debt conversion into shares">1,257,491</span> shares of the Company’s common stock pursuant to a share conversion cap limit as defined in the Notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unamortized debt discount was $<span id="xdx_904_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20221231__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zAY7MMM0t0Jk" title="Unamortized debt discount amount">976</span> at December 31, 2022. During the three months ended March 31, 2023, the Company incurred $<span id="xdx_907_eus-gaap--DeferredFinanceCostsNet_iI_pn3n3_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zWZlZxGE0KX9" title="Direct costs">145</span> of direct costs of the transactions, consisting primarily of placement agent fees and other offering expenses and the issuance of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--HoldersMember_zOZvKpsijZt7" title="Number of common stock issued">82,438</span> valued at $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--HoldersMember_zc5oVFlabMYk" title="New issuance of common stock">273</span> as inducement for the aforementioned waiver. These costs have been capitalized and are being amortized over the term of the Notes and waiver period. For the three months ended March 31, 2023, amortization of debt discount was $<span id="xdx_908_eus-gaap--AmortizationOfDebtDiscountPremium_pn3n3_c20230101__20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zEAmjzHnVOUi" title="Amortization of debt discount">240</span>, and as of March 31, 2023, the remaining unamortized debt discount balance is $<span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pn3n3_c20230331__us-gaap--TypeOfArrangementAxis__custom--NotePurchaseAgreementMember_zkEp0BRbktOh" title="Unamortized debt discount amount">1,154</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:DebtDisclosureTextBlock> <us-gaap:ScheduleOfDebtTableTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89B_eus-gaap--ScheduleOfDebtTableTextBlock_zoZWIjZuktb9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts outstanding under secured convertible notes payable are as follows (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B0_zNi9ZTxIlOl9" style="display: none">Schedule of Debt</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20230331_zbgWjfKK4fK3" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_ztfZ23A4fGK7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_402_eus-gaap--SecuredDebt_iI_pn3n3_maCNPzwQW_zgEzJGrRTW47" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Secured Convertible Note Payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">13,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">10,450</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_pn3n3_maCNPzwQW_zgRe811erj94" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,165</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,052</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredFinanceCostsNet_iNI_pn3n3_di_msCNPzwQW_zN8aolXsBwHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Capitalized financing costs</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,154</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(976</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ConvertibleNotesPayable_iTI_pn3n3_mtCNPzwQW_zm8UYqldvhYb" style="vertical-align: bottom; background-color: White"> <td>Total</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14,011</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">10,526</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleNotesPayableCurrent_iNI_pn3n3_di_zsXNfAVxRjk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Current portion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(5,485</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,434</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--ConvertibleLongTermNotesPayable_iI_pn3n3_z59erWFtAdA8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Long term portion</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,526</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,092</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfDebtTableTextBlock> <us-gaap:SecuredDebt contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">13000000</us-gaap:SecuredDebt> <us-gaap:SecuredDebt contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">10450000</us-gaap:SecuredDebt> <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2165000</us-gaap:InterestPayableCurrentAndNoncurrent> <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">1052000</us-gaap:InterestPayableCurrentAndNoncurrent> <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1154000</us-gaap:DeferredFinanceCostsNet> <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">976000</us-gaap:DeferredFinanceCostsNet> <us-gaap:ConvertibleNotesPayable contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">14011000</us-gaap:ConvertibleNotesPayable> <us-gaap:ConvertibleNotesPayable contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">10526000</us-gaap:ConvertibleNotesPayable> <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">5485000</us-gaap:ConvertibleNotesPayableCurrent> <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">2434000</us-gaap:ConvertibleNotesPayableCurrent> <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">8526000</us-gaap:ConvertibleLongTermNotesPayable> <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">8092000</us-gaap:ConvertibleLongTermNotesPayable> <us-gaap:SecuredDebt contextRef="AsOf2022-05-09_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">11250000</us-gaap:SecuredDebt> <us-gaap:DebtInstrumentInterestRateTerms contextRef="From2022-05-082022-05-09_custom_NotePurchaseAgreementMember">The Notes bear interest at a rate of 10% per annum (with 5% per annum payable in cash and 5% per annum payable in kind (“PIK”) by adding such PIK interest to the principal amount of the Notes)</us-gaap:DebtInstrumentInterestRateTerms> <us-gaap:DebtInstrumentMaturityDate contextRef="From2022-05-082022-05-09_custom_NotePurchaseAgreementMember">2025-05-09</us-gaap:DebtInstrumentMaturityDate> <us-gaap:SecuredDebt contextRef="AsOf2022-05-09_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">11250000</us-gaap:SecuredDebt> <us-gaap:SecuredDebt contextRef="AsOf2022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember" decimals="-3" unitRef="USD">2500000</us-gaap:SecuredDebt> <us-gaap:ProceedsFromIssuanceOfSecuredDebt contextRef="From2022-09-012022-09-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember" decimals="-3" unitRef="USD">12430000</us-gaap:ProceedsFromIssuanceOfSecuredDebt> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2022-11-012022-11-30_custom_NotePurchaseAgreementMember_custom_SeptemberTwoThousandTwentyTwoNotesMember" decimals="-3" unitRef="USD">2500000</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:SecuredDebt contextRef="AsOf2022-08-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">11250000</us-gaap:SecuredDebt> <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2022-08-012022-08-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">200000</us-gaap:DebtInstrumentPeriodicPayment> <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger contextRef="From2022-08-012022-08-31_custom_NotePurchaseAgreementMember" decimals="INF" unitRef="Pure">0.90</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger> <us-gaap:RepaymentsOfSecuredDebt contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">800000</us-gaap:RepaymentsOfSecuredDebt> <us-gaap:Cash contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">600000</us-gaap:Cash> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" decimals="INF" unitRef="Shares">32362</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:CommonStockValue contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">200000</us-gaap:CommonStockValue> <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">10450000</us-gaap:DebtInstrumentFaceAmount> <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2023-02-10_custom_OptionNotesMember" decimals="INF" unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage> <REED:PercentageOfRepurchasePrice contextRef="From2023-02-092023-02-10_custom_NotePurchaseAgreementMember" decimals="INF" unitRef="Pure">1.10</REED:PercentageOfRepurchasePrice> <REED:PercentageOfRepurchasePrice contextRef="From2022-01-012022-12-31_custom_NotePurchaseAgreementMember" decimals="INF" unitRef="Pure">1</REED:PercentageOfRepurchasePrice> <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2023-02-092023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember" decimals="-3" unitRef="USD">2550000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2023-02-10_custom_FebruaryTwoThousandTwentyThreeNotesMember" decimals="INF" unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage> <REED:PercentageForDeferredPayment contextRef="AsOf2023-02-13_custom_LimitedWaiverAndDeferralAgreementMember" decimals="INF" unitRef="Pure">0.10</REED:PercentageForDeferredPayment> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2023-02-132023-02-13_custom_LimitedWaiverAndDeferralAgreementMember" decimals="INF" unitRef="Shares">82438</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-02-132023-02-13_custom_LimitedWaiverAndDeferralAgreementMember" decimals="-3" unitRef="USD">273000</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="From2023-01-012023-03-31_custom_LimitedWaiverAndDeferralAgreementMember" decimals="-3" unitRef="USD">96000</us-gaap:InterestExpenseDebtExcludingAmortization> <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2023-03-31_custom_NotePurchaseAgreementMember_custom_FebruaryTwoThousandTwentyThreeNotesMember" decimals="0" unitRef="USD">13000</us-gaap:DebtInstrumentFaceAmount> <us-gaap:LineOfCreditFacilityExpirationDate1 contextRef="From2023-02-132023-02-13">2025-05-09</us-gaap:LineOfCreditFacilityExpirationDate1> <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2022-12-31_us-gaap_ConvertibleNotesPayableMember" decimals="-3" unitRef="USD">1052000</us-gaap:InterestPayableCurrentAndNoncurrent> <us-gaap:InterestExpense contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046" decimals="-3" unitRef="USD">1113000</us-gaap:InterestExpense> <us-gaap:InterestExpenseDebt contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046" decimals="-3" unitRef="USD">366000</us-gaap:InterestExpenseDebt> <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="From2023-01-012023-03-31_us-gaap_ConvertibleNotesPayableMember82537046" decimals="-3" unitRef="USD">747000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal> <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2023-03-31_us-gaap_ConvertibleNotesPayableMember" decimals="-3" unitRef="USD">2165000</us-gaap:InterestPayableCurrentAndNoncurrent> <us-gaap:DebtConversionConvertedInstrumentType contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember">The initial conversion rate of the Notes is 0.08306 shares of the Company’s common stock per one dollar of principal converted, or approximately $12.04 per share, subject to customary anti-dilution adjustments. In addition, if certain corporate events occur that constitute a make-whole fundamental change as defined, then the note holders are, under certain circumstances, are entitled to an increase in the conversion rate, limited to 0.12155 shares of Common Stock per one dollar of principal, or approximately $8.23 per share</us-gaap:DebtConversionConvertedInstrumentType> <REED:PercentageOfRepurchasePrice contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember" decimals="INF" unitRef="Pure">1</REED:PercentageOfRepurchasePrice> <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember" decimals="INF" unitRef="Shares">1257491</us-gaap:DebtConversionConvertedInstrumentSharesIssued1> <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2022-12-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">976000</us-gaap:DebtInstrumentUnamortizedDiscount> <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2023-03-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">145000</us-gaap:DeferredFinanceCostsNet> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2023-01-012023-03-31_custom_HoldersMember" decimals="INF" unitRef="Shares">82438</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-01-012023-03-31_custom_HoldersMember" decimals="-3" unitRef="USD">273000</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2023-01-012023-03-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">240000</us-gaap:AmortizationOfDebtDiscountPremium> <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2023-03-31_custom_NotePurchaseAgreementMember" decimals="-3" unitRef="USD">1154000</us-gaap:DebtInstrumentUnamortizedDiscount> <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_804_eus-gaap--LesseeOperatingLeasesTextBlock_zPYP6birGRs4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7. <span id="xdx_829_zJFAa3M0l19j">Leases Liabilities</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, lease costs totaled $<span id="xdx_90F_eus-gaap--LeaseCost_pn3n3_c20230101__20230331_zjYQox5l5S0k" title="Lease cost">32</span> and $<span id="xdx_90F_eus-gaap--LeaseCost_pn3n3_c20220101__20220331_ztt1tK7AkWGh" title="Lease cost">27</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, operating lease liabilities totaled $<span id="xdx_909_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20221231_z8M19u1X83Nb" title="Operating leases liability">394</span>. During the three months ended March 31, 2023, the Company made payments of $<span id="xdx_909_eus-gaap--OperatingLeasePayments_pn3n3_c20230101__20230331_zd8R4pDfSWp6" title="Payments of operating lease liability">44</span> towards its operating lease liability. As of March 31, 2023, operating lease liabilities totaled $<span id="xdx_907_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20230331_z8Ai7jRRC1Hc" title="Operating leases liability">350</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the weighted average remaining lease terms for an operating lease are <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20230331_zEJZHrfoJUBc" title="Weighted average remaining lease term for operating lease">1.76</span> years. As of March 31, 2023, the weighted average discount rate on the operating lease is <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20230331_zmwmr4X2epW8" title="Weighted average discount rate for operating lease">12.60</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:LesseeOperatingLeasesTextBlock> <us-gaap:LeaseCost contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">32000</us-gaap:LeaseCost> <us-gaap:LeaseCost contextRef="From2022-01-012022-03-31" decimals="-3" unitRef="USD">27000</us-gaap:LeaseCost> <us-gaap:OperatingLeaseLiability contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">394000</us-gaap:OperatingLeaseLiability> <us-gaap:OperatingLeasePayments contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">44000</us-gaap:OperatingLeasePayments> <us-gaap:OperatingLeaseLiability contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">350000</us-gaap:OperatingLeaseLiability> <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2023-03-31">P1Y9M3D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1> <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2023-03-31" decimals="INF" unitRef="Pure">0.1260</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent> <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_80E_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_ze8eFSXJhFwj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8. <span id="xdx_827_z8jqMLZVZi49">Stockholder’s Equity</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company repurchased <span id="xdx_903_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20230101__20230331__srt--TitleOfIndividualAxis__srt--OfficerMember_zfXCwokrrJw6" title="Stock repurchased, shares">274</span> shares of common stock from an officer for $<span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__srt--OfficerMember_zLWlAQbS37Ac" title="Stock repurchased, value">1</span> based on the market value of share on the date repurchased. The Company retired the shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> </us-gaap:StockholdersEquityNoteDisclosureTextBlock> <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2023-01-012023-03-31_srt_OfficerMember" decimals="INF" unitRef="Shares">274</us-gaap:StockRepurchasedDuringPeriodShares> <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2023-01-012023-03-31_srt_OfficerMember" decimals="-3" unitRef="USD">1000</us-gaap:StockRepurchasedDuringPeriodValue> <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_80F_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_z6zshYg2zRA1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9. <span id="xdx_82B_zM6GBH2EBPp9">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Restricted common stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zsFwyY3jB2c4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes restricted stock activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zP5XnOXUCWj1" style="display: none">Summary of Non-vested Restricted Stock Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Issuable<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value<br/> at Date of<br/> Issuance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> Average <br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Balance, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhYwL9dgtte" style="width: 12%; text-align: right" title="Unvested Shares, beginning balance">1,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKAygSFawnc3" style="width: 12%; text-align: right" title="Issuable Shares, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iS_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjmeN6GaKck1" style="width: 12%; text-align: right" title="Fair Value at Date of Issuance, beginning balance">26.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhxsnUtxjUd" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, beginning balance">44.75</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPOTajjURMtg" style="text-align: right" title="Unvested Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0794">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zTAfL3JeBBUd" style="text-align: right" title="Issuable Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziUSxI8gRGz5" style="text-align: right" title="Fair Value at Date of Issuance, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0798">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjS4kUDx2o99" style="text-align: right" title="Unvested Shares, Vested">(750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zysKmil7Odh7" style="text-align: right" title="Issuable Shares, Vested">750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoMYZGIy99m2" style="text-align: right" title="Fair Value at Date of Issuance, Vested"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSiZbyHdPTgb" style="text-align: right" title="Unvested Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zq5W7F6eoxX4" style="font-size: 11pt; text-align: right" title="Issuable Shares, Forfeited"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></span></td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9dcnj3qlqu" style="text-align: right" title="Fair Value at Date of Issuance, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z0InI5dTzM5a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unvested Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zIHWuo5JdpD1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Issuable Shares, Issued">(750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBd6N9SH05ma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value at Date of Issuance, Issued">(6.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zyKUsCOXHnk6" style="border-bottom: Black 2.5pt double; text-align: right" title="Unvested Shares, ending balance">710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoWWvVlsSbr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Issuable Shares, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iE_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSDcwkdf21Ki" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value at Date of Issuance, ending balance">20.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhGBB8xjbMO6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, ending balance">44.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zWnPAZCnuHDf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The total fair value of restricted common stock vesting during the three months ended March 31, 2023 and 2022, was $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zsRgMCXHOCF9" title="Number of restricted shares, value">4</span> and $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_pn3n3_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKepQwqMJnC1" title="Number of restricted shares, value">66</span>, respectively, and is included in general and administrative expenses in the accompanying statements of operations. As of March 31, 2023, the amount of unvested compensation related to issuances of restricted common stock was $<span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z4DoB3z18R11" title="Aggregate value of unvested compensation">20</span>, which will be recognized as an expense in future periods as the shares vest. When calculating basic loss per share, these shares are included in weighted average common shares outstanding from the time they vest. When calculating diluted net income per share, these shares are included in weighted average common shares outstanding as of their grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock options</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zBpYMW1oi4fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes stock option activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zVc2uhVTtMa1" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms <br/> (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2SNl00YKn1c" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning balance">164,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuUJaWCYKwP" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning">48.90</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSd9kSxrgQsc" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning">7.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9EmoXyXsnDe" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0840">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVoZWFJp3EHb" style="text-align: right" title="Shares, Granted">10,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvW0t2ZWOY98" style="text-align: right" title="Weighted-Average Exercise Price, Granted">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAF94qZxbk5" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvMl2ST4FSa" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkX6XQbtmmOc" style="text-align: right" title="Shares, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9YTMEtHPXIc" style="text-align: right" title="Weighted-Average Exercise Price, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vested forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxhyAq7UYtMj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvEDp1qr8MMa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zokyJJjusar5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">174,460</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIjfxCeyd1Ak" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending">46.34</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z273mWlE5KT" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending">7.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFRVpb2VdES" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Ending"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIwpHC2j7xjj" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Exercisable">102,520</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsHxWcMvpyqa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">54.41</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z63qbKqbFRPf" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">6.86</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znmhvM4p4fUk" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zxEMRl2eldLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023, the Company approved options exercisable into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember_zV0MmXgXXbv6" title="Options exercisable">10,037</span> shares to be issued pursuant to Reed’s 2020 Equity Incentive Plan. <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesEmployeeBenefitPlan_pid_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_za5WHnlcwQp5" title="Stock issued during period shares employee benefit plan">10,037</span> options were issued to employees, <span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20230331_zVuH69qFVCRf" title="Number of stock option shares vested">5,016</span> options vesting annually over a <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dxL_c20230101__20230331__us-gaap--PlanNameAxis__custom--TwoThousandTwentyEquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--EmployeesMember_zT4pCJzx1Tv7" title="Vesting period::XDX::P4Y"><span style="-sec-ix-hidden: xdx2ixbrl0880">four</span></span>-year vesting period, and <span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember_z373V8tAnIs" title="Number of stock option shares vested">5,021</span> options vesting based on performance criteria to be established by the board of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The stock options are exercisable at a price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20230101__20230331_zsCtKT0ar9Lb" title="Stock options exercisable price">4.50</span> per share and expire in <span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dc_c20230101__20230331_zHo5iTH38Ob5" title="Expiration years">ten years</span>. The total fair value of these options at grant date was approximately $<span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20220101__20221231_z5zmpSbHz3Qi" title="Options grant date">32</span>, which was determined using a Black-Scholes-Merton option pricing model with the following average assumption: stock price of $<span id="xdx_907_eus-gaap--SharePrice_iI_pid_c20230331_zi0S3GVSDUDd" title="Stock price">4.50</span> share, expected term of six years, volatility of <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20230101__20230331_zDSpvmuhEGUd" title="Volatility">82</span>%, dividend rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20230101__20230331_zge1amAGgO13" title="Dividend rate">0</span>%, and weighted average risk-free interest rate of <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20230101__20230331_zQoY9q1yNYUl" title="Weighted average risk-free interest rate">3.59</span>%. The expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s common stock; the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future; and the risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, the Company recognized $<span id="xdx_908_ecustom--FairValueOfVestedStockOption_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zC2nFxDUjdZg" title="Fair value of vested stock option">229</span> and $<span id="xdx_90D_ecustom--FairValueOfVestedStockOption_pn3n3_c20220101__20220331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zOvXuRUIkVbg" title="Fair value of vested stock option">225</span> of compensation expense relating to vested stock options. As of March 31, 2023, the aggregate amount of unvested compensation related to stock options was approximately $<span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_pn3n3_c20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z6Yt9Fc6m78d" title="Aggregate value of unvested compensation">1,039</span> which will be recognized as an expense as the options vest in future periods through March 28, 2027.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the outstanding and exercisable options have no intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2023, which was $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zdVPz8v6Nh1c" title="Stock price">3.45</span>, and the exercise price of the outstanding stock options.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock> <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89A_eus-gaap--NonvestedRestrictedStockSharesActivityTableTextBlock_zsFwyY3jB2c4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes restricted stock activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zP5XnOXUCWj1" style="display: none">Summary of Non-vested Restricted Stock Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Unvested<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Issuable<br/> Shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value<br/> at Date of<br/> Issuance</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> Average <br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Balance, December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhYwL9dgtte" style="width: 12%; text-align: right" title="Unvested Shares, beginning balance">1,460</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zKAygSFawnc3" style="width: 12%; text-align: right" title="Issuable Shares, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl0788">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iS_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjmeN6GaKck1" style="width: 12%; text-align: right" title="Fair Value at Date of Issuance, beginning balance">26.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zqhxsnUtxjUd" style="width: 12%; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, beginning balance">44.75</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zPOTajjURMtg" style="text-align: right" title="Unvested Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0794">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zTAfL3JeBBUd" style="text-align: right" title="Issuable Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0796">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziUSxI8gRGz5" style="text-align: right" title="Fair Value at Date of Issuance, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0798">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjS4kUDx2o99" style="text-align: right" title="Unvested Shares, Vested">(750</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zysKmil7Odh7" style="text-align: right" title="Issuable Shares, Vested">750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoMYZGIy99m2" style="text-align: right" title="Fair Value at Date of Issuance, Vested"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSiZbyHdPTgb" style="text-align: right" title="Unvested Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0806">-</span></td><td style="text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zq5W7F6eoxX4" style="font-size: 11pt; text-align: right" title="Issuable Shares, Forfeited"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0808">-</span></span></td><td style="font-size: 11pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9dcnj3qlqu" style="text-align: right" title="Fair Value at Date of Issuance, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0810">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Issued</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z0InI5dTzM5a" style="border-bottom: Black 1.5pt solid; text-align: right" title="Unvested Shares, Issued"><span style="-sec-ix-hidden: xdx2ixbrl0812">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross_iN_pid_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zIHWuo5JdpD1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Issuable Shares, Issued">(750</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued_iN_pn3n3_di_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zBd6N9SH05ma" style="border-bottom: Black 1.5pt solid; text-align: right" title="Fair Value at Date of Issuance, Issued">(6.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance, March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zyKUsCOXHnk6" style="border-bottom: Black 2.5pt double; text-align: right" title="Unvested Shares, ending balance">710</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zoWWvVlsSbr8" style="border-bottom: Black 2.5pt double; text-align: right" title="Issuable Shares, ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue_iE_pn3n3_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zSDcwkdf21Ki" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair Value at Date of Issuance, ending balance">20.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iE_pid_c20230101__20230331__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zhGBB8xjbMO6" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested, ending balance">44.75</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" decimals="INF" unitRef="Shares">1460</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" decimals="-3" unitRef="USD">26000.00</REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2022-12-31_us-gaap_RestrictedStockMember" decimals="INF" unitRef="USDPShares">44.75</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" decimals="INF" unitRef="Shares">750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" decimals="INF" unitRef="Shares">750</REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares> <REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" decimals="INF" unitRef="Shares">750</REED:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" decimals="-3" unitRef="USD">6000.00</REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" decimals="INF" unitRef="Shares">710</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" decimals="-3" unitRef="USD">20000.00</REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" decimals="INF" unitRef="USDPShares">44.75</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue> <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2023-01-012023-03-31_us-gaap_RestrictedStockMember" decimals="-3" unitRef="USD">4000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross> <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2022-01-012022-03-31_us-gaap_RestrictedStockMember" decimals="-3" unitRef="USD">66000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross> <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="AsOf2023-03-31_us-gaap_RestrictedStockMember" decimals="-3" unitRef="USD">20000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions> <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zBpYMW1oi4fl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes stock option activity during the three months ended March 31, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BA_zVc2uhVTtMa1" style="display: none">Schedule of Stock Option Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average <br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted-<br/> Average<br/> Remaining<br/> Contractual<br/> Terms <br/> (Years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate <br/> Intrinsic <br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z2SNl00YKn1c" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning balance">164,423</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zuUJaWCYKwP" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Beginning">48.90</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zSd9kSxrgQsc" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning">7.58</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9EmoXyXsnDe" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0840">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zVoZWFJp3EHb" style="text-align: right" title="Shares, Granted">10,037</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvW0t2ZWOY98" style="text-align: right" title="Weighted-Average Exercise Price, Granted">4.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zAF94qZxbk5" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0846">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_ztvMl2ST4FSa" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0848">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unvested forfeited</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zkX6XQbtmmOc" style="text-align: right" title="Shares, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0850">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9YTMEtHPXIc" style="text-align: right" title="Weighted-Average Exercise Price, Unvested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0852">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Vested forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zxhyAq7UYtMj" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0854">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zvEDp1qr8MMa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Vested forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zokyJJjusar5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">174,460</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIjfxCeyd1Ak" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding, Ending">46.34</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z273mWlE5KT" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending">7.47</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zFRVpb2VdES" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Shares Outstanding, Ending"><span style="-sec-ix-hidden: xdx2ixbrl0864">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zIwpHC2j7xjj" style="border-bottom: Black 2.5pt double; text-align: right" title="Shares, Exercisable">102,520</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zsHxWcMvpyqa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">54.41</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z63qbKqbFRPf" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">6.86</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pn3n3_c20230101__20230331__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_znmhvM4p4fUk" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl0872">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" decimals="INF" unitRef="Shares">164423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2022-12-31_us-gaap_StockOptionMember" decimals="INF" unitRef="USDPShares">48.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453">P7Y6M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" decimals="INF" unitRef="Shares">10037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross> <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453" decimals="INF" unitRef="USDPShares">4.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" decimals="INF" unitRef="Shares">174460</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" decimals="INF" unitRef="USDPShares">46.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice> <REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1 contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453">P7Y5M19D</REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" decimals="INF" unitRef="Shares">102520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2023-03-31_us-gaap_StockOptionMember" decimals="INF" unitRef="USDPShares">54.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2023-01-012023-03-31_us-gaap_StockOptionMember82538453">P6Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1> <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember" decimals="INF" unitRef="Shares">10037</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan> <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="From2023-01-012023-03-31_custom_TwoThousandTwentyEquityIncentivePlanMember_custom_EmployeesMember" decimals="INF" unitRef="Shares">10037</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="Shares">5016</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2023-01-012023-03-31_custom_BoardOfDirectorsMember" decimals="INF" unitRef="Shares">5021</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares> <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="USDPShares">4.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit> <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2023-01-01to2023-03-31">P10Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2> <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2022-01-012022-12-31" decimals="-3" unitRef="USD">32000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1> <us-gaap:SharePrice contextRef="AsOf2023-03-31" decimals="INF" unitRef="USDPShares">4.50</us-gaap:SharePrice> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="Pure">0.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="Pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate> <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2023-01-01to2023-03-31" decimals="INF" unitRef="Pure">0.0359</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate> <REED:FairValueOfVestedStockOption contextRef="From2023-01-012023-03-31_us-gaap_EmployeeStockOptionMember" decimals="-3" unitRef="USD">229000</REED:FairValueOfVestedStockOption> <REED:FairValueOfVestedStockOption contextRef="From2022-01-012022-03-31_us-gaap_EmployeeStockOptionMember" decimals="-3" unitRef="USD">225000</REED:FairValueOfVestedStockOption> <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="AsOf2023-03-31_us-gaap_EmployeeStockOptionMember" decimals="-3" unitRef="USD">1039000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions> <us-gaap:SharePrice contextRef="AsOf2023-03-31_us-gaap_EmployeeStockOptionMember" decimals="INF" unitRef="USDPShares">3.45</us-gaap:SharePrice> <REED:StockWarrantsTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_805_ecustom--StockWarrantsTextBlock_zVk03cY1LBbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10. <span id="xdx_82A_zRMkiE0Cjlha">Stock Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zkE55migrDKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s warrant activity during the three months ended March 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zedw11Hunbfi" style="display: none">Schedule of Warrant Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Remaining Contractual Terms (Years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBkeF3h1MYT4" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning Balance">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znnHiATgbCa" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding Beginning Balance">16.99</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z40a4hORR28" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance">4.20</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zEifyPmGoDOk" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGranted_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSzD7jaCcudj" style="text-align: right" title="Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zN0IwnPs5pNb" style="text-align: right" title="Weighted-Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercised_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zA8vUHqIWXZe" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z7dQrzo0QdOh" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw8mzZ4x5VX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zvA6Dbjp5ff3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUJtEiWUMC4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zikpFePQ6DK7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znJ4KgsFTRZi" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zuFQBiv9kFna" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisable_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_ziurI0G7Vyo2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Exercisable, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUnbOsyAA1q5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90C_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zdFeJPoEKYE9" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zc2ArIYcTpDf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zLT6poeJt3dk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 31, 2023, the outstanding and exercisable warrants have no aggregate intrinsic value. The aggregate intrinsic value was calculated as the difference between the closing market price as of March 31, 2023, which was $<span id="xdx_90B_eus-gaap--SharePrice_iI_pid_c20230331__us-gaap--StatementEquityComponentsAxis__custom--StockWarrantsMember_zffRYNkZXNGf" title="Share price">3.45</span>, and the exercise price of the Company’s warrants to purchase common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </REED:StockWarrantsTextBlock> <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_890_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zkE55migrDKb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s warrant activity during the three months ended March 31, 2023 is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BD_zedw11Hunbfi" style="display: none">Schedule of Warrant Activity</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Exercise Price</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average Remaining Contractual Terms (Years)</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%">Outstanding at December 31, 2022</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBkeF3h1MYT4" style="width: 12%; text-align: right" title="Shares Outstanding, Beginning Balance">235,946</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znnHiATgbCa" style="width: 12%; text-align: right" title="Weighted-Average Exercise Price, Outstanding Beginning Balance">16.99</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z40a4hORR28" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance">4.20</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iS_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zEifyPmGoDOk" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning"><span style="-sec-ix-hidden: xdx2ixbrl0916">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGranted_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zSzD7jaCcudj" style="text-align: right" title="Shares, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0918">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zN0IwnPs5pNb" style="text-align: right" title="Weighted-Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercised_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zA8vUHqIWXZe" style="text-align: right" title="Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0922">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z7dQrzo0QdOh" style="text-align: right" title="Weighted-Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0924">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Forfeited</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zw8mzZ4x5VX6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0926">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zvA6Dbjp5ff3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0928">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Outstanding at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUJtEiWUMC4f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Outstanding, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zikpFePQ6DK7" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Outstanding Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_903_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_znJ4KgsFTRZi" title="Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_988_ecustom--ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zuFQBiv9kFna" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Exercisable at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisable_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_ziurI0G7Vyo2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Shares Exercisable, Ending Balance">235,946</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice_iE_pid_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zUnbOsyAA1q5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted-Average Exercise Price, Exercisable Ending Balance">16.99</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span id="xdx_90C_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms_dtY_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zdFeJPoEKYE9" title="Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance">4.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_980_ecustom--ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue_iE_pn3n3_c20230101__20230331__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zc2ArIYcTpDf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl0944">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> </us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock> <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2022-12-31_us-gaap_WarrantMember" decimals="INF" unitRef="Shares">235946</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight> <REED:ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice contextRef="AsOf2022-12-31_us-gaap_WarrantMember" decimals="INF" unitRef="USDPShares">16.99</REED:ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice> <REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember">P4Y2M12D</REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms> <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2023-03-31_us-gaap_WarrantMember" decimals="INF" unitRef="Shares">235946</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight> <REED:ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice contextRef="AsOf2023-03-31_us-gaap_WarrantMember" decimals="INF" unitRef="USDPShares">16.99</REED:ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice> <REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1 contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember">P4Y2M12D</REED:ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1> <REED:ClassOfWarrantOrRightNumberOfSecuritieExercisable contextRef="AsOf2023-03-31_us-gaap_WarrantMember" decimals="INF" unitRef="Shares">235946</REED:ClassOfWarrantOrRightNumberOfSecuritieExercisable> <REED:ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice contextRef="AsOf2023-03-31_us-gaap_WarrantMember" decimals="INF" unitRef="USDPShares">16.99</REED:ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice> <REED:ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms contextRef="From2023-01-012023-03-31_us-gaap_WarrantMember">P4Y2M12D</REED:ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms> <us-gaap:SharePrice contextRef="AsOf2023-03-31_custom_StockWarrantsMember" decimals="INF" unitRef="USDPShares">3.45</us-gaap:SharePrice> <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zm66y4MsHNVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11. <span id="xdx_82A_zpGKqtA0piea">Transactions with California Custom Beverage, LLC, former related party</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2018, the Company signed a co-packing agreement with California Custom Beverage, LLC’s (“CCB”), an entity owned by Christopher J. Reed, a former related party, pursuant to which CCB agreed to produce certain products for the Company for agreed fees. The co-packing agreement, as amended, includes certain provisions for product inputs, shrinkage, and quality assurance. Also beginning in 2019, CCB agreed to pay the Company a <span id="xdx_906_ecustom--RoyaltyPercentage_iI_dp_uPure_c20181231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zmUY9VeOlmb" title="Royalty percentage">5</span>% royalty through 2021 on certain private label sales made by CCB.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three months ended March 31, 2023 and 2022, the Company incurred co-packing fees due to CCB of $<span id="xdx_90F_eus-gaap--OtherLiabilities_iI_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z0tzYQyOBWF1" title="Copacking fees">428</span> and $<span id="xdx_901_eus-gaap--OtherLiabilities_iI_pn3n3_c20220331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_z6TPwRSHF008" title="Copacking fees">636</span>, respectively. As of March 31, 2023 and 2022, the aggregate of co-packing fees payable to CCB were $<span id="xdx_907_eus-gaap--NotesPayable_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zlRtYXBO9zlg" title="Notes payable">1,859</span> and $<span id="xdx_904_eus-gaap--NotesPayable_iI_pn3n3_c20220331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zdPQTTiu7kW8" title="Notes payable">2,025</span>, respectively. At March 31, 2023 and December 31, 2022, the Company had also recorded receivables from CCB of $<span id="xdx_907_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zTNBmUEcepnb" title="Receivables">1,315</span> and $<span id="xdx_90C_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zfLN8yIbAP6e" title="Receivables">1,315</span>, respectively, including royalty receivable of $<span id="xdx_906_ecustom--RoyaltyReceivable_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_ztskNONfrZb4" title="Royalty receivable">297</span> and $<span id="xdx_904_ecustom--RoyaltyReceivable_pn3n3_c20220101__20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zvNJyuUxZ9vj" title="Royalty receivable">297</span>, and charge backs of certain costs management determined were permittable under the co-packing agreement of $<span id="xdx_906_ecustom--CopackingFees_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_z4CaJcCnff4g" title="Copacking fees">1,018</span> and $<span id="xdx_907_ecustom--CopackingFees_c20220101__20221231__srt--TitleOfIndividualAxis__custom--ChristopherJReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zZxQnappjeaa" title="Copacking fees">1,018</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zI3er1dz0J0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and December 31, 2022, accounts receivable due from and accounts payable due to CCB were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zaAiCH0xULVi" style="display: none">Schedule of Related Parties</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230331_zPRgkv1i2kF8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zmFe2ByAZxVg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zjiuF2a3bxie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable, net of provision of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zYDQzmCb14z" title="Net of provision">538</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_z28BqdJay44f" title="Net of provision">538</span> at March 31, 2023 and December 31, 2022, respectively</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zirQLj82PSE1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,859</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,025</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--OtherReceivables_iNTI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zidqRkyQ4hR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Net (payable) receivable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,082</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,248</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A8_zuD1eWdZmN6d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, CCB disputes that it owes $<span id="xdx_903_eus-gaap--OtherReceivables_iI_pn3n3_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zBFPQjliW6jh" title="Net receivable">1,043</span> of the $<span id="xdx_905_eus-gaap--ReceivablesNetCurrent_iI_pn3n3_c20221231__us-gaap--RelatedPartyTransactionAxis__custom--CaliforniaCustomBeverageLLCMember_zcS1McDftvbe" title="Receivables">1,315</span> recorded as receivable by the Company. The Company believes that it will prevail in this dispute, however, as of March 31, 2023 and December 31, 2022, due to the uncertainty about the ultimate amount that will be settled, the Company has provided a reserve for $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zVhnGQpx7Ua6" title="Provision for disputed receivable with former related party"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_zN8A9YOtUhF2" title="Provision for disputed receivable with former related party">538</span></span> based on management’s estimate. In addition, on April 19, 2023, the Company received a letter from CCB demanding payment of various amounts, including the $<span id="xdx_904_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_c20230331__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zsimglxOnxTh" title="Accounts payable">1,859</span> and $<span id="xdx_900_eus-gaap--OtherLiabilitiesCurrent_iI_pn3n3_c20221231__us-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zbVBV0lAURm7" title="Accounts payable">2,025</span> outstanding at March 31, 2023 and December 31, 2022, respectively. The Company has determined that the probability of realizing any loss on the demand from CCB is remote and therefore has not recorded any additional accruals related to the demand.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> </us-gaap:RelatedPartyTransactionsDisclosureTextBlock> <REED:RoyaltyPercentage contextRef="AsOf2018-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="INF" unitRef="Pure">0.05</REED:RoyaltyPercentage> <us-gaap:OtherLiabilities contextRef="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember" decimals="0" unitRef="USD">428</us-gaap:OtherLiabilities> <us-gaap:OtherLiabilities contextRef="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">636000</us-gaap:OtherLiabilities> <us-gaap:NotesPayable contextRef="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">1859000</us-gaap:NotesPayable> <us-gaap:NotesPayable contextRef="AsOf2022-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">2025000</us-gaap:NotesPayable> <us-gaap:ReceivablesNetCurrent contextRef="AsOf2023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">1315000</us-gaap:ReceivablesNetCurrent> <us-gaap:ReceivablesNetCurrent contextRef="AsOf2022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">1315000</us-gaap:ReceivablesNetCurrent> <REED:RoyaltyReceivable contextRef="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">297000</REED:RoyaltyReceivable> <REED:RoyaltyReceivable contextRef="From2022-01-012022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">297000</REED:RoyaltyReceivable> <REED:CopackingFees contextRef="From2023-01-012023-03-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="0" unitRef="USD">1018</REED:CopackingFees> <REED:CopackingFees contextRef="From2022-01-012022-12-31_custom_ChristopherJReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="0" unitRef="USD">1018</REED:CopackingFees> <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_89C_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zI3er1dz0J0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At March 31, 2023 and December 31, 2022, accounts receivable due from and accounts payable due to CCB were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B7_zaAiCH0xULVi" style="display: none">Schedule of Related Parties</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20230331_zPRgkv1i2kF8" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>March 31, </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20221231_zmFe2ByAZxVg" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">December 31,</p> <p style="margin-top: 0; margin-bottom: 0">2022</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherReceivablesNetCurrent_iI_pn3n3_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zjiuF2a3bxie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable, net of provision of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20230101__20230331_zYDQzmCb14z" title="Net of provision">538</span> and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlbGF0ZWQgUGFydGllcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_ecustom--ProvisionForReceivableWithFormerRelatedParty_pn3n3_c20220101__20221231_z28BqdJay44f" title="Net of provision">538</span> at March 31, 2023 and December 31, 2022, respectively</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">777</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherLiabilitiesCurrent_iNI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zirQLj82PSE1" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Accounts payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,859</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,025</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--OtherReceivables_iNTI_pn3n3_di_hus-gaap--RelatedAndNonrelatedPartyStatusAxis__us-gaap--RelatedPartyMember_zidqRkyQ4hR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Net (payable) receivable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,082</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,248</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> </table> </us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock> <REED:ProvisionForReceivableWithFormerRelatedParty contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">538000</REED:ProvisionForReceivableWithFormerRelatedParty> <REED:ProvisionForReceivableWithFormerRelatedParty contextRef="From2022-01-012022-12-31" decimals="-3" unitRef="USD">538000</REED:ProvisionForReceivableWithFormerRelatedParty> <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">777000</us-gaap:OtherReceivablesNetCurrent> <us-gaap:OtherReceivablesNetCurrent contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">777000</us-gaap:OtherReceivablesNetCurrent> <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">1859000</us-gaap:OtherLiabilitiesCurrent> <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">2025000</us-gaap:OtherLiabilitiesCurrent> <us-gaap:OtherReceivables contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">1082000</us-gaap:OtherReceivables> <us-gaap:OtherReceivables contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">1248000</us-gaap:OtherReceivables> <us-gaap:OtherReceivables contextRef="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">1043000</us-gaap:OtherReceivables> <us-gaap:ReceivablesNetCurrent contextRef="AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">1315000</us-gaap:ReceivablesNetCurrent> <REED:ProvisionForReceivableWithFormerRelatedParty contextRef="From2023-01-01to2023-03-31" decimals="-3" unitRef="USD">538000</REED:ProvisionForReceivableWithFormerRelatedParty> <REED:ProvisionForReceivableWithFormerRelatedParty contextRef="From2022-01-012022-12-31" decimals="-3" unitRef="USD">538000</REED:ProvisionForReceivableWithFormerRelatedParty> <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-03-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">1859000</us-gaap:OtherLiabilitiesCurrent> <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-12-31_us-gaap_RelatedPartyMember" decimals="-3" unitRef="USD">2025000</us-gaap:OtherLiabilitiesCurrent> <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_801_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z4RN0Cr9Ct8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12. <span id="xdx_821_zVxSF3Q4vw3d">Commitments and Contingencies</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2018, CCB assumed the monthly payments on our lease obligation for a Los Angeles manufacturing plant, and our release from the obligation by the lessor, however, is dependent upon CCB’s deposit of $<span id="xdx_90C_eus-gaap--SecurityDeposit_iI_pn3n3_c20181231__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zaG3wFUZUpel" title="Deposit of security with lessor">1,200</span> of security with the lessor. As of March 31, 2023, $<span id="xdx_900_eus-gaap--SecurityDeposit_iI_pn3n3_c20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zehoWZTXv85i" title="Deposit of security with lessor">800</span> has been deposited with the lessor and Chris J. Reed has placed approximately <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zzN9rQusiVt7" title="Number of common stock value placed">7,260</span> shares of the Company’s common stock valued at $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn3n3_c20230101__20230331__srt--TitleOfIndividualAxis__custom--ChrisReedMember__dei--LegalEntityAxis__custom--CaliforniaCustomBeverageLLCMember_zjarPTJku753" title="Value of stock placed">25</span> that remain in escrow with the lessor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, we are a party to claims and legal proceedings arising in the ordinary course of business. Our management evaluates our exposure to these claims and proceedings individually and in the aggregate and provides for potential losses on such litigation if the amount of the loss is estimable and the loss is probable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that there are no material litigation matters at the current time. Although the results of such litigation matters and claims cannot be predicted with certainty, we believe that the final outcome of such claims and proceedings will not have a material adverse impact on our financial position, liquidity, or results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> </us-gaap:CommitmentsAndContingenciesDisclosureTextBlock> <us-gaap:SecurityDeposit contextRef="AsOf2018-12-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">1200000</us-gaap:SecurityDeposit> <us-gaap:SecurityDeposit contextRef="AsOf2023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">800000</us-gaap:SecurityDeposit> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2023-01-012023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="INF" unitRef="Shares">7260</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2023-01-012023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember" decimals="-3" unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues> <us-gaap:SubsequentEventsTextBlock contextRef="From2023-01-01to2023-03-31"><p id="xdx_805_eus-gaap--SubsequentEventsTextBlock_z4OLh4ufw67c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13. <span id="xdx_829_zwLFW44aNbn5">Subsequent Events</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2023, the Company entered into a Securities Purchase Agreement with D&amp;D Source of Life Holding Ltd., as the lead investor, and certain of Reed’s affiliates pursuant to which the investors agreed to purchase an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230524__20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3JgqRecybr7" title="Common shares issued for cash">1,566,732</span> shares of Reed’s common stock and warrants to purchase <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6YwIWhJHuo9" title="Warrants to purchase stock">313,346</span> shares of Common Stock. The purchase price per share of Common Stock and associated warrant was $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zeSZDbXbFnge" title="Share price">2.585</span>. The gross proceeds to the Company, before deducting offering expenses, are approximately $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20230524__20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zrOGiRggY4dl" title="Proceeds from issuance of private placement">4,100</span>. <span style="background-color: white"> </span>The warrants are exercisable for a term of <span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dc_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUnuwl9lVJ98" title="Warrant term">three years</span> at a per share exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20230525__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__dei--LegalEntityAxis__custom--DDSourceofLifeHoldingLtdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0eUaZB4p7l8" title="Exercise price of warrants">2.50</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2023, in order to induce the lead investor to subscribe, the Company granted the lead investor certain preemptive rights and agreed to support the lead investor’s nomination of two board designees, one of which shall be an independent director.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 30, 2023, the Company entered into a Partial Option Exercise and Third Amendment to 10% Convertible Notes (the Notes, see Note 6) with Whitebox a Limited Waiver and Deferral Agreement. Whitebox exercised a partial option to purchase an aggregate of approximately $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_c20230529__20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zbslHR74Vc96" title="Common shares issued on exercise of options">1,500</span> of additional notes (the “Option Notes”) from the Company. The Option Notes bear interest at <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zXpt7Rrt22Xg" title="Debt instrument rate">10</span>% per annum. payable in cash and mature on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_dd_c20230529__20230530__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--OptionNotesMember_zbpmT8nzpQK1" title="Debt instrument, maturity date">September 29, 2023</span>. No amortization payments (as defined in the Notes) are payable on the Option Notes, and the Option Notes may be prepaid without premium or penalty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares issued and the shares of common stock issuable upon conversion of the Option Notes are registrable and subject to that certain Registration Rights Agreement dated May 25, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> </us-gaap:SubsequentEventsTextBlock> <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2023-05-242023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" decimals="INF" unitRef="Shares">1566732</us-gaap:StockIssuedDuringPeriodSharesNewIssues> <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" decimals="INF" unitRef="Shares">313346</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights> <us-gaap:SharePrice contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" decimals="INF" unitRef="USDPShares">2.585</us-gaap:SharePrice> <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2023-05-242023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" decimals="0" unitRef="USD">4100</us-gaap:ProceedsFromIssuanceOfPrivatePlacement> <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm> <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2023-05-25_custom_SecuritiesPurchaseAgreementMember_custom_DDSourceofLifeHoldingLtdMember_us-gaap_SubsequentEventMember" decimals="INF" unitRef="USDPShares">2.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1> <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2023-05-292023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember" decimals="0" unitRef="USD">1500</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised> <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember" decimals="INF" unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage> <us-gaap:DebtInstrumentMaturityDate contextRef="From2023-05-292023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember">2023-09-29</us-gaap:DebtInstrumentMaturityDate> </xbrl> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>64 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> begin 644 Financial_Report.xlsx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end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>65 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>66 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>67 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <XML> <?xml version='1.0' encoding='utf-8'?> <FilingSummary> <Version>3.23.1</Version> <ProcessingTime/> <ReportFormat>html</ReportFormat> <ContextCount>128</ContextCount> <ElementCount>271</ElementCount> <EntityCount>1</EntityCount> <FootnotesReported>false</FootnotesReported> <SegmentCount>44</SegmentCount> <ScenarioCount>0</ScenarioCount> <TuplesReported>false</TuplesReported> <UnitCount>5</UnitCount> <MyReports> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R1.htm</HtmlFileName> <LongName>00000001 - Document - Cover</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/Cover</Role> <ShortName>Cover</ShortName> <MenuCategory>Cover</MenuCategory> <Position>1</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R2.htm</HtmlFileName> <LongName>00000002 - Statement - Condensed Balance Sheets</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/BalanceSheets</Role> <ShortName>Condensed Balance Sheets</ShortName> <MenuCategory>Statements</MenuCategory> <Position>2</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R3.htm</HtmlFileName> <LongName>00000003 - Statement - Condensed Balance Sheets (Parenthetical)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/BalanceSheetsParenthetical</Role> <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName> <MenuCategory>Statements</MenuCategory> <Position>3</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R4.htm</HtmlFileName> <LongName>00000004 - Statement - Condensed Statements of Operations (Unaudited)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StatementsOfOperations</Role> <ShortName>Condensed Statements of Operations (Unaudited)</ShortName> <MenuCategory>Statements</MenuCategory> <Position>4</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R5.htm</HtmlFileName> <LongName>00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied</Role> <ShortName>Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)</ShortName> <MenuCategory>Statements</MenuCategory> <Position>5</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R6.htm</HtmlFileName> <LongName>00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StatementsOfCashFlows</Role> <ShortName>Condensed Statements of Cash Flows (Unaudited)</ShortName> <MenuCategory>Statements</MenuCategory> <Position>6</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R7.htm</HtmlFileName> <LongName>00000007 - Disclosure - Summary of Significant Accounting Policies</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies</Role> <ShortName>Summary of Significant Accounting Policies</ShortName> <MenuCategory>Notes</MenuCategory> <Position>7</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R8.htm</HtmlFileName> <LongName>00000008 - Disclosure - Inventory</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/Inventory</Role> <ShortName>Inventory</ShortName> <MenuCategory>Notes</MenuCategory> <Position>8</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R9.htm</HtmlFileName> <LongName>00000009 - Disclosure - Property and Equipment</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/PropertyAndEquipment</Role> <ShortName>Property and Equipment</ShortName> <MenuCategory>Notes</MenuCategory> <Position>9</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R10.htm</HtmlFileName> <LongName>00000010 - Disclosure - Intangible Assets</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/IntangibleAssets</Role> <ShortName>Intangible Assets</ShortName> <MenuCategory>Notes</MenuCategory> <Position>10</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R11.htm</HtmlFileName> <LongName>00000011 - Disclosure - Line of Credit</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/LineOfCredit</Role> <ShortName>Line of Credit</ShortName> <MenuCategory>Notes</MenuCategory> <Position>11</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R12.htm</HtmlFileName> <LongName>00000012 - Disclosure - Secured Convertible Notes Payable</LongName> <ReportType>Notes</ReportType> <Role>http://drinkreeds.com/role/SecuredConvertibleNotesPayable</Role> <ShortName>Secured Convertible Notes Payable</ShortName> <MenuCategory>Notes</MenuCategory> <Position>12</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R13.htm</HtmlFileName> <LongName>00000013 - Disclosure - Leases Liabilities</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/LeasesLiabilities</Role> <ShortName>Leases Liabilities</ShortName> <MenuCategory>Notes</MenuCategory> <Position>13</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R14.htm</HtmlFileName> <LongName>00000014 - Disclosure - Stockholder???s Equity</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StockholdersEquity</Role> <ShortName>Stockholder???s Equity</ShortName> <MenuCategory>Notes</MenuCategory> <Position>14</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R15.htm</HtmlFileName> <LongName>00000015 - Disclosure - Stock-Based Compensation</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/Stock-basedCompensation</Role> <ShortName>Stock-Based Compensation</ShortName> <MenuCategory>Notes</MenuCategory> <Position>15</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R16.htm</HtmlFileName> <LongName>00000016 - Disclosure - Stock Warrants</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StockWarrants</Role> <ShortName>Stock Warrants</ShortName> <MenuCategory>Notes</MenuCategory> <Position>16</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R17.htm</HtmlFileName> <LongName>00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty</Role> <ShortName>Transactions with California Custom Beverage, LLC, former related party</ShortName> <MenuCategory>Notes</MenuCategory> <Position>17</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R18.htm</HtmlFileName> <LongName>00000018 - Disclosure - Commitments and Contingencies</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/CommitmentsAndContingencies</Role> <ShortName>Commitments and Contingencies</ShortName> <MenuCategory>Notes</MenuCategory> <Position>18</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R19.htm</HtmlFileName> <LongName>00000019 - Disclosure - Subsequent Events</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SubsequentEvents</Role> <ShortName>Subsequent Events</ShortName> <MenuCategory>Notes</MenuCategory> <Position>19</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R20.htm</HtmlFileName> <LongName>00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role> <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName> <MenuCategory>Policies</MenuCategory> <ParentRole>http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies</ParentRole> <Position>20</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R21.htm</HtmlFileName> <LongName>00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables</Role> <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies</ParentRole> <Position>21</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R22.htm</HtmlFileName> <LongName>00000022 - Disclosure - Inventory (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/InventoryTables</Role> <ShortName>Inventory (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/Inventory</ParentRole> <Position>22</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R23.htm</HtmlFileName> <LongName>00000023 - Disclosure - Property and Equipment (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/PropertyAndEquipmentTables</Role> <ShortName>Property and Equipment (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/PropertyAndEquipment</ParentRole> <Position>23</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R24.htm</HtmlFileName> <LongName>00000024 - Disclosure - Intangible Assets (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/IntangibleAssetsTables</Role> <ShortName>Intangible Assets (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/IntangibleAssets</ParentRole> <Position>24</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R25.htm</HtmlFileName> <LongName>00000025 - Disclosure - Line of Credit (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/LineOfCreditTables</Role> <ShortName>Line of Credit (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/LineOfCredit</ParentRole> <Position>25</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R26.htm</HtmlFileName> <LongName>00000026 - Disclosure - Secured Convertible Notes Payable (Tables)</LongName> <ReportType>Notes</ReportType> <Role>http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables</Role> <ShortName>Secured Convertible Notes Payable (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/SecuredConvertibleNotesPayable</ParentRole> <Position>26</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R27.htm</HtmlFileName> <LongName>00000027 - Disclosure - Stock-Based Compensation (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/Stock-basedCompensationTables</Role> <ShortName>Stock-Based Compensation (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/Stock-basedCompensation</ParentRole> <Position>27</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R28.htm</HtmlFileName> <LongName>00000028 - Disclosure - Stock Warrants (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StockWarrantsTables</Role> <ShortName>Stock Warrants (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/StockWarrants</ParentRole> <Position>28</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R29.htm</HtmlFileName> <LongName>00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables</Role> <ShortName>Transactions with California Custom Beverage, LLC, former related party (Tables)</ShortName> <MenuCategory>Tables</MenuCategory> <ParentRole>http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty</ParentRole> <Position>29</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R30.htm</HtmlFileName> <LongName>00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails</Role> <ShortName>Schedule of Potentially Dilutive Securities (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>30</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R31.htm</HtmlFileName> <LongName>00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role> <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole> <Position>31</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R32.htm</HtmlFileName> <LongName>00000032 - Disclosure - Schedule of Inventory (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfInventoryDetails</Role> <ShortName>Schedule of Inventory (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>32</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R33.htm</HtmlFileName> <LongName>00000033 - Disclosure - Schedule of Property and Equipment (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails</Role> <ShortName>Schedule of Property and Equipment (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>33</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R34.htm</HtmlFileName> <LongName>00000034 - Disclosure - Property and Equipment (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative</Role> <ShortName>Property and Equipment (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/PropertyAndEquipmentTables</ParentRole> <Position>34</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R35.htm</HtmlFileName> <LongName>00000035 - Disclosure - Summary of Intangible Assets (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails</Role> <ShortName>Summary of Intangible Assets (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>35</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R36.htm</HtmlFileName> <LongName>00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails</Role> <ShortName>Schedule of Amount Outstanding Under Credit Facilities (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>36</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R37.htm</HtmlFileName> <LongName>00000037 - Disclosure - Schedule of Debt (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfDebtDetails</Role> <ShortName>Schedule of Debt (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>37</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R38.htm</HtmlFileName> <LongName>00000038 - Disclosure - Line of Credit (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/LineOfCreditDetailsNarrative</Role> <ShortName>Line of Credit (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/LineOfCreditTables</ParentRole> <Position>38</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R39.htm</HtmlFileName> <LongName>00000039 - Disclosure - Secured Convertible Notes Payable (Details Narrative)</LongName> <ReportType>Notes</ReportType> <Role>http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative</Role> <ShortName>Secured Convertible Notes Payable (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables</ParentRole> <Position>39</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R40.htm</HtmlFileName> <LongName>00000040 - Disclosure - Leases Liabilities (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative</Role> <ShortName>Leases Liabilities (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/LeasesLiabilities</ParentRole> <Position>40</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R41.htm</HtmlFileName> <LongName>00000041 - Disclosure - Stockholder???s Equity (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StockholdersEquityDetailsNarrative</Role> <ShortName>Stockholder???s Equity (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/StockholdersEquity</ParentRole> <Position>41</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R42.htm</HtmlFileName> <LongName>00000042 - Disclosure - Summary of Non-vested Restricted Stock Activity (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails</Role> <ShortName>Summary of Non-vested Restricted Stock Activity (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>42</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R43.htm</HtmlFileName> <LongName>00000043 - Disclosure - Schedule of Stock Option Activity (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails</Role> <ShortName>Schedule of Stock Option Activity (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>43</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R44.htm</HtmlFileName> <LongName>00000044 - Disclosure - Stock-Based Compensation (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative</Role> <ShortName>Stock-Based Compensation (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/Stock-basedCompensationTables</ParentRole> <Position>44</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R45.htm</HtmlFileName> <LongName>00000045 - Disclosure - Schedule of Warrant Activity (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails</Role> <ShortName>Schedule of Warrant Activity (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>45</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R46.htm</HtmlFileName> <LongName>00000046 - Disclosure - Stock Warrants (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/StockWarrantsDetailsNarrative</Role> <ShortName>Stock Warrants (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/StockWarrantsTables</ParentRole> <Position>46</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R47.htm</HtmlFileName> <LongName>00000047 - Disclosure - Schedule of Related Parties (Details)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails</Role> <ShortName>Schedule of Related Parties (Details)</ShortName> <MenuCategory>Details</MenuCategory> <Position>47</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R48.htm</HtmlFileName> <LongName>00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical</Role> <ShortName>Schedule of Related Parties (Details) (Parenthetical)</ShortName> <MenuCategory>Details</MenuCategory> <Position>48</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R49.htm</HtmlFileName> <LongName>00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative</Role> <ShortName>Transactions with California Custom Beverage, LLC, former related party (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables</ParentRole> <Position>49</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R50.htm</HtmlFileName> <LongName>00000050 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative</Role> <ShortName>Commitments and Contingencies (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/CommitmentsAndContingencies</ParentRole> <Position>50</Position> </Report> <Report instance="form10-q.htm"> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <HtmlFileName>R51.htm</HtmlFileName> <LongName>00000051 - Disclosure - Subsequent Events (Details Narrative)</LongName> <ReportType>Sheet</ReportType> <Role>http://drinkreeds.com/role/SubsequentEventsDetailsNarrative</Role> <ShortName>Subsequent Events (Details Narrative)</ShortName> <MenuCategory>Details</MenuCategory> <ParentRole>http://drinkreeds.com/role/SubsequentEvents</ParentRole> <Position>51</Position> </Report> <Report> <IsDefault>false</IsDefault> <HasEmbeddedReports>false</HasEmbeddedReports> <LongName>All Reports</LongName> <ReportType>Book</ReportType> <ShortName>All Reports</ShortName> </Report> </MyReports> <Logs> <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 - form10-q.htm 66</Log> </Logs> <InputFiles> <File doctype="10-Q" original="form10-q.htm">form10-q.htm</File> <File>ex31-1.htm</File> <File>ex31-2.htm</File> <File>ex32-1.htm</File> <File>ex32-2.htm</File> <File>ex4-1.htm</File> <File>reed-20230331.xsd</File> <File>reed-20230331_cal.xml</File> <File>reed-20230331_def.xml</File> <File>reed-20230331_lab.xml</File> <File>reed-20230331_pre.xml</File> </InputFiles> <SupplementalFiles/> <BaseTaxonomies> <BaseTaxonomy items="459">http://fasb.org/us-gaap/2023</BaseTaxonomy> <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2023</BaseTaxonomy> </BaseTaxonomies> <HasPresentationLinkbase>true</HasPresentationLinkbase> <HasCalculationLinkbase>true</HasCalculationLinkbase> </FilingSummary> </XML> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>70 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 19, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 459, "http://xbrl.sec.gov/dei/2023": 26 }, "contextCount": 128, "dts": { "calculationLink": { "local": [ "reed-20230331_cal.xml" ] }, "definitionLink": { "local": [ "reed-20230331_def.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "reed-20230331_lab.xml" ] }, "presentationLink": { "local": [ "reed-20230331_pre.xml" ] }, "schema": { "local": [ "reed-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 433, "entityCount": 1, "hidden": { "http://drinkreeds.com/20230331": 20, "http://fasb.org/us-gaap/2023": 29, "http://xbrl.sec.gov/dei/2023": 4, "total": 53 }, "keyCustom": 50, "keyStandard": 221, "memberCustom": 23, "memberStandard": 18, "nsprefix": "REED", "nsuri": "http://drinkreeds.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://drinkreeds.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Intangible Assets", "menuCat": "Notes", "order": "10", "role": "http://drinkreeds.com/role/IntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Line of Credit", "menuCat": "Notes", "order": "11", "role": "http://drinkreeds.com/role/LineOfCredit", "shortName": "Line of Credit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Secured Convertible Notes Payable", "menuCat": "Notes", "order": "12", "role": "http://drinkreeds.com/role/SecuredConvertibleNotesPayable", "shortName": "Secured Convertible Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Leases Liabilities", "menuCat": "Notes", "order": "13", "role": "http://drinkreeds.com/role/LeasesLiabilities", "shortName": "Leases Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Stockholder\u2019s Equity", "menuCat": "Notes", "order": "14", "role": "http://drinkreeds.com/role/StockholdersEquity", "shortName": "Stockholder\u2019s Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Stock-Based Compensation", "menuCat": "Notes", "order": "15", "role": "http://drinkreeds.com/role/Stock-basedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "REED:StockWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Stock Warrants", "menuCat": "Notes", "order": "16", "role": "http://drinkreeds.com/role/StockWarrants", "shortName": "Stock Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "REED:StockWarrantsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Transactions with California Custom Beverage, LLC, former related party", "menuCat": "Notes", "order": "17", "role": "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty", "shortName": "Transactions with California Custom Beverage, LLC, former related party", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "18", "role": "http://drinkreeds.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "19", "role": "http://drinkreeds.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://drinkreeds.com/role/BalanceSheets", "shortName": "Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "20", "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "21", "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - Inventory (Tables)", "menuCat": "Tables", "order": "22", "role": "http://drinkreeds.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - Property and Equipment (Tables)", "menuCat": "Tables", "order": "23", "role": "http://drinkreeds.com/role/PropertyAndEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - Intangible Assets (Tables)", "menuCat": "Tables", "order": "24", "role": "http://drinkreeds.com/role/IntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - Line of Credit (Tables)", "menuCat": "Tables", "order": "25", "role": "http://drinkreeds.com/role/LineOfCreditTables", "shortName": "Line of Credit (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - Secured Convertible Notes Payable (Tables)", "menuCat": "Tables", "order": "26", "role": "http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables", "shortName": "Secured Convertible Notes Payable (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - Stock-Based Compensation (Tables)", "menuCat": "Tables", "order": "27", "role": "http://drinkreeds.com/role/Stock-basedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "REED:StockWarrantsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - Stock Warrants (Tables)", "menuCat": "Tables", "order": "28", "role": "http://drinkreeds.com/role/StockWarrantsTables", "shortName": "Stock Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "REED:StockWarrantsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Tables)", "menuCat": "Tables", "order": "29", "role": "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables", "shortName": "Transactions with California Custom Beverage, LLC, former related party (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://drinkreeds.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - Schedule of Potentially Dilutive Securities (Details)", "menuCat": "Details", "order": "30", "role": "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "shortName": "Schedule of Potentially Dilutive Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "31", "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "REED:CovidNineteenConsiderationPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "lang": null, "name": "REED:CarryingCostPropertyAndExplorationRights", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - Schedule of Inventory (Details)", "menuCat": "Details", "order": "32", "role": "http://drinkreeds.com/role/ScheduleOfInventoryDetails", "shortName": "Schedule of Inventory (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - Schedule of Property and Equipment (Details)", "menuCat": "Details", "order": "33", "role": "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "Schedule of Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - Property and Equipment (Details Narrative)", "menuCat": "Details", "order": "34", "role": "http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "Property and Equipment (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IndefiniteLivedTradeNames", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - Summary of Intangible Assets (Details)", "menuCat": "Details", "order": "35", "role": "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails", "shortName": "Summary of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IndefiniteLivedTradeNames", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LinesOfCreditCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - Schedule of Amount Outstanding Under Credit Facilities (Details)", "menuCat": "Details", "order": "36", "role": "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails", "shortName": "Schedule of Amount Outstanding Under Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31_custom_AlternaCapitalSolutionsMember", "decimals": "-3", "lang": null, "name": "us-gaap:LinesOfCreditCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SecuredDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - Schedule of Debt (Details)", "menuCat": "Details", "order": "37", "role": "http://drinkreeds.com/role/ScheduleOfDebtDetails", "shortName": "Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "p", "REED:GoingConcernPoliciesTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - Line of Credit (Details Narrative)", "menuCat": "Details", "order": "38", "role": "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "shortName": "Line of Credit (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-03-272022-03-28_custom_AlternaCapitalSolutionsMember", "decimals": null, "lang": "en-US", "name": "us-gaap:DebtInstrumentTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:SecuredDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - Secured Convertible Notes Payable (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "shortName": "Secured Convertible Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-02-132023-02-13", "decimals": null, "lang": "en-US", "name": "us-gaap:LineOfCreditFacilityExpirationDate1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://drinkreeds.com/role/StatementsOfOperations", "shortName": "Condensed Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - Leases Liabilities (Details Narrative)", "menuCat": "Details", "order": "40", "role": "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative", "shortName": "Leases Liabilities (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Stockholder\u2019s Equity (Details Narrative)", "menuCat": "Details", "order": "41", "role": "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative", "shortName": "Stockholder\u2019s Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-03-31_srt_OfficerMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockRepurchasedDuringPeriodShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - Summary of Non-vested Restricted Stock Activity (Details)", "menuCat": "Details", "order": "42", "role": "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails", "shortName": "Summary of Non-vested Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-012023-03-31_us-gaap_RestrictedStockMember", "decimals": "INF", "lang": null, "name": "REED:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_StockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - Schedule of Stock Option Activity (Details)", "menuCat": "Details", "order": "43", "role": "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails", "shortName": "Schedule of Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_StockOptionMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - Stock-Based Compensation (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "shortName": "Stock-Based Compensation (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "REED:StockWarrantsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - Schedule of Warrant Activity (Details)", "menuCat": "Details", "order": "45", "role": "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails", "shortName": "Schedule of Warrant Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "REED:StockWarrantsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_us-gaap_WarrantMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - Stock Warrants (Details Narrative)", "menuCat": "Details", "order": "46", "role": "http://drinkreeds.com/role/StockWarrantsDetailsNarrative", "shortName": "Stock Warrants (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "REED:StockWarrantsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31_custom_StockWarrantsMember", "decimals": "INF", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31_us-gaap_RelatedPartyMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherReceivablesNetCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - Schedule of Related Parties (Details)", "menuCat": "Details", "order": "47", "role": "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "shortName": "Schedule of Related Parties (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "REED:ProvisionForReceivableWithFormerRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - Schedule of Related Parties (Details) (Parenthetical)", "menuCat": "Details", "order": "48", "role": "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical", "shortName": "Schedule of Related Parties (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "REED:ProvisionForReceivableWithFormerRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ReceivablesNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - Transactions with California Custom Beverage, LLC, former related party (Details Narrative)", "menuCat": "Details", "order": "49", "role": "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative", "shortName": "Transactions with California Custom Beverage, LLC, former related party (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2022-12-31_custom_CaliforniaCustomBeverageLLCMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ReceivablesNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2021-12-31_us-gaap_PreferredStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)", "menuCat": "Statements", "order": "5", "role": "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "shortName": "Condensed Statements of Changes in Stockholders' Equity (Deficit) (Unauditied)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember", "decimals": "-3", "lang": null, "name": "REED:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2022-01-012022-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Commitments and Contingencies (Details Narrative)", "menuCat": "Details", "order": "50", "role": "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "Commitments and Contingencies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31_custom_ChrisReedMember_custom_CaliforniaCustomBeverageLLCMember", "decimals": "-3", "lang": null, "name": "us-gaap:SecurityDeposit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2023-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Subsequent Events (Details Narrative)", "menuCat": "Details", "order": "51", "role": "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative", "shortName": "Subsequent Events (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-05-292023-05-30_us-gaap_SubsequentEventMember_custom_OptionNotesMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://drinkreeds.com/role/StatementsOfCashFlows", "shortName": "Condensed Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "7", "role": "http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Inventory", "menuCat": "Notes", "order": "8", "role": "http://drinkreeds.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Property and Equipment", "menuCat": "Notes", "order": "9", "role": "http://drinkreeds.com/role/PropertyAndEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2023-01-01to2023-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 44, "tag": { "REED_AccrualOfInterestOnConvertibleNote": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accrual of interest on convertible note.", "label": "Accrued interest" } } }, "localname": "AccrualOfInterestOnConvertibleNote", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REED_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital share based compensation stock options vested.", "label": "Fair value of vested options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsVested", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "monetaryItemType" }, "REED_AlternaCapitalSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alterna Capital Solutions [Member]", "label": "Alterna Capital Solutions [Member]" } } }, "localname": "AlternaCapitalSolutionsMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "REED_AmortizationOfLineOfCreditPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amortization of line of credit period.", "label": "Amortization of line of credit period" } } }, "localname": "AmortizationOfLineOfCreditPeriod", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "durationItemType" }, "REED_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board of Directors [Member]", "label": "Board of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_CaliforniaCustomBeverageLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "California Custom Beverage, LLC [Member]", "label": "California Custom Beverage, LLC [Member]" } } }, "localname": "CaliforniaCustomBeverageLLCMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_CarryingCostPropertyAndExplorationRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carrying cost property and exploration rights.", "label": "Shipping and handling costs" } } }, "localname": "CarryingCostPropertyAndExplorationRights", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "decimalItemType" }, "REED_ChrisReedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Chris Reed [Member]", "label": "Chris Reed [Member]" } } }, "localname": "ChrisReedMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_ChristopherJReedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Christopher J. Reed [Member]", "label": "Christopher J. Reed [Member]" } } }, "localname": "ChristopherJReedMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritieExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights exercisable.", "label": "Shares Exercisable, Ending Balance", "periodEndLabel": "Shares Exercisable, Ending Balance" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritieExercisable", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities exercisable aggregate intrinsic value.", "label": "Class of warrant or right number of securities exercisable aggregate intrinsic value", "periodEndLabel": "Aggregate Intrinsic Value, Exercisable" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritieExercisableAggregateIntrinsicValue", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "monetaryItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securitie exercisable weighted average remaining contractual terms.", "label": "Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance [Default Label]", "verboseLabel": "Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritieExercisableWeightedAverageRemainingContractualTerms", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities outstanding aggregate intrinsic value.", "label": "Aggregate Intrinsic Value Shares Outstanding Ending", "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending", "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritieOutstandingAggregateIntrinsicValue", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "monetaryItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining term of warrant oustanding.", "label": "Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining term of warrant oustanding.", "label": "Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending Balance" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritieOutstandingWeightedAverageRemainingContractualTerms1", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities exercisable weighted average exercise price.", "label": "Weighted-Average Exercise Price, Exercisable Ending Balance", "periodEndLabel": "Weighted-Average Exercise Price, Exercisable Ending Balance" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesExercisableWeightedAverageExercisePrice", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities exercised.", "label": "Shares, Exercised [Default Label]", "verboseLabel": "Shares, Exercised" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesExercised", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities exercised weighted average exercise price.", "label": "Weighted-Average Exercise Price, Exercised [Default Label]", "verboseLabel": "Weighted-Average Exercise Price, Exercised" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesExercisedWeightedAverageExercisePrice", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities forfeited weighted average exercise price.", "label": "Weighted-Average Exercise Price, Forfeited" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesForfeitedWeightedAverageExercisePrice", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities forfeited or expired.", "label": "Shares, Forfeited" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesForfitedOrExpired", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities granted.", "label": "Shares, Granted" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesGranted", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities granted weighted average exercise price.", "label": "Weighted-Average Exercise Price, Granted [Default Label]", "verboseLabel": "Weighted-Average Exercise Price, Granted" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesGrantedWeightedAverageExercisePrice", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "REED_ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right number of securities outstanding weighted average exercise price per share.", "label": "Weighted-Average Exercise Price, Outstanding Beginning Balance", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding Ending Balance", "periodStartLabel": "Weighted-Average Exercise Price, Outstanding Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesOutstandingWeightedAverageExercisePrice", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "REED_CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Equivalent Of Series A Convertible Preferred Stock [Member]" } } }, "localname": "CommonStockEquivalentOfSeriesAConvertiblePreferredStockMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "REED_ComputerHardwareAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Computer Hardware And Software [Member]" } } }, "localname": "ComputerHardwareAndSoftwareMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "REED_CopackingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Copacking fees.", "label": "CopackingFees", "verboseLabel": "Copacking fees" } } }, "localname": "CopackingFees", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "REED_CovidNineteenConsiderationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Covid 19 Consideration [Policy Text Block]", "label": "Recent Trends - Market Conditions" } } }, "localname": "CovidNineteenConsiderationPolicyTextBlock", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "REED_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_DDSourceofLifeHoldingLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "DD Source of Life Holding Ltd [Member]", "label": "DD Source of Life Holding Ltd [Member]" } } }, "localname": "DDSourceofLifeHoldingLtdMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_DebtInstrumentRemainingUnamortizedDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt instrument remaining unamortized discount.", "label": "Remaining unamortized debt discount amount" } } }, "localname": "DebtInstrumentRemainingUnamortizedDiscount", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "REED_DeliveryAndHandlingExpense": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Delivery and handling expense.", "label": "Delivery and handling expense" } } }, "localname": "DeliveryAndHandlingExpense", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "REED_DisclosureLeasesLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases Liabilities" } } }, "localname": "DisclosureLeasesLiabilitiesAbstract", "nsuri": "http://drinkreeds.com/20230331", "xbrltype": "stringItemType" }, "REED_DisclosureStockWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Warrants" } } }, "localname": "DisclosureStockWarrantsAbstract", "nsuri": "http://drinkreeds.com/20230331", "xbrltype": "stringItemType" }, "REED_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees [Member]", "label": "Employees [Member]" } } }, "localname": "EmployeesMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_FairValueOfCommonSharesIssuedAsFinancingCosts": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of common shares issued as financing costs.", "label": "Fair value of common shares issued as financing costs" } } }, "localname": "FairValueOfCommonSharesIssuedAsFinancingCosts", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REED_FairValueOfVestedOptions": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of vested options.", "label": "FairValueOfVestedOptions", "negatedLabel": "Fair value of vested options" } } }, "localname": "FairValueOfVestedOptions", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REED_FairValueOfVestedRestrictedSharesGrantedToOfficers": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of vested restricted shares granted to officers.", "label": "FairValueOfVestedRestrictedSharesGrantedToOfficers", "negatedLabel": "Fair value of vested restricted shares granted to officers" } } }, "localname": "FairValueOfVestedRestrictedSharesGrantedToOfficers", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REED_FairValueOfVestedStockOption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of vested stock option.", "label": "Fair value of vested stock option" } } }, "localname": "FairValueOfVestedStockOption", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "REED_FebruaryTwoThousandTwentyThreeNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February Two Thousand Twenty Three Notes [Member]", "label": "February Two Thousand Twenty Three Notes [Member]" } } }, "localname": "FebruaryTwoThousandTwentyThreeNotesMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_GoingConcernPoliciesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Going Concern Policies [Text Block]", "label": "Going Concern" } } }, "localname": "GoingConcernPoliciesTextBlock", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "REED_HoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Holders [Member]", "label": "Holders [Member]" } } }, "localname": "HoldersMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_IncreaseDecreaseInAmortizationOfRightOfUseAssets": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of right of use of asset.", "label": "Decrease in right of use assets" } } }, "localname": "IncreaseDecreaseInAmortizationOfRightOfUseAssets", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "REED_LimitedWaiverAndDeferralAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Limited Waiver And Deferral Agreement [Member]", "label": "Limited Waiver And Deferral Agreement [Member]" } } }, "localname": "LimitedWaiverAndDeferralAgreementMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_LineOfCreditMonitoringFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Monitoring fee.", "label": "Line of credit monitoring fee" } } }, "localname": "LineOfCreditMonitoringFee", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "REED_NotePurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Note Purchase Agreement [Member]", "label": "Note Purchase Agreement [Member]" } } }, "localname": "NotePurchaseAgreementMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_OptionNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Option Notes [Member]", "label": "Option Notes [Member]" } } }, "localname": "OptionNotesMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_PercentageForDeferredPayment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage for deferred payment.", "label": "Percentage for deferred payment" } } }, "localname": "PercentageForDeferredPayment", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "REED_PercentageOfCoPackersProducts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of co-packers products.", "label": "Percentage of co-packers products" } } }, "localname": "PercentageOfCoPackersProducts", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "REED_PercentageOfRepurchasePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of repurchase price.", "label": "Percentage of repurchase price" } } }, "localname": "PercentageOfRepurchasePrice", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "REED_ProvisionForReceivableWithFormerRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Provision for receivable with former related party.", "label": "Provision for disputed receivable with former related party" } } }, "localname": "ProvisionForReceivableWithFormerRelatedParty", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "REED_ReverseStockSplitPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Stock Split [PolicyText Block]", "label": "Reverse Stock Split" } } }, "localname": "ReverseStockSplitPolicyTextBlock", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "REED_RightOfUseAssetsUnderOperatingLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right Of Use Assets Under Operating Leases [Member]" } } }, "localname": "RightOfUseAssetsUnderOperatingLeasesMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "REED_RoyaltyPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royalty percentage", "label": "Royalty percentage" } } }, "localname": "RoyaltyPercentage", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "percentItemType" }, "REED_RoyaltyReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Royalty receivable.", "label": "Royalty receivable" } } }, "localname": "RoyaltyReceivable", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "REED_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_SeptemberTwoThousandTwentyTwoNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "September Two Thousand Twenty Two Notes [Member]", "label": "September Two Thousand Twenty Two Notes [Member]" } } }, "localname": "SeptemberTwoThousandTwentyTwoNotesMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options non-vested grants in period, gross.", "label": "Unvested Shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedGrantsInPeriodGross", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options nonvested number of issuable shares forfeited in period gross.", "label": "Issuable Shares, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesForfeitedInPeriodGross", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options non-vested issuable shares grants in period, gross.", "label": "Issuable Shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesGrantsInPeriodGross", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options non-vested shares issued in period, gross.", "label": "Number of Issuable Shares, Issued", "negatedLabel": "Issuable Shares, Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIssuableSharesIssuedInPeriodGross", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options vested forfeitures and expirations in period.", "label": "Shares, Vested forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriod", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options vested forfeiture and expirations in period, weighted average grant date fair value.", "label": "Weighted-Average Exercise Price, Vested forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options non-vested fair value.", "label": "Fair Value, Unvested, ending balance", "periodEndLabel": "Fair Value at Date of Issuance, ending balance", "periodStartLabel": "Fair Value at Date of Issuance, beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedFairValue", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "monetaryItemType" }, "REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Forfeited.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited", "negatedLabel": "Fair Value at Date of Issuance, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedForfeited", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "monetaryItemType" }, "REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options non-vested granted.", "label": "Fair Value at Date of Issuance, Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGranted", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "monetaryItemType" }, "REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options non-vested issued.", "label": "Fair Value, Issued", "negatedLabel": "Fair Value at Date of Issuance, Issued" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedIssued", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "monetaryItemType" }, "REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options non-vested, number of issuable shares.", "label": "Fair Value Unvested, beginning balance", "periodEndLabel": "Issuable Shares, ending balance", "periodStartLabel": "Issuable Shares, beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfIssuableShares", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award options outstanding weighted average remaining contractual term ending.", "label": "Weighted-Average Remaining Contractual Terms (Years), Outstanding Ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermEnding1", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "REED_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award options vested number of issuable shares.", "label": "Issuable Shares, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfIssuableShares", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "REED_StockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Warrants [Member]", "label": "Stock Warrants [Member]" } } }, "localname": "StockWarrantsMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_StockWarrantsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Warrants [Text Block]", "label": "StockWarrantsTextBlock", "verboseLabel": "Stock Warrants" } } }, "localname": "StockWarrantsTextBlock", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/StockWarrants" ], "xbrltype": "textBlockItemType" }, "REED_TwoThousandTwentyEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2020 Equity Incentive Plan [Member]", "label": "2020 Equity Incentive Plan [Member]" } } }, "localname": "TwoThousandTwentyEquityIncentivePlanMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "REED_UnvestedRestrictedCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested Restricted Common Stock [Member]" } } }, "localname": "UnvestedRestrictedCommonStockMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "REED_VendorOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor One [Member]", "label": "Vendor One [Member]" } } }, "localname": "VendorOneMember", "nsuri": "http://drinkreeds.com/20230331", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r494", "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r489" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r502" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r490" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r491" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r492" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r501" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://drinkreeds.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r188", "r468", "r527", "r564", "r565" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r188", "r468", "r527", "r564", "r565" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_OfficerMember": { "auth_ref": [ "r189", "r567" ], "lang": { "en-us": { "role": { "label": "Officer [Member]" } } }, "localname": "OfficerMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r264", "r520" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r163", "r264", "r503", "r520" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r163", "r264", "r503", "r504", "r520" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r521", "r558" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r14", "r471" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r190", "r191" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net of allowance of $213 and $252, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r41", "r124", "r366" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Property and equipment, accumulated depreciation", "negatedLabel": "Accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical", "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r67", "r471", "r568" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r301", "r302", "r303", "r383", "r517", "r518", "r519", "r555", "r570" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r308" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising costs" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r127", "r192", "r196" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts receivable, net of allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r3", "r53", "r83", "r234" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r78", "r234", "r335", "r514" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of prepaid financing costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r170" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Total" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r101", "r125", "r146", "r173", "r180", "r184", "r193", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r312", "r314", "r326", "r360", "r409", "r471", "r482", "r524", "r525", "r560" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r121", "r129", "r146", "r193", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r312", "r314", "r326", "r471", "r524", "r525", "r560" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r269", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r293", "r294", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r107", "r361", "r384", "r403", "r471", "r482", "r508" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r26", "r85", "r142" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r0", "r85" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price of warrants" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "periodEndLabel": "Shares Outstanding, Ending Balance", "periodStartLabel": "Shares Outstanding, Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Warrants to purchase stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r93", "r201", "r202", "r456", "r523" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r472", "r473", "r474", "r476", "r477", "r478", "r479", "r517", "r518", "r555", "r566", "r570" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r66", "r395" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r66", "r395", "r415", "r570", "r571" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r66", "r363", "r471" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $.0001 par value, 180,000,000 shares authorized; 2,602,399 and 2,519,485 shares issued and outstanding, respectively", "verboseLabel": "Common stock value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r31", "r34", "r51", "r52", "r188", "r455" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r31", "r34", "r51", "r52", "r188", "r375", "r455" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r31", "r34", "r51", "r52", "r188", "r455", "r506" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r62", "r111" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r31", "r34", "r51", "r52", "r188" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Percentage of sale accounted to customer" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r31", "r34", "r51", "r52", "r188", "r455" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r21" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible note payable, net of debt discount of $484 and $562, respectively, less current portion", "verboseLabel": "Long term portion" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r12", "r103", "r563" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "totalLabel": "Total" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r18" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Current portion of convertible notes payable, net of debt discount of $670 and $414, respectively", "negatedLabel": "Current portion" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r63", "r102" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r80", "r356" ], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r32", "r188" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r27", "r28" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt conversion into shares" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionConvertedInstrumentType": { "auth_ref": [ "r27", "r28" ], "lang": { "en-us": { "role": { "documentation": "The type of the financial instrument that the original debt is being converted into (for example, new debt, common stock, preferred stock, etc.) in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt instrument conversion, description" } } }, "localname": "DebtConversionConvertedInstrumentType", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r94", "r144", "r212", "r218", "r219", "r220", "r221", "r222", "r223", "r228", "r235", "r236", "r237" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Secured Convertible Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r12", "r63", "r64", "r102", "r103", "r149", "r213", "r214", "r215", "r216", "r217", "r219", "r224", "r225", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r336", "r463", "r464", "r465", "r466", "r467", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Weighted average interest" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r54", "r56", "r213", "r336", "r464", "r465" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal balance" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r20", "r214" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instrument rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateTerms": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Description of the interest rate as being fixed or variable, and, if variable, identification of the index or rate on which the interest rate is based and the number of points or percentage added to that index or rate to set the rate, and other pertinent information, such as frequency of rate resets.", "label": "Debt instrument rate terms" } } }, "localname": "DebtInstrumentInterestRateTerms", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r117", "r463", "r556" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt instrument maturity date", "verboseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r21", "r149", "r213", "r214", "r215", "r216", "r217", "r219", "r224", "r225", "r226", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r336", "r463", "r464", "r465", "r466", "r467", "r515" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r21", "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Monthly payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to principal.", "label": "Whole interest" } } }, "localname": "DebtInstrumentPeriodicPaymentPrincipal", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r53", "r56", "r526" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Unamortized debt discount amount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "auth_ref": [ "r53", "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.", "label": "Debt discount current" } } }, "localname": "DebtInstrumentUnamortizedDiscountCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": { "auth_ref": [ "r53", "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.", "label": "Debt discount, noncurrent" } } }, "localname": "DebtInstrumentUnamortizedDiscountNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFinanceCostsCurrentNet": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Capitalized financing costs", "negatedLabel": "Capitalized financing costs" } } }, "localname": "DeferredFinanceCostsCurrentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r55", "r526" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfDebtDetails": { "order": 3.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Direct costs", "negatedLabel": "Capitalized financing costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfDebtDetails", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r3", "r40" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r3", "r177" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [ "r386", "r387", "r400", "r401", "r402", "r405", "r406", "r407", "r408", "r410", "r411", "r412", "r413", "r428", "r429", "r430", "r431", "r434", "r435", "r436", "r437", "r448", "r449", "r450", "r451", "r472", "r474" ], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r47", "r48", "r49", "r50", "r386", "r387", "r400", "r401", "r402", "r405", "r406", "r407", "r408", "r410", "r411", "r412", "r413", "r428", "r429", "r430", "r431", "r434", "r435", "r436", "r437", "r448", "r449", "r450", "r451", "r459", "r472", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DirectOperatingCosts": { "auth_ref": [ "r81" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate direct operating costs incurred during the reporting period.", "label": "Direct operating costs" } } }, "localname": "DirectOperatingCosts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r265", "r268", "r298", "r299", "r300", "r469" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r136", "r155", "r156", "r157", "r158", "r159", "r164", "r165", "r167", "r168", "r169", "r171", "r324", "r325", "r357", "r369", "r460" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per share \u2013 basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r29", "r30" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Aggregate value of unvested compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r6", "r119", "r132", "r133", "r134", "r150", "r151", "r152", "r154", "r160", "r162", "r172", "r194", "r195", "r253", "r301", "r302", "r303", "r309", "r310", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r327", "r328", "r329", "r330", "r331", "r332", "r344", "r370", "r371", "r372", "r383", "r440" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r5", "r11" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r82", "r419" ], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r79", "r146", "r173", "r179", "r183", "r185", "r193", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r326", "r462", "r524" ], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r2" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r2" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r2" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r2" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r507", "r513" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r2" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r90" ], "calculation": { "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "totalLabel": "Total" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedTradeNames": { "auth_ref": [ "r90" ], "calculation": { "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trade name to gain or protect exclusive use thereof for a projected indefinite period of benefit.", "label": "Brand names" } } }, "localname": "IndefiniteLivedTradeNames", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedTrademarks": { "auth_ref": [ "r90" ], "calculation": { "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.", "label": "Trademarks" } } }, "localname": "IndefiniteLivedTrademarks", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r38", "r39" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r55", "r106", "r135", "r176", "r334", "r425", "r480", "r569" ], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r83", "r232", "r238", "r466", "r467" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest on the notes" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r84", "r233", "r466", "r467" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Amortization of interest" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r138", "r140", "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r59", "r562" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfDebtDetails": { "order": 2.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "verboseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfDebtDetails", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r510" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfInventoryDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished products" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r128", "r458", "r471" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://drinkreeds.com/role/ScheduleOfInventoryDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, net", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r511" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfInventoryDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials and packaging" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfInventoryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r199" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory write-downs" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r340", "r470" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "verboseLabel": "Leases Liabilities" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r17", "r146", "r193", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r313", "r314", "r315", "r326", "r394", "r461", "r482", "r524", "r560", "r561" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r71", "r104", "r365", "r471", "r516", "r522", "r557" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r19", "r122", "r146", "r193", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r313", "r314", "r315", "r326", "r471", "r524", "r560", "r561" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r12", "r103", "r563" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r15", "r515" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.", "label": "Line of credit facility, borrowing capacity" } } }, "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Maturity date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityInterestRateDescription": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.", "label": "Line of credit facility, interest rate description" } } }, "localname": "LineOfCreditFacilityInterestRateDescription", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r15", "r515" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum amount borrowed under the credit facility at any time during the period.", "label": "Line of credit facility, maximum amount outstanding during period" } } }, "localname": "LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r15" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of credit facility, additional borrowing capacity", "verboseLabel": "Line of credit facility, borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r15", "r515" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditDetailsNarrative", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LinesOfCreditCurrent": { "auth_ref": [ "r63", "r102" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Revolving line of credit, net of capitalized financing costs of $322 and $363, respectively", "verboseLabel": "Total" } } }, "localname": "LinesOfCreditCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfAmountOutstandingUnderCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r139" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r139" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r85", "r86", "r87" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r77", "r87", "r105", "r120", "r130", "r131", "r134", "r146", "r153", "r155", "r156", "r157", "r158", "r161", "r162", "r166", "r173", "r179", "r183", "r185", "r193", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r325", "r326", "r368", "r417", "r438", "r439", "r462", "r480", "r524" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://drinkreeds.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "negatedLabel": "Net income loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/StatementsOfOperations", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.", "label": "Summary of Non-vested Restricted Stock Activity" } } }, "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r12", "r103", "r563" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OffsettingAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Offsetting Assets [Line Items]" } } }, "localname": "OffsettingAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OffsettingAssetsTable": { "auth_ref": [ "r75", "r76" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.", "label": "Offsetting Assets [Table]" } } }, "localname": "OffsettingAssetsTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r173", "r179", "r183", "r185", "r462" ], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r338" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating leases liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r338" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Current portion of lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r338" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Lease liabilities, less current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r339", "r341" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Payments of operating lease liability" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r514" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.", "label": "Amortization of right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r343", "r470" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted average discount rate for operating lease" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r342", "r470" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining lease term for operating lease" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LeasesLiabilitiesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r60", "r359", "r390", "r391", "r482", "r567" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Copacking fees" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r18", "r471" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Payable to former related party", "negatedLabel": "Accounts payable", "verboseLabel": "Accounts payable" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivables": { "auth_ref": [ "r126", "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from parties in nontrade transactions, classified as other.", "label": "Net receivable", "negatedTotalLabel": "Net (payable) receivable" } } }, "localname": "OtherReceivables", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Receivable from former related party", "verboseLabel": "Accounts receivable, net of provision of $538 and $538 at March 31, 2023 and December 31, 2022, respectively" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r24" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [ "r472", "r473", "r476", "r477", "r478", "r479", "r566", "r570" ], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r65", "r240" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Series A convertible preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r65", "r395" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Series A convertible preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r65", "r240" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Series A convertible preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r65", "r395", "r415", "r570", "r571" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Series A convertible preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r65", "r362", "r471" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Series A Convertible Preferred stock, $10 par value, 500,000 shares authorized, 9,411 shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r512" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r23" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible note payable, net of expenses" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r1" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from sale of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r1" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from issuance of private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r23" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from issuance of notes" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r23", "r515" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Amounts from former related party, net" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductConcentrationRiskMember": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.", "label": "Product Concentration Risk [Member]" } } }, "localname": "ProductConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r91", "r112", "r115", "r116" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r92", "r123", "r367" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Total cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r4", "r358", "r367", "r471" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net of accumulated depreciation of $867 and $787, respectively", "totalLabel": "Net book value" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r137", "r197" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Change in allowance for doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedAndNonrelatedPartyStatusAxis": { "auth_ref": [ "r147", "r148", "r348", "r349", "r350", "r351", "r389", "r390", "r391", "r392", "r393", "r414", "r416", "r475" ], "lang": { "en-us": { "role": { "documentation": "Information by related and nonrelated party status.", "label": "Related and Nonrelated Party Status [Axis]" } } }, "localname": "RelatedAndNonrelatedPartyStatusAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedAndNonrelatedPartyStatusDomain": { "auth_ref": [ "r147", "r148", "r348", "r349", "r350", "r351", "r389", "r390", "r391", "r392", "r393", "r414", "r416", "r475" ], "lang": { "en-us": { "role": { "documentation": "Related and nonrelated party status." } } }, "localname": "RelatedAndNonrelatedPartyStatusDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyMember": { "auth_ref": [ "r147", "r148", "r348", "r349", "r350", "r351", "r389", "r390", "r391", "r392", "r393", "r414", "r416", "r447" ], "lang": { "en-us": { "role": { "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family.", "label": "Related Party [Member]" } } }, "localname": "RelatedPartyMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r348", "r349", "r559" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [ "r420", "r421", "r424" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r345", "r346", "r347", "r349", "r352", "r380", "r381", "r382", "r422", "r423", "r424", "r444", "r446" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Transactions with California Custom Beverage, LLC, former related party" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r25", "r515" ], "calculation": { "http://drinkreeds.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedLabel": "Payments on line of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r25" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Principal payment" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r68", "r96", "r364", "r373", "r374", "r379", "r396", "r471" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed earnings (deficit).", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r119", "r150", "r151", "r152", "r154", "r160", "r162", "r194", "r195", "r301", "r302", "r303", "r309", "r310", "r316", "r318", "r319", "r321", "r323", "r370", "r372", "r383", "r570" ], "lang": { "en-us": { "role": { "documentation": "Accumulated undistributed earnings (deficit).", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r174", "r175", "r178", "r181", "r182", "r186", "r187", "r188", "r262", "r263", "r356" ], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Net Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r118", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r457" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r188", "r505" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Potentially Dilutive Securities" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r42", "r98" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r9", "r90" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Summary of Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r13", "r72", "r73", "r74" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Schedule of Amount Outstanding Under Credit Facilities" } } }, "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCreditTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r57", "r58", "r420", "r421", "r424" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/ScheduleOfRelatedPartiesDetails", "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "Schedule of Related Parties" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/TransactionsWithCaliforniaCustomBeverageLlcFormerRelatedPartyTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r266", "r267", "r269", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r293", "r294", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r7", "r8", "r45" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Warrant Activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StockWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r12", "r103", "r563" ], "calculation": { "http://drinkreeds.com/role/ScheduleOfDebtDetails": { "order": 1.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Convertible Note Payable", "verboseLabel": "Secured convertible promissory notes" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfDebtDetails", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r509" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Deposit of security with lessor" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://drinkreeds.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and marketing expense" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Shares, Unvested forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Weighted-Average Exercise Price, Unvested forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Weighted average risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [ "r266", "r267", "r269", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r293", "r294", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Shares, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r275" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Exercisable Ending Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Unvested Shares, Issued", "verboseLabel": "Shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Shares Outstanding, Ending", "periodStartLabel": "Aggregate Intrinsic Value, Shares Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Shares Outstanding, Ending Balance", "periodStartLabel": "Shares Outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted-Average Exercise Price, Outstanding, Ending", "periodStartLabel": "Weighted-Average Exercise Price, Outstanding, Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r269", "r270", "r271", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r293", "r294", "r295", "r296", "r297" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted-Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted-Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r265", "r272", "r291", "r292", "r293", "r294", "r297", "r304", "r305", "r306", "r307" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock Compensation Expense" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Stock options exercisable price" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Stock price", "verboseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r44" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted-Average Remaining Contractual Terms (Years), Exercisable Ending Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "periodEndLabel": "Unvested Shares, ending balance", "periodStartLabel": "Unvested Shares, beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options forfeited.", "label": "Unvested Shares, Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant Date Fair Value, Unvested, ending balance", "periodStartLabel": "Weighted Average Grant Date Fair Value, Unvested, beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted-Average Remaining Contractual Terms (Years), Outstanding Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r288" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Fair Value at Date of Issuance, Vested", "verboseLabel": "Options grant date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Number of stock option shares vested", "negatedLabel": "Unvested Shares, Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative", "http://drinkreeds.com/role/SummaryOfNon-vestedRestrictedStockActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Expiration years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r94" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "Line of Credit" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/LineOfCredit" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r88", "r143" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r6", "r22", "r119", "r132", "r133", "r134", "r150", "r151", "r152", "r154", "r160", "r162", "r172", "r194", "r195", "r253", "r301", "r302", "r303", "r309", "r310", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r327", "r328", "r329", "r330", "r331", "r332", "r344", "r370", "r371", "r372", "r383", "r440" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [ "r150", "r151", "r152", "r172", "r356", "r376", "r385", "r388", "r389", "r390", "r391", "r392", "r393", "r395", "r398", "r399", "r400", "r401", "r402", "r405", "r406", "r407", "r408", "r410", "r411", "r412", "r413", "r414", "r416", "r418", "r419", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r440", "r475" ], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r150", "r151", "r152", "r172", "r356", "r376", "r385", "r388", "r389", "r390", "r391", "r392", "r393", "r395", "r398", "r399", "r400", "r401", "r402", "r405", "r406", "r407", "r408", "r410", "r411", "r412", "r413", "r414", "r416", "r418", "r419", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r440", "r475" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/StockWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.", "label": "Stock issued during period shares employee benefit plan" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r6", "r65", "r66", "r96", "r377", "r440", "r452" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Common shares issued for cash, net of offering costs, shares", "terseLabel": "Number of common stock value placed", "verboseLabel": "Number of common stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Common shares issued for financing costs, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r6", "r65", "r66", "r96" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Fair value of vested restricted shares granted to officers, shares" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r6", "r65", "r66", "r96", "r278" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Shares, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r6", "r65", "r66", "r96", "r383", "r440", "r452", "r481" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Common shares issued for cash, net of offering costs", "terseLabel": "Value of stock placed", "verboseLabel": "New issuance of common stock" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Common shares issued for financing costs" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": { "auth_ref": [ "r6", "r65", "r66", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.", "label": "Number of restricted shares, value" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r6", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Fair value of vested restricted shares granted to officers" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r6", "r22", "r96" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Options to purchase", "verboseLabel": "Common shares issued on exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r6", "r65", "r66", "r96", "r378", "r440", "r453" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock repurchased, shares", "negatedLabel": "Repurchase of common stock, shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r6", "r65", "r66", "r96", "r383", "r440", "r453", "r481" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock repurchased, value", "negatedLabel": "Repurchase of common stock" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r66", "r69", "r70", "r89", "r397", "r415", "r441", "r442", "r471", "r482", "r516", "r522", "r557", "r570" ], "calculation": { "http://drinkreeds.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.", "label": "Equity, Attributable to Parent", "negatedLabel": "Equity, Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets", "http://drinkreeds.com/role/StatementsOfChangesInStockholdersEquityDeficitUnauditied", "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r95", "r145", "r239", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r253", "r322", "r443", "r445", "r454" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for equity.", "label": "Stockholder\u2019s Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse stock split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [ "r333", "r354" ], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r333", "r354" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r333", "r354" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r333", "r354" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r333", "r354" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r353", "r355" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SecuredConvertibleNotesPayableDetailsNarrative", "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r35", "r36", "r37", "r109", "r110", "r113", "r114" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [ "r472", "r473", "r476", "r477", "r478", "r479" ], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/ScheduleOfPotentiallyDilutiveSecuritiesDetails", "http://drinkreeds.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r164", "r169" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average number of shares outstanding \u2013 basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://drinkreeds.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org//606/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(2))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org//330/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//350-30/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org//718/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.C.Q3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "808", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(i)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iii)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(h)(1)(iv)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(i)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//842-20/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org//850/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org//855/tableOfContent", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(21))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(22))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(i)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(4)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(f)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(14))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(16)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(17))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(19))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(2)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(3)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(5)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(6)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(9)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-11", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(c))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(e))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07(9))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(1)(d))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(a)(1)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "55", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "830", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r483": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r484": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r485": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r486": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r487": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r488": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r489": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r491": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r492": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r493": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r494": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r495": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r496": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r497": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r498": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r499": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r501": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r502": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org//450/tableOfContent", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(18))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(i)", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(4)(b))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org//235/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org//360/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org//440/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org//470/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org//505/tableOfContent", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>71 <FILENAME>0001493152-23-019742-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> begin 644 0001493152-23-019742-xbrl.zip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®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end </TEXT> </DOCUMENT> </SEC-DOCUMENT>